0001144204-18-043655.txt : 20180810 0001144204-18-043655.hdr.sgml : 20180810 20180810170750 ACCESSION NUMBER: 0001144204-18-043655 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 54 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180810 DATE AS OF CHANGE: 20180810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Guardion Health Sciences, Inc. CENTRAL INDEX KEY: 0001642375 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474428421 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55723 FILM NUMBER: 181009623 BUSINESS ADDRESS: STREET 1: 15150 AVENUE OF SCIENCE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92128 BUSINESS PHONE: 858-605-9055 MAIL ADDRESS: STREET 1: 15150 AVENUE OF SCIENCE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92128 FORMER COMPANY: FORMER CONFORMED NAME: Guardion Health Sciences, LLC DATE OF NAME CHANGE: 20150513 10-Q 1 tv500249_10q.htm FORM 10-Q

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 

FORM 10-Q

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2018

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____ to ____

 

Commission file number: 000-55723

 

GUARDION HEALTH SCIENCES, INC.

(Exact name of Registrant as specified in its charter)

 

Delaware  

15150 Avenue of Science, Suite 200

San Diego, California 92128

Telephone: 858-605-9055

 47-4428421

(State or other jurisdiction of
incorporation or organization)

  

(Address and telephone number
of principal executive offices)

  

(I.R.S. Employer

Identification No.)

 

15150 Avenue of Science, Suite 200

San Diego, California 92128

Telephone: 858-605-9055

(Address and telephone number of principal executive offices)

 

Not applicable

 (Former name, former address, and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or Section 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes ¨ No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). x Yes ¨ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer ¨
Non-accelerated filer ¨ Smaller reporting company x
(Do not check if a smaller reporting company) Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ¨ 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ¨ Yes x No

 

As of August 10, 2018, there were 40,329,475 shares of the Registrant’s common stock, par value $0.001 per share, issued and outstanding. Registrant’s common stock is not publicly traded. 

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page No.
PART I – FINANCIAL INFORMATION  
     
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 4
     
  Balance Sheets – As of June 30, 2018 (Unaudited) and December 31, 2017 4
     
  Statements of Operations (Unaudited) – Three and Six Months Ended June 30, 2018 and June 30, 2017 5
     
  Statement of Stockholders’ Equity (Unaudited) – Six Months Ended June 30, 2018 6
     
  Statements of Cash Flows (Unaudited) – Six Months Ended June 30, 2018 and June 30, 2017 7
     
  Notes to Condensed Consolidated Financial Statements (Unaudited) 8
     
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 18
     
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 28
     
ITEM 4. CONTROLS AND PROCEDURES 28
     
PART II – OTHER INFORMATION  
     
ITEM 1. LEGAL PROCEEDINGS 29
     
ITEM 1A. RISK FACTORS 29
     
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 29
     
ITEM 3. DEFAULTS UPON SENIOR SECURITIES 29
     
ITEM 4. MINE SAFETY DISCLOSURES 29
     
ITEM 5. OTHER INFORMATION 30
     
ITEM 6. EXHIBITS 30
     
SIGNATURES   30

 

 2 

 

 

Introductory Comment

 

Throughout this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “our company,” “Guardion,” the “Company” and the “Registrant” refer to Guardion Health Sciences, Inc.

 

FORWARD LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These statements relate to future events or future predictions, including events or predictions relating to the Company’s future financial performance, and are based on current expectations, estimates, forecasts and projections about the Company, its future performance, its beliefs and management’s assumptions.  They are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “feel,” “confident,” “estimate,” “intend,” “predict,” “forecast,” “potential” or “continue” or the negative of such terms or other variations on these words or comparable terminology. These statements involve unknown risks and uncertainties that may individually or materially impact the matters discussed herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the Company’s ability to raise sufficient financing to implement its business plan and its ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company’s recent filings with the U. S. Securities and Exchange Commission (the “SEC”), including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2017 and in other documents the Company files with the SEC from time to time. These filings are available at the SEC’s website (www.sec.gov). The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, in each case, except to the extent required by applicable law.

 

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance or achievements.  The Company will not update or revise the forward-looking statements except to the extent required by applicable law.

 

 3 

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Guardion Health Sciences, Inc.

Condensed Consolidated Balance Sheets

 

   June 30,   December 31, 
   2018   2017 
   (Unaudited)     
Assets          
           
Current assets          
Cash  $2,066,365   $4,735,230 
Accounts receivable   29,843    72,771 
Inventories   412,357    154,730 
Prepaid expenses   25,830    117,164 
           
Total current assets   2,534,395    5,079,895 
           
Deposits   11,751    10,470 
Property and equipment, net   191,427    95,597 
Intangible assets, net   563,423    620,741 
Goodwill   1,563,520    1,563,520 
           
Total assets  $4,864,516   $7,370,223 
           
Liabilities and Stockholders’ Equity          
           
Current liabilities          
Accounts payable and accrued liabilities  $457,438   $311,236 
Accrued expenses and deferred rent   11,618    12,043 
Line of credit   -    30,535 
Due to related parties   117,473    146,133 
           
Total current liabilities   586,529    499,947 
           
Commitments and contingencies          
           
Stockholders’ Equity          
           
Preferred stock, $0.001 par value; 10,000,000 shares authorized   -    - 
Common stock, $0.001 par value; 90,000,000 shares authorized; 40,329,475 and 40,183,475 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively   40,329    40,183 
Additional paid-in capital   35,246,639    33,696,049 
Accumulated deficit   (31,008,981)   (26,865,956)
           
Total stockholders’ equity   4,277,987    6,870,276 
           
Total liabilities and stockholders’ equity  $4,864,516   $7,370,223 

 

See accompanying notes to condensed consolidated financial statements.

 

 4 

 

 

Guardion Health Sciences, Inc.

Condensed Consolidated Statements of Operations

 

  

Three Months Ended

June 30,

  

Six Months Ended

June 30,

 
   2018   2017   2018   2017 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Revenue  $220,778   $59,977   $413,818   $115,912 
                     
Cost of goods sold   87,776    29,692    167,055    52,326 
                     
Gross profit   133,002    30,285    246,763    63,586 
                     
Operating expenses                    
Research and development   34,320    15,530    194,708    25,770 
Sales and marketing   378,750    101,598    984,464    178,333 
General and administrative   1,034,914    766,894    2,714,680    1,365,807 
                     
Total operating expenses   1,447,984    884,022    3,893,852    1,569,910 
                     
Loss from operations   (1,314,982)   (853,737)   (3,647,089)   (1,506,324)
                     
Other expenses:                    
Interest expense   710    1,924    1,545    18,355 
Fair value of warrants - extension of expiration dates   494,391    -    494,391    - 
                     
Total other expenses   495,101    1,924    495,936    18,355 
                     
Net loss   (1,810,083)   (855,661)   (4,143,025)   (1,524,679)
                     
Adjustments related to Series A and Series B convertible preferred stock:                    
Accretion of deemed dividend   -    (53,675)   -    (85,517)
Dividend declared   -    (45,106)   -    (81,183)
Net loss attributable to common shareholders  $(1,810,083)  $(954,442)  $(4,143,025)  $(1,691,379)
                     
Net loss per common share – basic and diluted  $(0.04)  $(0.04)  $(0.10)  $(0.07)
Weighted average common shares outstanding – basic and diluted   40,329,475    25,470,418    40,322,215    25,287,759 

 

See accompanying notes to condensed consolidated financial statements.

 

 5 

 

 

Guardion Health Sciences, Inc.

Condensed Consolidated Statement of Stockholders’ Equity

(Unaudited)

 

   Common Stock             
   Shares   Amount  

Additional

Paid-In

Capital

  

Accumulated

Deficit

  

Total

Stockholders’

Equity

 
Balance at December 31, 2017   40,183,475   $40,183   $33,696,049   $(26,865,956)  $6,870,276 
Fair value of vested stock options   -    -    1,054,885    -    1,054,885 
Issuance of common stock – warrant exercises   146,000    146    1,314    -    1,460 
Fair value of warrants - extension of expiration dates             494,391         494,391 
Net loss   -    -    -    (4,143,025)   (4,143,025)
Balance at June 30, 2018   40,329,475   $40,329   $35,246,639   $(31,008,981)  $4,277,987 

 

See accompanying notes to condensed consolidated financial statements. 

  

 6 

 

 

Guardion Health Sciences, Inc.

Condensed Consolidated Statements of Cash Flows

 

  

Six Months Ended

June 30,

 
   2018   2017 
   (Unaudited)   (Unaudited) 
Operating Activities          
Net loss  $(4,143,025)  $(1,524,679)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   148,560    31,331 
Accrued interest expense included in notes payable   -    13,746 
Stock-based compensation   1,054,885    405,918 
Stock-based compensation – related parties   -    108,051 
Fair value of warrant modification   494,391    - 
Changes in operating assets and liabilities:          
(Increase) decrease in -          
Accounts receivable   42,928    11 
Inventories   (257,627)   (64,305)
Deposits and prepaid expenses   90,053    22,788 
Increase (decrease) in -          
Accounts payable and accrued expenses   146,202    57,442 
Accrued and deferred rent costs   (425)   (73,624)
           
Net cash used in operating activities   (2,424,058)   (1,023,321)
           
Investing Activities          
Purchase of property and equipment   (137,073)   (5,500)
Purchase of intellectual property   (50,000)   - 
           
Net cash used in investing activities   (187,073)   (5,500)
           
Financing Activities          
Proceeds from issuance of promissory notes   -    100,000 
Payments on promissory notes   -    (14,000)
Payments on line of credit   (30,535)   - 
Proceeds from issuance of preferred stock   -    1,100,000 
Proceeds from exercise of warrants   1,460    - 
(Decrease) increase in due to related parties   (28,659)   77,837 
           
Net cash (used in) provided by financing activities   (57,734)   1,263,837 
           
Cash:          
Net (decrease) increase   (2,668,865)   235,016 
Balance at beginning of period   4,735,230    62,520 
Balance at end of period  $2,066,365   $297,536 
           
Supplemental disclosure of cash flow information:          
Cash paid for-          
Interest  $-   $1,500 
Income taxes  $-   $- 
           
Non-cash financing activities:          
Issuance of common stock dividends on preferred stock  $-   $81,183 

 

See accompanying notes to condensed consolidated financial statements.

 

 7 

 

 

Guardion Health Sciences, Inc.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Six Months Ended June 30, 2018 and 2017

 

1.Organization and Business Operations

 

Organization and Business

 

Guardion Health Sciences, Inc. (the “Company”) was formed in December 2009 as a California limited liability company under the name P4L Health Sciences, LLC. On June 30, 2015, the Company converted from a California limited liability company to a Delaware corporation, changing its name from Guardion Health Sciences, LLC to Guardion Health Sciences, Inc.

 

The Company is a specialty health sciences company that develops, formulates and distributes condition-specific medical foods with an initial medical food product on the market under the brand name Lumega-Z® that replenishes and restores the macular protective pigment.

 

The Company also developed a proprietary medical device called the MapcatSF® that accurately measures the macular pigment optical density.

 

On September 29, 2017, the Company completed its acquisition of substantially all of the assets and certain liabilities of VectorVision, Inc., a company that specializes in the standardization of contrast sensitivity, glare sensitivity, low contrast acuity, and ETDRS visual acuity testing. VectorVision develops, manufactures and sells equipment and supplies for standardized vision testing.

 

The Company has had limited operations to date and has been primarily engaged in research and development, product commercialization and capital raising activities.

 

Going Concern and Liquidity

 

The financial statements have been prepared assuming the Company will continue as a going concern. The Company had a net loss of $4,143,025 and utilized cash in operating activities of $2,424,058 during the six months ended June 30, 2018. The Company expects to continue to incur net losses and negative operating cash flows in the near-term. As a result, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued.

 

The Company’s independent registered public accounting firm has also included explanatory language in their opinion accompanying the Company’s audited financial statements for the year ended December 31, 2017. The Company’s financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

The Company will continue to incur significant expenses for continued commercialization activities related to Lumega-Z, the MapcatSF® medical device, and VectorVision products. Development and commercialization of medical foods and medical devices involves a lengthy and complex process. Additionally, the Company’s long-term viability and growth may depend upon the successful development and commercialization of new complementary products or product lines. The Company is continuing to attempt to raise additional debt and/or equity capital to fund future operations, but there can be no assurances that the Company will be able to secure such additional financing in the amounts necessary to fully fund its operating requirements on acceptable terms or at all. If the Company is unable to access sufficient capital resources on a timely basis, the Company may be forced to reduce or discontinue its technology and product development programs and curtail or cease operations.

 

 8 

 

  

2.Summary of Significant Accounting Policies

 

Basis of Presentation and Use of Estimates

 

The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

Intangible Assets

 

In connection with the VectorVision transaction, the Company identified and allocated estimated fair values to intangible assets including goodwill and customer relationships.

 

In accordance with Accounting Standard Codification (“ASC”) 350 – Intangibles – Goodwill and Other, the Company determined whether these assets are expected to have indefinite (such as goodwill) or limited useful lives, and for those with limited lives, the Company established an amortization period and method of amortization. Its goodwill and other intangible assets are subject to periodic impairment testing.

 

The Company utilized the services of an independent third-party valuation firm to assist in identifying intangible assets and in estimating their fair values. The useful lives for the Company’s intangible assets other than goodwill were estimated based on Management’s consideration of various factors, including assumptions that market participants might use about sales expectations as well as potential effects of obsolescence, competition, technological progress and the regulatory environment. Because the future pattern in which the economic benefits of these intangible assets may not be reliably determined, amortization expense is generally calculated on a straight-line basis.

 

Amortization expense for the identifiable intangible assets associated with the VectorVision acquisition is approximately $54,000 per quarter and is included with general and administrative expenses in the Company’s Statements of Operations.

 

Impairment of Long-Lived Assets

 

The Company reviews long-lived assets, including property and equipment, identifiable intangible assets, and goodwill for impairment at each fiscal year end or when events or changes in circumstances indicate the carrying value of these assets may exceed their current fair values. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the assets. Assets to be disposed of are separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell and are no longer depreciated. The Company has not historically recorded any impairment to its long-lived assets. In the future, if events or market conditions affect the estimated fair value to the extent that a long-lived asset is impaired, the Company will adjust the carrying value of these long-lived assets in the period in which the impairment occurs. As of June 30, 2018 and December 31, 2017, the Company had not deemed any long-lived assets as impaired and was not aware of the existence of any indicators of impairment at such dates.

 

Segment Information

 

The Company operates and manages its business as one reporting and operating segment, which is the business of developing and commercializing a variety of products that support the detection, intervention and monitoring of a range of eye diseases. The Company’s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for purposes of allocating resources and evaluating financial performance.

 

 9 

 

 

Revenue Recognition

 

The Company’s revenue is comprised of sales of medical foods and dietary supplements to consumers through a direct sales/credit card process. In addition, the Company sells medical device equipment and supplies to customers both in the U.S. and internationally.

 

In September 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09 (ASU No. 2014-09) regarding revenue recognition. The new standard provides authoritative guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. generally accepted accounting principles. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in the exchange for those goods or services. The ASU became effective January 1, 2018.

 

Due to the nature of the products sold by the Company, the adoption of the new standard has had no quantitative effect on the financial statements. However, the guidance requires additional disclosures to help readers of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized.

 

The Company previously recognized revenue when risk of loss transferred to its customers and collection of the receivable was reasonably assured, which generally occurs when the product is shipped. A product is not shipped without an order from the customer and credit acceptance procedures performed. The Company allows for returns within 30 days of purchase, although for all periods presented, returns have been insignificant.

 

Under the new guidance, revenue is recognized when control of promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company reviews its sales transactions to identify contractual rights, performance obligations, and transaction prices, including the allocation of prices to separate performance obligations, if applicable. Revenue and costs of sales are recognized once products are delivered to the customer’s control and performance obligations are satisfied.

 

All products sold by the Company are distinct individual products and consist of medical foods, supplemental formulas, medical devices and related supplies. The products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them. Contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time.

 

Control of products sold transfers to customers upon shipment from the Company’s facilities, and the Company’s performance obligations are satisfied at that time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer. Payment for sales of Lumega-Z is generally made by approved credit cards. Payments for medical device sales are generally made by check, credit card, or wire transfer. Historically the Company has not experienced any significant payment delays from customers.

 

The Company provides a 30-day right of return to its retail Lumega-Z customers. A right of return does not represent a separate performance obligation, but because customers are allowed to return products, the consideration to which the Company expects to be entitled is variable. Upon evaluation of historical Lumega-Z and VectorVision product returns, the Company determined that less than one percent of products is returned, and therefore believes it is probable that such returns will not cause a significant reversal of revenue in the future. Due to the insignificant amount of historical returns as well as the standalone nature of the Company’s products and assessment of performance obligations and transaction pricing for the Company’s sales contracts, the Company does not currently maintain a contract asset or liability balance at this time. The Company assesses its contracts and the reasonableness of its conclusions on a quarterly basis.

 

The following table presents the Company’s revenues disaggregated by product type:

 

  

Three Months Ended

June 30,

  

Six Months Ended

June 30,

 
   2018   2017   2018   2017 
Lumega-Z and supplements  $79,993   $59,977   $152,132   $115,912 
VectorVision medical devices and supplies   140,785    -    261,686    - 
   $220,778   $59,977   $413,818   $115,912 

 

 10 

 

 

Research and Development Costs

 

Research and development costs consist primarily of fees paid to consultants and outside service providers and other expenses relating to the acquisition, design, development and testing of the Company’s medical foods and related products. Research and development expenditures, which include stock compensation expense, are expensed as incurred and totaled $194,708 and $25,770 for the six months ended June 30, 2018 and 2017, respectively.

 

Stock-Based Compensation

 

The Company periodically issues stock-based compensation to officers, directors, contractors and consultants for services rendered. Such issuances vest and expire according to terms established at the issuance date.

 

Stock-based payments to officers, directors, consultants, contractors, and employees, which include grants of employee stock options, are recognized in the financial statements based on their fair values. Stock option grants, which are generally time vested, will be measured at the grant date fair value and charged to operations on a straight-line basis over the vesting period. The fair value of stock options is determined utilizing the Black-Scholes option-pricing model, which is affected by several variables, including the risk-free interest rate, the expected dividend yield, the expected life of the equity award, the exercise price of the stock option as compared to the fair market value of the common stock on the grant date and the estimated volatility of the common stock over the term of the equity award.

 

The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the FASB whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period using a graded vesting basis. In certain circumstances where there are no future performance requirements by the non-employee, grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

 

The Company recognizes stock compensation expense, on stock purchases at a price less than fair value, and for fully-vested stock issued to consultants and other service providers, for the excess of fair value of the stock over the price paid for the stock. The Company recognizes the fair value of stock-based compensation within its statements of operations with classification depending on the nature of the services rendered. The Company will issue new shares to satisfy stock option exercises.

 

Net Loss per Share

 

The Company’s computation of basic and diluted net loss per common share is measured as net loss divided by the weighted average common shares outstanding during the respective periods, excluding unvested restricted common stock, if applicable. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Potential common shares such as from unexercised warrants, options, and shares of common stock issuable upon conversion of convertible debt and convertible preferred stock outstanding that have an anti-dilutive effect are excluded from the calculation of diluted net loss per share. The Company’s basic and diluted net loss per share is the same for all periods presented because all shares of common stock issuable upon exercise of warrants, options, and conversion of convertible debt and convertible preferred stock outstanding are anti-dilutive as they decrease loss per share.

 

 11 

 

 

The following table sets forth the number of shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive:

 

   June 30, 
   2018   2017 
Warrants   2,656,423    2,983,666 
Options   2,625,000    - 
Estimated shares issuable upon conversion of convertible notes payable   -    31,250 
Shares issuable upon conversion of convertible preferred stock   -    4,308,600 
    5,281,423    7,323,516 

 

Recent Accounting Pronouncements

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (ASU 2016-02), Leases (Topic 842). ASU 2016-02 requires a lessee to record a right-of-use asset and a corresponding lease liability, initially measured at the present value of the lease payments, on the balance sheet for all leases with terms longer than 12 months, as well as the disclosure of key information about leasing arrangements. ASU 2016-02 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term, generally on a straight-line basis. ASU 2016-02 requires classification of all cash payments within operating activities in the statement of cash flows. Disclosures are required to provide the amount, timing and uncertainty of cash flows arising from leases. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted. The Company has not yet evaluated the impact of the adoption of ASU 2016-02 on the Company’s financial statement presentation or disclosures.

 

In July 2017, the FASB issued Accounting Standards Update No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features; (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (“ASU 2017-11”). ASU 2017-11 allows companies to exclude a down round feature when determining whether a financial instrument (or embedded conversion feature) is considered indexed to the entity’s own stock. As a result, financial instruments (or embedded conversion features) with down round features may no longer be required to be accounted for as derivative liabilities. A company will recognize the value of a down round feature only when it is triggered and the strike price has been adjusted downward. For equity-classified freestanding financial instruments, an entity will treat the value of the effect of the down round as a dividend and a reduction of income available to common shareholders in computing basic earnings per share. For convertible instruments with embedded conversion features containing down round provisions, entities will recognize the value of the down round as a beneficial conversion discount to be amortized to earnings. ASU 2017-11 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The guidance in ASU 2017-11 is to be applied using a full or modified retrospective approach. The adoption of ASU 2017-11 is not currently expected to have any impact on the Company’s financial statement presentation or disclosures.

 

In June 2018, the FASB issued Accounting Standards Update 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). ASU 2018-07 expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company will adopt the provisions of ASU 2018-07 in the quarter beginning January 1, 2019. The adoption of ASU 2018-07 is not expected to have any impact on the Company’s financial statement presentation or disclosures.

 

The Company’s management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.

 

 12 

 

  

3.VectorVision Acquisition

 

On September 29, 2017, the Company, through a wholly-owned subsidiary, completed the acquisition of substantially all of the assets and certain liabilities of VectorVision, Inc., an Ohio corporation (“VectorVision”), in exchange for 3,050,000 shares of the Company’s common stock, valued at $2,287,500, pursuant to the terms of an Asset Purchase and Reorganization Agreement dated September 29, 2017 (the “VectorVision Agreement”). The VectorVision Agreement was entered into on an arm’s-length basis. The wholly-owned subsidiary that acquired the business is called VectorVision Ocular Health, Inc., a Delaware corporation, doing business as VectorVision. With respect to the 3,050,000 shares of common stock, 250,000 shares are held back by the Company through November 28, 2019 as security for VectorVision’s indemnification obligations to the Company and the remaining 2,800,000 shares were issued to VectorVision at the closing of the transaction. Per the VectorVision Agreement, the 2,800,000 shares were subsequently distributed to the two VectorVision shareholders in proportion to their shareholdings in VectorVision. The shares represented approximately 11% of the Company’s issued and outstanding common stock immediately following consummation of the transaction. The shares held back as security are included in the Company’s weighted average common shares outstanding for per-share calculations.

 

VectorVision develops, manufactures and sells equipment and supplies for standardized vision testing for use by eye doctors in clinical trials, for real-world vision evaluation, and industrial vision testing. VectorVision specializes in the standardization of contrast sensitivity, glare sensitivity, low contrast acuity, and ETDRS (Early Treatment Diabetic Retinopathy Study) visual acuity testing. VectorVision developed and commercialized its CSV-1000 medical device to conduct contrast sensitivity testing and it developed and commercialized its ESV-3000 medical device to conduct ETDRS visual acuity testing. The patented standardization system provides the practitioner or researcher with the ability to delineate very small changes in visual capability, either as compared to the population or from visit to visit. The Company believes VectorVision’s CSV-1000 device to be the standard of care for clinical trials. The VectorVision transaction expanded the Company’s technical portfolio and the Company believes it further established the Company’s position at the forefront of early detection, intervention and monitoring of a range of eye diseases.

 

In accordance with ASC 805, the Company utilized the acquisition method of accounting, whereby the purchase consideration is allocated to specific tangible and intangible assets at their estimated fair values on the date of acquisition. The following table summarizes the allocation of preliminary fair values of the purchase consideration to the assets and liabilities assumed:

 

   Fair Values 
Common stock consideration  $2,287,500 
Liabilities assumed   108,722 
Total purchase consideration   2,396,222 
      
Cash   (4,895)
Accounts receivable   (50,105)
Inventory   (93,293)
Prepaid assets   (551)
Property and equipment   (9,458)
Intangible assets   (674,400)
Goodwill  $1,563,520 

 

Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the expected revenue and benefits of the combined company.

 

The following unaudited pro forma financial information gives effect to the Company’s acquisition of VectorVision as if the acquisition had occurred on January 1, 2017 and had been included in the Company’s consolidated statements of operations during the three and six-month periods ended June 30, 2017:

 

 13 

 

  

   Three Months
Ended June 30,		   Six Months
Ended June 30,		 
   2017   2017 
Pro forma net revenues  $121,622   $366,793 
Pro forma net loss attributable to common shareholders  $(1,088,909)  $(1,825,640)
Pro forma net loss per share  $(0.04)  $(0.06)

 

4.Inventories

 

Inventories consisted of the following:

 

   June 30,   December 31, 
   2018   2017 
Raw materials  $380,899   $133,354 
Finished goods   31,458    21,376 
   $412,357   $154,730 

 

5.Property and Equipment, net

 

Property and equipment consisted of the following: 

 

   June 30,   December 31, 
   2018   2017 
Leasehold improvements  $98,357   $98,357 
Testing equipment   169,552    150,603 
Furniture and fixtures   145,411    50,300 
Computer equipment   39,476    16,464 
Office equipment   8,193    8,193 
    460,989    323,917 
Less accumulated depreciation and amortization   (269,562)   (228,320)
   $191,427   $95,597 

 

For the six months ended June 30, 2018 and 2017, depreciation expense was $41,242 and $31,331, respectively, of which $15,376 and $14,650 were included in research and development expense, $4,138 and $0 were included in sales and marketing expense, and $21,728 and $16,861 were included in general and administrative expense, respectively.

 

6.Acquisition of Intellectual Property

 

On January 26, 2018, the Company acquired the rights to the trademark GLAUCO-HEALTH as well as the name “International Eye Wellness Institute” (together, the “IP Assets”) from an unrelated third party. The purchase included all rights, title, and interest in and to the IP Assets, including (a) the right to register and use the IP Assets; (b) all goodwill associated with the IP Assets; (c) all income, royalties, and damages hereafter due or payable with respect to the IP Assets; (d) all rights to sue for past, present, and future infringements or misappropriations of the IP Assets; and (e) and all other intellectual property rights owned or claimed by the seller or embodied in the IP Assets. In exchange for these rights, the Company paid the seller $50,000 in cash.

 

ASC 350-30-20 defines a defensive intangible asset as an acquired intangible asset in a situation in which an entity does not intend to actively use the asset but intends to hold (lock up) the asset to prevent others from obtaining access to the asset. The Company determined that the acquired intangible asset met the definition of a defensive intangible asset. The Company accounted for the $50,000 payment as an acquired intangible asset as of the closing of the agreement. As the Company can renew the underlying rights to the IP Assets indefinitely at nominal cost, the assets have been classified as a non-amortizable intangible asset on the Company’s balance sheet at June 30, 2018. The Company will evaluate the status of the assets for impairment annually or more frequently if warranted.

 

On January 26, 2018 the Company entered into a consulting agreement with the principal of the seller to assist with the development of the IP Assets and other assets acquired by the Company in the transaction. In conjunction with the consulting agreement, the Company granted a stock option on January 26, 2018 to the consultant to purchase a total of 500,000 shares of the common stock of the Company (see Note 8).

 

 14 

 

  

7.Related Party Transactions

 

Due to and from related parties represents unreimbursed expenses and compensation incurred on behalf of, and amounts loaned to the Company by, Michael Favish, the Company’s Chief Executive Officer, as well as other stockholders. The advances are unsecured, non-interest bearing and are due on demand. As of June 30, 2018 and December 31, 2017, the Company had $117,473 and $146,133, respectively, due to related parties.

 

8.Stockholders’ Equity

 

Preferred Stock

 

Series A

During 2016, the Company sold 1,170,000 shares of the Company's Series A Senior Convertible Preferred Stock (the "Series A Preferred Stock") to various investors. The purchase price of the Series A Preferred Stock was $1.00 per share, for an aggregate purchase price of $1,170,000. In addition, during 2016, the Company issued 535,154 shares of its Series A Preferred Stock with a fair value of $784,888 upon conversion of $535,149 of notes payable and accrued interest. The Series A Preferred Stock had a stated value of $1.00 per share and accrued an annual dividend at the rate of 8% of the stated value, calculated quarterly, paid in shares of common stock at the rate of $0.60 per share.

 

During the six months ended June 30, 2017, the Company declared dividends of $67,646 on its Series A Preferred Stock which were satisfied in full through the issuance of an aggregate of 112,759 shares of common stock.

 

Series B

 

Beginning in March 2017 and through September 30, 2017, the Company sold 3,105,000 shares of the Company's Series B Convertible Preferred Stock (the "Series B Preferred Stock") to various investors. The purchase price of the Series B Preferred Stock was $1.00 per share, for an aggregate purchase price of $3,105,000. The Series B Preferred Stock had a stated value of $1.00 per share and accrued an annual dividend at the rate of 6% of the stated value, calculated quarterly, paid in shares of common stock at the rate of $0.75 per share.

 

During the six months ended June 30, 2017, the Company declared dividends of $13,537 on its Series B Preferred Stock which were satisfied in full through the issuance of an aggregate of 18,054 shares of common stock.

 

On November 3, 2017, the Company completed the issuance and sale of an aggregate of 4,347,827 shares of common stock (see below). The completion of the private placement triggered, at the Company's election, the automatic conversion of the Series A Preferred Stock and the Series B Preferred Stock into shares of common stock. Accordingly, immediately following the completion of the private placement, the Company effected the conversion of all outstanding shares of Series A Preferred Stock and the Series B Preferred Stock into 6,981,938 shares of common stock (excluding accrued but unpaid dividends) effective November 3, 2017. On April 26, 2018, the Company filed a Certificate of Elimination with the Secretary of the State of Delaware, withdrawing the respective Certificates of Designation that established the right, privileges and preferences of the Series A Preferred Stock and Series B Preferred Stock, thereby making all 10,000,000 authorized shares of preferred stock available for issuance.

 

Common Stock

 

On November 3, 2017, the Company completed the issuance and sale of an aggregate of 4,347,827 shares of common stock, par value $0.001 per share, at a purchase price of $1.15 per share. Total gross proceeds were $5,000,001. These shares were sold in a private placement to certain purchasers pursuant to a Stock Purchase Agreement dated as of November 3, 2017. Pursuant to the agreement, the purchasers have customary preemptive rights to participate in future equity and equity-linked issuances by the Company up to the extent necessary to maintain such purchaser’s pro rata ownership percentage in the Company’s securities, subject to customary exceptions. The preemptive rights terminate at the earlier of (i) May 3, 2019, (ii) such time as the Purchasers hold less than five percent (5%) of the issued and outstanding shares of the Company’s common stock, or (iii) such time as the shares of common stock of the Company shall become listed or approved for listing on a national securities exchange.

 

 15 

 

 

Warrants

 

A summary of the Company’s warrant activity is as follows: 

 

   Shares 
December 31, 2017   2,983,666 
Granted   - 
Forfeitures   - 
Expirations   (181,243)
Exercised   (146,000)
June 30, 2018, all exercisable   2,656,423 

 

In January 2018, an investor exercised warrants for 146,000 shares of common stock. The warrants were exercisable for $0.01 per share, and the Company received $1,460 in cash. The Company issued the shares and recorded the cash received as additional equity.

 

On April 30, 2018, The Company offered a one-month exercise period extension to stockholders who held warrants to purchase shares of common stock of the Company that were scheduled to expire on May 1, 2018. Pursuant to the terms of a Note and Warrant Purchase Agreement entered into by the Company and such holders, such warrants were issued upon the conversion of certain promissory notes into common stock on May 1, 2015. Four of the warrant holders did not extend their warrants, resulting in the expiration of 151,006 warrants on May 1, 2018. Six warrant holders elected to extend the term of an aggregate of 403,085 warrants by one month to June 1, 2018. The exercise price of such warrants is $1.00 per share.

 

On May 31, 2018, the six warrant holders noted above were offered a further extension of the exercise period for their warrants. One holder did not extend, resulting in the expiration of 30,237 warrants on June 1, 2018. Five warrant holders elected to extend the term of an aggregate of 372,848 warrants. These warrants are now scheduled to expire on the earlier of (a) May 31, 2019 or (b) sixty days following the date on which the common stock of the Company becomes listed or approved for listing on a national securities exchange. The exercise price of such warrants remains unchanged at $1.00 per share, but cashless exercise provisions have been eliminated from such warrants.

 

Management applied the guidance in ASC 718 – Compensation-Stock Compensation which indicates that a modification to the terms of an award should be treated as an exchange of the original award for a new award with the resulting total compensation cost equal to the grant-date fair value of the original award plus the incremental value of the modification to the award. Under ASC 718, the calculation of the incremental value is based on the excess of the fair value of the new (modified) award based on current circumstances over the fair value of the original award measured immediately before its terms are modified based on current circumstances. The Company recognized expense of $494,391 relating to the extension of the exercise period of the warrants based upon a Black-Scholes option-pricing model using a stock price of $1.15, volatility of 118%, and an average risk-free rate of 2.61. The expense is reflected as Fair value of warrants - extension of expiration dates in the Company’s statements of operations.

 

As of June 30, 2018, the Company had an aggregate of 2,656,423 outstanding warrants to purchase shares of its common stock with a weighted average exercise price of $0.43, weighted average remaining life of 0.7 years and aggregate intrinsic value of $1,905,475, based upon a stock valuation of $1.15 per share. The intrinsic value is calculated as the difference between the market value of the underlying common stock and the exercise price of the warrants.

 

 16 

 

 

Stock Options

 

A summary of the Company’s stock option activity is as follows:

 

   Shares 
December 31, 2017   2,125,000 
Granted   500,000 
Forfeitures   - 
Exercised   - 
June 30, 2018, outstanding   2,625,000 
June 30, 2018, exercisable   2,225,000 

 

On September 30, 2017, the Company entered into a consulting agreement pursuant to which the Company granted a total of 1,250,000 common stock options. 650,000 of the options with a fair value of $486,070 vested immediately, and the remaining 600,000 options vest ratably over twelve months on a quarterly basis with compensation cost measured as the fair value at the end of each reporting period. The options are non-qualified, have an exercise price of $1.00 per share, and will expire 5 years from the grant date. As of December 31, 2017, the Company had recognized compensation cost of $658,383 relating to the vesting of 800,000 options. During the six months ended June 30, 2018, the Company recognized stock compensation costs of $256,962 related to the vesting of 450,000 options based upon a graded vesting schedule. As of June 30, 2018, the remaining 150,000 options to vest were valued at $172,388 based upon a Black-Scholes option-pricing model.

 

On December 30, 2017, the Company entered into a consulting agreement pursuant to which the Company granted a total of 750,000 common stock options. 250,000 of the options with a fair value of $312,275 vested immediately, and the remaining 500,000 options vested ratably over six months on a quarterly basis with compensation cost measured as the fair value at the end of each reporting period, using a Black Scholes option-pricing model and a graded vesting schedule. The options are non-qualified, have an exercise price of $1.25 per share, and will expire 5 years from the grant date. As of June 30, 2018, all options were fully vested. During the six months ended June 30, 2018, the Company recognized stock compensation costs of $413,877 related to these options.

 

On January 26, 2018, the Company entered into an agreement with a consultant to develop products based on certain intellectual property owned by the Company (see Note 6). In conjunction with the consulting agreement, the Company granted a stock option to the consultant to purchase a total of 500,000 shares of the common stock of the Company. 250,000 shares of the option with a fair value of $287,500 vested immediately, 125,000 shares vest on December 31, 2018 and the remaining 125,000 shares vest on December 31, 2019 provided the consultant is still an active service provider. As of June 30, 2018, the 250,000 options that remain to vest were valued in total at $287,365 based upon a Black-Scholes option-pricing model. Compensation cost is measured as the fair value at the end of each reporting period and cost is amortized based upon a graded vesting schedule. The options are non-qualified, have an exercise price of $1.25 per share, and will expire 5 years from the grant date. During the six months ended June 30, 2018, the Company recognized stock compensation costs of $384,046 related to these options.

 

As of June 30, 2018, options were valued based upon the Black-Scholes option-pricing model, with a stock price of $1.15, volatility of 120%, and an average risk-free rate of 2.65%.

 

As of June 30, 2018, the Company had an aggregate of 400,000 remaining unvested options outstanding, with estimated fair value of $459,754. The Company remeasures unvested options for non-employees to fair value at the end of each reporting period. The aggregate intrinsic value of options outstanding as of June 30, 2018 was $187,500.

 

9.Commitments and Contingencies

 

The Company is periodically the subject of various pending or threatened legal actions and claims arising out of its operations in the normal course of business. In the opinion of management of the Company, adequate provision has been made in the Company’s condensed financial statements at June 30, 2018 with respect to such matters, including the matter noted below.

 

 17 

 

 

On or about July 26, 2017, the Company received a payment demand from a former consultant to the Company alleging that the consultant is owed approximately $192,000 for services rendered. The Company has disputed this demand and attempts to resolve this matter were unsuccessful. On January 29, 2018, the Company filed a lawsuit against the consultant and its related entities in the United States District Court for the Southern District of California (Case No. 18CV200-W-KSC) seeking declaratory relief regarding advisory fees and ownership interest in the Company. On March 6, 2018, the consultant and its related entities filed counterclaims against the Company, seeking payment for services rendered and seeking declaratory relief regarding ownership interest in the Company. The Company intends to vigorously defend its rights. The Company cannot predict the outcome of this matter.

 

10.Subsequent Events

 

On July 25, 2018, the Board of Directors approved the Company entering into a product development consulting agreement with a product development company to design and create a working prototype device, named AcQviz, intended to embody the inventions described in US Patent No. 10,022,045 and US Patent Application 15/277,849, each of which the Company owns. Under this agreement, the product development company is to create a prototype device using sensor circuitry and communication software/firmware unique to the product development company, oversee the integration of the prototype circuitry design into a commercial product, develop specifications for the Company to mass produce a commercial product based on the prototype and integrate the communication channel for the device into various vision testing software programs. In conjunction with the product development agreement, the Board of Directors of the Company also approved a stock option grant to the product development company to purchase 100,000 shares of the common stock of the Company based on certain performance metrics set forth in the product development agreement and stock option agreement. The President of the product development company, Joseph Tate Evans, Jr., is the brother of David Evans, Chief Science Officer and a director of the Company.

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Presentation of Information

 

As used in this Quarterly Report on Form 10-Q, the terms “we,” “us” “our” and the “Company” mean Guardion Health Sciences, Inc. unless the context requires otherwise. The following discussion and analysis should be read in conjunction with our audited financial statements and the related notes that appear elsewhere in this report and our audited financing statements for the year ended December 31, 2017, and the notes thereto, which are set forth in the 2017 Form 10-K. All dollar amounts refer to U.S. dollars unless otherwise indicated.

 

 18 

 

 

Overview

 

Guardion Health Sciences, Inc. was formed in December 2009 in California as a limited liability company under the name P4L Health Sciences, LLC and we subsequently changed our name to Guardion Health Sciences, LLC. On June 30, 2015, we converted from a California limited liability company to a Delaware corporation, changing our name to Guardion Health Sciences, Inc.

 

We are a specialty health sciences company that develops, formulates and distributes condition-specific medical foods with an initial medical food product on the market under the brand name Lumega-Z® that replenishes and restores the macular protective pigment. A depleted macular protective pigment is a modifiable risk factor for retina-based diseases such as age-related macular degeneration (“AMD”), computer vision syndrome (“CVS”) and diabetic retinopathy. Additional research has also shown a depleted macular protective pigment to be a biomarker for neurodegenerative diseases such as Alzheimer’s and dementia. We have had limited operations to date, and have primarily been engaged in research, product development, commercialization and capital raising.

 

We have also developed a proprietary medical device called the MapcatSF® that accurately measures the macular pigment optical density (“MPOD”). We invented our own proprietary patented technology embodied in the MapcatSF. On November 8, 2016, the USPTO issued patent number 9,486,136 for the MapcatSF invention. Using the MapcatSF to measure the MPOD allows one to monitor the increase in the density of the macular protective pigment after taking Lumega-Z. The MapcatSF is a non-mydriatic, non-invasive device that is designed to accurately measure the MPOD, the lens optical density and lens equivalent age, thereby creating an evidence-based protocol that is shared with the patient. A non-mydriatic device is one that does not require dilation of the pupil for it to function. The MapcatSF is intended to be the first device using a patented “single fixation” process and “automatic lens density correction” that produces accurate serialized data.

 

Lumega-Z has a patent-pending formula that replenishes and restores the macular protective pigment simultaneously delivering critical and essential nutrients to the eye. Formulated by Dr. Sheldon Hendler in 2010, modifications were made over a two-year period to improve the taste and method of delivery. We believe that there is an increasing level of acceptance of medical foods as a primary therapy by patients and healthcare providers to treat pain syndromes, sleep and cognitive disorders, obesity, hypertension, and viral infection. In clinical practice, medical foods are being prescribed as both a standalone therapy and as an adjunct therapy to low doses of commonly prescribed drugs. We believe that medical foods will continue to grow in importance over the coming years.

 

In September 2017, the Company, through its wholly-owned subsidiary VectorVision Ocular Health, Inc., acquired substantially all the assets and certain liabilities of VectorVision, Inc., a company that specializes in the standardization of contrast sensitivity, glare sensitivity, low contrast acuity, and early treatment diabetic retinopathy study (“ETDRS”) visual acuity testing. VectorVision’s standardization system is designed to provide the practitioner or researcher with the ability to delineate very small changes in visual capability, either as compared to the population or from visit to visit. VectorVision develops, manufactures and sells equipment and supplies for standardized vision testing for use by eye doctors in clinical trials, for real-world vision evaluation, and industrial vision testing. The acquisition expands the Company’s technical portfolio and the Company believes it further establishes its position at the forefront of early detection, intervention and monitoring of a range of eye diseases.

 

By combining the MapcatSF medical device, the newly acquired VectorVision standardized vision testing technology and Lumega-Z medical food, the Company has developed, based on Management’s knowledge of the industry, what it believes to be the only reliable three-pronged, evidence-based protocol for replenishing and restoring the macular protective pigment, increasing overall retinal health and measuring the related improvements in visual function.

 

 19 

 

 

Recent Developments

 

Development of Sales Force

 

The Company entered into an agreement with a third party in March 2018 to provide a direct sales force comprised of a field-based team of account managers located in key geographical locations based on high population density areas with demographics that match the Company’s target markets. Each account manager will have responsibility for a pre-defined geographical area and will be expected to travel extensively to support the needs of customers. The account managers will be tasked with prospecting for new accounts, closing leads generated by the Company’s marketing efforts, and generating revenue through account management activities including physician and staff training, and implementation of patient education resources. The account managers will also participate in national and regional trade shows and events, including supporting professional optometric and ophthalmological societies at a State level. Each account manager will be tasked with a quota that includes units of Lumega-Z sold, as well as sales of the MapcatSF, CSV-1000 and ESV-3000. Commissions are based on sales performance and achievement of quota. During the second quarter of 2018, the Company hired three members of the sales team as employees of Guardion and cancelled the agreement with the third party sales organization.

 

Patents

 

On July 10, 2018, the USPTO issued US Patent No. 10,016,128, titled Method and Apparatus for Visual Acuity Testing. This patent describes an invention pertaining to automatic light calibration of the display screens used for vision testing. The Company owns this patent, and its VectorVision CSV-1000 and ESV-3000 devices each embody this invention.

 

On July 17, 2018, the USPTO issued US Patent No. 10,022,045, also titled Method and Apparatus for Visual Acuity Testing, which describes a methodology to continuously calibrate display monitors to automatically hold display luminance constant for vision testing. This second patent also covers a methodology to compensate for other testing factors, such as room illumination and when patients view the vision test through a mirror, which is a common practice in eye doctors’ offices worldwide. The Company also owns this patent, and its VectorVision CSV-1000 and ESV-3000 devices each embody this invention.

 

These patents serve as the basis for developing follow-on products to the CSV-1000, the CSV-2000, in which the proprietary standardized contrast sensitivity test patterns can be presented to the patient using a computer monitor as opposed to the current calibrated backlit system. The Company also anticipates commercializing these proprietary methodologies for use with other types of vision tests so that other tests can be properly calibrated to adhere to recognized government vision test lighting standards.

 

Prior to the issuance of US Patent No. 9,486,136, the Company filed a continuation application, Patent Application 15/346,010, covering new embodiments around the MapcatSF® device. These new embodiments contain improvements related to the accuracy of intensity measurements made with the device, as well as updated features around photodiode detector calibrations.

 

Going Concern

 

The financial statements have been prepared assuming the Company will continue as a going concern. The Company had a net loss of $4,143,025 and utilized cash in operating activities of $2,424,058 during the six months ended June 30, 2018. The Company expects to continue to incur net losses and negative operating cash flows in the near-term. As a result, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued.

 

The Company’s independent registered public accounting firm has also included explanatory language in their opinion accompanying the Company’s audited financial statements for the year ended December 31, 2017. The Company’s financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

The Company will continue to incur significant expenses for continued commercialization activities related to Lumega-Z, the MapcatSF® medical device, and VectorVision products. Development and commercialization of medical foods and medical devices involves a lengthy and complex process. Additionally, the Company’s long-term viability and growth may depend upon the successful development and commercialization of new complementary products or product lines. The Company is continuing to attempt to raise additional debt and/or equity capital to fund future operations, but there can be no assurances that the Company will be able to secure such additional financing in the amounts necessary to fully fund its operating requirements on acceptable terms or at all. If the Company is unable to access sufficient capital resources on a timely basis, the Company may be forced to reduce or discontinue its technology and product development programs and curtail or cease operations.

 

 20 

 

 

Recent Accounting Pronouncements

 

See Note 2 to the condensed consolidated financial statements for managements’ discussion of recent accounting pronouncements.

 

Critical Accounting Policies and Estimates

 

The Company’s financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of its financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates. The Company’s financial statements included herein include all adjustments, consisting of only normal recurring adjustments, necessary to present fairly its financial position, results of operations and cash flows.

 

The following critical accounting policies affect the more significant judgments and estimates used in the preparation of the Company’s financial statements.

 

Intangible Assets

 

In connection with the VectorVision transaction, the Company identified and allocated estimated fair values to intangible assets including goodwill and customer relationships.

 

In accordance with Accounting Standard Codification (“ASC”) 350 – Intangibles – Goodwill and Other, the Company determined whether these assets are expected to have indefinite (such as goodwill) or limited useful lives, and for those with limited lives, the Company established an amortization period and method of amortization. The Company’s goodwill and other intangible assets are subject to periodic impairment testing.

 

The Company utilized the services of an independent third-party valuation firm to assist it in identifying intangible assets and in estimating their fair values. The useful lives for its intangible assets other than goodwill were estimated based on Management’s consideration of various factors, including assumptions that market participants might use about sales expectations as well as potential effects of obsolescence, competition, technological progress and the regulatory environment. Because the future pattern in which the economic benefits of these intangible assets may not be reliably determined, amortization expense is generally calculated on a straight-line basis.

 

Impairment of Long-Lived Assets

 

The Company reviews long-lived assets, including property and equipment, identifiable intangible assets, and goodwill for impairment at each fiscal year end or when events or changes in circumstances indicate the carrying value of these assets may exceed their current fair values. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the assets. Assets to be disposed of are separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell and are no longer depreciated. The Company has not historically recorded any impairment to its long-lived assets. In the future, if events or market conditions affect the estimated fair value to the extent that a long-lived asset is impaired, the Company will adjust the carrying value of these long-lived assets in the period in which the impairment occurs. As of June 30, 2018 and December 31, 2017, the Company had not deemed any long-lived assets as impaired and was not aware of the existence of any indicators of impairment at such dates.

 

Stock-Based Compensation

 

The Company periodically issues stock-based compensation to officers, directors, contractors and consultants for services rendered. Such issuances vest and expire according to terms established at the issuance date.

 

 21 

 

 

Stock-based payments to officers, directors, consultants, contractors, and employees, which include grants of employee stock options, are recognized in the financial statements based on their fair values. Stock option grants, which are generally time vested, will be measured at the grant date fair value and charged to operations on a straight-line basis over the vesting period. The fair value of stock options is determined utilizing the Black-Scholes option-pricing model, which is affected by several variables, including the risk-free interest rate, the expected dividend yield, the expected life of the equity award, the exercise price of the stock option as compared to the fair market value of the common stock on the grant date and the estimated volatility of the common stock over the term of the equity award.

 

The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the FASB whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period using a graded vesting basis. In certain circumstances where there are no future performance requirements by the non-employee, grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

 

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant. Until the Company has established a trading market for its common stock, estimated volatility is based on the average historical volatilities of comparable public companies in a similar industry. The expected dividend yield is based on the current yield at the grant date. The Company has never declared or paid dividends on its common stock and has no plans to do so for the foreseeable future.

 

The fair value of common stock was determined based on management’s judgment. In order to assist management in calculating such fair value, the Company retained a third-party valuation firm in determining the value of the Company. The third-party valuation firm’s input was utilized in determining the related per unit or share valuations of the Company’s equity used during 2017. Management used a valuation of $0.88 per share for the six months ended June 30, 2017. Internal valuations are based on various inputs, including valuation reports prepared by third-party valuation firms and are impacted by the dilutive effect of the issuance of common shares as compensation during the periods. There are numerous acceptable ways to estimate company value, including using net tangible assets, a market-based approach, or discounted cash flows. The Company considered alternative methods and concluded that due to the lack of suitably comparable market data, the discounted cash flows method was the most appropriate. A discounted cash flows (i.e. free cash flows to equity) methodology was applied by the third-party valuation firm to assist management in their determination of the $0.88 used during 2017. This methodology used multiple years of balance sheet and income statement projections along with the following primary assumptions:

 

   Six Months Ended 
   June 30, 2017 
Discount rate   16%
Risk free rate   2.48%
Rate of return   16%
Sustainable growth rate   5%
Company survival probability   65%
Liquidation value  $0 

 

Due to the availability of historical data from the Company’s recent common stock sales, Management used a valuation of $1.15 for the six months ended June 30, 2018. Management considered business and market factors affecting the Company during the six-month periods ended June 30, 2018 and 2017, including capital raising efforts, its proprietary technology, and other factors. Based on this evaluation, management believes that $1.15 and $0.88 per share valuations are appropriate for accounting purposes at June 30, 2018 and 2017, respectively.

 

The Company recognizes stock compensation expense, on stock purchases at a price less than fair value, and for fully-vested stock issued to consultants and other service providers, for the excess of fair value of the stock over the price paid for the stock. The Company recognizes the fair value of stock-based compensation within its statements of operations with classification depending on the nature of the services rendered. The Company will issue new shares to satisfy stock option exercises.

 

 22 

 

 

Plan of Operations

 

General Overview

 

Based on the availability of sufficient funding, the Company intends to increase its commercialization activities and:

 

·Further the commercial production of the MapcatSF, starting with the manufacture of at least 15 new units for sale or lease;
·Expand the Company’s domestic sales and marketing efforts, which include revamping its web site and new promotional materials;
·Explore sales and marketing opportunities in foreign markets such as Asia and Europe;
·Increase production of Lumega-Z as is necessary to support the additional sales resulting from the deployment of additional MapcatSF units and increased marketing and promotional activity;
·Commence certain FDA electrical safety testing of the MapcatSF;
·Increase the Company’s focus on intellectual property protection and strategy;
·Expand the sales and marketing of its VectorVision product line; and
·Explore opportunities and channels to enter the expansive market opportunity in China for non-pharmacologic treatments of macular degeneration, glaucoma and diabetic retinopathy.

 

The FDA and other regulatory bodies require electronic medical devices to comply with IEC 60601 standards. The International Electrical Commission (“IEC”) established technical standards for the safety and effectiveness of medical electrical equipment. Adherence to these standards is required for commercialization of electrical medical equipment. As a medical device powered by electricity, the MapcatSF will need to undergo testing to demonstrate compliance with the IEC 60601 standards. This testing is typically conducted by a Nationally Recognized Testing Laboratory (“NRTL”), which is an independent laboratory recognized by the Occupational Safety and Health Administration (“OSHA”) to test products to the specifications of applicable product safety standards. The Company is in discussions with its contract manufacturer of the MapcatSF to engage an NRTL at the appropriate juncture prior to commercialization of the MapcatSF. The relevant predicate device for the MapcatSF is the MPS II, the applicable Class I product code for the MapcatSF is HJW and the applicable Code of Federal Regulation is 886.1050. The FDA does not require test documents to be submitted to the FDA for a Class I medical device, but that the evidence of such testing be placed in a Design History file and be kept internally at the company or manufacturer and readily available should the FDA or other regulatory bodies request to review the testing documents. While the FDA does not require that a Class I medical device have formal validation, the Company expects to complete applicable IEC 60601-1 testing prior to commercialization because the Company believes in marketing a product that has evidence that it is safe and effective.

 

Results of Operations

 

Through June 30, 2018, the Company had limited operations and has primarily been engaged in research and development, product commercialization and raising capital. The Company has incurred and will continue to incur significant expenditures for the development of its products and intellectual property, which includes research and development of both medical foods and medical diagnostic equipment for the treatment of various eye diseases. The Company had limited revenue during the six-month periods ended June 30, 2018 and 2017. In the fourth quarter of 2017, the Company began recognizing product revenue from the sale of VectorVision products in addition to sales of its proprietary product, Lumega-Z.

 

 23 

 

 

Comparison of Three Months Ended June 30, 2018 and 2017

 

   Three Months Ended June 31,     
   2018   2017   Change 
Revenue  $220,778   $59,977   $160,801    268%
Cost of goods sold   87,776    29,692    58,084    196%
Gross Profit   133,002    30,285    102,717    339%
Operating Expenses:                    
Research and development   34,320    15,530    18,790    121%
Sales and marketing   378,750    101,598    277,152    273%
General and administrative   1,034,914    766,894    268,020    35%
Total Operating Expenses   1,447,984    884,022    563,962    64%
Loss from Operations   (1,314,982)   (853,737)   (461,245)   54%
Other Expense:                    
Interest expense   710    1,924    (1,214)   (63)%
Fair value of warrants - extension of expiration dates   494,391    -    494,391    -%
Net Loss  $(1,810,083)  $(855,661)  $(954,422)   112%

 

Revenue

 

For the three months ended June 30, 2018, revenue from product sales was $220,778 compared to $59,977 for the three months ended June 30, 2017, resulting in an increase of $160,801 or 268%. The increase reflects both an increased customer base for Lumega-Z as the Company expands into new clinics and sales of VectorVision products. $79,993, or 36% of revenue in the second quarter of 2018 was generated by sales of Lumega-Z products, representing a 33% increase in Lumega-Z sales over the prior period. As of June 30, 2018, the Company had a sales backlog of approximately $89,000 in VectorVision products, all of which were delivered and recognized as revenue in July.

 

The following table presents the Company’s revenues disaggregated by product type:

 

  

Three Months Ended

June 30,

 
   2018   2017 
Lumega-Z and supplements  $79,993   $59,977 
VectorVision medical devices and supplies   140,785    - 
   $220,778   $59,977 

 

Cost of Goods Sold

 

For the three months ended June 30, 2018, cost of goods sold was $87,776 compared to $29,692 for the three months ended June 30, 2017, resulting in an increase of $58,084 or 196%. The increase reflects the additional sales recorded in 2018.

 

Gross Profit

 

For the three months ended June 30, 2018, gross profit was $133,002 compared to $30,285 for the three months ended June 30, 2017, resulting in an increase of $102,717 or 339%. The increase is primarily due to the sales of VectorVision products, which did not occur in the prior period.

 

Research and Development

 

For the three months ended June 30, 2018, research and development costs were $34,320 compared to $15,530 for the three months ended June 30, 2017, resulting in an increase of $18,790 or 121%. The increase was due to research associated with the Company’s MapcatSF® medical device.

 

Sales and Marketing

 

For the three months ended June 30, 2018, sales and marketing expenses were $378,750 compared to $101,598 for the three months ended June 30, 2017. The increase in sales and marketing expenses of $277,152 or 273% compared to the prior period was due to costs associated with engagement of a third party national sales team, as well as an increased presence at trade shows.

 

 24 

 

 

General and Administrative

 

For the three months ended June 30, 2018, general and administrative expenses were $1,034,914 compared to $766,894 for the three months ended June 30, 2017. The increase of $268,020 or 35% compared to the prior period was primarily due to increased labor, legal, and consulting costs during the period.

 

Interest Expense

 

For the three months ended June 30, 2018, interest expense was $710 compared to $1,924 for the three months ended June 30, 2017. The decrease of $1,214, or 63%, was due to the repayment or conversion of all promissory notes and convertible debt that had been outstanding during 2017.

 

Fair Value of Warrants

 

During April and May of 2018, the Company offered exercise period extensions to stockholders who held warrants to purchase shares of common stock of the Company that were scheduled to expire on May 1, 2018. The Company recognized expense of $494,391 relating to the extension of the exercise period of the warrants using a Black-Scholes option-pricing model to estimate fair value.

 

Net Loss

 

For the three months ended June 30, 2018, the Company incurred a net loss of $1,810,083, compared to a net loss of $855,661 for the three months ended June 30, 2017. The increase in net loss of $954,422 or 112% compared to the prior year period was due to the non-cash expense related to the extension of warrant expiration dates, as well as to the increased costs associated with the sales team, legal expenses, and its internal labor force.

 

Comparison of Six Months Ended June 30, 2018 and 2017

 

   Six Months Ended June 31,     
   2018   2017   Change 
Revenue  $413,818   $115,912   $297,906    257%
Cost of goods sold   167,055    52,326    114,729    219%
Gross Profit   246,763    63,586    183,177    288%
Operating Expenses:                    
Research and development   194,708    25,770    168,938    656%
Sales and marketing   984,464    178,333    806,131    452%
General and administrative   2,714,680    1,365,807    1,348,873    99%
Total Operating Expenses   3,893,852    1,569,910    2,323,942    148%
Loss from Operations   (3,647,089)   (1,506,324)   (2,140,765)   142%
Other Expense:                    
Interest expense   1,545    18,355    (16,810)   (92)%
Fair value of warrants - extension of expiration dates   494,391    -    494,391    -%
Net Loss  $(4,143,025)  $(1,524,679)  $(2,618,346)   172%

 

Revenue

 

For the six months ended June 30, 2018, revenue from product sales was $413,818 compared to $115,912 for the six months ended June 30, 2017, resulting in an increase of $297,906 or 257%. The increase reflects both an increased customer base for Lumega-Z as the Company expands into new clinics and sales of VectorVision products. $152,132, or 37% of revenue in 2018 was generated by sales of Lumega-Z products, representing a 31% increase in Lumega-Z sales over the prior period. As of June 30, 2018, the Company had a sales backlog of approximately $89,000 in VectorVision products, all of which were delivered and recognized as revenue in July.

 

 25 

 

 

The following table presents the Company’s revenues disaggregated by product type:

 

  

Six Months Ended

June 30,

 
   2018   2017 
Lumega-Z and supplements  $152,132   $115,912 
VectorVision medical devices and supplies   261,686    - 
   $413,818   $115,912 

 

Cost of Goods Sold

 

For the six months ended June 30, 2018, cost of goods sold was $167,055 compared to $52,326 for the six months ended June 30, 2017, resulting in an increase of $114,729 or 219%. The increase reflects the additional sales recorded in 2018.

 

Gross Profit

 

For the six months ended June 30, 2018, gross profit was $246,763 compared to $63,586 for the six months ended June 30, 2017, resulting in an increase of $183,177 or 288%. The increase is primarily due to the sales of VectorVision products, which did not occur in the prior period.

 

Research and Development

 

For the six months ended June 30, 2018, research and development costs were $194,708 compared to $25,770 for the six months ended June 30, 2017, resulting in an increase of $168,938 or 656%. The increase was due to research associated with the Company’s MapcatSF® medical device.

 

Sales and Marketing

 

For the six months ended June 30, 2018, sales and marketing expenses were $984,464 compared to $178,333 for the six months ended June 30, 2017. The increase in sales and marketing expenses of $806,131 or 452% compared to the prior period was due to costs associated with engagement of a third party national sales team, an increased presence at trade shows, and increased consulting, marketing and promotional costs.

 

General and Administrative

 

For the six months ended June 30, 2018, general and administrative expenses were $2,714,680 compared to $1,365,807 for the six months ended June 30, 2017. The increase of $1,348,873 or 99% compared to the prior period was primarily due to a $562,000 increase in non-cash stock compensation expense. Labor, legal, and consulting costs also increased during the period.

 

Interest Expense

 

For the six months ended June 30, 2018, interest expense was $1,545 compared to $18,355 for the six months ended June 30, 2017. The decrease of $16,810, or 92%, was due to the repayment or conversion of all promissory notes and convertible debt that had been outstanding during 2017.

 

Fair Value of Warrants

 

During April and May of 2018, the Company offered exercise period extensions to stockholders who held warrants to purchase shares of common stock of the Company that were scheduled to expire on May 1, 2018. The Company recognized expense of $494,391 relating to the extension of the exercise period of the warrants using a Black-Scholes option-pricing model to estimate fair value.

 

 26 

 

 

Net Loss

 

For the six months ended June 30, 2018, the Company incurred a net loss of $4,143,025, compared to a net loss of $1,524,679 for the six months ended June 30, 2017. The increase in net loss of $2,618,346 or 172% compared to the prior year period was due to the non-cash expenses related to stock compensation and to the extension of warrant expiration dates, as well as to the increased costs associated with the sales team, legal expenses, and its internal labor force.

 

Liquidity and Capital Resources

 

Since its formation in 2009, the Company has devoted substantial effort and capital resources to the development and commercialization activities related to its lead product Lumega-Z and its MapcatSF medical device. As a result of these activities, the Company utilized cash in operating activities of $2,424,058 during the six months ended June 30, 2018. The Company had positive working capital of $1,947,866 at June 30, 2018 due primarily to its sale of its common stock in November 2017. As of June 30, 2018, the Company had cash in the amount of $2,066,365 and no available borrowings. The Company’s financing has historically come from the issuance of convertible notes, promissory notes and from the sale of common and preferred stock and exercise of warrants.

 

The financial statements have been prepared assuming the Company will continue as a going concern. The Company had a net loss of $4,143,025 and utilized cash in operating activities of $2,424,058 during the six months ended June 30, 2018. The Company expects to continue to incur net losses and negative operating cash flows in the near-term. As a result, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued.

 

The Company’s independent registered public accounting firm has also included explanatory language in their opinion accompanying the Company’s audited financial statements for the year ended December 31, 2017. The Company’s financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

The Company will continue to incur significant expenses for continued commercialization activities related to Lumega-Z, the MapcatSF® medical device, and VectorVision products. Development and commercialization of medical foods and medical devices involves a lengthy and complex process. Additionally, the Company’s long-term viability and growth may depend upon the successful development and commercialization of new complementary products or product lines. The Company is continuing attempts to raise additional debt and/or equity capital to fund future operations, but there can be no assurances that the Company will be able to secure such additional financing in the amounts necessary to fully fund its operating requirements on acceptable terms or at all. If the Company is unable to access sufficient capital resources on a timely basis, the Company may be forced to reduce or discontinue its technology and product development programs and curtail or cease operations.

 

Sources and Uses of Cash

 

The following table sets forth the Company’s major sources and uses of cash for each of the following periods:

 

  

Six Months Ended

June 30,

 
   2018   2017 
Net cash used in operating activities  $(2,424,058)  $(1,023,321)
Net cash used in investing activities   (187,073)   (5,500)
Net cash (used in) provided by financing activities   (57,734)   1,263,837 
Net (decrease) increase in cash  $(2,668,865)  $235,016 

 

Operating Activities

 

Net cash used in operating activities was $2,424,058 during the six months ended June 30, 2018, versus $1,023,321 used during the comparable prior year period. The increase in 2018 was due primarily to higher sales, marketing, labor, and legal costs.

 

 27 

 

 

Investing Activities

 

Net cash used in investing activities was $187,073 for the six months ended June 30, 2018 and $5,500 for the six months ended June 30, 2017. In January 2018, we acquired the rights to a trademark portfolio for $50,000. In addition, we invested in a trade show booth in February.

 

Financing Activities

 

Net cash used in financing activities was $57,734 for the six months ended June 30, 2018 was due primarily to the Company payoff of a line of credit balance that had been assumed from the VectorVision transaction. Financing activities for the prior year comparable period provided proceeds of $100,000 from the issuance of short-term loans, offset by payments of principal and interest on loans of $14,000, $1,100,000 in proceeds from the issuance of Series B Preferred Stock, and $77,837 in amounts due to related parties on a net basis.

 

Off-Balance Sheet Arrangements

 

At June 30, 2018 and December 31, 2017, we did not have any transactions, obligations or relationships that could be considered off-balance sheet arrangements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

As of the end of the period covered by this Quarterly Report on Form 10-Q, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Accounting Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Based upon this evaluation, the Chief Executive Officer and Chief Accounting Officer each concluded that the Company’s disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms, and that such information has been accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and Chief Accounting Officer, in a manner that allows timely decisions regarding required disclosure. There have been no changes in the Company’s internal control over financial reporting identified in connection with the evaluation that occurred during the first quarter ended in 2018 that have materially affected, or are reasonably likely to materially affect, the internal control over financial reporting.

 

 28 

 

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

The Company is periodically the subject of various pending or threatened legal actions and claims arising out of its operations in the normal course of business. In the opinion of management of the Company, adequate provision has been made in the Company’s condensed consolidated financial statements at June 30, 2018 with respect to such matters, including the matter noted below.

 

On or about July 26, 2017, the Company received a payment demand from a former consultant to the Company alleging that the consultant is owed approximately $192,000 for services rendered. The Company has disputed this demand and attempts to resolve this matter were unsuccessful. On January 29, 2018, the Company filed a lawsuit against the consultant and its related entities in the United States District Court for the Southern District of California (Case No. 18CV200-W-KSC) seeking declaratory relief regarding advisory fees and ownership interest in the Company. On March 6, 2018, the consultant and its related entities filed counterclaims against the Company, seeking payment for services rendered and seeking declaratory relief regarding ownership interest in the Company. The Company intends to vigorously defend its rights. The Company cannot predict the outcome of this matter.

 

ITEM 1A. RISK FACTORS

 

Not required for smaller reporting companies.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

In January 2018, an investor exercised warrants for 146,000 shares of common stock. The warrants were exercisable for $0.01 per share, and the Company received $1,460 in cash. The Company issued the shares and recorded the cash received as additional equity.

 

On January 26, 2018, the Company entered into an agreement with a consultant to develop products based on certain intellectual property owned by the Company (see Note 6). In conjunction with the consulting agreement, the Company granted a stock option to the consultant to purchase a total of 500,000 shares of the common stock of the Company. 250,000 shares of the option with a fair value of $287,500 vested immediately, 125,000 shares vest on December 31, 2018 and the remaining 125,000 shares vest on December 31, 2019 provided the consultant is still an active service provider. As of June 30, 2018, the 250,000 options that remain to vest were valued in total at $287,365 based upon a Black-Scholes option-pricing model. Compensation cost is measured as the fair value at the end of each reporting period and cost is amortized based upon a graded vesting schedule. The options are non-qualified, have an exercise price of $1.25 per share, and will expire 5 years from the grant date. During the six months ended June 30, 2018, the Company recognized stock compensation costs of $384,046 related to these options.

 

On July 25, 2018, the Company entered into a product development consulting agreement with a product development company to design and create a working prototype device based on certain intellectual property owned by the Company. In conjunction with the product development agreement, the Company granted a stock option to the consultant to purchase a total of 100,000 shares of the common stock of the Company. 25,000 shares of the option vested immediately, 50,000 shares vest upon completion of design and construction of the AcQviz device to the reasonable satisfaction of the Company, and the remaining 25,000 shares vest upon integration of the AcQviz send/receive functionality with vision testing software platform to the reasonable satisfaction of the Company.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

Not applicable.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

 29 

 

 

ITEM 5. OTHER INFORMATION

 

Not applicable.

 

ITEM 6. EXHIBITS

 

A list of exhibits required to be filed as part of this report is set forth in the Index to Exhibits, which is presented elsewhere in this document, and is incorporated herein by reference.

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized on the 10th day of August, 2018.

 

Signature   Title   Date
         
/s/ Michael Favish   CEO, President and   August 10, 2018
Michael Favish  

Chairman of the Board
(Principal Executive Officer)

    
         
/s/ John Townsend Controller and Chief Accounting Officer   August 10, 2018
John Townsend   (Principal Accounting Officer)    

 

 30 

 

  

INDEX TO EXHIBITS

 

Exhibit No.   Description  
3.1   Certificate of Elimination of Designations, Preferences and Rights of Series A and Series B Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on May 2, 2018)
31.1   Certification of Chief Executive Officer pursuant to Rule 13a – 14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2   Certification of Chief Accounting Officer pursuant to Rule 13a – 14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*   Certification of Chief Executive Officer and Chief Accounting Officer pursuant to 18.U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
101   The following materials from the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2018, formatted in XBRL (eXtensible Business Reporting Language), (i) Balance Sheets, (ii) Statements of Income, (iii) Statements of Comprehensive Income, (iv) Statements of Cash Flows, (v) Statement of Stockholders’ Equity and (vi) Notes to Financial Statements

  

*A certification furnished pursuant to Item 601(b)(2) of the Regulation S-K will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

 

 31 

 EX-31.1 2 tv500249_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION

 

I, Michael Favish, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Guardion Health Sciences, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:  August 10, 2018 /s/ Michael Favish    
  Michael Favish
  Chief Executive Officer
  (Principal Executive Officer)

 

 

 EX-31.2 3 tv500249_ex31-2.htm EXHIBIT 31.2

  

Exhibit 31.2

 

CERTIFICATION

 

I, John Townsend, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Guardion Health Sciences, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:  August 10, 2018 /s/ John Townsend    
  John Townsend
  Controller and Chief Accounting Officer
  (Principal Accounting Officer)

 

 

 

 EX-32.1 4 tv500249_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATIONS PURSUANT TO

18 U.S.C. SECTION 1350,

AS ENACTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Guardion Health Sciences, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of Michael Favish, Chief Executive Officer of the Company, and John Townsend, Controller and Chief Accounting Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as enacted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

August 10, 2018 /s/ Michael Favish  
  Michael Favish
  Chief Executive Officer
  (Principal Executive Officer)
   
   
August 10, 2018 /s/ John Townsend            
  John Townsend
  Controller and Chief Accounting Officer
  (Principal Accounting Officer)

 

 

 

 EX-101.INS 5 cik0001642375-20180630.xml XBRL INSTANCE DOCUMENT 0001642375 2018-01-01 2018-06-30 0001642375 2018-06-30 0001642375 2017-12-31 0001642375 2018-04-01 2018-06-30 0001642375 2017-04-01 2017-06-30 0001642375 2017-01-01 2017-06-30 0001642375 2016-12-30 2017-09-29 0001642375 2017-09-29 0001642375 2018-08-10 0001642375 2017-09-30 0001642375 2018-01-31 0001642375 2018-05-31 0001642375 2016-01-01 2016-12-31 0001642375 2018-01-01 2018-01-26 0001642375 2017-12-30 0001642375 2018-01-01 2018-01-31 0001642375 2018-01-26 0001642375 2017-09-01 2017-09-30 0001642375 2018-04-26 0001642375 2018-05-02 2018-05-31 0001642375 2018-05-05 2018-05-31 0001642375 2018-04-30 0001642375 2018-03-29 2018-06-01 0001642375 2019-05-02 2019-05-31 0001642375 2016-12-31 0001642375 2017-06-30 0001642375 us-gaap:PropertyPlantAndEquipmentMember 2018-01-01 2018-06-30 0001642375 cik0001642375:LumegazAndSupplementsMember 2018-01-01 2018-06-30 0001642375 cik0001642375:VectorvisionMedicalDevicesAndSuppliesMember 2018-01-01 2018-06-30 0001642375 us-gaap:WarrantMember 2018-01-01 2018-06-30 0001642375 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-06-30 0001642375 us-gaap:ConvertibleDebtSecuritiesMember 2018-01-01 2018-06-30 0001642375 cik0001642375:ConversionOfPreferredStockMember 2018-01-01 2018-06-30 0001642375 us-gaap:CommonStockMember 2018-01-01 2018-06-30 0001642375 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0001642375 us-gaap:RetainedEarningsMember 2018-01-01 2018-06-30 0001642375 us-gaap:WarrantMember 2018-01-01 2018-06-30 0001642375 us-gaap:LeaseholdImprovementsMember 2018-06-30 0001642375 us-gaap:OtherMachineryAndEquipmentMember 2018-06-30 0001642375 us-gaap:FurnitureAndFixturesMember 2018-06-30 0001642375 us-gaap:ComputerEquipmentMember 2018-06-30 0001642375 us-gaap:OfficeEquipmentMember 2018-06-30 0001642375 us-gaap:WarrantMember 2018-06-30 0001642375 cik0001642375:NonQualifiedStockOptionsMember 2018-06-30 0001642375 cik0001642375:NonQualifiedStockOptionsMember cik0001642375:ConsultantMember 2018-06-30 0001642375 us-gaap:LeaseholdImprovementsMember 2017-12-31 0001642375 us-gaap:OtherMachineryAndEquipmentMember 2017-12-31 0001642375 us-gaap:FurnitureAndFixturesMember 2017-12-31 0001642375 us-gaap:ComputerEquipmentMember 2017-12-31 0001642375 us-gaap:OfficeEquipmentMember 2017-12-31 0001642375 cik0001642375:LumegazAndSupplementsMember 2017-04-01 2017-06-30 0001642375 cik0001642375:VectorvisionMedicalDevicesAndSuppliesMember 2017-04-01 2017-06-30 0001642375 cik0001642375:LumegazAndSupplementsMember 2018-04-01 2018-06-30 0001642375 cik0001642375:VectorvisionMedicalDevicesAndSuppliesMember 2018-04-01 2018-06-30 0001642375 us-gaap:PropertyPlantAndEquipmentMember 2017-01-01 2017-06-30 0001642375 cik0001642375:LumegazAndSupplementsMember 2017-01-01 2017-06-30 0001642375 cik0001642375:VectorvisionMedicalDevicesAndSuppliesMember 2017-01-01 2017-06-30 0001642375 us-gaap:WarrantMember 2017-01-01 2017-06-30 0001642375 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-06-30 0001642375 us-gaap:ConvertibleDebtSecuritiesMember 2017-01-01 2017-06-30 0001642375 cik0001642375:ConversionOfPreferredStockMember 2017-01-01 2017-06-30 0001642375 us-gaap:SeriesAPreferredStockMember 2017-01-01 2017-06-30 0001642375 us-gaap:SeriesBPreferredStockMember 2017-01-01 2017-06-30 0001642375 us-gaap:DividendDeclaredMember us-gaap:SeriesBPreferredStockMember 2017-01-01 2017-06-30 0001642375 cik0001642375:VectorvisionIncMember 2016-12-30 2017-09-29 0001642375 cik0001642375:VectorvisionIncMember 2017-09-29 0001642375 us-gaap:IntellectualPropertyMember 2018-01-01 2018-01-26 0001642375 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2018-01-01 2018-01-26 0001642375 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2018-01-01 2018-01-26 0001642375 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2018-01-01 2018-01-26 0001642375 us-gaap:SeriesAPreferredStockMember 2016-01-01 2016-12-31 0001642375 us-gaap:PreferredStockMember 2016-01-01 2016-12-31 0001642375 us-gaap:SeriesAPreferredStockMember 2016-12-31 0001642375 us-gaap:SeriesBPreferredStockMember 2017-04-01 2017-09-30 0001642375 us-gaap:SeriesBPreferredStockMember 2017-09-30 0001642375 us-gaap:PrivatePlacementMember 2017-11-01 2017-11-03 0001642375 us-gaap:CommonStockMember 2017-11-01 2017-11-03 0001642375 us-gaap:PrivatePlacementMember 2017-11-03 0001642375 us-gaap:SeriesBPreferredStockMember 2017-11-03 0001642375 cik0001642375:NonQualifiedStockOptionsMember cik0001642375:ConsultantMember 2017-12-01 2017-12-30 0001642375 us-gaap:SubsequentEventMember 2018-07-01 2018-07-31 0001642375 us-gaap:MeasurementInputPriceVolatilityMember 2018-05-31 0001642375 us-gaap:MeasurementInputRiskFreeInterestRateMember 2018-05-31 0001642375 cik0001642375:NonQualifiedStockOptionsMember 2017-09-01 2017-09-30 0001642375 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2017-09-01 2017-09-30 0001642375 cik0001642375:NonQualifiedStockOptionsMember cik0001642375:ConsultantMember 2017-12-30 0001642375 us-gaap:WarrantMember 2018-05-01 0001642375 us-gaap:CommonStockMember 2017-12-31 0001642375 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001642375 us-gaap:RetainedEarningsMember 2017-12-31 0001642375 us-gaap:CommonStockMember 2018-06-30 0001642375 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001642375 us-gaap:RetainedEarningsMember 2018-06-30 <div style="text-align:left;"><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0px; margin-bottom: 0px; width: 99%; border-collapse: collapse; border-spacing: 0px; table-layout: fixed;"><tr style="vertical-align:top; text-align:justify"><td style="width: 0px; padding: 0px; font-family: &quot;times new roman&quot;, times, serif;"></td><td style="width: 0.5in; text-align: left; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">3.</div></td><td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">VectorVision Acquisition</div></td></tr></table><div style="clear: both; background: none;"></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On September 29, 2017, the Company, through a wholly-owned subsidiary, completed the acquisition of substantially all of the assets and certain liabilities of VectorVision, Inc., an Ohio corporation (&#8220;VectorVision&#8221;), in exchange for 3,050,000 shares of the Company&#8217;s common stock, valued at $2,287,500, pursuant to the terms of an Asset Purchase and Reorganization Agreement dated September 29, 2017&#160;</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(the &#8220;VectorVision Agreement&#8221;). The VectorVision Agreement&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> was entered into on an arm&#8217;s-length basis. The wholly-owned subsidiary that acquired the business is called VectorVision Ocular Health, Inc., a Delaware corporation, doing business as VectorVision. With respect to the 3,050,000 shares of common stock, 250,000 shares are held back by the Company through November 28, 2019 as security for VectorVision&#8217;s indemnification obligations to the Company and the remaining 2,800,000 shares were issued to VectorVision at the closing of the </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;">transaction</div>. Per the VectorVision Agreement, the 2,800,000 shares</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> were subsequently distributed to the two VectorVision shareholders in proportion to their shareholdings in VectorVision. The shares represented approximately 11% of the Company&#8217;s issued and outstanding common stock immediately following consummation of the </div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">transaction</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">. The shares held back as security are included in the Company&#8217;s weighted average common shares outstanding for per-share calculations.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">VectorVision develops, manufactures and sells equipment and supplies for standardized vision testing for use by eye doctors in clinical trials, for real-world vision evaluation, and industrial vision testing. VectorVision specializes in the standardization of contrast sensitivity, glare sensitivity, low contrast acuity, and ETDRS (Early Treatment Diabetic Retinopathy Study) visual acuity testing. VectorVision developed and commercialized its CSV-1000 medical device to conduct contrast sensitivity testing and it developed and commercialized its ESV-3000 medical device to conduct ETDRS visual acuity testing. The patented standardization system provides the practitioner or researcher with the ability to delineate very small changes in visual capability, either as compared to the population or from visit to visit. The Company believes VectorVision&#8217;s CSV-1000 device to be the standard of care for clinical trials. The VectorVision transaction expanded the Company&#8217;s technical portfolio and the Company believes it further established the Company&#8217;s position at the forefront of early detection, intervention and monitoring of a range of eye diseases.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In accordance with ASC 805, the Company utilized the acquisition method of accounting, whereby the purchase consideration is allocated to specific tangible and intangible assets at their estimated fair values on the date of acquisition. The following table summarizes the allocation of preliminary fair values of the purchase consideration to the assets and liabilities assumed:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.75in; width: 70%;;text-align:left;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Values</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Common stock consideration</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,287,500</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Liabilities assumed</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1px solid black; border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding-top: 0pt; padding-right: 0px; padding-left: 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1px solid black; border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding-top: 0pt; padding-right: 0px; padding-left: 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">108,722</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;Total purchase consideration</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,396,222</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Cash</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(4,895</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(50,105</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Inventory</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(93,293</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Prepaid assets</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(551</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(9,458</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1px solid black; border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding-top: 0pt; padding-right: 0px; padding-left: 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1px solid black; border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding-top: 0pt; padding-right: 0px; padding-left: 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(674,400</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Goodwill</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,563,520</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr></table><div style="clear:both;"></div></div> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the expected revenue and benefits of the combined company.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following unaudited pro forma financial information gives effect to the Company&#8217;s acquisition of VectorVision as if the acquisition had occurred on January 1, 2017 and had been included in the Company&#8217;s consolidated statements of operations during the three and six-month periods ended June 30, 2017:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.5in; width: 85%;;text-align:left;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-right-width: initial; border-bottom: 1px solid black; border-left-width: initial; border-right-color: initial; border-left-color: initial; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three&#160;Months&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended&#160;</div><div style="font-weight:bold;display:inline;">&#8206;</div><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-right-width: initial; border-bottom: 1px solid black; border-left-width: initial; border-right-color: initial; border-left-color: initial; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended&#160;</div><div style="font-weight:bold;display:inline;">&#8206;</div><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Pro forma net revenues</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">121,622</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">366,793</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Pro forma net loss attributable to common shareholders</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(1,088,909</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(1,825,640</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Pro forma net loss per share</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(0.04</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(0.06</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr></table><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0px; margin-bottom: 0px; width: 99%; border-collapse: collapse; border-spacing: 0px; table-layout: fixed;"><tr style="vertical-align:top; text-align:justify"><td style="width: 0px; padding: 0px; font-family: &quot;times new roman&quot;, times, serif;"></td><td style="width: 0.5in; text-align: left; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">4.</div></td><td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">Inventories</div></td></tr></table><div style="clear: both; background: none;"></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Inventories consisted of the following:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.5in; width: 85%;;text-align:left;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Raw materials</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">380,899</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">133,354</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Finished goods</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">31,458</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">21,376</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">412,357</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">154,730</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="text-align:left;"><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0px; margin-bottom: 0px; width: 99%; border-collapse: collapse; border-spacing: 0px; table-layout: fixed;"><tr style="vertical-align:top; text-align:justify"><td style="width: 0px; padding: 0px; font-family: &quot;times new roman&quot;, times, serif;"></td><td style="width: 0.5in; text-align: left; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">5.</div></td><td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">Property and Equipment, net</div></td></tr></table><div style="clear: both; background: none;"></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment consisted of the following:&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.5in; width: 85%;;text-align:left;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">98,357</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">98,357</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Testing equipment</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">169,552</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">150,603</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">145,411</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">50,300</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Computer equipment</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">39,476</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">16,464</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Office equipment</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">8,193</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">8,193</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">460,989</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">323,917</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Less accumulated depreciation and amortization</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(269,562</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(228,320</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">191,427</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">95,597</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div></div> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">For the six months ended June 30, 2018 and 2017, depreciation expense was $41,242 and $31,331, respectively, of which $15,376 and $14,650 were&#160;included in research and development expense, $4,138 and $0 were&#160;included in sales and marketing expense, and $21,728 and $16,861 were&#160;included in general and administrative expense, respectively.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0px; margin-bottom: 0px; width: 99%; border-collapse: collapse; border-spacing: 0px; table-layout: fixed;"><tr style="vertical-align:top; text-align:justify"><td style="width: 0px; padding: 0px; font-family: &quot;times new roman&quot;, times, serif;"></td><td style="width: 0.5in; text-align: left; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">6.</div></td><td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">Acquisition of Intellectual Property</div></td></tr></table><div style="clear: both; background: none;"></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On January 26, 2018, the Company acquired the rights to the trademark GLAUCO-HEALTH as well as the name &#8220;International Eye Wellness Institute&#8221; (together, the &#8220;IP Assets&#8221;) from an unrelated third&#160;party. The purchase included all rights, title, and interest in and to the IP Assets, including (a) the right to register and use the IP Assets; (b) all goodwill associated with the IP Assets; (c) all income, royalties, and damages hereafter due or payable with respect to the IP Assets; (d) all rights to sue for past, present, and future infringements or misappropriations of the IP Assets; and (e) and all other intellectual property rights owned or claimed by the seller or embodied in the IP Assets. In exchange for these rights, the Company paid the seller $50,000 in cash.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">ASC 350-30-20 defines a defensive intangible asset as an acquired intangible asset in a situation in which an entity does not intend to actively use the asset but intends to hold (lock up) the asset to prevent others from obtaining access to the asset. The Company determined that the acquired intangible asset met the definition of a defensive intangible asset. The Company accounted for the $50,000 payment as an acquired intangible asset as of the closing of the agreement. As the Company can renew the underlying rights to the IP Assets indefinitely at nominal cost, the assets have been classified as a non-amortizable intangible asset on the Company&#8217;s balance sheet at June 30, 2018. The Company will evaluate the status of the assets for impairment annually&#160;or&#160;more&#160;frequently&#160;if&#160;warranted.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On January 26, 2018 the Company entered into a consulting agreement with the principal of the seller to assist with the development of the IP Assets and other assets acquired by the Company in the transaction. In conjunction with the consulting agreement, the Company granted a stock option on January 26, 2018 to the consultant to purchase a total of 500,000 shares of the common stock of the Company (see Note 8).</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0px; margin-bottom: 0px; width: 99%; border-collapse: collapse; border-spacing: 0px; table-layout: fixed;"><tr style="vertical-align:top; text-align:justify"><td style="width: 0px; padding: 0px; font-family: &quot;times new roman&quot;, times, serif;"></td><td style="width: 0.5in; text-align: left; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">7.</div></td><td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">Related Party Transactions</div></td></tr></table><div style="clear: both; background: none;"></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Due to and from related parties represents unreimbursed expenses and compensation incurred on behalf of, and amounts loaned to the Company by, Michael Favish, the Company&#8217;s Chief Executive Officer, as well as other stockholders. The advances are unsecured, non-interest bearing and are due on demand. As of June 30, 2018 and December 31, 2017, the Company had $117,473 and $146,133, respectively, due to related parties.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0px; margin-bottom: 0px; width: 99%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align:top; text-align:justify"><td style="width: 0.5in; text-align: left; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;">8.</div></td><td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;">Stockholders&#8217; Equity</div></td></tr></table><div style="clear: both; background: none;"></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Stock</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Series A</div></div><div style="background-color: initial; font-size: 10pt; letter-spacing: 0px; white-space: pre-line; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During 2016, the Company sold 1,170,000 shares of the Company's Series A Senior Convertible Preferred Stock (the "Series A Preferred Stock") to various investors. The purchase price of the Series A Preferred Stock was $1.00 per share, for an aggregate purchase price of $1,170,000. In addition, during 2016, the Company issued 535,154 shares of its Series A Preferred Stock with a fair value of $784,888 upon conversion of $535,149 of notes payable and accrued interest. The Series A Preferred Stock had a stated value of $1.00 per share and accrued an annual dividend at the rate of 8% of the stated value, calculated quarterly, paid in shares of common stock at the rate of $0.60 per share.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the six&#160;months ended June 30, 2017, the Company declared dividends of $67,646 on its Series A Preferred Stock which were satisfied in full through the issuance of an aggregate of 112,759 shares of common stock.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Series B</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Beginning in March 2017 and through September 30, 2017, the Company sold 3,105,000 shares of the Company's Series B Convertible Preferred Stock (the "Series B Preferred Stock") to various investors. The purchase price of the Series B Preferred Stock was $1.00 per share, for an aggregate purchase price of $3,105,000. The Series B Preferred Stock had a stated value of $1.00 per share and accrued an annual dividend at the rate of 6% of the stated value, calculated quarterly, paid in shares of common stock at the rate of $0.75 per share.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the six&#160;months ended June&#160;30, 2017, the Company declared dividends of $13,537 on its Series B Preferred Stock which were satisfied in full through the issuance of an aggregate of 18,054 shares of common stock.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On November 3, 2017, the Company completed the issuance and sale of an aggregate of 4,347,827 shares of common stock (see below). The completion of the private placement triggered, at the Company's election, the automatic conversion of the </div>Series A Preferred Stock and the Series B P<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">referred Stock into shares of common stock. Accordingly, immediately following the completion of the private placement, the Company effected the conversion of all outstanding shares of Series A Preferred Stock and the Series B Preferred Stock into 6,981,938 shares of common stock (excluding accrued but unpaid dividends) effective November 3, 2017. On April 26, 2018, the Company filed a Certificate of Elimination with the </div>Secretary of the State of Delaware, withdrawing the respective Certificates of Designation that established the right, privileges and preferences of the Series A Preferred Stock and Series B Preferred Stock, thereby making all<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> 10,000,000 authorized shares of preferred stock available for issuance.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Common Stock</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On November 3, 2017, the Company completed the issuance and sale of an aggregate of 4,347,827 shares of common stock, par value $0.001 per share, at a purchase price of $1.15 per share. Total gross proceeds were $5,000,001. These shares were sold in a private placement to certain purchasers pursuant to a Stock Purchase Agreement dated as of November 3, 2017. Pursuant to the agreement, the purchasers have customary preemptive rights to participate in future equity and equity-linked issuances by the Company up to the extent necessary to maintain such purchaser&#8217;s pro rata ownership percentage in the Company&#8217;s securities, subject to customary exceptions. The preemptive rights terminate at the earlier of (i) </div>May 3, 2019<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">, (ii) such time as the Purchasers hold less than five percent (5%) of the issued and outstanding shares of the Company&#8217;s common stock, or (iii) such time as the shares of common stock of the Company shall become listed or approved for listing on a national securities exchange.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">A summary of the Company&#8217;s warrant activity is as follows:&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.5in; width: 85%;;text-align:left;"><tr><td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in 0in 1pt; vertical-align: bottom;"><div style="font-size: 10pt; line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></div></div></td><td style="border-top: none; padding: 0in 0in 0.5pt; vertical-align: bottom;"><div style="font-size: 10pt; line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2017</div></div></div></td><td style="background: rgb(204, 238, 255); border-top: none; padding: 0in; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,983,666</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Forfeitures</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Expirations</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(181,243</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: left; margin: 0px 0px 0px 0in; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1pt; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(146,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: left; margin: 0px 0px 0px 0in; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2018, all exercisable</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,656,423</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div></div> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In January 2018, an investor exercised warrants for 146,000 shares of common stock. The warrants were exercisable for $0.01 per share, and the Company received $1,460 in cash. The Company issued the shares and recorded the cash received as additional equity.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On April 30, 2018, The Company offered a one-month exercise period extension to stockholders who held warrants to purchase shares of common stock of the Company that were scheduled to expire on May 1, 2018. Pursuant to the terms of a Note and Warrant Purchase Agreement entered into by the Company and such holders, such warrants were issued upon the conversion of certain promissory notes into common stock on May 1, 2015. Four of the warrant holders did not extend their warrants, resulting in the expiration of 151,006 warrants on May 1, 2018. Six warrant holders elected to extend the term of an aggregate of 403,085 warrants by one month to June 1, 2018. The exercise price of such warrants is $1.00 per share.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On May 31, 2018, the six warrant holders noted above were offered a further extension of the exercise period for their warrants. One holder did not extend, resulting in the expiration of 30,237 warrants on June 1, 2018. Five warrant holders elected to extend the term of an aggregate of 372,848 warrants. These warrants are now scheduled to expire on the earlier of (a) May 31, 2019 or (b) sixty days following the date on which the common stock of the Company becomes listed or approved for listing on a national securities exchange. The exercise price of such warrants remains unchanged at $1.00 per share, but cashless exercise provisions have been eliminated from such warrants.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Management applied the guidance in ASC 718 &#8211; Compensation-Stock Compensation which&#160;indicates that a modification to the terms of an award should be treated as an exchange of the original award for a new award with the resulting total compensation cost equal to the grant-date fair value of the original award plus the incremental value of the modification to the award. Under ASC 718, the calculation of the incremental value is based on the excess of the fair value of the new (modified) award based on current circumstances over the fair value of the original award measured immediately before its terms are modified based on current circumstances. The Company recognized expense of $494,391 relating to the extension of the exercise period of the warrants based upon a Black-Scholes option-pricing model using a stock price of $1.15, volatility of 118%, and an average risk-free rate of 2.61. The expense is reflected as Fair value of warrants - extension of expiration dates in the Company&#8217;s statements of operations.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2018, the Company had an aggregate of 2,656,423 outstanding warrants to purchase shares of its common stock with a weighted average exercise price of $0.43, weighted average remaining life of 0.7 years and aggregate intrinsic value of $1,905,475, based upon a stock valuation of $1.15 per share. The intrinsic value is calculated as the difference between the market value of the underlying common stock and the exercise price of the warrants.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Stock Options</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">A summary of the Company&#8217;s stock option activity is as follows:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.5in; width: 85%;;text-align:left;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2017</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,125,000</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">500,000</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Forfeitures</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-right-width: initial; border-bottom: 1px solid black; border-left-width: initial; border-right-color: initial; border-left-color: initial; padding-top: 0pt; padding-right: 0px; padding-left: 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-right-width: initial; border-bottom: 1px solid black; border-left-width: initial; border-right-color: initial; border-left-color: initial; padding-top: 0pt; padding-right: 0px; padding-left: 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2018, outstanding</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,625,000</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; font-weight: normal;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2018, exercisable</div></div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none; text-decoration: none; font-weight: normal;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none; text-decoration: none; font-weight: normal;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; font-weight: normal;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">2,225,000</div></div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none; text-decoration: none; font-weight: normal;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr></table><div style="clear:both;"></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On September 30, 2017, the Company entered into a consulting agreement pursuant to which the Company granted&#160;a total of 1,250,000 common stock options. 650,000 of the options with a fair value of $486,070 vested immediately,&#160;and the remaining 600,000 options vest ratably over twelve months on a quarterly basis with compensation cost measured as the fair value at the end of each reporting period. The options are non-qualified, have an exercise price of $1.00 per share, and will expire 5 years from the grant date. As of December 31, 2017, the Company had recognized compensation cost of $658,383 relating to the vesting of 800,000 options. During the six months ended June 30, 2018, the Company recognized stock compensation costs of $256,962 related to the vesting of 450,000 options based upon a graded vesting schedule.&#160;As of June 30, 2018, the remaining 150,000 options to vest were valued at $172,388 based upon a Black-Scholes option-pricing model. </div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On December 30, 2017, the Company entered into a consulting agreement pursuant to which the Company granted&#160;a total of 750,000 common stock options. 250,000 of the options with a fair value of $312,275 vested immediately,&#160;and&#160;the&#160;remaining 500,000 </div>options vested ratably over six months on a quarterly basis with compensation cost measured as the fair value at the end of each reporting period, using a Black Scholes option-pricing model and a graded vesting schedule. The options are non-qualified, have an exercise price <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">of $1.25 per share, and will expire </div>5 years from the grant date. As of June 30, 2018, all options were fully vested. During the six months ended June 30, 2018, the Company recognized stock compensation costs of $413,877 related to these options<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On January 26, 2018, the Company entered into an agreement with a consultant to develop products based on certain intellectual property owned by the Company (see Note 6). In conjunction with the consulting agreement, the Company granted a stock option to the consultant to purchase a total of 500,000 shares of the common stock of the Company.&#160;250,000 shares of the option with a fair value of $287,500 vested immediately, 125,000 shares vest on December 31, 2018 and the remaining 125,000 shares vest on December 31, 2019 provided the consultant is still an active service provider. As of June 30, 2018, the 250,000 options that remain to vest were valued in total at $287,365 based upon a Black-Scholes option-pricing model. Compensation cost is measured as the fair value at the end of each reporting period and cost is amortized based upon a graded vesting schedule. The options are non-qualified, have an exercise price of $1.25 per share, and will expire&#160;5 years&#160;</div>from the grant date. During the six months ended June 30, 2018, the Company recognized stock compensation costs of $384,046 related to these options<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2018, options were valued based upon the Black-Scholes option-pricing model, with a stock price of $1.15, volatility of 120%, and an average risk-free rate of 2.65%.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2018, the Company had an aggregate of 400,000 remaining unvested options outstanding, with estimated fair value of $459,754. The Company remeasures unvested options for non-employees to fair value at the end of each reporting period. The aggregate intrinsic value of options outstanding as of June 30, 2018 was $187,500.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0px; margin-bottom: 0px; width: 99%; border-collapse: collapse; border-spacing: 0px; table-layout: fixed;"><tr style="vertical-align:top; text-align:justify"><td style="width: 0px; padding: 0px; font-family: &quot;times new roman&quot;, times, serif;"></td><td style="width: 0.5in; text-align: left; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">9.</div></td><td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">Commitments and Contingencies</div></td></tr></table><div style="clear: both; background: none;"></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company is periodically the subject of various pending or threatened legal actions and claims arising out of its operations in the normal course of business. In the opinion of management of the Company, adequate provision has been made in the Company&#8217;s condensed financial statements at June 30, 2018 with respect to such matters, including the matter noted below.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On or about July 26, 2017, the Company received a payment demand from a former consultant to the Company alleging that the consultant is owed approximately $192,000 for services rendered. The Company has disputed this demand and attempts to resolve this matter were unsuccessful. On January 29, 2018, the Company filed a lawsuit against the consultant and its related entities in the United States District Court for the Southern District of California (Case No. 18CV200-W-KSC) seeking declaratory relief regarding advisory fees and ownership interest in the Company. On March 6, 2018, the consultant and its related entities filed counterclaims against the Company, seeking payment for services rendered and seeking declaratory relief regarding ownership interest in the Company. </div>The Company intends to vigorously defend its rights. The Company cannot predict the outcome of this matter.</div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Inventories consisted of the following:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.5in; width: 85%;;text-align:left;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Raw materials</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">380,899</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">133,354</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Finished goods</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">31,458</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">21,376</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">412,357</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">154,730</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment consisted of the following:&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.5in; width: 85%;;text-align:left;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">98,357</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">98,357</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Testing equipment</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">169,552</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">150,603</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Furniture and fixtures</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">145,411</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">50,300</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Computer equipment</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">39,476</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">16,464</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Office equipment</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">8,193</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">8,193</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">460,989</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">323,917</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Less accumulated depreciation and amortization</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(269,562</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(228,320</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">191,427</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">95,597</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">A summary of the Company&#8217;s warrant activity is as follows:&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.5in; width: 85%;;text-align:left;"><tr><td style="border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none; text-align: center; white-space: nowrap;"><div style="background: none;;font-weight:bold;display:inline;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td style="border-top: none; padding: 0in 0in 1pt; vertical-align: bottom;"><div style="font-size: 10pt; line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 11%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></div></div></td><td style="border-top: none; padding: 0in 0in 0.5pt; vertical-align: bottom;"><div style="font-size: 10pt; line-height: normal; margin-bottom: 0px; margin-top: 0px;"><div style="background: none;;font-weight:bold;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2017</div></div></div></td><td style="background: rgb(204, 238, 255); border-top: none; padding: 0in; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: 0px none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,983,666</div></div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Forfeitures</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in; vertical-align: bottom; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Expirations</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: none; border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0in; vertical-align: bottom; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(181,243</div></div></td><td style="background: rgb(255, 255, 255); padding: 0in; vertical-align: bottom; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: left; margin: 0px 0px 0px 0in; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-top: none; border-bottom: none; padding: 0px 0px 1pt; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 1pt; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(204, 238, 255); width: 1%; border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-top: none; padding: 0in; vertical-align: bottom; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(146,000</div></div></td><td style="background: rgb(204, 238, 255); padding: 0in 0in 0.5pt; vertical-align: bottom; width: 1%; text-align: left;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: left; margin: 0px 0px 0px 0in; line-height: normal; text-indent: 0in; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-top: none; border-bottom: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2018, all exercisable</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background-color: rgb(255, 255, 255); width: 1%; border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; text-align: left; vertical-align: bottom; padding: 0in;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-top: 0px none; padding: 0in; vertical-align: bottom; width: 10%; text-align: right;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0in; margin-bottom: 0px; margin-top: 0px; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,656,423</div></div></div></td><td style="background: rgb(255, 255, 255); padding: 0in 0in 1.25pt; vertical-align: bottom; width: 1%; text-align: left;"><div style="font-size: 10pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0px; margin-bottom: 0px; width: 99%; border-collapse: collapse; border-spacing: 0px; table-layout: fixed;"><tr style="vertical-align:top; text-align:justify"><td style="width: 0px; padding: 0px; font-family: &quot;times new roman&quot;, times, serif;"></td><td style="width: 0.5in; text-align: left; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">10.</div></td><td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px; font-family: &quot;times new roman&quot;, times, serif;"><div style="font-weight:bold;display:inline;">Subsequent Events</div></td></tr></table><div style="clear: both; background: none;"></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On July 25, 2018, the Board of Directors approved the Company entering into a product development consulting agreement with a product development company to design and create a working prototype device, named AcQviz, intended to embody the inventions described in US Patent No. 10,022,045 and US Patent Application 15/277,849, each of which the Company owns. Under this agreement, the product development company is to create a prototype device using sensor circuitry and communication software/firmware unique to the product development company, oversee the integration of the prototype circuitry design into a commercial product, develop specifications for the Company to mass produce a commercial product based on the prototype and integrate the communication channel for the device into various vision testing software programs. In conjunction with the product development agreement, the Board of Directors of the Company also approved a stock option grant to the product development company to purchase 100,000 shares of the common stock of the Company based on certain performance metrics set forth in the product development agreement and stock option agreement. </div> The President of the product development company, Joseph Tate Evans, Jr., is the brother of David Evans, Chief Science Officer and a director of the Company.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;">&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Basis of Presentation and Use of Estimates</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; table-layout: fixed;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px; vertical-align: top; width: 0.3pt;"></td><td style="width: 0.5in; text-align: left; font-size: 10pt;"><div style="font-size:10pt;display:inline;"><div style="font-weight:bold;display:inline;">1.</div></div></td><td style="text-align: justify; font-size: 10pt;"><div style="font-size:10pt;display:inline;"><div style="font-weight:bold;display:inline;">Organization and Business Operations</div></div></td></tr></table></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Organization and Business</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Guardion Health Sciences, Inc. (the &#8220;Company&#8221;) was formed in December 2009 as a California limited liability company under the name P4L Health Sciences, LLC. On June 30, 2015, the Company converted from a California limited liability company to a Delaware corporation, changing its name from Guardion Health Sciences, LLC to Guardion Health Sciences, Inc.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-size:10pt;;display:inline;"><div style="font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;">The Company is a specialty health sciences company&#160;</div>that develops, formulates<div style="font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; font-size: 10pt;;display:inline;"> and distributes condition-specific medical foods with an initial medical food product on the market under the brand name Lumega-Z<div style="vertical-align: super;font-size: smaller;display:inline;">&#174;</div>&#160;that replenishes and restores the macular protective pigment.</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company also developed a proprietary medical device called the MapcatSF<div style="vertical-align: super;font-size: smaller;display:inline;">&#174; </div>that accurately measures the macular pigment optical density.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On September 29, 2017, the Company completed its acquisition of substantially all of the assets and certain liabilities of VectorVision, Inc., a company that specializes in the standardization of contrast sensitivity, glare sensitivity, low contrast acuity, and ETDRS visual acuity testing. VectorVision develops, manufactures and sells equipment and supplies for standardized vision testing.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;">The Company has had limited operations to date and has been primarily engaged in research and development, product commercialization and capital raising activities.</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Going Concern and Liquidity</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The financial statements have been prepared assuming the Company will continue as a going concern. The Company had a net loss of $4,143,025 and utilized cash in operating activities of $2,424,058 during the six months ended June 30, 2018. The Company expects to continue to incur net losses and negative operating cash flows in the near-term. As a result, management has concluded that there is substantial doubt about the Company&#8217;s ability to continue as a going concern within one year of the date that the financial statements are issued.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s independent registered public accounting firm has also included explanatory language in their opinion accompanying the Company&#8217;s audited financial statements for the year ended December 31, 2017. The Company&#8217;s financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company will continue to incur significant expenses for continued commercialization activities related to Lumega-Z, the MapcatSF<div style="vertical-align: super;font-size: smaller;display:inline;">&#174;</div> medical device, and VectorVision products. Development and commercialization of medical foods and medical devices involves a lengthy and complex process. Additionally, the Company&#8217;s long-term viability and growth may depend upon the successful development and commercialization of new complementary products or product lines. The Company is continuing to attempt to raise additional debt and/or equity capital to fund future operations, but there can be no assurances that the Company will be able to secure such additional financing in the amounts necessary to fully fund its operating requirements on acceptable terms or at all. If the Company is unable to access sufficient capital resources on a timely basis, the Company may be forced to reduce or discontinue its technology and product development programs and curtail or cease operations.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="text-align:left;"><table style="font: 10pt &quot;times new roman&quot;, times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin-top: 0px; margin-bottom: 0px; width: 99%; border-collapse: collapse; border-spacing: 0px;"><tr style="vertical-align:top; text-align:justify"><td style="width: 0.5in; text-align: left; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;">2.</div></td><td style="text-align: justify; padding-left: 0px; font-size: 10pt; line-height: 10pt; padding-top: 0px; padding-bottom: 0px;"><div style="font-weight:bold;display:inline;">Summary of Significant Accounting Policies</div></td></tr></table><div style="clear: both; background: none;"></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;">&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Basis of Presentation and Use of Estimates</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div></div> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Intangible Assets</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In connection with the VectorVision transaction, the Company identified and allocated estimated fair values to intangible assets including goodwill and customer relationships.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In accordance with Accounting Standard Codification (&#8220;ASC&#8221;) 350 &#8211; Intangibles &#8211; Goodwill and Other, the Company determined whether these assets are expected to have indefinite (such as goodwill) or limited useful lives, and for those with limited lives, the Company established an amortization period and method of amortization. Its goodwill and other intangible assets are subject to periodic impairment testing.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company utilized the services of an independent third-party valuation firm to assist in identifying intangible assets and in estimating their fair values. The useful lives for the Company&#8217;s intangible assets other than goodwill were estimated based on Management&#8217;s consideration of various factors, including assumptions that market participants might use about sales expectations as well as potential effects of obsolescence, competition, technological progress and the regulatory environment. Because the future pattern in which the economic benefits of these intangible assets may not be reliably determined, amortization expense is generally calculated on a straight-line basis.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Amortization expense for the identifiable intangible assets associated with the VectorVision acquisition is approximately $54,000 per quarter and is included with general and administrative expenses in the Company&#8217;s Statements of Operations.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Impairment of Long-Lived Assets</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company reviews long-lived assets, including property and equipment, identifiable intangible assets, and goodwill for impairment at each fiscal year end or when events or changes in circumstances indicate the carrying value of these assets may exceed their current fair values. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the assets. Assets to be disposed of are separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell and are no longer depreciated. The Company has not historically recorded any impairment to its long-lived assets. In the future, if events or market conditions affect the estimated fair value to the extent that a long-lived asset is impaired, the Company will adjust the carrying value of these long-lived assets in the period in which the impairment occurs. As of June 30, 2018 and December 31, 2017, the Company had not deemed any long-lived assets as impaired and was not aware of the existence of any indicators of impairment at such dates.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Segment Information</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company operates and manages its business as one reporting and operating segment, which is the business of developing and commercializing a variety of products that support the detection, intervention and monitoring of a range of eye diseases. The Company&#8217;s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for purposes of allocating resources and evaluating financial performance.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Revenue Recognition</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s revenue is comprised of sales of medical foods and dietary supplements to consumers through a direct sales/credit card process. In addition, the Company sells medical device equipment and </div> supplies to customers both in the&#160;<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">U.S. and internationally.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In September 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09 (ASU No. 2014-09) regarding revenue recognition. The new standard provides authoritative guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. generally accepted accounting principles. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in the exchange for those goods or services. The ASU became effective January 1, 2018.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Due to the nature of the products sold by the Company, the adoption of the new standard has had no quantitative effect on the financial statements. However, the guidance requires additional disclosures to help readers of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company previously recognized revenue when risk of loss transferred to its customers and collection of the receivable was reasonably assured, which generally occurs when the product is shipped. A product is not shipped without an order from the customer and credit acceptance procedures performed. The Company allows for returns within 30 days of purchase, although for all periods presented, returns have been insignificant.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Under the new guidance, revenue is recognized when control of promised goods or services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company reviews its sales transactions to identify contractual rights, performance obligations, and transaction prices, including the allocation of prices to separate performance obligations, if applicable. Revenue and costs of sales are recognized once products are delivered to the customer&#8217;s control and performance obligations are satisfied.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">All products sold by the Company are distinct individual products and consist of medical foods, supplemental formulas, medical devices and related supplies. The products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them. Contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Control of products sold transfers to customers upon shipment from the Company&#8217;s facilities, and the Company&#8217;s performance obligations are satisfied at that time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer. Payment for sales of Lumega-Z is generally made by approved credit cards. Payments for medical device sales are generally made by check, credit card, or wire transfer. Historically the Company has not experienced any significant payment delays from customers.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company provides a 30-day right of return to its retail Lumega-Z customers. A right of return does not represent a separate performance obligation, but because customers are allowed to return products, the consideration to which the Company expects to be entitled is variable. Upon evaluation of historical Lumega-Z and VectorVision product returns, the Company determined that less than one </div> percent of products&#160;is returned, and therefore&#160;<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">believes it is probable that such returns will not cause a significant reversal of revenue in the future. Due to the insignificant amount of historical returns as well as the standalone nature of the Company&#8217;s products and assessment of performance obligations and transaction pricing for the Company&#8217;s sales contracts, the Company does not currently maintain a contract asset or liability balance at this time. </div> The Company assesses its contracts&#160;<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">and the reasonableness of its conclusions on a quarterly basis.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the Company&#8217;s revenues disaggregated by product type:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div><br/><div style="font-weight:bold;display:inline;">&#8206;</div><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div><br/><div style="font-weight:bold;display:inline;">&#8206;</div><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; vertical-align: bottom; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Lumega-Z and supplements</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">79,993</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">59,977</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">152,132</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">115,912</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">VectorVision medical devices and supplies</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">140,785</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">261,686</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt 7.2pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">220,778</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">59,977</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">413,818</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">115,912</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Research and Development Costs</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Research and development costs consist primarily of fees paid to consultants and outside service providers and other expenses relating to the acquisition, design, development and testing of the Company&#8217;s medical foods and related products. Research and development expenditures, which include stock compensation expense, are expensed as incurred and totaled $194,708 and $25,770 for the six months ended June 30, 2018 and 2017, respectively.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Stock-Based Compensation</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company periodically issues stock-based compensation to officers, directors, contractors and consultants for services rendered. Such issuances vest and expire according to terms established at the issuance date.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Stock-based payments to officers, directors, consultants, contractors, and employees, which include grants of employee stock options, are recognized in the financial statements based on their fair values. Stock option grants, which are generally time vested, will be measured at the grant date fair value and charged to operations on a straight-line basis over the vesting period. The fair value of stock options is determined utilizing the Black-Scholes option-pricing model, which is affected by several variables, including the risk-free interest rate, the expected dividend yield, the expected life of the equity award, the exercise price of the stock option as compared to the fair market value of the common stock on the grant date and the estimated volatility of the common stock over the term of the equity award.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the FASB whereby&#160;the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period using a graded vesting basis. In certain circumstances where there are no future performance requirements by the non-employee, grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes stock compensation expense, on stock purchases at a price less than fair value, and for fully-vested stock issued to consultants and other service providers, for the excess of fair value of the stock over the price paid for the stock. The Company recognizes the fair value of stock-based compensation within its statements of operations with classification depending on the nature of the services rendered. The Company will issue new shares to satisfy stock option exercises.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Net Loss per Share</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;">The Company&#8217;s computation of basic and diluted net loss per common share is measured as net loss divided by the weighted average common shares outstanding during the respective periods, excluding unvested restricted common stock, if applicable. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Potential common shares such as from unexercised warrants, options, and shares of common stock issuable upon conversion of convertible debt and convertible preferred stock outstanding that have an anti-dilutive effect are excluded from the calculation of diluted net loss per share. The Company&#8217;s basic and diluted net loss per share is the same for all periods presented because all shares of common stock issuable upon exercise of warrants, options, and conversion of convertible debt and convertible preferred stock outstanding are anti-dilutive as they decrease loss per share.</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the number of shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.75in; width: 75%;;text-align:left;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 74%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Warrants</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,656,423</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,983,666</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Options</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,625,000</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Estimated shares issuable upon conversion of convertible notes payable</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">31,250</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Shares issuable upon conversion of convertible preferred stock</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">4,308,600</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">5,281,423</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">7,323,516</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Recent Accounting Pronouncements</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (ASU 2016-02), Leases (Topic 842). ASU 2016-02 requires a lessee to record a right-of-use asset and a corresponding lease liability, initially measured at the present value of the lease payments, on the balance sheet for all leases with terms longer than 12 months, as well as the disclosure of key information about leasing arrangements. ASU 2016-02 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term, generally on a straight-line basis. ASU 2016-02 requires classification of all cash payments within operating activities in the statement of cash flows. Disclosures are required to provide the amount, timing and uncertainty of cash flows arising from leases. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted. The Company has not yet evaluated the impact of the adoption of ASU 2016-02 on the Company&#8217;s financial statement presentation or disclosures.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In July 2017, the FASB issued Accounting Standards Update No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features; (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (&#8220;ASU 2017-11&#8221;). ASU 2017-11 allows companies to exclude a down round feature when determining whether a financial instrument (or embedded conversion feature) is considered indexed to the entity&#8217;s own stock. As a result, financial instruments (or embedded conversion features) with down round features may no longer be required to be accounted for as derivative liabilities. A company will recognize the value of a down round feature only when it is triggered and the strike price has been adjusted downward. For equity-classified freestanding financial instruments, an entity will treat the value of the effect of the down round as a dividend and a reduction of income available to common shareholders in computing basic earnings per share. For convertible instruments with embedded conversion features containing down round provisions, entities will recognize the value of the down round as a beneficial conversion discount to be amortized to earnings. ASU 2017-11 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The guidance in ASU 2017-11 is to be applied using a full or modified retrospective approach. The adoption of ASU 2017-11 is not currently expected to have any impact on the Company&#8217;s financial statement presentation or disclosures.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In June 2018, the FASB issued Accounting Standards Update 2018-07, Compensation &#8211; Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (&#8220;ASU 2018-07&#8221;). ASU 2018-07 expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company will adopt the provisions of ASU 2018-07 in the quarter beginning January 1, 2019. The adoption of ASU 2018-07 is not expected to have any impact on the Company&#8217;s financial statement presentation or disclosures.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;">&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company&#8217;s financial statement presentation or disclosures.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the Company&#8217;s revenues disaggregated by product type:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div><br/><div style="font-weight:bold;display:inline;">&#8206;</div><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div><br/><div style="font-weight:bold;display:inline;">&#8206;</div><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; vertical-align: bottom; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Lumega-Z and supplements</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">79,993</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">59,977</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">152,132</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">115,912</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">VectorVision medical devices and supplies</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">140,785</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">261,686</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt 7.2pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">220,778</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">59,977</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">413,818</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">115,912</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> The following table summarizes the allocation of preliminary fair values of the purchase consideration to the assets and liabilities assumed:<table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.75in; width: 70%;;text-align:left;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Values</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Common stock consideration</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,287,500</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Liabilities assumed</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1px solid black; border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding-top: 0pt; padding-right: 0px; padding-left: 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1px solid black; border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding-top: 0pt; padding-right: 0px; padding-left: 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">108,722</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;&#160;&#160;&#160;Total purchase consideration</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,396,222</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Cash</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(4,895</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(50,105</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Inventory</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(93,293</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Prepaid assets</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(551</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Property and equipment</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(9,458</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1px solid black; border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding-top: 0pt; padding-right: 0px; padding-left: 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1px solid black; border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding-top: 0pt; padding-right: 0px; padding-left: 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(674,400</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 80%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Goodwill</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom; width: 17%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1,563,520</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr></table><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following unaudited pro forma financial information gives effect to the Company&#8217;s acquisition of VectorVision as if the acquisition had occurred on January 1, 2017 and had been included in the Company&#8217;s consolidated statements of operations during the three and six-month periods ended June 30, 2017:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.5in; width: 85%;;text-align:left;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-right-width: initial; border-bottom: 1px solid black; border-left-width: initial; border-right-color: initial; border-left-color: initial; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three&#160;Months&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended&#160;</div><div style="font-weight:bold;display:inline;">&#8206;</div><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-top: none; border-right-width: initial; border-bottom: 1px solid black; border-left-width: initial; border-right-color: initial; border-left-color: initial; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six&#160;Months&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ended&#160;</div><div style="font-weight:bold;display:inline;">&#8206;</div><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;;width:;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Pro forma net revenues</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">121,622</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">366,793</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Pro forma net loss attributable to common shareholders</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(1,088,909</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(1,825,640</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 70%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Pro forma net loss per share</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(0.04</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 12%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">(0.06</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">)</div></div></td></tr></table><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the number of shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.75in; width: 75%;;text-align:left;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 74%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Warrants</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,656,423</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,983,666</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Options</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,625,000</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Estimated shares issuable upon conversion of convertible notes payable</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">31,250</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Shares issuable upon conversion of convertible preferred stock</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">4,308,600</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">5,281,423</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">7,323,516</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Intangible Assets</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In connection with the VectorVision transaction, the Company identified and allocated estimated fair values to intangible assets including goodwill and customer relationships.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In accordance with Accounting Standard Codification (&#8220;ASC&#8221;) 350 &#8211; Intangibles &#8211; Goodwill and Other, the Company determined whether these assets are expected to have indefinite (such as goodwill) or limited useful lives, and for those with limited lives, the Company established an amortization period and method of amortization. Its goodwill and other intangible assets are subject to periodic impairment testing.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company utilized the services of an independent third-party valuation firm to assist in identifying intangible assets and in estimating their fair values. The useful lives for the Company&#8217;s intangible assets other than goodwill were estimated based on Management&#8217;s consideration of various factors, including assumptions that market participants might use about sales expectations as well as potential effects of obsolescence, competition, technological progress and the regulatory environment. Because the future pattern in which the economic benefits of these intangible assets may not be reliably determined, amortization expense is generally calculated on a straight-line basis.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Amortization expense for the identifiable intangible assets associated with the VectorVision acquisition is approximately $54,000 per quarter and is included with general and administrative expenses in the Company&#8217;s Statements of Operations.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">A summary of the Company&#8217;s stock option activity is as follows:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.5in; width: 85%;;text-align:left;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 87%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2017</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,125,000</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Granted</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">500,000</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Forfeitures</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Exercised</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-right-width: initial; border-bottom: 1px solid black; border-left-width: initial; border-right-color: initial; border-left-color: initial; padding-top: 0pt; padding-right: 0px; padding-left: 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-top: none; border-right-width: initial; border-bottom: 1px solid black; border-left-width: initial; border-right-color: initial; border-left-color: initial; padding-top: 0pt; padding-right: 0px; padding-left: 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px 0.5px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2018, outstanding</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2,625,000</div></div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; font-weight: normal;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2018, exercisable</div></div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none; text-decoration: none; font-weight: normal;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none; text-decoration: none; font-weight: normal;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; font-weight: normal;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">2,225,000</div></div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none; text-decoration: none; font-weight: normal;"><div style="font-weight:bold;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr></table><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Impairment of Long-Lived Assets</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company reviews long-lived assets, including property and equipment, identifiable intangible assets, and goodwill for impairment at each fiscal year end or when events or changes in circumstances indicate the carrying value of these assets may exceed their current fair values. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the assets. Assets to be disposed of are separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell and are no longer depreciated. The Company has not historically recorded any impairment to its long-lived assets. In the future, if events or market conditions affect the estimated fair value to the extent that a long-lived asset is impaired, the Company will adjust the carrying value of these long-lived assets in the period in which the impairment occurs. As of June 30, 2018 and December 31, 2017, the Company had not deemed any long-lived assets as impaired and was not aware of the existence of any indicators of impairment at such dates.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Segment Information</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company operates and manages its business as one reporting and operating segment, which is the business of developing and commercializing a variety of products that support the detection, intervention and monitoring of a range of eye diseases. The Company&#8217;s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for purposes of allocating resources and evaluating financial performance.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Revenue Recognition</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s revenue is comprised of sales of medical foods and dietary supplements to consumers through a direct sales/credit card process. In addition, the Company sells medical device equipment and </div> supplies to customers both in the&#160;<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">U.S. and internationally.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In September 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09 (ASU No. 2014-09) regarding revenue recognition. The new standard provides authoritative guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. generally accepted accounting principles. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in the exchange for those goods or services. The ASU became effective January 1, 2018.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Due to the nature of the products sold by the Company, the adoption of the new standard has had no quantitative effect on the financial statements. However, the guidance requires additional disclosures to help readers of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company previously recognized revenue when risk of loss transferred to its customers and collection of the receivable was reasonably assured, which generally occurs when the product is shipped. A product is not shipped without an order from the customer and credit acceptance procedures performed. The Company allows for returns within 30 days of purchase, although for all periods presented, returns have been insignificant.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Under the new guidance, revenue is recognized when control of promised goods or services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company reviews its sales transactions to identify contractual rights, performance obligations, and transaction prices, including the allocation of prices to separate performance obligations, if applicable. Revenue and costs of sales are recognized once products are delivered to the customer&#8217;s control and performance obligations are satisfied.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">All products sold by the Company are distinct individual products and consist of medical foods, supplemental formulas, medical devices and related supplies. The products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them. Contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Control of products sold transfers to customers upon shipment from the Company&#8217;s facilities, and the Company&#8217;s performance obligations are satisfied at that time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer. Payment for sales of Lumega-Z is generally made by approved credit cards. Payments for medical device sales are generally made by check, credit card, or wire transfer. Historically the Company has not experienced any significant payment delays from customers.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company provides a 30-day right of return to its retail Lumega-Z customers. A right of return does not represent a separate performance obligation, but because customers are allowed to return products, the consideration to which the Company expects to be entitled is variable. Upon evaluation of historical Lumega-Z and VectorVision product returns, the Company determined that less than one </div> percent of products&#160;is returned, and therefore&#160;<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">believes it is probable that such returns will not cause a significant reversal of revenue in the future. Due to the insignificant amount of historical returns as well as the standalone nature of the Company&#8217;s products and assessment of performance obligations and transaction pricing for the Company&#8217;s sales contracts, the Company does not currently maintain a contract asset or liability balance at this time. </div> The Company assesses its contracts&#160;<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">and the reasonableness of its conclusions on a quarterly basis.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the Company&#8217;s revenues disaggregated by product type:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months Ended</div><br/><div style="font-weight:bold;display:inline;">&#8206;</div><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; margin-right: 0px; line-height: normal;"><div style="font-size: 10pt; font-family: &quot;times new roman&quot;, times, serif; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months Ended</div><br/><div style="font-weight:bold;display:inline;">&#8206;</div><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; vertical-align: bottom; width: 48%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Lumega-Z and supplements</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">79,993</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">59,977</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">152,132</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">115,912</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0in; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">VectorVision medical devices and supplies</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">140,785</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">261,686</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt 7.2pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">220,778</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">59,977</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">413,818</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">115,912</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 380899 133354 220778 59977 413818 115912 2125000 121622 366793 192000 2983666 0 -1825640 -1088909 500000 167055 52326 87776 29692 31458 21376 <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Research and Development Costs</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Research and development costs consist primarily of fees paid to consultants and outside service providers and other expenses relating to the acquisition, design, development and testing of the Company&#8217;s medical foods and related products. Research and development expenditures, which include stock compensation expense, are expensed as incurred and totaled $194,708 and $25,770 for the six months ended June 30, 2018 and 2017, respectively.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Stock-Based Compensation</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company periodically issues stock-based compensation to officers, directors, contractors and consultants for services rendered. Such issuances vest and expire according to terms established at the issuance date.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Stock-based payments to officers, directors, consultants, contractors, and employees, which include grants of employee stock options, are recognized in the financial statements based on their fair values. Stock option grants, which are generally time vested, will be measured at the grant date fair value and charged to operations on a straight-line basis over the vesting period. The fair value of stock options is determined utilizing the Black-Scholes option-pricing model, which is affected by several variables, including the risk-free interest rate, the expected dividend yield, the expected life of the equity award, the exercise price of the stock option as compared to the fair market value of the common stock on the grant date and the estimated volatility of the common stock over the term of the equity award.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the FASB whereby&#160;the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period using a graded vesting basis. In certain circumstances where there are no future performance requirements by the non-employee, grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes stock compensation expense, on stock purchases at a price less than fair value, and for fully-vested stock issued to consultants and other service providers, for the excess of fair value of the stock over the price paid for the stock. The Company recognizes the fair value of stock-based compensation within its statements of operations with classification depending on the nature of the services rendered. The Company will issue new shares to satisfy stock option exercises.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 412357 154730 133002 30285 246763 63586 0.001 0.001 2066365 4735230 0 -0.04 -0.06 0 10-Q false 50000 0 181243 3050000 41242 31331 0 29843 72771 10000000 10000000 <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Net Loss per Share</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;">The Company&#8217;s computation of basic and diluted net loss per common share is measured as net loss divided by the weighted average common shares outstanding during the respective periods, excluding unvested restricted common stock, if applicable. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Potential common shares such as from unexercised warrants, options, and shares of common stock issuable upon conversion of convertible debt and convertible preferred stock outstanding that have an anti-dilutive effect are excluded from the calculation of diluted net loss per share. The Company&#8217;s basic and diluted net loss per share is the same for all periods presented because all shares of common stock issuable upon exercise of warrants, options, and conversion of convertible debt and convertible preferred stock outstanding are anti-dilutive as they decrease loss per share.</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The following table sets forth the number of shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive:</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align:left;"><table style="border-width: initial; border-top-style: none; border-bottom-style: none; border-color: initial; border-image: initial; border-collapse: collapse; margin: 0in 0in 0in 0.75in; width: 75%;;text-align:left;"><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="6" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2017</div></div></div></td><td style="border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: center; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 74%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Warrants</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,656,423</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 10%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,983,666</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom; width: 1%;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Options</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">2,625,000</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Estimated shares issuable upon conversion of convertible notes payable</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">31,250</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Shares issuable upon conversion of convertible preferred stock</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">-</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(255, 255, 255); border-bottom: 1pt solid rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">4,308,600</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 1pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">5,281,423</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: rgb(204, 238, 255); border-bottom: 2.5pt double rgb(0, 0, 0); border-left-width: initial; border-left-color: initial; border-right-width: initial; border-right-color: initial; border-top: none; padding: 0pt 0px; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; text-align: right; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">7,323,516</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-bottom-style: none; border-color: initial; border-top-style: none; padding: 0px 0px 2.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal; background: none;"><div style="white-space: pre-wrap; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear:both;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Recent Accounting Pronouncements</div></div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (ASU 2016-02), Leases (Topic 842). ASU 2016-02 requires a lessee to record a right-of-use asset and a corresponding lease liability, initially measured at the present value of the lease payments, on the balance sheet for all leases with terms longer than 12 months, as well as the disclosure of key information about leasing arrangements. ASU 2016-02 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term, generally on a straight-line basis. ASU 2016-02 requires classification of all cash payments within operating activities in the statement of cash flows. Disclosures are required to provide the amount, timing and uncertainty of cash flows arising from leases. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted. The Company has not yet evaluated the impact of the adoption of ASU 2016-02 on the Company&#8217;s financial statement presentation or disclosures.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In July 2017, the FASB issued Accounting Standards Update No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features; (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (&#8220;ASU 2017-11&#8221;). ASU 2017-11 allows companies to exclude a down round feature when determining whether a financial instrument (or embedded conversion feature) is considered indexed to the entity&#8217;s own stock. As a result, financial instruments (or embedded conversion features) with down round features may no longer be required to be accounted for as derivative liabilities. A company will recognize the value of a down round feature only when it is triggered and the strike price has been adjusted downward. For equity-classified freestanding financial instruments, an entity will treat the value of the effect of the down round as a dividend and a reduction of income available to common shareholders in computing basic earnings per share. For convertible instruments with embedded conversion features containing down round provisions, entities will recognize the value of the down round as a beneficial conversion discount to be amortized to earnings. ASU 2017-11 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The guidance in ASU 2017-11 is to be applied using a full or modified retrospective approach. The adoption of ASU 2017-11 is not currently expected to have any impact on the Company&#8217;s financial statement presentation or disclosures.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In June 2018, the FASB issued Accounting Standards Update 2018-07, Compensation &#8211; Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (&#8220;ASU 2018-07&#8221;). ASU 2018-07 expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company will adopt the provisions of ASU 2018-07 in the quarter beginning January 1, 2019. The adoption of ASU 2018-07 is not expected to have any impact on the Company&#8217;s financial statement presentation or disclosures.</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;">&#160;</div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company&#8217;s financial statement presentation or disclosures.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 194708 25770 34320 15530 0.001 0.001 79993 59977 140785 0 152132 115912 261686 0 2625000 15376 14650 With respect to the 3,050,000 shares of common stock, 250,000 shares are held back by the Company through November 28, 2019 as security for VectorVision's indemnification obligations to the Company and the remaining 2,800,000 shares were issued to VectorVision at the closing of the transaction. Per the VectorVision Agreement, the 2,800,000 shares were subsequently distributed to the two VectorVision shareholders in proportion to their shareholdings in VectorVision. 500000 146000 2018-06-30 2018 0.11 21728 16861 -1524679 25830 117164 90000000 90000000 378750 101598 984464 178333 2287500 108722 2714680 1365807 1034914 766894 40329475 40183475 2534395 5079895 4138 0 Q2 54000 Guardion Health Sciences, Inc. 148560 31331 11751 10470 40329475 40183475 1447984 884022 3893852 1569910 2396222 98357 98357 169552 150603 145411 50300 39476 16464 8193 8193 460989 323917 269562 228320 4895 -3647089 -1506324 -1314982 -853737 191427 95597 0 13746 0001642375 --12-31 1054885 405918 563423 620741 50105 93293 1563520 1563520 2656423 2983666 2625000 0 0 31250 0 4308600 5281423 7323516 0 108051 Smaller Reporting Company 40329475 494391 0 40183 33696049 -26865956 6870276 4864516 7370223 551 -1810083 -855661 -4143025 9458 40183475 0 1054885 0 1054885 -42928 -11 674400 0 85517 0 53675 0 45106 0 81183 1563520 457438 311236 257627 64305 146 1314 0 1460 117473 146133 146000 -90053 -22788 11618 12043 -4143025 -1691379 -1810083 -954442 -0.04 -0.04 -0.10 -0.07 0 30535 494391 494391 40322215 25287759 40329475 25470418 146202 57442 0 0 -4143025 40329 35246639 -31008981 4277987 -425 -73624 586529 499947 0 0 137073 5500 50000 40329 40183 33696049 35246639 -187073 -5500 -31008981 -26865956 4277987 6870276 0 100000 0 14000 4864516 7370223 30535 0 0 1100000 1460 0 -28659 77837 -57734 1263837 -2668865 235016 62520 297536 0.001 4347827 4347827 1.00 1.00 1.15 1.00 0.43 0.01 2656423 P8M12D 1905475 1.15 1.25 1.15 1.00 1.00 1.15 3105000 1170000 1170000 3105000 0.06 0.08 0.60 0.75 250000 650000 250000 125000 125000 256962 535149 112759 18054 0.0265 1.2 535154 784888 67646 13537 459754 312275 287500 486070 800000 500000 400000 172388 287365 1250000 750000 5 years 5000001 6981938 146000 1460 150000 250000 600000 450000 413877 658383 1.25 P5Y P5Y 187500 40329475 0 81183 0 1500 0 0 -2424058 -1023321 100000 10000000 30237 151006 372848 403085 1.00 2019-05-31 These warrants are now scheduled to expire on the earlier of (a) May 31, 2019 or (b) sixty days following the date on which the common stock of the Company becomes listed or approved for listing on a national securities exchange. 494391 118 2.61 710 1924 1545 18355 494391 0 -495101 -1924 -495936 -18355 2225000 384046 iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares EX-101.SCH 6 cik0001642375-20180630.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Consolidated Statement of Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Organization and Business Operations link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - VectorVision Acquisition link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Property and Equipment, net link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Acquisition of Intellectual Property link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - VectorVision Acquisition (Tables) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Property and Equipment, net (Tables) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Organization and Business Operations (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Summary of Significant Accounting Policies (Details 1) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Summary of Significant Accounting Policies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - VectorVision Acquisition (Details) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - VectorVision Acquisition (Details 1) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - VectorVision Acquisition (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Inventories (Details) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Property and Equipment, net (Details) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Property and Equipment, net (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Acquisition of Intellectual Property (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Related Party Transactions (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - Stockholders' Equity (Details 1) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - Stockholders' Equity (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - Commitments and Contingencies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Subsequent Events (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 cik0001642375-20180630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 cik0001642375-20180630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 cik0001642375-20180630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 cik0001642375-20180630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document And Entity Information - shares
 6 Months Ended
Jun. 30, 2018
Aug. 10, 2018
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q2  
Entity Registrant Name Guardion Health Sciences, Inc.  
Entity Central Index Key 0001642375  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   40,329,475
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2018
Dec. 31, 2017
Current assets    
Cash $ 2,066,365 $ 4,735,230
Accounts receivable 29,843 72,771
Inventories 412,357 154,730
Prepaid expenses 25,830 117,164
Total current assets 2,534,395 5,079,895
Deposits 11,751 10,470
Property and equipment, net 191,427 95,597
Intangible assets, net 563,423 620,741
Goodwill 1,563,520 1,563,520
Total assets 4,864,516 7,370,223
Current liabilities    
Accounts payable and accrued liabilities 457,438 311,236
Accrued expenses and deferred rent 11,618 12,043
Line of credit 0 30,535
Due to related parties 117,473 146,133
Total current liabilities 586,529 499,947
Commitments and contingencies
Stockholders' Equity    
Preferred stock, $0.001 par value; 10,000,000 shares authorized 0 0
Common stock, $0.001 par value; 90,000,000 shares authorized; 40,329,475 and 40,183,475 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively 40,329 40,183
Additional paid-in capital 35,246,639 33,696,049
Accumulated deficit (31,008,981) (26,865,956)
Total stockholders' equity 4,277,987 6,870,276
Total liabilities and stockholders' equity $ 4,864,516 $ 7,370,223
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2018
Dec. 31, 2017
Preferred Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Preferred Stock, Shares Authorized 10,000,000 10,000,000
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock, Shares Authorized 90,000,000 90,000,000
Common Stock, Shares, Issued 40,329,475 40,183,475
Common Stock, Shares, Outstanding 40,329,475 40,183,475
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Revenue $ 220,778 $ 59,977 $ 413,818 $ 115,912
Cost of goods sold 87,776 29,692 167,055 52,326
Gross profit 133,002 30,285 246,763 63,586
Operating expenses        
Research and development 34,320 15,530 194,708 25,770
Sales and marketing 378,750 101,598 984,464 178,333
General and administrative 1,034,914 766,894 2,714,680 1,365,807
Total operating expenses 1,447,984 884,022 3,893,852 1,569,910
Loss from operations (1,314,982) (853,737) (3,647,089) (1,506,324)
Other expenses:        
Interest expense 710 1,924 1,545 18,355
Fair value of warrants - extension of expiration dates 494,391 0 494,391 0
Total other expenses 495,101 1,924 495,936 18,355
Net loss (1,810,083) (855,661) (4,143,025) (1,524,679)
Adjustments related to Series A and Series B convertible preferred stock:        
Accretion of deemed dividend 0 (53,675) 0 (85,517)
Dividend declared 0 (45,106) 0 (81,183)
Net loss attributable to common shareholders $ (1,810,083) $ (954,442) $ (4,143,025) $ (1,691,379)
Net loss per common share – basic and diluted $ (0.04) $ (0.04) $ (0.10) $ (0.07)
Weighted average common shares outstanding – basic and diluted 40,329,475 25,470,418 40,322,215 25,287,759
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statement of Stockholders' Equity - 6 months ended Jun. 30, 2018 - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2017 $ 6,870,276 $ 40,183 $ 33,696,049 $ (26,865,956)
Beginning Balance (in shares) at Dec. 31, 2017   40,183,475    
Fair value of vested stock options 1,054,885 $ 0 1,054,885 0
Issuance of common stock – warrant exercises 1,460 $ 146 1,314 0
Issuance of common stock – warrant exercises (in shares)   146,000    
Fair value of warrants - extension of expiration dates 494,391   494,391  
Net loss (4,143,025) $ 0 0 (4,143,025)
Ending Balance at Jun. 30, 2018 $ 4,277,987 $ 40,329 $ 35,246,639 $ (31,008,981)
Ending Balance (in shares) at Jun. 30, 2018   40,329,475    
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Operating Activities    
Net loss $ (4,143,025) $ (1,524,679)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 148,560 31,331
Accrued interest expense included in notes payable 0 13,746
Stock-based compensation 1,054,885 405,918
Stock-based compensation - related parties 0 108,051
Fair value of warrant modification 494,391 0
(Increase) decrease in -    
Accounts receivable 42,928 11
Inventories (257,627) (64,305)
Deposits and prepaid expenses 90,053 22,788
Increase (decrease) in -    
Accounts payable and accrued expenses 146,202 57,442
Accrued and deferred rent costs (425) (73,624)
Net cash used in operating activities (2,424,058) (1,023,321)
Investing Activities    
Purchase of property and equipment (137,073) (5,500)
Purchase of intellectual property (50,000) 0
Net cash used in investing activities (187,073) (5,500)
Financing Activities    
Proceeds from issuance of promissory notes 0 100,000
Payments on promissory notes 0 (14,000)
Payments on line of credit (30,535) 0
Proceeds from issuance of preferred stock 0 1,100,000
Proceeds from exercise of warrants 1,460 0
(Decrease) increase in due to related parties (28,659) 77,837
Net cash (used in) provided by financing activities (57,734) 1,263,837
Cash:    
Net (decrease) increase (2,668,865) 235,016
Balance at beginning of period 4,735,230 62,520
Balance at end of period 2,066,365 297,536
Supplemental disclosure of cash flow information:    
Cash paid for - Interest 0 1,500
Cash paid for - Income taxes 0 0
Non-cash financing activities:    
Issuance of common stock dividends on preferred stock $ 0 $ 81,183
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Business Operations
 6 Months Ended
Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
1.
Organization and Business Operations
 
Organization and Business
 
Guardion Health Sciences, Inc. (the “Company”) was formed in December 2009 as a California limited liability company under the name P4L Health Sciences, LLC. On June 30, 2015, the Company converted from a California limited liability company to a Delaware corporation, changing its name from Guardion Health Sciences, LLC to Guardion Health Sciences, Inc.
 
The Company is a specialty health sciences company 
that develops, formulates
and distributes condition-specific medical foods with an initial medical food product on the market under the brand name Lumega-Z
®
 that replenishes and restores the macular protective pigment.
 
The Company also developed a proprietary medical device called the MapcatSF
®
that accurately measures the macular pigment optical density.
 
On September 29, 2017, the Company completed its acquisition of substantially all of the assets and certain liabilities of VectorVision, Inc., a company that specializes in the standardization of contrast sensitivity, glare sensitivity, low contrast acuity, and ETDRS visual acuity testing. VectorVision develops, manufactures and sells equipment and supplies for standardized vision testing.
 
The Company has had limited operations to date and has been primarily engaged in research and development, product commercialization and capital raising activities.
 
Going Concern and Liquidity
 
The financial statements have been prepared assuming the Company will continue as a going concern. The Company had a net loss of $4,143,025 and utilized cash in operating activities of $2,424,058 during the six months ended June 30, 2018. The Company expects to continue to incur net losses and negative operating cash flows in the near-term. As a result, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued.
 
The Company’s independent registered public accounting firm has also included explanatory language in their opinion accompanying the Company’s audited financial statements for the year ended December 31, 2017. The Company’s financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.
 
The Company will continue to incur significant expenses for continued commercialization activities related to Lumega-Z, the MapcatSF
®
medical device, and VectorVision products. Development and commercialization of medical foods and medical devices involves a lengthy and complex process. Additionally, the Company’s long-term viability and growth may depend upon the successful development and commercialization of new complementary products or product lines. The Company is continuing to attempt to raise additional debt and/or equity capital to fund future operations, but there can be no assurances that the Company will be able to secure such additional financing in the amounts necessary to fully fund its operating requirements on acceptable terms or at all. If the Company is unable to access sufficient capital resources on a timely basis, the Company may be forced to reduce or discontinue its technology and product development programs and curtail or cease operations.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Significant Accounting Policies [Text Block]
2.
Summary of Significant Accounting Policies
 
Basis of Presentation and Use of Estimates
 
The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
 
Intangible Assets
 
In connection with the VectorVision transaction, the Company identified and allocated estimated fair values to intangible assets including goodwill and customer relationships.
 
In accordance with Accounting Standard Codification (“ASC”) 350 – Intangibles – Goodwill and Other, the Company determined whether these assets are expected to have indefinite (such as goodwill) or limited useful lives, and for those with limited lives, the Company established an amortization period and method of amortization. Its goodwill and other intangible assets are subject to periodic impairment testing.
 
The Company utilized the services of an independent third-party valuation firm to assist in identifying intangible assets and in estimating their fair values. The useful lives for the Company’s intangible assets other than goodwill were estimated based on Management’s consideration of various factors, including assumptions that market participants might use about sales expectations as well as potential effects of obsolescence, competition, technological progress and the regulatory environment. Because the future pattern in which the economic benefits of these intangible assets may not be reliably determined, amortization expense is generally calculated on a straight-line basis.
 
Amortization expense for the identifiable intangible assets associated with the VectorVision acquisition is approximately $54,000 per quarter and is included with general and administrative expenses in the Company’s Statements of Operations.
 
Impairment of Long-Lived Assets
 
The Company reviews long-lived assets, including property and equipment, identifiable intangible assets, and goodwill for impairment at each fiscal year end or when events or changes in circumstances indicate the carrying value of these assets may exceed their current fair values. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the assets. Assets to be disposed of are separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell and are no longer depreciated. The Company has not historically recorded any impairment to its long-lived assets. In the future, if events or market conditions affect the estimated fair value to the extent that a long-lived asset is impaired, the Company will adjust the carrying value of these long-lived assets in the period in which the impairment occurs. As of June 30, 2018 and December 31, 2017, the Company had not deemed any long-lived assets as impaired and was not aware of the existence of any indicators of impairment at such dates.
 
Segment Information
 
The Company operates and manages its business as one reporting and operating segment, which is the business of developing and commercializing a variety of products that support the detection, intervention and monitoring of a range of eye diseases. The Company’s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for purposes of allocating resources and evaluating financial performance.
 
Revenue Recognition
 
The Company’s revenue is comprised of sales of medical foods and dietary supplements to consumers through a direct sales/credit card process. In addition, the Company sells medical device equipment and
supplies to customers both in the 
U.S. and internationally.
 
In September 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09 (ASU No. 2014-09) regarding revenue recognition. The new standard provides authoritative guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. generally accepted accounting principles. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in the exchange for those goods or services. The ASU became effective January 1, 2018.
 
Due to the nature of the products sold by the Company, the adoption of the new standard has had no quantitative effect on the financial statements. However, the guidance requires additional disclosures to help readers of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized.
 
The Company previously recognized revenue when risk of loss transferred to its customers and collection of the receivable was reasonably assured, which generally occurs when the product is shipped. A product is not shipped without an order from the customer and credit acceptance procedures performed. The Company allows for returns within 30 days of purchase, although for all periods presented, returns have been insignificant.
 
Under the new guidance, revenue is recognized when control of promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company reviews its sales transactions to identify contractual rights, performance obligations, and transaction prices, including the allocation of prices to separate performance obligations, if applicable. Revenue and costs of sales are recognized once products are delivered to the customer’s control and performance obligations are satisfied.
 
All products sold by the Company are distinct individual products and consist of medical foods, supplemental formulas, medical devices and related supplies. The products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them. Contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time.
 
Control of products sold transfers to customers upon shipment from the Company’s facilities, and the Company’s performance obligations are satisfied at that time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer. Payment for sales of Lumega-Z is generally made by approved credit cards. Payments for medical device sales are generally made by check, credit card, or wire transfer. Historically the Company has not experienced any significant payment delays from customers.
 
The Company provides a 30-day right of return to its retail Lumega-Z customers. A right of return does not represent a separate performance obligation, but because customers are allowed to return products, the consideration to which the Company expects to be entitled is variable. Upon evaluation of historical Lumega-Z and VectorVision product returns, the Company determined that less than one
percent of products is returned, and therefore 
believes it is probable that such returns will not cause a significant reversal of revenue in the future. Due to the insignificant amount of historical returns as well as the standalone nature of the Company’s products and assessment of performance obligations and transaction pricing for the Company’s sales contracts, the Company does not currently maintain a contract asset or liability balance at this time.
The Company assesses its contracts 
and the reasonableness of its conclusions on a quarterly basis.
 
The following table presents the Company’s revenues disaggregated by product type:
 
 
 
Three Months Ended

‎
June 30,
 
 
Six Months Ended

‎
June 30,
 
 
 
2018
 
 
2017
 
 
2018
 
 
2017
 
Lumega-Z and supplements
 
$
79,993
 
 
$
59,977
 
 
$
152,132
 
 
$
115,912
 
VectorVision medical devices and supplies
 
 
140,785
 
 
 
-
 
 
 
261,686
 
 
 
-
 
 
 
$
220,778
 
 
$
59,977
 
 
$
413,818
 
 
$
115,912
 
 
Research and Development Costs
 
Research and development costs consist primarily of fees paid to consultants and outside service providers and other expenses relating to the acquisition, design, development and testing of the Company’s medical foods and related products. Research and development expenditures, which include stock compensation expense, are expensed as incurred and totaled $194,708 and $25,770 for the six months ended June 30, 2018 and 2017, respectively.
 
Stock-Based Compensation
 
The Company periodically issues stock-based compensation to officers, directors, contractors and consultants for services rendered. Such issuances vest and expire according to terms established at the issuance date.
 
Stock-based payments to officers, directors, consultants, contractors, and employees, which include grants of employee stock options, are recognized in the financial statements based on their fair values. Stock option grants, which are generally time vested, will be measured at the grant date fair value and charged to operations on a straight-line basis over the vesting period. The fair value of stock options is determined utilizing the Black-Scholes option-pricing model, which is affected by several variables, including the risk-free interest rate, the expected dividend yield, the expected life of the equity award, the exercise price of the stock option as compared to the fair market value of the common stock on the grant date and the estimated volatility of the common stock over the term of the equity award.
 
The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the FASB whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period using a graded vesting basis. In certain circumstances where there are no future performance requirements by the non-employee, grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.
 
The Company recognizes stock compensation expense, on stock purchases at a price less than fair value, and for fully-vested stock issued to consultants and other service providers, for the excess of fair value of the stock over the price paid for the stock. The Company recognizes the fair value of stock-based compensation within its statements of operations with classification depending on the nature of the services rendered. The Company will issue new shares to satisfy stock option exercises.
 
Net Loss per Share
 
The Company’s computation of basic and diluted net loss per common share is measured as net loss divided by the weighted average common shares outstanding during the respective periods, excluding unvested restricted common stock, if applicable. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Potential common shares such as from unexercised warrants, options, and shares of common stock issuable upon conversion of convertible debt and convertible preferred stock outstanding that have an anti-dilutive effect are excluded from the calculation of diluted net loss per share. The Company’s basic and diluted net loss per share is the same for all periods presented because all shares of common stock issuable upon exercise of warrants, options, and conversion of convertible debt and convertible preferred stock outstanding are anti-dilutive as they decrease loss per share.
 
The following table sets forth the number of shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive:
 
 
 
June 30,
 
 
 
2018
 
 
2017
 
Warrants
 
 
2,656,423
 
 
 
2,983,666
 
Options
 
 
2,625,000
 
 
 
-
 
Estimated shares issuable upon conversion of convertible notes payable
 
 
-
 
 
 
31,250
 
Shares issuable upon conversion of convertible preferred stock
 
 
-
 
 
 
4,308,600
 
 
 
 
5,281,423
 
 
 
7,323,516
 
 
Recent Accounting Pronouncements
 
In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (ASU 2016-02), Leases (Topic 842). ASU 2016-02 requires a lessee to record a right-of-use asset and a corresponding lease liability, initially measured at the present value of the lease payments, on the balance sheet for all leases with terms longer than 12 months, as well as the disclosure of key information about leasing arrangements. ASU 2016-02 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term, generally on a straight-line basis. ASU 2016-02 requires classification of all cash payments within operating activities in the statement of cash flows. Disclosures are required to provide the amount, timing and uncertainty of cash flows arising from leases. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted. The Company has not yet evaluated the impact of the adoption of ASU 2016-02 on the Company’s financial statement presentation or disclosures.
 
In July 2017, the FASB issued Accounting Standards Update No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features; (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (“ASU 2017-11”). ASU 2017-11 allows companies to exclude a down round feature when determining whether a financial instrument (or embedded conversion feature) is considered indexed to the entity’s own stock. As a result, financial instruments (or embedded conversion features) with down round features may no longer be required to be accounted for as derivative liabilities. A company will recognize the value of a down round feature only when it is triggered and the strike price has been adjusted downward. For equity-classified freestanding financial instruments, an entity will treat the value of the effect of the down round as a dividend and a reduction of income available to common shareholders in computing basic earnings per share. For convertible instruments with embedded conversion features containing down round provisions, entities will recognize the value of the down round as a beneficial conversion discount to be amortized to earnings. ASU 2017-11 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The guidance in ASU 2017-11 is to be applied using a full or modified retrospective approach. The adoption of ASU 2017-11 is not currently expected to have any impact on the Company’s financial statement presentation or disclosures.
 
In June 2018, the FASB issued Accounting Standards Update 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). ASU 2018-07 expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company will adopt the provisions of ASU 2018-07 in the quarter beginning January 1, 2019. The adoption of ASU 2018-07 is not expected to have any impact on the Company’s financial statement presentation or disclosures.
 
The Company’s management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
VectorVision Acquisition
 6 Months Ended
Jun. 30, 2018
Business Combinations [Abstract]  
Business Combination Disclosure [Text Block]
3.
VectorVision Acquisition
 
On September 29, 2017, the Company, through a wholly-owned subsidiary, completed the acquisition of substantially all of the assets and certain liabilities of VectorVision, Inc., an Ohio corporation (“VectorVision”), in exchange for 3,050,000 shares of the Company’s common stock, valued at $2,287,500, pursuant to the terms of an Asset Purchase and Reorganization Agreement dated September 29, 2017 
(the “VectorVision Agreement”). The VectorVision Agreement 
was entered into on an arm’s-length basis. The wholly-owned subsidiary that acquired the business is called VectorVision Ocular Health, Inc., a Delaware corporation, doing business as VectorVision. With respect to the 3,050,000 shares of common stock, 250,000 shares are held back by the Company through November 28, 2019 as security for VectorVision’s indemnification obligations to the Company and the remaining 2,800,000 shares were issued to VectorVision at the closing of the
transaction
. Per the VectorVision Agreement, the 2,800,000 shares
were subsequently distributed to the two VectorVision shareholders in proportion to their shareholdings in VectorVision. The shares represented approximately 11% of the Company’s issued and outstanding common stock immediately following consummation of the
transaction
. The shares held back as security are included in the Company’s weighted average common shares outstanding for per-share calculations.
 
VectorVision develops, manufactures and sells equipment and supplies for standardized vision testing for use by eye doctors in clinical trials, for real-world vision evaluation, and industrial vision testing. VectorVision specializes in the standardization of contrast sensitivity, glare sensitivity, low contrast acuity, and ETDRS (Early Treatment Diabetic Retinopathy Study) visual acuity testing. VectorVision developed and commercialized its CSV-1000 medical device to conduct contrast sensitivity testing and it developed and commercialized its ESV-3000 medical device to conduct ETDRS visual acuity testing. The patented standardization system provides the practitioner or researcher with the ability to delineate very small changes in visual capability, either as compared to the population or from visit to visit. The Company believes VectorVision’s CSV-1000 device to be the standard of care for clinical trials. The VectorVision transaction expanded the Company’s technical portfolio and the Company believes it further established the Company’s position at the forefront of early detection, intervention and monitoring of a range of eye diseases.
 
In accordance with ASC 805, the Company utilized the acquisition method of accounting, whereby the purchase consideration is allocated to specific tangible and intangible assets at their estimated fair values on the date of acquisition. The following table summarizes the allocation of preliminary fair values of the purchase consideration to the assets and liabilities assumed:
 
 
 
Fair Values
 
Common stock consideration
 
$
2,287,500
 
Liabilities assumed
 
 
108,722
 
     Total purchase consideration
 
 
2,396,222
 
 
 
 
 
 
Cash
 
 
(4,895
)
Accounts receivable
 
 
(50,105
)
Inventory
 
 
(93,293
)
Prepaid assets
 
 
(551
)
Property and equipment
 
 
(9,458
)
Intangible assets
 
 
(674,400
)
Goodwill
 
$
1,563,520
 
 
Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the expected revenue and benefits of the combined company.
 
The following unaudited pro forma financial information gives effect to the Company’s acquisition of VectorVision as if the acquisition had occurred on January 1, 2017 and had been included in the Company’s consolidated statements of operations during the three and six-month periods ended June 30, 2017:
 
 
 
Three Months 
Ended 
‎
June 30,
 
 
Six Months 
Ended 
‎
June 30,
 
 
 
2017
 
 
2017
 
Pro forma net revenues
 
$
121,622
 
 
$
366,793
 
Pro forma net loss attributable to common shareholders
 
$
(1,088,909
)
 
$
(1,825,640
)
Pro forma net loss per share
 
$
(0.04
)
 
$
(0.06
)
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Inventories
 6 Months Ended
Jun. 30, 2018
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block]
4.
Inventories
 
Inventories consisted of the following:
 
 
 
June 30,
 
 
December 31,
 
 
 
2018
 
 
2017
 
Raw materials
 
$
380,899
 
 
$
133,354
 
Finished goods
 
 
31,458
 
 
 
21,376
 
 
 
$
412,357
 
 
$
154,730
 
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment, net
 6 Months Ended
Jun. 30, 2018
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment Disclosure [Text Block]
5.
Property and Equipment, net
 
Property and equipment consisted of the following: 
 
 
 
June 30,
 
 
December 31,
 
 
 
2018
 
 
2017
 
Leasehold improvements
 
$
98,357
 
 
$
98,357
 
Testing equipment
 
 
169,552
 
 
 
150,603
 
Furniture and fixtures
 
 
145,411
 
 
 
50,300
 
Computer equipment
 
 
39,476
 
 
 
16,464
 
Office equipment
 
 
8,193
 
 
 
8,193
 
 
 
 
460,989
 
 
 
323,917
 
Less accumulated depreciation and amortization
 
 
(269,562
)
 
 
(228,320
)
 
 
$
191,427
 
 
$
95,597
 
 
For the six months ended June 30, 2018 and 2017, depreciation expense was $41,242 and $31,331, respectively, of which $15,376 and $14,650 were included in research and development expense, $4,138 and $0 were included in sales and marketing expense, and $21,728 and $16,861 were included in general and administrative expense, respectively.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisition of Intellectual Property
 6 Months Ended
Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets Disclosure [Text Block]
6.
Acquisition of Intellectual Property
 
On January 26, 2018, the Company acquired the rights to the trademark GLAUCO-HEALTH as well as the name “International Eye Wellness Institute” (together, the “IP Assets”) from an unrelated third party. The purchase included all rights, title, and interest in and to the IP Assets, including (a) the right to register and use the IP Assets; (b) all goodwill associated with the IP Assets; (c) all income, royalties, and damages hereafter due or payable with respect to the IP Assets; (d) all rights to sue for past, present, and future infringements or misappropriations of the IP Assets; and (e) and all other intellectual property rights owned or claimed by the seller or embodied in the IP Assets. In exchange for these rights, the Company paid the seller $50,000 in cash.
 
ASC 350-30-20 defines a defensive intangible asset as an acquired intangible asset in a situation in which an entity does not intend to actively use the asset but intends to hold (lock up) the asset to prevent others from obtaining access to the asset. The Company determined that the acquired intangible asset met the definition of a defensive intangible asset. The Company accounted for the $50,000 payment as an acquired intangible asset as of the closing of the agreement. As the Company can renew the underlying rights to the IP Assets indefinitely at nominal cost, the assets have been classified as a non-amortizable intangible asset on the Company’s balance sheet at June 30, 2018. The Company will evaluate the status of the assets for impairment annually or more frequently if warranted.
 
On January 26, 2018 the Company entered into a consulting agreement with the principal of the seller to assist with the development of the IP Assets and other assets acquired by the Company in the transaction. In conjunction with the consulting agreement, the Company granted a stock option on January 26, 2018 to the consultant to purchase a total of 500,000 shares of the common stock of the Company (see Note 8).
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions
 6 Months Ended
Jun. 30, 2018
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
7.
Related Party Transactions
 
Due to and from related parties represents unreimbursed expenses and compensation incurred on behalf of, and amounts loaned to the Company by, Michael Favish, the Company’s Chief Executive Officer, as well as other stockholders. The advances are unsecured, non-interest bearing and are due on demand. As of June 30, 2018 and December 31, 2017, the Company had $117,473 and $146,133, respectively, due to related parties.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity
 6 Months Ended
Jun. 30, 2018
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
8.
Stockholders’ Equity
 
Preferred Stock
 
Series A
 
During 2016, the Company sold 1,170,000 shares of the Company's Series A Senior Convertible Preferred Stock (the "Series A Preferred Stock") to various investors. The purchase price of the Series A Preferred Stock was $1.00 per share, for an aggregate purchase price of $1,170,000. In addition, during 2016, the Company issued 535,154 shares of its Series A Preferred Stock with a fair value of $784,888 upon conversion of $535,149 of notes payable and accrued interest. The Series A Preferred Stock had a stated value of $1.00 per share and accrued an annual dividend at the rate of 8% of the stated value, calculated quarterly, paid in shares of common stock at the rate of $0.60 per share.
 
During the six months ended June 30, 2017, the Company declared dividends of $67,646 on its Series A Preferred Stock which were satisfied in full through the issuance of an aggregate of 112,759 shares of common stock.
 
Series B
 
Beginning in March 2017 and through September 30, 2017, the Company sold 3,105,000 shares of the Company's Series B Convertible Preferred Stock (the "Series B Preferred Stock") to various investors. The purchase price of the Series B Preferred Stock was $1.00 per share, for an aggregate purchase price of $3,105,000. The Series B Preferred Stock had a stated value of $1.00 per share and accrued an annual dividend at the rate of 6% of the stated value, calculated quarterly, paid in shares of common stock at the rate of $0.75 per share.
 
During the six months ended June 30, 2017, the Company declared dividends of $13,537 on its Series B Preferred Stock which were satisfied in full through the issuance of an aggregate of 18,054 shares of common stock.
 
On November 3, 2017, the Company completed the issuance and sale of an aggregate of 4,347,827 shares of common stock (see below). The completion of the private placement triggered, at the Company's election, the automatic conversion of the
Series A Preferred Stock and the Series B P
referred Stock into shares of common stock. Accordingly, immediately following the completion of the private placement, the Company effected the conversion of all outstanding shares of Series A Preferred Stock and the Series B Preferred Stock into 6,981,938 shares of common stock (excluding accrued but unpaid dividends) effective November 3, 2017. On April 26, 2018, the Company filed a Certificate of Elimination with the
Secretary of the State of Delaware, withdrawing the respective Certificates of Designation that established the right, privileges and preferences of the Series A Preferred Stock and Series B Preferred Stock, thereby making all
10,000,000 authorized shares of preferred stock available for issuance.
 
Common Stock
 
On November 3, 2017, the Company completed the issuance and sale of an aggregate of 4,347,827 shares of common stock, par value $0.001 per share, at a purchase price of $1.15 per share. Total gross proceeds were $5,000,001. These shares were sold in a private placement to certain purchasers pursuant to a Stock Purchase Agreement dated as of November 3, 2017. Pursuant to the agreement, the purchasers have customary preemptive rights to participate in future equity and equity-linked issuances by the Company up to the extent necessary to maintain such purchaser’s pro rata ownership percentage in the Company’s securities, subject to customary exceptions. The preemptive rights terminate at the earlier of (i)
May 3, 2019
, (ii) such time as the Purchasers hold less than five percent (5%) of the issued and outstanding shares of the Company’s common stock, or (iii) such time as the shares of common stock of the Company shall become listed or approved for listing on a national securities exchange.
 
Warrants
 
A summary of the Company’s warrant activity is as follows: 
 
 
 
Shares
 
December 31, 2017
 
 
2,983,666
 
Granted
 
 
-
 
Forfeitures
 
 
-
 
Expirations
 
 
(181,243
)
Exercised
 
 
(146,000
)
June 30, 2018, all exercisable
 
 
2,656,423
 
 
In January 2018, an investor exercised warrants for 146,000 shares of common stock. The warrants were exercisable for $0.01 per share, and the Company received $1,460 in cash. The Company issued the shares and recorded the cash received as additional equity.
 
On April 30, 2018, The Company offered a one-month exercise period extension to stockholders who held warrants to purchase shares of common stock of the Company that were scheduled to expire on May 1, 2018. Pursuant to the terms of a Note and Warrant Purchase Agreement entered into by the Company and such holders, such warrants were issued upon the conversion of certain promissory notes into common stock on May 1, 2015. Four of the warrant holders did not extend their warrants, resulting in the expiration of 151,006 warrants on May 1, 2018. Six warrant holders elected to extend the term of an aggregate of 403,085 warrants by one month to June 1, 2018. The exercise price of such warrants is $1.00 per share.
 
On May 31, 2018, the six warrant holders noted above were offered a further extension of the exercise period for their warrants. One holder did not extend, resulting in the expiration of 30,237 warrants on June 1, 2018. Five warrant holders elected to extend the term of an aggregate of 372,848 warrants. These warrants are now scheduled to expire on the earlier of (a) May 31, 2019 or (b) sixty days following the date on which the common stock of the Company becomes listed or approved for listing on a national securities exchange. The exercise price of such warrants remains unchanged at $1.00 per share, but cashless exercise provisions have been eliminated from such warrants.
 
Management applied the guidance in ASC 718 – Compensation-Stock Compensation which indicates that a modification to the terms of an award should be treated as an exchange of the original award for a new award with the resulting total compensation cost equal to the grant-date fair value of the original award plus the incremental value of the modification to the award. Under ASC 718, the calculation of the incremental value is based on the excess of the fair value of the new (modified) award based on current circumstances over the fair value of the original award measured immediately before its terms are modified based on current circumstances. The Company recognized expense of $494,391 relating to the extension of the exercise period of the warrants based upon a Black-Scholes option-pricing model using a stock price of $1.15, volatility of 118%, and an average risk-free rate of 2.61. The expense is reflected as Fair value of warrants - extension of expiration dates in the Company’s statements of operations.
 
As of June 30, 2018, the Company had an aggregate of 2,656,423 outstanding warrants to purchase shares of its common stock with a weighted average exercise price of $0.43, weighted average remaining life of 0.7 years and aggregate intrinsic value of $1,905,475, based upon a stock valuation of $1.15 per share. The intrinsic value is calculated as the difference between the market value of the underlying common stock and the exercise price of the warrants.
 
Stock Options
 
A summary of the Company’s stock option activity is as follows:
 
 
 
Shares
 
December 31, 2017
 
 
2,125,000
 
Granted
 
 
500,000
 
Forfeitures
 
 
-
 
Exercised
 
 
-
 
June 30, 2018, outstanding
 
 
2,625,000
 
June 30, 2018, exercisable
 
 
2,225,000
 
 
On September 30, 2017, the Company entered into a consulting agreement pursuant to which the Company granted a total of 1,250,000 common stock options. 650,000 of the options with a fair value of $486,070 vested immediately, and the remaining 600,000 options vest ratably over twelve months on a quarterly basis with compensation cost measured as the fair value at the end of each reporting period. The options are non-qualified, have an exercise price of $1.00 per share, and will expire 5 years from the grant date. As of December 31, 2017, the Company had recognized compensation cost of $658,383 relating to the vesting of 800,000 options. During the six months ended June 30, 2018, the Company recognized stock compensation costs of $256,962 related to the vesting of 450,000 options based upon a graded vesting schedule. As of June 30, 2018, the remaining 150,000 options to vest were valued at $172,388 based upon a Black-Scholes option-pricing model.
 
On December 30, 2017, the Company entered into a consulting agreement pursuant to which the Company granted a total of 750,000 common stock options. 250,000 of the options with a fair value of $312,275 vested immediately, and the remaining 500,000
options vested ratably over six months on a quarterly basis with compensation cost measured as the fair value at the end of each reporting period, using a Black Scholes option-pricing model and a graded vesting schedule. The options are non-qualified, have an exercise price
of $1.25 per share, and will expire
5 years from the grant date. As of June 30, 2018, all options were fully vested. During the six months ended June 30, 2018, the Company recognized stock compensation costs of $413,877 related to these options
.
 
On January 26, 2018, the Company entered into an agreement with a consultant to develop products based on certain intellectual property owned by the Company (see Note 6). In conjunction with the consulting agreement, the Company granted a stock option to the consultant to purchase a total of 500,000 shares of the common stock of the Company. 250,000 shares of the option with a fair value of $287,500 vested immediately, 125,000 shares vest on December 31, 2018 and the remaining 125,000 shares vest on December 31, 2019 provided the consultant is still an active service provider. As of June 30, 2018, the 250,000 options that remain to vest were valued in total at $287,365 based upon a Black-Scholes option-pricing model. Compensation cost is measured as the fair value at the end of each reporting period and cost is amortized based upon a graded vesting schedule. The options are non-qualified, have an exercise price of $1.25 per share, and will expire 5 years 
from the grant date. During the six months ended June 30, 2018, the Company recognized stock compensation costs of $384,046 related to these options
.
 
As of June 30, 2018, options were valued based upon the Black-Scholes option-pricing model, with a stock price of $1.15, volatility of 120%, and an average risk-free rate of 2.65%.
 
As of June 30, 2018, the Company had an aggregate of 400,000 remaining unvested options outstanding, with estimated fair value of $459,754. The Company remeasures unvested options for non-employees to fair value at the end of each reporting period. The aggregate intrinsic value of options outstanding as of June 30, 2018 was $187,500.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]
9.
Commitments and Contingencies
 
The Company is periodically the subject of various pending or threatened legal actions and claims arising out of its operations in the normal course of business. In the opinion of management of the Company, adequate provision has been made in the Company’s condensed financial statements at June 30, 2018 with respect to such matters, including the matter noted below.
 
On or about July 26, 2017, the Company received a payment demand from a former consultant to the Company alleging that the consultant is owed approximately $192,000 for services rendered. The Company has disputed this demand and attempts to resolve this matter were unsuccessful. On January 29, 2018, the Company filed a lawsuit against the consultant and its related entities in the United States District Court for the Southern District of California (Case No. 18CV200-W-KSC) seeking declaratory relief regarding advisory fees and ownership interest in the Company. On March 6, 2018, the consultant and its related entities filed counterclaims against the Company, seeking payment for services rendered and seeking declaratory relief regarding ownership interest in the Company.
The Company intends to vigorously defend its rights. The Company cannot predict the outcome of this matter.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events
 6 Months Ended
Jun. 30, 2018
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
10.
Subsequent Events
 
On July 25, 2018, the Board of Directors approved the Company entering into a product development consulting agreement with a product development company to design and create a working prototype device, named AcQviz, intended to embody the inventions described in US Patent No. 10,022,045 and US Patent Application 15/277,849, each of which the Company owns. Under this agreement, the product development company is to create a prototype device using sensor circuitry and communication software/firmware unique to the product development company, oversee the integration of the prototype circuitry design into a commercial product, develop specifications for the Company to mass produce a commercial product based on the prototype and integrate the communication channel for the device into various vision testing software programs. In conjunction with the product development agreement, the Board of Directors of the Company also approved a stock option grant to the product development company to purchase 100,000 shares of the common stock of the Company based on certain performance metrics set forth in the product development agreement and stock option agreement.
The President of the product development company, Joseph Tate Evans, Jr., is the brother of David Evans, Chief Science Officer and a director of the Company.
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Policies)
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Basis Of Presentation And Use Of Estimates Policy [Policy Text Block]
 
Basis of Presentation and Use of Estimates
 
The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]
Intangible Assets
 
In connection with the VectorVision transaction, the Company identified and allocated estimated fair values to intangible assets including goodwill and customer relationships.
 
In accordance with Accounting Standard Codification (“ASC”) 350 – Intangibles – Goodwill and Other, the Company determined whether these assets are expected to have indefinite (such as goodwill) or limited useful lives, and for those with limited lives, the Company established an amortization period and method of amortization. Its goodwill and other intangible assets are subject to periodic impairment testing.
 
The Company utilized the services of an independent third-party valuation firm to assist in identifying intangible assets and in estimating their fair values. The useful lives for the Company’s intangible assets other than goodwill were estimated based on Management’s consideration of various factors, including assumptions that market participants might use about sales expectations as well as potential effects of obsolescence, competition, technological progress and the regulatory environment. Because the future pattern in which the economic benefits of these intangible assets may not be reliably determined, amortization expense is generally calculated on a straight-line basis.
 
Amortization expense for the identifiable intangible assets associated with the VectorVision acquisition is approximately $54,000 per quarter and is included with general and administrative expenses in the Company’s Statements of Operations.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Impairment of Long-Lived Assets
 
The Company reviews long-lived assets, including property and equipment, identifiable intangible assets, and goodwill for impairment at each fiscal year end or when events or changes in circumstances indicate the carrying value of these assets may exceed their current fair values. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the assets. Assets to be disposed of are separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell and are no longer depreciated. The Company has not historically recorded any impairment to its long-lived assets. In the future, if events or market conditions affect the estimated fair value to the extent that a long-lived asset is impaired, the Company will adjust the carrying value of these long-lived assets in the period in which the impairment occurs. As of June 30, 2018 and December 31, 2017, the Company had not deemed any long-lived assets as impaired and was not aware of the existence of any indicators of impairment at such dates.
Segment Reporting, Policy [Policy Text Block]
Segment Information
 
The Company operates and manages its business as one reporting and operating segment, which is the business of developing and commercializing a variety of products that support the detection, intervention and monitoring of a range of eye diseases. The Company’s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for purposes of allocating resources and evaluating financial performance.
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition
 
The Company’s revenue is comprised of sales of medical foods and dietary supplements to consumers through a direct sales/credit card process. In addition, the Company sells medical device equipment and
supplies to customers both in the 
U.S. and internationally.
 
In September 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09 (ASU No. 2014-09) regarding revenue recognition. The new standard provides authoritative guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. generally accepted accounting principles. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in the exchange for those goods or services. The ASU became effective January 1, 2018.
 
Due to the nature of the products sold by the Company, the adoption of the new standard has had no quantitative effect on the financial statements. However, the guidance requires additional disclosures to help readers of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized.
 
The Company previously recognized revenue when risk of loss transferred to its customers and collection of the receivable was reasonably assured, which generally occurs when the product is shipped. A product is not shipped without an order from the customer and credit acceptance procedures performed. The Company allows for returns within 30 days of purchase, although for all periods presented, returns have been insignificant.
 
Under the new guidance, revenue is recognized when control of promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company reviews its sales transactions to identify contractual rights, performance obligations, and transaction prices, including the allocation of prices to separate performance obligations, if applicable. Revenue and costs of sales are recognized once products are delivered to the customer’s control and performance obligations are satisfied.
 
All products sold by the Company are distinct individual products and consist of medical foods, supplemental formulas, medical devices and related supplies. The products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them. Contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time.
 
Control of products sold transfers to customers upon shipment from the Company’s facilities, and the Company’s performance obligations are satisfied at that time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer. Payment for sales of Lumega-Z is generally made by approved credit cards. Payments for medical device sales are generally made by check, credit card, or wire transfer. Historically the Company has not experienced any significant payment delays from customers.
 
The Company provides a 30-day right of return to its retail Lumega-Z customers. A right of return does not represent a separate performance obligation, but because customers are allowed to return products, the consideration to which the Company expects to be entitled is variable. Upon evaluation of historical Lumega-Z and VectorVision product returns, the Company determined that less than one
percent of products is returned, and therefore 
believes it is probable that such returns will not cause a significant reversal of revenue in the future. Due to the insignificant amount of historical returns as well as the standalone nature of the Company’s products and assessment of performance obligations and transaction pricing for the Company’s sales contracts, the Company does not currently maintain a contract asset or liability balance at this time.
The Company assesses its contracts 
and the reasonableness of its conclusions on a quarterly basis.
 
The following table presents the Company’s revenues disaggregated by product type:
 
 
 
Three Months Ended

‎
June 30,
 
 
Six Months Ended

‎
June 30,
 
 
 
2018
 
 
2017
 
 
2018
 
 
2017
 
Lumega-Z and supplements
 
$
79,993
 
 
$
59,977
 
 
$
152,132
 
 
$
115,912
 
VectorVision medical devices and supplies
 
 
140,785
 
 
 
-
 
 
 
261,686
 
 
 
-
 
 
 
$
220,778
 
 
$
59,977
 
 
$
413,818
 
 
$
115,912
 
Research and Development Expense, Policy [Policy Text Block]
Research and Development Costs
 
Research and development costs consist primarily of fees paid to consultants and outside service providers and other expenses relating to the acquisition, design, development and testing of the Company’s medical foods and related products. Research and development expenditures, which include stock compensation expense, are expensed as incurred and totaled $194,708 and $25,770 for the six months ended June 30, 2018 and 2017, respectively.
Compensation Related Costs, Policy [Policy Text Block]
Stock-Based Compensation
 
The Company periodically issues stock-based compensation to officers, directors, contractors and consultants for services rendered. Such issuances vest and expire according to terms established at the issuance date.
 
Stock-based payments to officers, directors, consultants, contractors, and employees, which include grants of employee stock options, are recognized in the financial statements based on their fair values. Stock option grants, which are generally time vested, will be measured at the grant date fair value and charged to operations on a straight-line basis over the vesting period. The fair value of stock options is determined utilizing the Black-Scholes option-pricing model, which is affected by several variables, including the risk-free interest rate, the expected dividend yield, the expected life of the equity award, the exercise price of the stock option as compared to the fair market value of the common stock on the grant date and the estimated volatility of the common stock over the term of the equity award.
 
The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the FASB whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period using a graded vesting basis. In certain circumstances where there are no future performance requirements by the non-employee, grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.
 
The Company recognizes stock compensation expense, on stock purchases at a price less than fair value, and for fully-vested stock issued to consultants and other service providers, for the excess of fair value of the stock over the price paid for the stock. The Company recognizes the fair value of stock-based compensation within its statements of operations with classification depending on the nature of the services rendered. The Company will issue new shares to satisfy stock option exercises.
Earnings Per Share, Policy [Policy Text Block]
Net Loss per Share
 
The Company’s computation of basic and diluted net loss per common share is measured as net loss divided by the weighted average common shares outstanding during the respective periods, excluding unvested restricted common stock, if applicable. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Potential common shares such as from unexercised warrants, options, and shares of common stock issuable upon conversion of convertible debt and convertible preferred stock outstanding that have an anti-dilutive effect are excluded from the calculation of diluted net loss per share. The Company’s basic and diluted net loss per share is the same for all periods presented because all shares of common stock issuable upon exercise of warrants, options, and conversion of convertible debt and convertible preferred stock outstanding are anti-dilutive as they decrease loss per share.
 
The following table sets forth the number of shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive:
 
 
 
June 30,
 
 
 
2018
 
 
2017
 
Warrants
 
 
2,656,423
 
 
 
2,983,666
 
Options
 
 
2,625,000
 
 
 
-
 
Estimated shares issuable upon conversion of convertible notes payable
 
 
-
 
 
 
31,250
 
Shares issuable upon conversion of convertible preferred stock
 
 
-
 
 
 
4,308,600
 
 
 
 
5,281,423
 
 
 
7,323,516
 
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
 
In February 2016, the FASB issued Accounting Standards Update No. 2016-02 (ASU 2016-02), Leases (Topic 842). ASU 2016-02 requires a lessee to record a right-of-use asset and a corresponding lease liability, initially measured at the present value of the lease payments, on the balance sheet for all leases with terms longer than 12 months, as well as the disclosure of key information about leasing arrangements. ASU 2016-02 requires recognition in the statement of operations of a single lease cost, calculated so that the cost of the lease is allocated over the lease term, generally on a straight-line basis. ASU 2016-02 requires classification of all cash payments within operating activities in the statement of cash flows. Disclosures are required to provide the amount, timing and uncertainty of cash flows arising from leases. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted. The Company has not yet evaluated the impact of the adoption of ASU 2016-02 on the Company’s financial statement presentation or disclosures.
 
In July 2017, the FASB issued Accounting Standards Update No. 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features; (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception (“ASU 2017-11”). ASU 2017-11 allows companies to exclude a down round feature when determining whether a financial instrument (or embedded conversion feature) is considered indexed to the entity’s own stock. As a result, financial instruments (or embedded conversion features) with down round features may no longer be required to be accounted for as derivative liabilities. A company will recognize the value of a down round feature only when it is triggered and the strike price has been adjusted downward. For equity-classified freestanding financial instruments, an entity will treat the value of the effect of the down round as a dividend and a reduction of income available to common shareholders in computing basic earnings per share. For convertible instruments with embedded conversion features containing down round provisions, entities will recognize the value of the down round as a beneficial conversion discount to be amortized to earnings. ASU 2017-11 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The guidance in ASU 2017-11 is to be applied using a full or modified retrospective approach. The adoption of ASU 2017-11 is not currently expected to have any impact on the Company’s financial statement presentation or disclosures.
 
In June 2018, the FASB issued Accounting Standards Update 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”). ASU 2018-07 expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company will adopt the provisions of ASU 2018-07 in the quarter beginning January 1, 2019. The adoption of ASU 2018-07 is not expected to have any impact on the Company’s financial statement presentation or disclosures.
 
The Company’s management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Disaggregation of Revenue [Table Text Block]
The following table presents the Company’s revenues disaggregated by product type:
 
 
 
Three Months Ended

‎
June 30,
 
 
Six Months Ended

‎
June 30,
 
 
 
2018
 
 
2017
 
 
2018
 
 
2017
 
Lumega-Z and supplements
 
$
79,993
 
 
$
59,977
 
 
$
152,132
 
 
$
115,912
 
VectorVision medical devices and supplies
 
 
140,785
 
 
 
-
 
 
 
261,686
 
 
 
-
 
 
 
$
220,778
 
 
$
59,977
 
 
$
413,818
 
 
$
115,912
 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
The following table sets forth the number of shares excluded from the computation of diluted loss per share, as their inclusion would have been anti-dilutive:
 
 
 
June 30,
 
 
 
2018
 
 
2017
 
Warrants
 
 
2,656,423
 
 
 
2,983,666
 
Options
 
 
2,625,000
 
 
 
-
 
Estimated shares issuable upon conversion of convertible notes payable
 
 
-
 
 
 
31,250
 
Shares issuable upon conversion of convertible preferred stock
 
 
-
 
 
 
4,308,600
 
 
 
 
5,281,423
 
 
 
7,323,516
 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
VectorVision Acquisition (Tables)
 6 Months Ended
Jun. 30, 2018
Business Combinations [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] The following table summarizes the allocation of preliminary fair values of the purchase consideration to the assets and liabilities assumed:
 
 
Fair Values
 
Common stock consideration
 
$
2,287,500
 
Liabilities assumed
 
 
108,722
 
     Total purchase consideration
 
 
2,396,222
 
 
 
 
 
 
Cash
 
 
(4,895
)
Accounts receivable
 
 
(50,105
)
Inventory
 
 
(93,293
)
Prepaid assets
 
 
(551
)
Property and equipment
 
 
(9,458
)
Intangible assets
 
 
(674,400
)
Goodwill
 
$
1,563,520
 
Business Acquisition, Pro Forma Information [Table Text Block]
The following unaudited pro forma financial information gives effect to the Company’s acquisition of VectorVision as if the acquisition had occurred on January 1, 2017 and had been included in the Company’s consolidated statements of operations during the three and six-month periods ended June 30, 2017:
 
 
 
Three Months 
Ended 
‎
June 30,
 
 
Six Months 
Ended 
‎
June 30,
 
 
 
2017
 
 
2017
 
Pro forma net revenues
 
$
121,622
 
 
$
366,793
 
Pro forma net loss attributable to common shareholders
 
$
(1,088,909
)
 
$
(1,825,640
)
Pro forma net loss per share
 
$
(0.04
)
 
$
(0.06
)
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Inventories (Tables)
 6 Months Ended
Jun. 30, 2018
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current [Table Text Block]
Inventories consisted of the following:
 
 
 
June 30,
 
 
December 31,
 
 
 
2018
 
 
2017
 
Raw materials
 
$
380,899
 
 
$
133,354
 
Finished goods
 
 
31,458
 
 
 
21,376
 
 
 
$
412,357
 
 
$
154,730
 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment, net (Tables)
 6 Months Ended
Jun. 30, 2018
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment [Table Text Block]
Property and equipment consisted of the following: 
 
 
 
June 30,
 
 
December 31,
 
 
 
2018
 
 
2017
 
Leasehold improvements
 
$
98,357
 
 
$
98,357
 
Testing equipment
 
 
169,552
 
 
 
150,603
 
Furniture and fixtures
 
 
145,411
 
 
 
50,300
 
Computer equipment
 
 
39,476
 
 
 
16,464
 
Office equipment
 
 
8,193
 
 
 
8,193
 
 
 
 
460,989
 
 
 
323,917
 
Less accumulated depreciation and amortization
 
 
(269,562
)
 
 
(228,320
)
 
 
$
191,427
 
 
$
95,597
 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2018
Stockholders' Equity Note [Abstract]  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
A summary of the Company’s warrant activity is as follows: 
 
 
 
Shares
 
December 31, 2017
 
 
2,983,666
 
Granted
 
 
-
 
Forfeitures
 
 
-
 
Expirations
 
 
(181,243
)
Exercised
 
 
(146,000
)
June 30, 2018, all exercisable
 
 
2,656,423
 
Share-based Compensation, Stock Options, Activity [Table Text Block]
A summary of the Company’s stock option activity is as follows:
 
 
 
Shares
 
December 31, 2017
 
 
2,125,000
 
Granted
 
 
500,000
 
Forfeitures
 
 
-
 
Exercised
 
 
-
 
June 30, 2018, outstanding
 
 
2,625,000
 
June 30, 2018, exercisable
 
 
2,225,000
 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Business Operations (Details Textual) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Net Cash Provided by (Used in) Operating Activities     $ (2,424,058) $ (1,023,321)
Net Income (Loss) Attributable to Parent, Total $ (1,810,083) $ (855,661) $ (4,143,025) $ (1,524,679)
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Revenues $ 220,778 $ 59,977 $ 413,818 $ 115,912
Lumega-Z and supplements [Member]        
Revenues 79,993 59,977 152,132 115,912
VectorVision medical devices and supplies [Member]        
Revenues $ 140,785 $ 0 $ 261,686 $ 0
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Details 1) - shares
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 5,281,423 7,323,516
Convertible Debt Securities [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 0 31,250
Conversion of Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 0 4,308,600
Employee Stock Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2,625,000 0
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2,656,423 2,983,666
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Details Textual) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Research and Development Expense $ 34,320 $ 15,530 $ 194,708 $ 25,770
Amortization of Intangible Assets     $ 54,000  
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
VectorVision Acquisition (Details) - USD ($)
 9 Months Ended
Sep. 29, 2017
Jun. 30, 2018
Dec. 31, 2017
Goodwill   $ 1,563,520 $ 1,563,520
VectorVision Inc [Member]      
Common stock consideration $ 2,287,500    
Liabilities assumed 108,722    
Total purchase consideration 2,396,222    
Cash (4,895)    
Accounts receivable (50,105)    
Inventory (93,293)    
Prepaid assets (551)    
Property and equipment (9,458)    
Intangible assets (674,400)    
Goodwill $ 1,563,520    
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
VectorVision Acquisition (Details 1) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2017
Pro forma net revenues $ 121,622 $ 366,793
Pro forma net loss attributable to common shareholders $ (1,088,909) $ (1,825,640)
Pro forma net loss per share $ (0.04) $ (0.06)
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
VectorVision Acquisition (Details Textual)
 9 Months Ended
Sep. 29, 2017
USD ($)
shares
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares 3,050,000
Business Acquisition, Equity Interest Issued or Issuable, Description With respect to the 3,050,000 shares of common stock, 250,000 shares are held back by the Company through November 28, 2019 as security for VectorVision's indemnification obligations to the Company and the remaining 2,800,000 shares were issued to VectorVision at the closing of the transaction. Per the VectorVision Agreement, the 2,800,000 shares were subsequently distributed to the two VectorVision shareholders in proportion to their shareholdings in VectorVision.
Equity Method Investment, Ownership Percentage 11.00%
VectorVision Inc [Member]  
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable | $ $ 2,287,500
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Inventories (Details) - USD ($)
Jun. 30, 2018
Dec. 31, 2017
Raw materials $ 380,899 $ 133,354
Finished goods 31,458 21,376
Inventory, Net $ 412,357 $ 154,730
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment, net (Details) - USD ($)
Jun. 30, 2018
Dec. 31, 2017
Property, Plant and Equipment, Gross, Total $ 460,989 $ 323,917
Less accumulated depreciation and amortization (269,562) (228,320)
Property, Plant and Equipment, Net, Total 191,427 95,597
Office Equipment [Member]    
Property, Plant and Equipment, Gross, Total 8,193 8,193
Computer Equipment [Member]    
Property, Plant and Equipment, Gross, Total 39,476 16,464
Testing equipment [Member]    
Property, Plant and Equipment, Gross, Total 169,552 150,603
Leasehold Improvements [Member]    
Property, Plant and Equipment, Gross, Total 98,357 98,357
Furniture and Fixtures [Member]    
Property, Plant and Equipment, Gross, Total $ 145,411 $ 50,300
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment, net (Details Textual) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Depreciation, Depletion and Amortization, Nonproduction, Total     $ 148,560 $ 31,331
Research and Development Expense $ 34,320 $ 15,530 194,708 25,770
General and Administrative Expense, Total 1,034,914 766,894 2,714,680 1,365,807
Selling and Marketing Expense, Total $ 378,750 $ 101,598 984,464 178,333
Property, Plant and Equipment [Member]        
Depreciation, Depletion and Amortization, Nonproduction, Total     41,242 31,331
Research and Development Expense     15,376 14,650
General and Administrative Expense, Total     21,728 16,861
Selling and Marketing Expense, Total     $ 4,138 $ 0
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisition of Intellectual Property (Details Textual) - USD ($)
 1 Months Ended 6 Months Ended
Jan. 26, 2018
Jun. 30, 2018
Jun. 30, 2017
Payments to Acquire Intangible Assets   $ 50,000 $ 0
Intellectual Property [Member]      
Stock Issued During Period, Shares, Issued for Services 500,000    
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions (Details Textual) - USD ($)
Jun. 30, 2018
Dec. 31, 2017
Related Party Transaction [Line Items]    
Due to Officers or Stockholders, Current $ 117,473 $ 146,133
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Details)
 6 Months Ended
Jun. 30, 2018
shares
Class of Warrant or Right [Line Items]  
Membership Units or Shares, Balance 2,983,666
Membership Units or Shares, Granted 0
Membership Units or Shares, Forfeitures 0
Membership Units or Shares,Expirations (181,243)
Membership Units or Shares, Exercised (146,000)
Membership Units or Shares, Balance 2,656,423
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Details 1)
 6 Months Ended
Jun. 30, 2018
shares
Class of Warrant or Right [Line Items]  
Beginning Balance 2,125,000
Granted 500,000
Forfeitures 0
Exercised 0
Ending Balance 2,625,000
June 30, 2018, exercisable 2,225,000
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Details Textual)
 1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Nov. 03, 2017
USD ($)
$ / shares
shares
May 31, 2019
May 31, 2018
USD ($)
$ / shares
shares
May 31, 2018
$ / shares
shares
Jan. 31, 2018
USD ($)
$ / shares
shares
Jan. 26, 2018
USD ($)
$ / shares
shares
Dec. 30, 2017
USD ($)
$ / shares
shares
Sep. 30, 2017
USD ($)
$ / shares
shares
Jun. 01, 2018
$ / shares
Jun. 30, 2018
USD ($)
$ / shares
shares
Jun. 30, 2017
USD ($)
Jun. 30, 2018
USD ($)
$ / shares
shares
Sep. 30, 2017
USD ($)
$ / shares
shares
Jun. 30, 2017
USD ($)
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
May 01, 2018
$ / shares
Apr. 30, 2018
shares
Apr. 26, 2018
shares
Dec. 31, 2017
USD ($)
$ / shares
shares
Class of Warrant or Right [Line Items]                                      
Common Stock, Par or Stated Value Per Share | $ / shares                   $ 0.001   $ 0.001             $ 0.001
Shares Issued, Price Per Share | $ / shares               $ 1.00         $ 1.00            
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares         $ 0.01                            
Class of Warrant or Right, Outstanding                   2,656,423   2,656,423             2,983,666
Warrants Intrinsic Value | $                       $ 1,905,475              
Share Price | $ / shares     $ 1.15 $ 1.15           $ 1.15   $ 1.15              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares                       256,962              
Debt Conversion, Original Debt, Amount | $                             $ 535,149        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate                       2.65%              
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate                       120.00%              
Stock Issued | $                       $ 0   $ 81,183          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | $           $ 287,500           $ 459,754              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number             500,000     400,000   400,000             800,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | $                   $ 287,365   $ 287,365              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                       500,000              
Stock Issued During Period, Shares Warrants Exercised         146,000                            
Stock Issued During Period, Value Warrants Exercised | $         $ 1,460             $ 1,460              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares               600,000   250,000   250,000 600,000            
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options | $                   $ 450,000   $ 450,000             $ 658,383
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $ / shares           $ 1.25                          
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period           5 years   5 years                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $                   187,500   187,500              
Preferred Stock, Capital Shares Reserved for Future Issuance                                   10,000,000  
Number Of Warrants Expired     30,237 151,006                              
Number Of Warrants Subject To Term Extension     372,848 372,848                         403,085    
Investment Warrants, Exercise Price | $ / shares                 $ 1.00                    
Investment Warrants Expiration Date     May 31, 2019                                
Warrant Expiration Date Description   These warrants are now scheduled to expire on the earlier of (a) May 31, 2019 or (b) sixty days following the date on which the common stock of the Company becomes listed or approved for listing on a national securities exchange.                                  
Fair Value Adjustment of Warrants | $     $ 494,391             494,391 $ 0 494,391   $ 0          
Stock or Unit Option Plan Expense | $                       384,046              
Measurement Input, Price Volatility [Member]                                      
Class of Warrant or Right [Line Items]                                      
Warrants and Rights Outstanding, Measurement Input     118 118                              
Measurement Input, Risk Free Interest Rate [Member]                                      
Class of Warrant or Right [Line Items]                                      
Warrants and Rights Outstanding, Measurement Input     2.61 2.61                              
Non Qualified Stock Options [Member]                                      
Class of Warrant or Right [Line Items]                                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares               650,000                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | $                   $ 172,388   $ 172,388              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross               1,250,000                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares                   150,000   150,000              
Non Qualified Stock Options [Member] | Consultant [Member]                                      
Class of Warrant or Right [Line Items]                                      
Share Price | $ / shares             $ 1.25                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares             250,000                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | $             $ 312,275                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross             750,000                        
Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award             5 years                        
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options | $                   $ 413,877   $ 413,877              
Warrant [Member]                                      
Class of Warrant or Right [Line Items]                                      
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares                   $ 0.43   $ 0.43       $ 1.00      
Warrants Weighted Average Remaining Life                       8 months 12 days              
Share-based Compensation Award, Tranche One [Member]                                      
Class of Warrant or Right [Line Items]                                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares           250,000                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | $               $ 486,070                      
Share-based Compensation Award, Tranche Two [Member]                                      
Class of Warrant or Right [Line Items]                                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares           125,000                          
Share-based Compensation Award, Tranche Three [Member]                                      
Class of Warrant or Right [Line Items]                                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares           125,000                          
Common Stock [Member]                                      
Class of Warrant or Right [Line Items]                                      
Stock Issued During Period, Shares, Issued for Services 4,347,827                                    
Stock Issued During Period, Shares Warrants Exercised                       146,000              
Stock Issued During Period, Value Warrants Exercised | $                       $ 146              
Preferred Stock [Member]                                      
Class of Warrant or Right [Line Items]                                      
Debt Conversion, Converted Instrument, Shares Issued                             535,154        
Stock Issued | $                             $ 784,888        
Private Placement [Member]                                      
Class of Warrant or Right [Line Items]                                      
Common Stock, Par or Stated Value Per Share | $ / shares $ 0.001                                    
Stock Issued During Period, Shares, Issued for Services 4,347,827                                    
Shares Issued, Price Per Share | $ / shares $ 1.15                                    
Share Price | $ / shares $ 1.15                                    
Proceeds from Issuance of Private Placement | $ $ 5,000,001                                    
Series A Preferred Stock [Member]                                      
Class of Warrant or Right [Line Items]                                      
Shares Issued, Price Per Share | $ / shares                             $ 1.00        
Share Price | $ / shares                             $ 1.00        
Stock Issued During Period, Shares, New Issues                             1,170,000        
Stock Issued During Period, Value, New Issues | $                             $ 1,170,000        
Preferred Stock, Dividend Rate, Percentage                             8.00%        
Preferred Stock, Dividends Per Share, Declared | $ / shares                             $ 0.60        
Common Stock Dividends, Shares                           112,759          
Dividends, Preferred Stock, Stock | $                           $ 67,646          
Series B Preferred Stock [Member]                                      
Class of Warrant or Right [Line Items]                                      
Share Price | $ / shares               $ 1.00         $ 1.00            
Stock Issued During Period, Shares, New Issues                         3,105,000            
Stock Issued During Period, Value, New Issues | $                         $ 3,105,000            
Preferred Stock, Dividend Rate, Percentage                         6.00%            
Preferred Stock, Dividends Per Share, Declared | $ / shares                         $ 0.75            
Common Stock Dividends, Shares                           18,054          
Convertible Preferred Stock, Shares Issued upon Conversion 6,981,938                                    
Series B Preferred Stock [Member] | Dividend Declared [Member]                                      
Class of Warrant or Right [Line Items]                                      
Dividends, Preferred Stock, Stock | $                           $ 13,537          
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies (Details Textual)
 6 Months Ended
Jun. 30, 2018
USD ($)
Loss Contingency, Damages Sought, Value $ 192,000
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events (Details Textual)
 1 Months Ended
Jul. 31, 2018
shares
Subsequent Event [Member]  
Subsequent Event [Line Items]  
Stock Issued During Period, Shares, Issued for Services 100,000
EXCEL 50 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 51 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 52 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 54 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 93 180 1 false 31 0 false 4 false false R1.htm 1001 - Document - Document And Entity Information Sheet http://www.guardionhealth.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 1002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.guardionhealth.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.guardionhealth.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.guardionhealth.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Condensed Consolidated Statement of Stockholders' Equity Sheet http://www.guardionhealth.com/role/CondensedConsolidatedStatementOfStockholdersEquity Condensed Consolidated Statement of Stockholders' Equity Statements 5 false false R6.htm 1006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.guardionhealth.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 1007 - Disclosure - Organization and Business Operations Sheet http://www.guardionhealth.com/role/OrganizationAndBusinessOperations Organization and Business Operations Notes 7 false false R8.htm 1008 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.guardionhealth.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - VectorVision Acquisition Sheet http://www.guardionhealth.com/role/VectorvisionAcquisition VectorVision Acquisition Notes 9 false false R10.htm 1010 - Disclosure - Inventories Sheet http://www.guardionhealth.com/role/Inventories Inventories Notes 10 false false R11.htm 1011 - Disclosure - Property and Equipment, net Sheet http://www.guardionhealth.com/role/PropertyAndEquipmentNet Property and Equipment, net Notes 11 false false R12.htm 1012 - Disclosure - Acquisition of Intellectual Property Sheet http://www.guardionhealth.com/role/AcquisitionOfIntellectualProperty Acquisition of Intellectual Property Notes 12 false false R13.htm 1013 - Disclosure - Related Party Transactions Sheet http://www.guardionhealth.com/role/RelatedPartyTransactions Related Party Transactions Notes 13 false false R14.htm 1014 - Disclosure - Stockholders' Equity Sheet http://www.guardionhealth.com/role/StockholdersEquity Stockholders' Equity Notes 14 false false R15.htm 1015 - Disclosure - Commitments and Contingencies Sheet http://www.guardionhealth.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 1016 - Disclosure - Subsequent Events Sheet http://www.guardionhealth.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 1017 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.guardionhealth.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.guardionhealth.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 1018 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.guardionhealth.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.guardionhealth.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 1019 - Disclosure - VectorVision Acquisition (Tables) Sheet http://www.guardionhealth.com/role/VectorvisionAcquisitionTables VectorVision Acquisition (Tables) Tables http://www.guardionhealth.com/role/VectorvisionAcquisition 19 false false R20.htm 1020 - Disclosure - Inventories (Tables) Sheet http://www.guardionhealth.com/role/InventoriesTables Inventories (Tables) Tables http://www.guardionhealth.com/role/Inventories 20 false false R21.htm 1021 - Disclosure - Property and Equipment, net (Tables) Sheet http://www.guardionhealth.com/role/PropertyAndEquipmentNetTables Property and Equipment, net (Tables) Tables http://www.guardionhealth.com/role/PropertyAndEquipmentNet 21 false false R22.htm 1022 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.guardionhealth.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.guardionhealth.com/role/StockholdersEquity 22 false false R23.htm 1023 - Disclosure - Organization and Business Operations (Details Textual) Sheet http://www.guardionhealth.com/role/OrganizationAndBusinessOperationsDetailsTextual Organization and Business Operations (Details Textual) Details http://www.guardionhealth.com/role/OrganizationAndBusinessOperations 23 false false R24.htm 1024 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.guardionhealth.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.guardionhealth.com/role/SummaryOfSignificantAccountingPoliciesTables 24 false false R25.htm 1025 - Disclosure - Summary of Significant Accounting Policies (Details 1) Sheet http://www.guardionhealth.com/role/SummaryOfSignificantAccountingPoliciesDetails1 Summary of Significant Accounting Policies (Details 1) Details http://www.guardionhealth.com/role/SummaryOfSignificantAccountingPoliciesTables 25 false false R26.htm 1026 - Disclosure - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.guardionhealth.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual Summary of Significant Accounting Policies (Details Textual) Details http://www.guardionhealth.com/role/SummaryOfSignificantAccountingPoliciesTables 26 false false R27.htm 1027 - Disclosure - VectorVision Acquisition (Details) Sheet http://www.guardionhealth.com/role/VectorvisionAcquisitionDetails VectorVision Acquisition (Details) Details http://www.guardionhealth.com/role/VectorvisionAcquisitionTables 27 false false R28.htm 1028 - Disclosure - VectorVision Acquisition (Details 1) Sheet http://www.guardionhealth.com/role/VectorvisionAcquisitionDetails1 VectorVision Acquisition (Details 1) Details http://www.guardionhealth.com/role/VectorvisionAcquisitionTables 28 false false R29.htm 1029 - Disclosure - VectorVision Acquisition (Details Textual) Sheet http://www.guardionhealth.com/role/VectorvisionAcquisitionDetailsTextual VectorVision Acquisition (Details Textual) Details http://www.guardionhealth.com/role/VectorvisionAcquisitionTables 29 false false R30.htm 1030 - Disclosure - Inventories (Details) Sheet http://www.guardionhealth.com/role/InventoriesDetails Inventories (Details) Details http://www.guardionhealth.com/role/InventoriesTables 30 false false R31.htm 1031 - Disclosure - Property and Equipment, net (Details) Sheet http://www.guardionhealth.com/role/PropertyAndEquipmentNetDetails Property and Equipment, net (Details) Details http://www.guardionhealth.com/role/PropertyAndEquipmentNetTables 31 false false R32.htm 1032 - Disclosure - Property and Equipment, net (Details Textual) Sheet http://www.guardionhealth.com/role/PropertyAndEquipmentNetDetailsTextual Property and Equipment, net (Details Textual) Details http://www.guardionhealth.com/role/PropertyAndEquipmentNetTables 32 false false R33.htm 1033 - Disclosure - Acquisition of Intellectual Property (Details Textual) Sheet http://www.guardionhealth.com/role/AcquisitionOfIntellectualPropertyDetailsTextual Acquisition of Intellectual Property (Details Textual) Details http://www.guardionhealth.com/role/AcquisitionOfIntellectualProperty 33 false false R34.htm 1034 - Disclosure - Related Party Transactions (Details Textual) Sheet http://www.guardionhealth.com/role/RelatedPartyTransactionsDetailsTextual Related Party Transactions (Details Textual) Details http://www.guardionhealth.com/role/RelatedPartyTransactions 34 false false R35.htm 1035 - Disclosure - Stockholders' Equity (Details) Sheet http://www.guardionhealth.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://www.guardionhealth.com/role/StockholdersEquityTables 35 false false R36.htm 1036 - Disclosure - Stockholders' Equity (Details 1) Sheet http://www.guardionhealth.com/role/StockholdersEquityDetails1 Stockholders' Equity (Details 1) Details http://www.guardionhealth.com/role/StockholdersEquityTables 36 false false R37.htm 1037 - Disclosure - Stockholders' Equity (Details Textual) Sheet http://www.guardionhealth.com/role/StockholdersEquityDetailsTextual Stockholders' Equity (Details Textual) Details http://www.guardionhealth.com/role/StockholdersEquityTables 37 false false R38.htm 1038 - Disclosure - Commitments and Contingencies (Details Textual) Sheet http://www.guardionhealth.com/role/CommitmentsAndContingenciesDetailsTextual Commitments and Contingencies (Details Textual) Details http://www.guardionhealth.com/role/CommitmentsAndContingencies 38 false false R39.htm 1039 - Disclosure - Subsequent Events (Details Textual) Sheet http://www.guardionhealth.com/role/SubsequentEventsDetailsTextual Subsequent Events (Details Textual) Details http://www.guardionhealth.com/role/SubsequentEvents 39 false false All Reports Book All Reports cik0001642375-20180630.xml cik0001642375-20180630.xsd cik0001642375-20180630_cal.xml cik0001642375-20180630_def.xml cik0001642375-20180630_lab.xml cik0001642375-20180630_pre.xml http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/invest/2013-01-31 true true ZIP 56 0001144204-18-043655-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-18-043655-xbrl.zip M4$L#!!0 ( !V)"DWRH]V='LL /'>#@ : 8VEK,# P,38T,C,W-2TR M,#$X,#8S,"YX;6SLO6MSVTC2)OK]C7C_ X[6?M>.@&3>15KCWI!O,^[M;GM; M[IF-<^*$HP@4R6J# !H%2.*O$XKX3N,*?OCE)XLGI\.1__/2?__&W_^OT]._< MYQ&+N6N-%]9[%K.O$7.^R_1NJWO6LN#_VJW3RV2:R/BTTVH/K?^G-7S=;[_N MM?]?Z_^[_/7_6!^NOEJGULW-S9D+CXC5(\Z<8'YZBJ^Y'4>>>(W_M:!@OGSM MB.^M5JL]Z'6ZY_TW)[,X#E^_>H6W3Q,6N?#>&6=>/,-'O,(7M@9=J(.^V1/^ M]](]^."S()K"E:WN*_QYS"1/+\=?79'=4+QX\$K_F%VZ\NB;KKJV/1J-7JE? MLTNEJ+H0'MI^];]__>7*F?$Y.Q6^C)GOE,HB-I1]^7HA@UZG?;[I#GU%>H/+ MPX@[V)UK[QF]8I$3!1Y_E5^Z<38/K5^9'[(_STU;[M-O. M;DNB"/"U[C[S:\6-+A?5]\ /JM_+E_-;9U9]/?Y2<8/PK[F,JV_1O^%-W?)- M/A..K+Y'_511#RFI/\T/% M+;?>!M3\[U\*4$[B: -8X->LV%&\6@+XLOAV'.XX3EY+-0)^YQ-+C9O7\2+D M;TZDF(<>PEM]-XOXY,U)B0Q.T]%^=BL!EJ]R^G "/^:WL24 VE]:[6_P/[SV M:] :?.NVU.>3_&KNQR)>Y'\+%[^9"!Y9JF2\5.6T^=]]^I\G/^6%^=NKY9OQ M@:^JWQ#R2 1N_C>,Y"@&0N4_I'%%K=-??JC6[5UK?7[:[L"XV5FM6[WS> MDPV,K+'."XU5+ZB4&NO\/HUUONO&:C>NL;:GW%TW%A*/:J !--;H6V=4\\8: M*!IJ;=U8H]/.:+?VJ9Z-5&+J4JUW8I]:PV_M&C)TV2H/3]N[MI191M>XWH-;]G2JPU$X"]6?Z#>HU "*]G4*D_ZW525FDGIIDF47Z MIZW.UBS2WZE5AL;J-ZZQ^D_36&8\U3'2MCR>=FF5N\9?UW'&5@,@TBUX[UO$ M&5N['4^*?$:%\32J;V.-[D,^HT<83S7UFPKC:;#CN'UICJ9>TJ4<%]GI'$WU M--ZW+U$ #XH77SQX^J7O?O@K$>$)22AZ_ M\YB4E[="[J?QS-#@4RQ7^H4+K[P-/>$(4U3+%?"[7H9AYFI?;RAX>LD=#:!+ MM/*R0K,7RK4/'^9Q)AK*H/@EF?,I^S>TQE42AA['^DE=<1G%T&)NXL2?HRL> M70N'UQD(4-S7U>4M386_WE#CHT3 /[D3!]!:V(J_R*'QXETP#P,?!U*=\9#:@3L*GUY6JO91=OR' M>>@%"\ZOXL#Y_CF,U?C(0:"_^>2[_):[7X-/4B; $;I1OR["6G-#VLG;U2&] M>FV#'"4\W@7^->@I,?;X>SZ.K[B31"+.N%*#Y)-:$(A5;PHDJDJ<_G9'E8\8 M!MB&GR=?(C[A4<1=-4(.#P=EX7!7S8\4#O-YX*_T_S$HAI6J'R4 +EU7H&5D MWA9]\&4<)UK@)?;^VV$?H1I:W1'S[A3/)9X'G?IJ'47!=C+3I+E\;D'W; M&/]QJRJD%V]HD,< QB-O RGT].=XQJ-?F3,#>HL6Z^86CJV[[VJ59O?YQP2L M6)Q$'"KV4=SBIZ,>W.O;H]G]C&HFB7E$0UI[>%6-T>P>_CR9"(=3_R)E5S5% MLWN7I'83>^VWP/]?"?.PU=S";$/9P@*B?V/S9HS"4EG+8=3-=6UV/[Z#>B1> MO#0 OXK8XY\GGWQ77 L7ZH[-0GV^39]O_?;*-JZ(X)>ZIX%@RW?CD\-='X=[ MUR<0+/4T.=PU=+@?N<_)X:Z)P_W(_4P.]Y,[W(_-WN1P/Z7#_6BG Y7.<*&E MU7M=6OVTI_A4(X"65M=I:74]$$+;+YYT^T4-CD6C[1?UY8BG14CE67"T;^^I M]^T]Z9EW:T!!AF//XK)V""##42?#44>$T+Z](^UXVK=7FWU[=80'[=O;^[Z] M^L* ]NT]P;Z].L(!A!:,A\OU2,C,KW+1/D_4!4T Q(:"9Y>LK_P1@^'M,8.A MLO)'"8;WN( *'\X=CT%[%'&0_J8T^ '#IE3/'"K53;,!)833'>"T.@]$*2+R MR7>*N'N;2.%S*2\=\!"DVI?;!-2M+?;Z0$A6\4>'0(VR6U#7/WK7/V+.CNKC MZK]]@DL\#^J7,"^= EC:Q2!B_HNXYBYG=J#D&^7?S*_@RBYDR"W*.#T^&)1/Q2[ M3\Q$('@*$#QBZL]V8:8"/W?3I;+B&EKAB\<XS<9:M2.<^5J2STS4OYX58\7F: ME?,;$B__*T&;>UUA3 H_-659Y-IBK[E@?S'A\_O$A,]WGF4T2\7Z[5?.9!(I M>O[DATD,IM7A_PP\%@M/E">?ER]M"@K6EWO=%96-\,B&:"F;[&X.95O?S[\+ M^?UCQ#G.J$=W1,-ZO#IY.<(U M(D\*B'2FAUP0$9/OK80>)OY] O[]H3Y= MWF8&-1N#N$=\OA?2\0(,"WZ%B]]ZP$*JTS\R)Q;NMW9W.!KU!R>6>=KO?+(V MS^/)3__EQ1?@Z5DR7GC0@WC#*?B74_^UQR?QQ,+O"9F8X^G5TW@R:^M M=BN,K?]B\_#BKR2 *Z!WI.7S&RL*YLS/?[ M]9-M2:COY,+R>!SSZ%2&S(&^ M>&WY031GWH451.&,^?*UU;FP5#F$CRAY;;7"6_--#,Z+G,#U>)?/+ZP;X08W M^I:;('+SAZI[3F_X^+N V_!><(B"[_P4[HAGQ6>ZW DBU;"GJGJO+=SL);!$ MR[\[@1=$A=_G+)H*_S0.0O- \\4XB.-@;KXS+QR-GE]88R@C5!V>X[%0PJO2 M3]E/Y0JH5C_UV")(H!TFXI:[A2Z)TOY01ZC%U\.F%SX2U>/Z"3LW>]BMWUKSWK"[]44DN!+BW**?Y5+(\4 M_^8:=X B&!:G,RZFLSC]*KTM[X_TFU*'[*IJA6&C'GFC"S,./!=^DR%T&PQZ M+*>^IWNF&@1NV]@XQ>8P/7>H+:(WQ_Y3;8ZU"AMI-[33JSC*/^+HJ'BWXW$& MPQ2J.(-QQ9SOTRA(?-=P1@[-XAL*GY=K\?"&6>VC*H)889%*!)BK(MV]ZKKU M52M4X68F8JYH!0H11L FV/P_VN6K-5LIC&78,IJ.7[1L"__WU6&P]Z]B=X;G=;T$?A$DD$Z@HM+EZ#G3& M7#T4BJPVG5M?D@C>+[FJ\^\\B*;,%__6=;B<1EQ)8LMEV)*K_;)^Y"R#KV1> M[H^*%UCZ-4V:E[/8N&?65[AETW7;%+L98\:Z8=+B:B+?!4Q!9T-MH8M9-"]" M!FR^/XUG4! II&Z?->,'P )(4J,F,D-H;-P'2P#T8,C UZ7&_>PD'HNL?W#F MQ;-L9%CON<=N ,K%P6%;;@!5RQ\)I2\^Z\SZEX!B OY#^#;%;M78*(^!3OEW M?.N,>ZYJ>&N\*(ZDC$)^PUQA"M)#!>D1%D;J0P,7:DQ6C5XU -&IF/O@>CIZ MN 1CX&;U4:9E3M^&@PO_CO@<. 7KWK&'K5)I;Z#SH&TECF*XN]2VT!=X-_IJ M>*\AA4<>#CM!_\J@JBRY\NW0A2WKOS/K"_1SO)85M)%9[IA#80B$E\S6 M_8'9@\OB2(R36 -.F8>;)>"I)L"L>CQ"O(/J"V 0*[3K6T247X/A$+RH/)21 M90S$(PZJ42)/@:$*X5FW8@Z&!U([<9A M5U[SB$UYUH6&T0N=B]0;8DEGRGHP#^V+(M=5Y[>!*IU<+G*YZC+ 2Y3O\FON M!2$4!(J73(#($B6F@'LE]SS0F6E.#OV=.7Q?C5%GD0JE=2Y]4!DVH%JNI MWQ/P,T"'\04'!8CO5/;"@9)@S-$"<\0\>#%>&H&./+T)(B][$$<7Q^A'?#/( MKT2J6Y9>=;9DPT!$PD50)IE24U[.S#!@B#MB,H9*^N@H7@.MV=84CWHL?P6& M);^8.8GZ$LOSX>O[WZ^L%Q]8!!;H*Y1?'4QLO0?_D<*"A>$+)XMK*LX M<1W03K*D5&A&HO3;_RST@%Q)<2]07>,JF5+T4 M1FA%\6>0;0H2DC/P5N&O&_0/E,.N?/,%%L+EB&AX@06V96').?KUVK=6'6^* MY;#0W&1;7& :6;1D&"Y@4:Z$PB TY@;?/(&QJD"FG!'U0=#>TGUSO M+&2]E+?:F)? J%"(<$/X+XV)"F>V(#,L?@NE<(VC5F5W8^[,]/-0OH$\$D'F MDZS4 6HY22+5,M!W#+P:.=OP[# P@17CI4#Q.3080!\JQ-5H<#D40(]<@5XJ M;CI1=T 1P/P+J)7Q:Y@5J6 (WHHL(23F=2:33R:_9IW9<)/_"0:? YWJ,A_( M2-'IY=4[:]CJET*M5H);@?Y=$46=\W@6*,["YR0^9K*%*ZJD 7W'RO.[3RI^5% M!N9K&#U3OOIUU5("W?70%*"?LG]GYVJRW93SO/7\XF)]!;,YUGQ:>G,][U^? ME98IK#^(=7\N+6NP]$LN+G09]D/F%<-HJS%9FHQ/5[@\; #>1"P\G@%8N29B MG^"[5?_:V$0$P,.R ]8HK(E:-<"&*H$1?3?G'1.EL"<=A\@S9+@V[E+]3:7 M(3.O [[Z;0W$%6#6W:A_7#\XZLW)1;WCJ G4W0Z3AGL)#X$Y9OFU5)K?E:DS M(FHBZD,GZL*JPDKM6V@ K'.GU;.M3A?7'O3[.5770!NG^GX(^KYQJ&\X[[XK M3FR7@@SWI]'& :[=0+R1/_9@?XSP27QX%[Z>'0.LSO>$JZ+/H\!%4"M +5L\ M?0R0:R"3D:6]GZ6]KS_2[RN\/AEH<2L?>26UI,9?5FCOK'@+<&\F'#L?62)G (;/L"VZ4^O1.3,SA<7*L\:!25 MJ2/02.51U)#P2?BL!3[)"ZF#\7[1;]GMU@[CKMT9=8\!< TDQ(:# MB^9 "&Q[ ]N7B(=,N"9S%T53:HDQ4GA'%%XF?!(^ZXQ/\D#J8+=?]/OM8T!; M ]FPXI)=9(YAU1H)GP2?BL,S[) M#:F#_7XQLGO]X3'@K8%\V'!L'>H\"*7YJ2WD/ODQ\Z=B[/&#F1"AD_5)[ST4 MI<>9VH1& HT$&@GD8]5%E+P8G/?LWBZRLI(6(>%[-),^M^I?!Q 7DZ]50\A5 ME?RN0[__'@3NC?"\C6AM4O#I/B!M(BW2P?8USS62=JF"H.4&"<8^RLU1(XE+ M\=H#(_1GA/$?P#CY9TW%?=ON#[IVO[/9J2,E4Q]R)B6S7R53\#1?Q>IHKM52 M.!YG$;P_GN6%K'JTM2>@;495D47_3&0L)HM*B!XYT+8"35,ZL^&F+?6W+2$M MH',G\5C,<;.8%<^XQ6\=+J453-1?I32W5APQ7TYX%,'E 9@#=8G/8S.OBD?N M!5,?*N&JI9\1!PQ+CH?QZ2>'W,$W1?R:^PE7UXRYSRO&K&@$T<)]&TXEL_,S]AT<)J@^)MM<\53> U8\Y]*)+C)2Y<*/RU M14#2PND\16LRAO^;*Q*"XN#"=%4?:;E)A"V #XEG$==T),7MZ1PZ8V;!A2)P MH<8^ONWGQ.=6MZ5+]/H08$R<=#].*C0K!@WRUE(Z-G/>-CIG*Z[6@YTV,6=3 MOOHU7.VQ4,(OZ:>TZZ$I8,1D_\[ZPL\G2OK/+R[6UZ]J2J@V2SDO=!F.QO6D MU1T$/HI[-"WN$:,_XT$1_3BQ=M$GG]DU=+&J'5E++R>8Z&H<1S0 M=CS:4_"Z6(@?K56]@M=?40/G(/\51;"\/^BIUQO5ZQ_0NUG?RP\CR6&G-?CA M1Z4>UX_-I9!4(*G0.*E X"7P-A:\I'-)\=19\5R)6U*Y1];GI'))*)!0J)-0 MN&O+"2&:YA>.87Y!+[!L;UA>>6P )$I]#-\K=Z9BXTPU>*G\<;A@S5A.]!"8 MXQJ:Q@A>8FABZ$:'=@G !&"2&"0Q2&(00Q-#'SA#-^@HE^VV0Y_3(2Y/<7Z_ MV0J">[O,;JT=G)I9>[ =T19FBO,2/HD+[\;7YK-,#@16'3IRI 90:W?:]J#3 M.0; -9#'R,Z2G25\$CX)GT=IG$D'D@[<$]2Z@X%]/NH> ^ :R&-D9^]G9YN6 MR(DBTC6DQ')$V@NDM%@<1V*2IU@-J+MMT:#NU1:W0,F",JJVL"(X(5*3A2<(3/ Z$]4G"D MX/:GX(:=OCWH'4 B2J*R^N'K %-04I2XKF"KB!*'/-(A89I-JR7BR).@52MU MQF?#&9%6K9 GL2]/HG76ZAT#W(C%ZNI$$*Q(O)%X(WP>".V1>"/QMD?Q-C@& MN!&+U56\[3(UM(*I6ABJD?/FI)6=5J21T&ZUGD/)\9I3*'&0Q*\GXI:[%R>6 MPSW/5%#=AW\;H.'?56'J;:OSMU>)/)TR%KY^FTAH(2G?J72W2HF\%]+Q IE$ M_"MPU5LO<+[_])__\;?TCD_^-??C(%I47&<)]\W)1^;$POW6[O:ZP_[Y"6;! M1-+[G4_>G'QIM;_!_SJM]O!KT!I\Z[;4YY.?\I8J($N#XB&X6L9'*A2#*)PQ M7[ZV.H:)A>]R/QT:ZAN=6QBN3P$('1770'=ZP\??!=R&]\HX"K[S ME&CR9^8R+^6-C%*6?U^FG)6A635^S0M'H^=%ZEK)P&A^6AHU1>Q9!GPYN-+^ M6"(T*$_)EID$GR>KY%QLC.)90S^LO$\VVH3TM3K!9-'JJJR2:5'445_%\A3) MJ,2"^JOTMKP_TF]*';*KJMWWS)[>:IKJJL:I3,UZF"V2TI6H.#CF(:1O*=;? MX'%2#MX#=:";TID-UVF% :L2: N)V;,#G:X[2QA.J:^/<-A1ZFM*34%QXUK$ MC0E\3P2^@R'_!VCY+0&[%KSKSXP^-B#32<\[!R=E4"->/5)>)? 2>!L+7A(% M) H>#9SON8FABZ$:'Q0C !&"2&"0QCDUB4(Y58NBC8V@ZJZ@.J&\XX?[.;J"> MO?T"P6CGXX6/T)7 MRAEWK6D0N,U.F[H]T(@A#Y\A[XW1@UI@04@GI!\9TLG-JH.>Z+;M7G_S\F/2 M$<2N!\RNA%'":-TQ>I@*@)!.2#\.I)/6K8/6[;3M[OD.0CB!VK06[-FAY MNP9NYZQ_J/,*A-U#6'ER'Y@2PQ)*5U":=HF"D.4&"1Z[?0@2MH%@;[A+47*SZH#;7KMC=_N;]QN3#B =<- Z@%!***T_2@]6"300[ VW^J162:TV M$;?M?L\^[[9(!]28&DD'/'A>X @2-&]*MUQ,R_PE"D(8&XLO'O/C2]_]\%F>:YN&H->C>(TUSH9FW2\B'&*-4SA5L4$49E,IY[6N/*Y5SGU(Y+[5( M2G$6\UTKXS<;7AGOQ%Q8XWND=J9\LP>J-)K2F0WHN@?T46F,\W2,;TP$?5"] M2D.44D)32FARQFL]_I[\$&4"WT&2_P-\@BT!NQ:\E/V1#J9_-'!22FCBU2/E M50(O@;>QX"510*+@T9"DE=$T138$LR@9&E-I$2J5\C:2 FZ& M*24T,?21,C0!F #<: "3Q"")T0R)02FAB:&/CJ$;=&86I82N*^'^PIGD,\"G M)>9A%%QS7()+N:'KB36*\Q["61>'B\^&. 7!$B$2(A$_")^&3\$GX/#Q\DJ"LA:#L MM^Q!JWL,@"-"/'A"I.7:=4!MPRGQ8Q)!/R815V/ 7!$B$2(A$_")^&3\$GX/#Q\DJ"L@Z#LM^QN MJ]DY?XD/B0]I!7E]4-MP1GP7S,,$;J(EY#7'&;'C$:VH('P2/NN,3_)FZF"[ MNR.[=SXX!KP1'Q(?$CX)GX1/PB?A\_#P27JR#GJR/;![@]XQX(WX\.#YL$$+ MR.\^Y9XBY$_'BI\G$^'P7<;'&P$UXLC#Y\A[8_2@,MD0T@GI1X9T\K/JH"B& M=GNT@WVZ)".(7)M)KH11PFC=,7J8 H"03D@_#J23U"6I2S*"R)76W!_>C *A M]HC6!A ^"9^$3\(GX9,8Z0KU!RQX-1\< .")$(D3")^&3\$GX)'P>'CY) M4-9!4'8[77O4WD$VU/H#C@CQX F15NO7!;D-I\5?N)06P@CRLI M"5*T50A[2="J+;3(=)/I)I%*2">DDTBML81XT>D,[6ZGV0??'[:2:#C"MA6I M#5H_K_'6.>L?:J2?3/HA3-K?!Z9-)$9"Z2.C-.T2!2'+#9*QQP]">S80[ U7 M <\(H^0?-1"W[5';[G6:O9:*= #I $(IH?3 47JP2J"!8&^XU2>U2FJUB;@= M]>W^B,1JG9F19,"#E_^_BAG0945K.1YGT6OHBUG>F%6/MO8$E,VH*%+8GXF, MQ611";&' 44U]=$ I2F=V7"[\C&(K'C&+2ENK3F\=B8M[KO+G+X5F! M2LJ0OMZ&=]OMKB[ELTU/DLR#'L#+H"._\QA:*7^(NKO3ML\[YDGM@3TZ7-V'?QNSBW]73;UNR\9_>Y7(TRECX>LO41"" MR5Y\\9@?7_KNAS0SQGLA'2^02<2_PH!YZP7.]Y_^\S_^EM[WR8^9/Q7PO$LI M>2PK+K>$^^;D(X,V/JE=#Z)PQGP)VMZP@H 1XL=%GH!N]^4$KD_')_1: M<*-ON8$N71J3IS=\_%W ;7@O8";XSE,-EC\S)]M44F5J:_GW936V0F95C&=> M.!H]+ZHZCX427I5^RGY:(I4B$"V#Q!QI:7\LJ3PH3XE7#:V>K.K68F,4)>0/ MV[^3C7(Y?>U97_AE"X".6584Y:85RU/DZI(TU%^EM^7]D7Y3ZI!=56W9$MWH MPHP#SZVT 8-57JIJG$J#>)@MJO\"HNQR%HO7W7R[_>/?Y]!\?+G_Y^@\+Q.X-\ '^/U[FLSG7K?#?AIU. MZP+9(O(5BH N/BRX]2^XVL<]RI]\:.?O">A$'4PX/BG3!BD_Z8FG5 M5+C\I36!U@7):25^Q/5VYW@F(C>'7YJV%5T9\"LJ71^K.!-Y6NA5J.'ZI MWCL- O=&J):3 ?H04)X;$<]6KG?T]?#*8(X:.E@P+Q:((.4"L#F; M*@R3B; MX'O=A(-* QNR4&I0/=,([Y6:P./=EX5FP LDW#]1#Y"QC60D0=_IETV2&,0J M%&420=TY2EZ)[YH+R<(0;$&D?2&)AF+I17C_"_Y2^P?PP@![635U9DU"8TW2 MP@0W/C0*/-_Q&(P9UQHOM'^&MT3X Y^/ U=H!Z3TOC. %_@=T-]03E4=^%GR MO+<+J ^9<(O/?=9OV:U6"Y_I,#G;Z*@TA;G(#)$9JHL9NKQZ9W7[K=-NZ[33 MLEP^@5^DQ? 3]R4&#$3F*",[\ABM"Y!\9IY6?D>BMD"C)CH4 W_JV K8!J8XZ"=,YRK;M*&*"4>ET/3S86OK!:+]65KZSCG^@K58)D< MW]1LY;=!<: WT;7S /4:0#)F,5)UDBFH-C: NX0D6YD'Q28YRUR2@JB_#,4NQ!?FT3\KP1N M*EXM)OGG&Q9%#+N4;!39J'IU9L-M5(6K5.(UKEP$Q9%@2#!"*Q-/A= S+LS5 M/,ABWQ$AL)AA!B,T\59@+EFXM!C17];02CIKV6RH):-J(XS3TADUK *Q:.4" M7^EA*.6?B:_^SM]85?2R/IYJCD$+&Z,9#$)M?*J:*"@^$VY35C+UNQC\%>M6 MZ+>TZ9$S!@Y&9E:"^1P>:UXS*97BA>3<^BT IAV^;/#7?>/770ZPX'?9HZH*D#FCK85Z#\G*8.EEK$L)>EZ,LJ\A=-&) *)A5< M=Q7\/N%*I&+H%V,;:8P=@^H"2AMQ$QZ6*@ OYN,DDO"[6?"A%2N(.OPKC+? MS02?6!]NN9.H]2>?)Q/AX)1"8;)"ZVBE-#'"PR.IG7OF7F, (H>8;Q"PC.@ MN+8**F3S F-@'R68L=APG0JY^Q9.D/BNBH& >%U=-/2>.WP^AM?B:B"]@JA8 MQ1G#=3;P;>^\FZX&&MCM;G=YZ9"KNV6I-]:*8JO^JO@>,K>HCJ\*W8>+<.(% M.@AW:N-1J]5KDS:NMS9^#!G\)'KTP>II6%<]^> :%<=K@;$M/79)$Y(F)$U8 M=TU857)M.T0,E7>VONDNLO@2\0E76E'1QL:-% V'!(UO&M\U'=_+O:RGV9$&L%WCK27;'TL\G+]&IO@;//DAP'<(U M>/I!&A;(YK#"2#@\+<:Z1^D]0.TS7%N!408LNZT6 N#ZBNDTXE-<,K#ZT&=9 MA=6$'6IO''7H\J]I)B%E J_M=_MVN]\K-).(Y8;RX>P?LR9,1!8N8- O/Q_V M[.%P:"5AH"8+H2&E66;R3+V@-\+//OC8,EM?J&(@CA,E/%\XJ=ML[=LQT,'4 M8@GX*G]]N;U*#\9F4^LF+$"Y<'$!CUDO$V%#PMW#Y]GD:N&YM@7NHF,2X?R5 ML"C&]2>V7O*'>Z"RYBI-/2X]^UGK;% H&2VV(,E1K\X\#!M@MEX6%T.MV8.Y M%#@%1'@,Z24E!S6BGPW.[4%O@('9S5RH5@KBQD8+@]1R8M833Q+/@]= C:=Z MI012K5HNW\JB'NWY934O>T^H+'L-[&CRN]W3>)^^)J+:NG=EPJMW:>\I_NI<;U>[: M_>[YDAM5P7L[<:.&=JL4Q2(OBIBCOIW9<.;X[%N_!==&@E4Q B[=@^>: P&R M@8O: D^/JAK!/;O;.[>'G?-UZD#MXQAS+[AYJ86.>8D)-)O],M=*)'F ?[45 M)H9&GW*U$,^HBUS_<=P^KH+D:M-= MT**'66 MCJ-($"S-:&@[1"+>JOYG;P M4M749J4UW&I=.C"\<:D/*CPQGW,7SR3P%E!>#SHK-3%;]%890WPR@?XQ$"KW MB3H&((E! MFM+C(M+ED7)FP?"YA,I[:P[3F A/;9IZAS[)1#AF@'SP!.YH+6_"*B/3B7B, MVZI25R,VM[[G'KM1_@3>Z$8LZY5\?6CQ=5+?)('&]/O4+F/P;=C8$W)6/.?# M5MT()9Z:5;NA:E>NEL+>-=N%UZ_K$-4F$1\O@#Z_J_;VO.8.*'@!>FC*'P6F MF041O-8MH"S,:F]\H6LF/#5/IK8!&P8E)4-*IEZ=V7 EL[=%:>^T%:$5:32X MF].9#1_<3^&F8) S71KSK'76:K6+X5Q04:QR][0*E+BX58. MYZ[4(9)G?:,CVLH)DCPMAPZ@8.1;G6E3X0H%E@,2C\'/:0DBB1^QUNIG9F39 ME[2 E]F1!*X*Y>IS7%8%[9?"0TK'NNCF+KQ.';[B .( )"!40[PN5/(S/]=% M;4O"8P]BKN- ZNPPKI;ZJ[[1'Y$SOF.HR'2;7#[,( G3\@#:L1(^QW-U\+WP M_9SA\2X8C$Z<65[$_RKN!X.FQV@T4P>*17(F0NPD!Y[%ICP]+*%J(YG:_27T M86LR&?]ICE#+*PYN!%>G(:1S!:L-H4[XP38PCBMGD2?P]+*)]4*\+"G_7]G" M=,:HN:/5AFI!O51W8"'2DP&_%-"#\/;4V4@S&)@3;"[3(=:+_O.7J<-AUK:I M8R\JW<1U_58>R2"\H4A595KC'2Z=/ %7@:,ZYGC^GN7AX7[J4#IUXMVU.4X) MOU8'(N&@S%\&J5@# 'Z^DC(E&O"HF:08?"Y>O#,@#'/NCOVYF% M9E7;Q_,-Y\5S C9G$UO)#?;@+&,"SW]>_;IJF[WN>F@*<'FR?WI/O"GFL/_\ MXF)]_0IG/"Q5LY!5;RD'X)K49^TM$I\-SP\B\UEI'#KJY,"EG6M^H!*?5=5U MY6D7VUFE.P;OD25:*WZN3 VX(3>D&2B; +M>B*X[;B$%RS8P>SQ8[*'_Z]/5 M@$1XG?_FI'.RU.UIZT,78^A-N-6Y2M>@X^[\C?M*X%C%,SNEMFU)JZ98?$R7 M\\ZC3U2HZ2&^XT,)J[4QN2A15MTIJW#F3:7P6LYFV^K95J<[7,IF>Q]A=IB" M;,\H2@6Y:?/\^S#02;2*6CW_53^LZI>(AYS%U;^Q.&;.;*Y."JOZ/8 6%&O> MZ'@B+/SRE.2XCW'CO4?&_!1#>U] MS>HJ'Q+3-HAI[^NP]/L**.2PD,/RE/SY=YW>YL?9;PG/Y%34C:#N="J6>O ^ M3@4Y%,>,HAU9M"V="?(^W ; M"CU8=J#Z*=9? _??'S+N7D'-CE M!.\&.4 _/HNC_G6V&A/D A'0'V/?6S&),/ VGNO*M2>%1W=M'#F[#(JI?]N- M!/*LZN!9;3U9I#K56$<)F?ZV>E%)B5)(7D(/B9" MC+IICDNX*7\8@RO VIB$(#KE#>4 (4:I5VU2"*G$ MJSJUES/C;H*98>$I')-&6X33Z58,OFZ>+:< M6R6.[[?!/@SRBBRWZ96X77FERAR=]D3Z5M7:E2GC6EV[->SGKX"F!3Q9&D_P M#!5UZB MM#+%?,3$>3]&:MWSCCWL#0OEU=DHLY<")V'H89W=6LYHR%X6FWND&1P+1 J)E?FF',?ND:G?L?BP@@IOXZ8GYB_7IW9<.;_ ME?ELJA4QL 0PE&;":2)06%4YU(M_B5 M9JJ\HX7O"H>A_%4:GX$<=,4$OS*^1%G S/!@ <-/@L2<"G&\%O$TZ2\\&O* M4"GSZ;@]L)B^#5F.J7;6?]^(6+-F;DIBE7/8*1;9"62,H0?XWA1HBI1SJLAW MPD2:Z+CZG:&7Z&RIPG\^L/WPT?*:=;1,?\9S$RZQ<]9-! M&8\91H%2&W.+.7_3ZU?+C$WR0I>#NR]-R;,G@ &($ >.B)QDCHED,<\PV(UH MS>.6FF#.F4R42S6?[>%S'4M#;$.+8DKE2,COIQ/P M1S'MLKJWVE&F!+:ZN*NGW&W!7/(YOJ+>7VOB/&AF1;EU[]4JM\O'=GIBH*UMGY]8"G!H=V\\++?PX G] M.#E-/6O;HU;?[IT#+Y985I<.K\L,G:+/0J1'L>'R,X$54_NH:5$Y24*YHBA: MQCR^05="F5T6?>=QV7 E:&^]!5:GU$[I9,=JNQ0M!3$C,6.].K/AS%BY+@0_ M[SHYN794/H=W'V_2<$#0Z*;179?1O54J<1/(5"-S;3[Q ^A+&IB41?Q'LXBO MJ>;]J[/2,(5]2+'NSOOF1:WKKJ,'CKLC2P"^(8?N7D!W]^D?QP*\@R'\!ZCT M+<&Z%K@_G,(V#W)"[Y?CG#B9 M.+GAG+R;4\1J('MIXWVSJ/9),J;7"*>;ML77%:9$SGL7S(1OPC?ANX[XKD]" M&Y(>]]VCW^[T[SQ [0 A2Y1,E+QC?[#Z^)<:@+YQ2&\X$3]6$GI"%$VLU?64 M*P(E@9) 68/I+_*+EG'6;[5VVJJ<4AM./=]#*()%W%R MUU1^LZ,ZC4,5\=\C9S4A4!(H"93DCM30))\2O(CSFLIY39L346F;#@BO#>>^ M'6:Z)&01$]94_6V;76OC1HQ\$\BMV00RQL-^MMK]L7$31^76$(/N%"-Q_DT1 M7.EW)O4!P9_@3_ G-ZN64F,';A9)#.+8)CE;3Q@6V"8?:./PVG &?,B"R:5S MWPJGN1W, N&#A"JM#:[Y=HWMLT#2MGX:(31":(20#_A464L/;$<4"1ZB\Q^F M\P9-_!TFWHM=?"<]WPF%'W<-"RDY=\N4A)S'9LIU//3D$'LLP5D-*1*Y86DL]&;[7EN MA9FF=&;# UR??>N*A[$Y/5#[9N?E=$VE!.(,TW^GR059EF0\+.0HSY.WID^8 MFN,LLHYG)B\A9HRS.WVUNW8IU:O.77)F#+E)?I2G>AJTS#O,P_%VS%4'G+0P>0%ON'=MDGM+G5'VKX1% M,697PE1/PI1H-=%BEBS09&\JE)C%.@F3KW+T<0:M%O$PB%3;ZN1].BU46BZ= M?=<_Q=R-*J^@K=/)JDR1*QFNEE/38KUOA.>E^7K[)JV52CZ;I8%4B?3.+)W$ M:^52?6L-S^9];[)$I3 F-R9M/L MT%#PE@V)Q0IET2A:*9&JU;-.?V"/!AU=))W#>*E$O7X9$:5L7M!.6)#T\C07 M\ED.L;4IT'+,M9?> &50L%/)IA4^3(+A\PXTW_"^61O/K$,@5[*49"EK9"ES M.GP"0WF^T4QV[F,FNVWP!,_[=YK)_ ]X9OY'3F+F8(P2UQ2-*#R\9$8+9+X_ M&VIG&6P5;5H;D]VJ'(]K&?Z!UKBYH-E*$5;=\D M\0 /&CV/K@1Z[:X]/#]?4@(RZ^3F]APE[R3[7Z_.;+[]_YGY">;WZPRJ.*=L M_OV"T3=6V @"8_U=?LV]( 3 !F[BQ(4,]PZ/8C"P^"#N84IT,#!X&7 P9EF_ M\3&A_*+T[A>2<^NW(.;6X.69]0DISO\S\1U%=^KU>'65(K&K!$B6LM@D*C0. M4KD"64+F@DA)!4&>HUG?5Y0LI>2(!:TT)JH5,9WANPRNKA(QECB5. M'Z>O[JW(@UJNY7+'Z$:Y^NQ)$"DIQ^>A%RPX5S,?#YD4 MRRL%?A*H,BFZ5-U'_YM%K#@WU5+HK==*O&W5XD\G3(6 MOKY"I@9&A\+)#W\EP,WH"[X7TO$"[(>O,!S>>G#-3__Y'W]+;X+>FHL8?4!Y MZ;OO +90)NX[@LN*.RWAOCGYB,Z,^ZW=[76'_)^FBF2 *9\R7KZV.&?X"5+D?%PDA M!B4O 8#S="!"[P4W^I8;Z-JEP7=ZP\??!=R&]\HX"K[S=%53_LR<5=-%2MGZ MI>7?E]V^2ZU&J_Q4U3B5EN\P6Z1 8$J!EBAL)^O.++7P;(/D:Z+H(05+"K8N M"K:H&H4T^@YMD:?CVS(9_\D=M9#HFL%O"5ZCY1SHR'@6<1" & _W0 IZ*M:J MXH48=_28F&/H4*C97S"!^!2!D39X#=,7"NT4:PT!M4HBJ?3C&*>,N90JEJ[# MT&"VP86&WZ#MP,E5@?UR+!O\8)?_E: D55%>B3?,0&&..??A-I>G[S,W:"@. M.^WS"XE:"O0*^NH3X3/@,"@0:->8&X*+EZ4KZG*0V"&V#VAHF8!4!HT.70!= M*7S'2]PT5JF_AFJB$A]S+[@A7YR8K%Z=V7 F^^PC([$Q\LS/B9=-$IZOS 1P M<:UFV$*V4"3B@B,.?*7F&QCZQW,8JN6IMN(3@!OY5 ]LXRN7)YZ"&WQZ" QT MJUQV*,JS]JBC?'YTOLU$E(2B .%$W"W[[LA76+]$S3_,X(&F?.H?-,L\C)7/ M#M03X)I8=8TA&!5W3* T#KQ 3A+OS"I.FXZJ8A03X:GF\-B-!,\5_'H&SOQ* MS?#U2-[IU BT'+A1/*/P/\"K@J^OD#&E!0YL' D@QG= Z;&J-UYT!;TSXY&? M_PX,_@[GE(+(%\QZ\0[G,W\+SJSV\-T_.ZW6Z;]._^?5NY?0:/P[MCF,6X_! MP TB[$I/\(F%08A(!QA["JF M 0Q$"?!T^82GE40^D&5$.LP'PX7,[6*/*6N"-F" GIGSUZZIP MI.YZ: JP#-D_':\SQ1SVGU]':-S@"K6?W/2.3ER(!<%BJ-6ZM(Y=SLZSNEAT#QN.!*O-II7";P$ MWL:"ET0!B8)' V>Z1R8':;=-"H%(]JA(]JZC;@G1%,@ZAD"6/IVOO>%LOF,# M(%'J8^C6/-5?;%+]-?BH4U+ S5; .'_>&,%+#$T,W>BP& &8 $P2@R3&L4F, M3,#I(KCSUO/FH;[AA/L[N\'UXO!>YJWN$KV3.1N'L78# M(4;AW0>'=PF?1(%WX>O9,<"JLR=<40+=35#K#EOV<#0Z!L UD,?(SI*=)7P2 M/@F?1VF<20>2#MP3U-K=KMWM]XX!< WD,;*S][.S]PU$/WF&W$W3+Q2,?CI: M_ A=*6??DQZ0ABUP-F5\(H8;3N&#U,!4!()Z0?!]))Z]9!ZW;:=O=\0#J"V/5 V+5! MR]LU<#MG_4.=5R#L'L+*D_O E!B64+J"TK1+%(0L-TCPV.U#D+ -!'O#Y>JC M+;8Z6(R2FU4'W/;:';O;W[S?F'0 Z8"#U@&$4D)I_5%ZL$J@@6!ON-4GM4IJ MM8FX;?=[]GFW13J@QM1(.N#!\P)WY*L?8[KZD\K'%3[7.ROFMKDMB_DPOT28 MTSM>?/&8'U_Z[H>_$A%B8LWUF3 'K2/)A%FSXZ<>,WE4I:GG:M1MS96XU MQ)K2J\=^S-A].Y.R9E*R =(KM8A;$/B>"'P'0_X5744)LNCLWEH(TX> D[)F M$J\>*:\2> F\C04OB0(2!8\&3LJ:221[]"1+63-KBF@*9%'"%*+4)E(JI;0B M!=P,!4Q9,XFACY2A"< $X$8#F"0&28QF2 S*FDD,?70,W:!C12AK9ET)]Q?. M))\!/BTQ#Z/@FN,27$J?64^L49SW$+8#'RX^&\Z%E#:)MC/N"6JC8>//WCA< M&B,S2V:6\$GX)'P>I6TF&4@RD&0@T1B9V8--GDGQZ+HRXETHH+P2?BL,S[) MFZF#[>Z.[-[YX!CP1GQ(?$CX)'P2/@F?A,_#PR?IR3KHR?; [@UZQX WXL.# MY\,&+2"_^Y1[BI _'2M^GDR$PW<9'V\$U(@C#Y\C[XW1@\ID0T@GI!\9TLG/ MJH.B&-KMT0[VZ9*,(')M)KD21@FC=#,*A-HC6AM ^"1\$CX)GX1/7CX)$%9!T'9[73M47L'V5#K#S@BQ(,G1%JM7Q?D-IP6?^%26LQQDGGBL9B[ MELMA8#E"(5H= \_F ?3:O]47-#-96QP2@]*R#](*A'1".KEA-=8;+SJ8QW6P M@SRNI"1(T58A["5!J[;0(M--IIM$*B&=D$XBM<82XD6G,[2[G68??'_82J+A M"-M6I#9H_;S&6^>L?ZB1?C+IAS!I?Q^8-I$8":6/C-*T2Q2$+#=(QAX_".W9 M0+ W7 4\(XR2?]1 W+9';;O7:?9:*M(!I ,(I832 T?IP2J!!H*]X5:?U"JI MU2;B=M2W^R,2JW5F1I(!#U[^_RIF0)<5K>5XG$6OH2]F>6.N>[1ZA@'BFY/6 M2=;B"E+M5NLY5 &O.86B!TG\>B)NN7MQ8CG<\TQ-U7WXM\$M_ETU=[%M=?[V M*I&G4\;"UU^B( 3,+[YXS(\O??=#>K3\5^B!MU[@?/_I/__C;^G55\Z,NXG' M/T^N8OAI%GA0*8GWQ(O?@IC_BT41/$=^CGY'#,KL(99PWYQ\9$XLW&_M;J\[ M' RA0@ .N.!W/GES\J75_@;_Z[3:PZ]!:_"MVU*?3W[:TU#;/*Z*1N#/1,9B MLJ@:I%L-+ 7-)QM8#QA!EY9,YE#9A15,K'C&+KM1V)1^?B"E/FW/[YM2"RU1:%94DGEK:6Y,1<%& MH[]BPA\L!L2<3?GJUW"UQT()OZ2?TJZ'IA!^_N^L+_Q,$0S[SR\NUM>O:EYY M1?PN2?4?6&TP/#\(@5(:APX8(QY!%8O#R0^4/JFJZ\K3+E3I;_1+QV"RJD%- M>NA>"GZ#"V<&RB; K@5IL6TJP;(-S!X/%GOH__IT-2 17N>_.>F<+'7[E@L$ MUZ#C;C=K7WY6%<_LE-JV):V:8G%7$O(AM;V:L8C+K9&[ \)J;8P!$&75G;)V MLW'_/L+L, 79GE&4"G+3YOGW82"%QE.NU?-?]<.J?HEXR%E<_1N+8^;,,,!1 M_7L +2C6O-'Q1%CXY2G)\3UW^'S,(ZO;!OBV[CA[94=+JQ]LSC>,@3O)-UOR;TONK%!8A::_;A98P*M)O-]6($]>01D<.MB<#OV M:-BU!X/!HQK:^YK553XDIFT0T^YF!Q(Y+,2?>^7/O^-,'W=WONJ#G(JZ$=2= M3L52#]['J2"'XIA1M".+MJ4S09X#6;Y=6+[3)[=YI/@;384T14&*OX&\]S&( M)ES$R5T3LON(>9#J?W+5_P-3":3ZCQE%.[)JI/K)^C5+]5.<_YBID.+\I/H; MR'L?;D.A!\L.5#_%^FM.4A3K)U-W"+%^6CA$!O&1#.*+]K!M=WK=)[>&]_ ' M'@OBFD"S#9)FDZ+ZAW6HA/ J)1.HGQS4CW5<\H]/71SVME>"^9Z=&1XY0NYB MV=*&8,Z=&U_)I:F32[/U1,;V&UW)R3E.7.TBH#?( ?KQ61SU;[N3"D]JY*6Z?=7;OJ1$3UX^)C^LT[ >?;UTZ)#L92_Y7 CC]< W_67<( M]G T&G;N<0AVZ:Q74(C\-?XNX#;\%X91\%WGA[PFS\S1W9ZC&]&K>%HE*O/JL-^S4]+PZF(17?K#QK'2C]57I;WA_I-Z4.V575[FLLVZVSK=A#M(I.?7^"4]]KW9D-/U#WLV_]G'@+ MD.=I9 X3,[P-6.1BEH;W(N).'$328F$8!=?<+29NL-1)Q_ JL*-Q8#& :> F M#OC-_)I[@4K_@;I$)EZ,5[%IQ+GZ\D;$L[77ZV?# UTNH?DMYKN6$X$#QN$6 MT ;?\5EP:QS$BY#CS<+AMN6S.13OTOE?U^+?-I:(@^AP\3E\/@[AJ$'YAD?8+7[ MKSKGY_:P-[(M#BX@MA<,6OA0;*+@QI=GUA]0E B^QV06:2/HIM[4!' UE#ZK M^G*5K41B2TCNRR"R'!$Y("^CA6ZO8#Y/_+2H,IC$-RSBKR8BFN,'"WX#LL;' MWU$(VX)>CR3GIOEB/M4,D";QR$N5E\!TG$$%E@4CO7$ M-!]1J?7@_CF3TMS'*Q\&HT-")T*)RL7!9DC+JTM?;A0')*K/O>R=IE%5H:]9 M)()$6M="XJ4QEPK :3OB6^"Q<^C93SXB_,_$=]1#%;#7->E2UU>,LG)B%(MY M,LA''@-^0?4?A.I54Y4GY>X>Q$O")(+J2@[(;N$,K"75H=CI^[!A$";Z\>4R M9*WK@#1E,%1"'J%N9SXTUIS'D7 D8##&=H2Z"__NZJNN*=4E^^G,*AH"ZRL\ MZ@L45*#[4$#<>K3^'$@>SJROV.3<3?&)=.8)CM3Y/ ))P%9:36:[IGJ6669& -7=)UWF3Z'(ZXCN@HCWH=;KG M_==OF13R\P0;'JY4H^72=_^0X,Y^@($PA[:57P(@PH7^[_KL3-W#S)XT+H "!6^S\;$UJ'3!J*%G!9R6NHR M]%$53(0/"@1EH(01J;2#M&;L&@PPYSYB+P2%H[0]&" 4+)A,3OL=C@.EBK47 M(> AH0=5G'*?1\P#7PA^YV&L[T5[_XA[K6SW!QL(3L3"/@J9W MO$ FD6(Y-./09$J^K;E'O\5%Z;6ILGA?55'X;0BN##S(3913F1=9=16T>>"> M@8,7)_ \:!3P*B44*_&PJ%#+R)H 1N$VD(!YJZQ&ZFHOV7:DQHIS"9^C*?/% MO]7=[P ;N'8X?53QR9\G'],NN\IZ['T&A'53$,->J_G5EJW&Q02G[>Y80\!^41CQT!CN0.PM='_@3KNA.A66FIMO.U=/B?- M]*PMC-6%-=-#5IHAF])$=8^K>)29M8.*(!,F7AHX;V;3I(&R.!+C)%8-X+M" M+T$T4]L6T#WZV/# P)4F!.FGGGKIUVQJTTQF _B^\[A ^.,(WZ>X]9=DSJ?L M]/]>:KMECUXFX"I>%.HBY\SSX*L- _6\5QZ<66>J#HQXZ'%?R!E/0WDR#C!& MJ4OL0)=&:AJ>.[&XYE8HIFIFE[0ID7IM.[/AVO3K\J(1P[)JU0B,Q3 2/&;1 M(F,;L]C%02[0:[I^9:'#XJN/C\,GUHH=8(Z3X,H<#PO%,+B\Q"":-M0*$5UB M7X(0)3U(U%&OSFPX=8"3>(73G=H3'>DLX,N>XAQ,OIH1Q>D[YZ]$Z'UT.&LG MD[&,F8]:!N=./2^=^RO,$J93E<790KCJGVI9U3_5&COM[-EZA9_V-)$EC-*$ MEI#I="R^S46/\=_9O"I./$5,QFHM)#S^&HC"MJ8>NJBEK[S@)K^8X6I%^!)+ M^.'K^]^O<+D?SBWJ'])5?V>E6TB\1KQ6K\Y<$18SABLLW"PX%&234&JQMEJD#(C'R\P:# %/ MA;I9W)^RJ0YZX5PSBYR9=ISR%9QVYOOD*WR+T6Z'A1A0MR(FU*IGG'J^5DRR M,G*:TL T6@YMM#17!>QM&NOO 8[>=X$/FD"/[%\$&$P7#"Y-9-%8;T1G-GRL MWV?YI%I.F"[&2X7 C0"5K]<#)EQ/7$W5L';TL-9K'W/9@$$(G\>@OJ72_<]Z M=KO7M5L=O;TJB86G%+'#I-I 8H1%R]+-$NKM=$/80-XR5J.]I,+Y,$ST3(HO.D#IL!GV$<)'&QM=,) MQ/;Y!;S S,85R[_:_BK&C.T([;" J8>F:LW0IEUFM5K,U6Y9,)=Z ;1QG%;%4M%K%Q&@?P:6B_C$2Y>OA\#- A<%3Q*,N5A)9ZM5V<>#L\N*=5,Z>'N=#74@7*S72?(;^FE;E44*M>B M$<=E"^IL@70:WM[#)%H14$LS>3J*70I4FWB:/ .:+FS"]JOJ!HQ57J6 EY7? M@(;J.O"N41U#M_C3>)8=-1!Z_!;?!U?!ZRY=O0(")P3LM;;&"_ P&U#.UK4H M*:K5=M%*0L/P,G'P#9/$*^\K7U:CV7F$ $G@\JR,49:S*\ J>R=4)7UFP$BZ? ,)3@Y4' M3&UKG*1N * 0G"X8!,K9BIA:1Y.I]!*2X3*U*P:>*[F#CX0FF14+8\RL.I*C M9.)\CDV';: *A7,UJF@XHY,[.&:_F3:_6C7P4._$P:Y2[89SMYYW9GTJ6SEH ML\1/2\=41T'I<".]4!OTT_@MET$2817Q\8HE/'7(@)#E22<$ -071J6C1QJ( M(CP" DJ &]/2,8WEC[DS\X$]IAI!5><#I 6,>9DI4K7?#/AP_<%TO>YC[@JCP^OVUS>=H#?W/XZ#7TZ%(0.!?GQ0T&L)HU8HE^BW[K0[]Z4UR<06_Y4S;A<*LHA@44C MO!&=V? 1KD^Z]?G20;>E.0<5&&..W@]>B@YC"$U,!!IW%"2>%SAJ"B4UR:XU M82*RKIF7<*EG:K)Q;J2%GB9&LS\- E<%Q'4T5T+?@*%7LS*H<68BW'SL5U,0 M0\.?AG^-AC_Z2)&K#GY6P[\0++PR.UM@P+OY@HNB+W1Y]:[H"EG=?BL[+J/= MOK!RNRY+W_^].-8_XY19F5EGD90[ MB"']"<;/N?5"3Z')C%1>XKQ0NL#%*\ZL3[$L$YT^N7J5%]4NIV3\ MI_+H O-HX5@"BB$B[1[2)B,BQ3IV9L-)L;AH(%O&K)8J\$@OFL!A[9?6^,4S M$;FG(8OBA9([FA#4XKY8K0$0$I?$I9)I8?)K+ ]ZE=T@E4\F,@("JJ"B=+2I MR&#+^166UB$NOR,P; H5R(CH!I RV\X"R-9TY4$:N&+6C2 ZQBPL77@:8H'EN!* M2^Y?BRCP=2@L#X]X,Y4/.8^V!_XC0!@^05 MK8\+('!UY!C?BR$UKVCL[+(],6$R7(61QRRA#DZB5RJIQ182Y#DVG^)"O>:" M+ )9A'IU9L,MPF75J$QI-_6"F5XOO,+I4@:.4..UVKTN;KT7)B?3K6)B&.W/ M^CV5V@7TG_57 IQI$I@(F:\55X\U!*$=<1?8!(\OTEM=LFB[F>6HLA/YFB%D MK\]W+YUJ$OJ(2HA*ZD(E^PNIYXXBC.A?<&'N+P(S3E& G<9[@SJSX>.]Z$Q& M_%KP&[-*WE.#48N$HL.$!WOQR*R;SXZ=L>^0&3J,E3ETJ$T*D2)PNU0RPXF0 MZ *EF[TP)G8SXR!IKK7EC_1QKUHJJ,Q_<]S)JO<)X+Z!-.<>BR+EPBJ?-/=W M"DX.OW6X=IO!=762*,)RE/S8W\M;N_(5"N P@WLTXYX.I27HC(+>,0>*@7NZ M2 \4BH3,EUMDA=(+#8R3KIZ9)M3+75SH:5QO#M?Q;"5_82-P,;8(9='B*M;O MSHY!RE;+;WJS;@>IEK07ID66WVBK@$+>8] /T51Y?K@#;NJK&,2DM,,-RY)[ MH15ER J:%4*YLED?E,]T.C.&P509L1RH,,!$QR+U\A;4I*%>'9&G1AUXI E7DT=J.*@8X8(Q)C#!(71+)39P4R^ ':NC DUP.A="J>GE? MNE3^]4S@^97H\'L+U821JP*VBU( -5#=LC(<50+(W.V'L31AV7+D4M"LT0 MX*%]JO_Q6:6-]JKI5S:$EHN'1P%@D[N8[%&W\6I)6%XY]B,QL^QHNB2>^4-&N!]?IC+5C':6HJ)M6Y,_D:735UG>TPE7H$2< CD_9= MESOP!4H^>!JJ!RM"1T8M-EXH-8M[0N7ZHRP<#Z6S16*4@K9"^ M)J\VC H=PL55VG!IZM_E:Z%%3FQJM@:38D\C/(/(3-4H31\F$6IM/:^H%U'I M?;OIKEKE"III175F2/K\0MIN4D'$D/7JS(8SY-Y4T._H6X(C][OV]$D%T1AO M3&KN"89@SH;G&=G7>%:F02T#BH(J,)T M!M+$%1'&B]3#7CD1/ J/THC<_+057)=ISO\H!UOT:>1+"1_*AY.7=CYE)Y5C M4S%/\ZNSLS:*5R>P])S:D@2$5W6JS,;3I>?2FDE6NV> M)J?LY)FJQ>/2>AL@M^D#2*NO^"-46TE_"\[44T];(^O%Y=4?Q2]>XCH]S+*@ M'"/-SE$NF+1CAZV5IF- ,KT6+GI/23P#QS#6JV&FB="KW1T/7,Y)=G1B88,P M^F3IM$OQ?873[;73BFYLX&>_9Z_&!RA2JMAJ7+DG61 LRYG:$YM-$64EP:/[>2C,I(0^V49/P$"KS)4UFV:6*UO66K(1PC?K MVY-TSL(ZQ)A1@U3(-TJ M"(0Q=S ]FE[OB;WX,_,3M+9M@:*?&?="N(ZY7$\D5IY5,%:-I-,RJN(6*F\;'E0= DVH M5ULDOCF808@6[+AR69SM0-F 9.+R61^1H@.WM.?B2/\ MG\1+Y$?G5JS,;3GY_9(FC ML5RI#K*+,9P*80%5*,PD6H%8X!0>J2S$H+YD] ] M=WAIP:[2O&;65ML,?8U>OJA73:Y_OIC@CA\/J!+,"RZ*S4,->A%D%G7&A7*% MC@T,X6LUCC^Z')?<%;HN[:9RWQDLJ$.5JTNE%WS"9XEG>Q"!$X'7JS,;3N"7 MGK?1C=:#6>#A#J@-?:BE0X/ M3?15?@BD?MPKGQXTKTXB5.9*'RNHMWH7PJ=C7CC/",6O6G^-GZ_1^@)VB!>) M%^O5F0WGQ7K&&-Z6PPS?DR$Y^F9?_T^$,(L/^"#Y7+?J.9E:7AF?6&+C'ZSY0UI ISRT1-S MYG*U^PJWJ./FCL+:!9D]24<7EI8HY!)V]7'.C#O?[>+#;+4S343YU-69]8_B MCI[R_A,=/4$;$0GG=EP(B^'9]-9 M>*O;.G4QUYXZ[$=-F&#@, W"PE^8OB=CGGQX6IU:>LDIJ Z6B?URR7UH-!@WCF ,!TOKE T?%C?#YZARBHM$YA#5B M8P[^S;7:UX!] M4?Z[Q6LW0O81X/!_\,L:6!PDJ&!#V$"(Q9<<)/%#>+GEF% MJ=-2(+RP,[?0Z>E;"^=;J:/&U(2IASU8GG^M5"U%OQ W7$J9GONP5M!4A+74 MUH(-9XEI&YY&SY91F(Y(L]=;V7>A73"6W62VNJJS&-.-W^GN8:6J, :I5%4) MMZ49#%4_LT$E*\PA0#0_D,S,+_%T]XRIJN,E4J<5-%^+.9ORU:^KL@IW.8R-!_K0*Q^6P-7U>'K;M0_K@=Z/;GVWH)FPQBH@O?ZG<"%0OQH MK?:[A_FN[O'OKP5"RW!G?JWKL>E1Y4M?5> M:;((9!'J:1$(C 3&VH"1Y G)DQK+DRMQ2^*$[ '9@[W8@U>%>!Y%]@B=]4(G M467]P'@P\SL/%A!W OANZ=TAZ5WWX='PV>V'P!M/6B%!6R\8$DOOG:4)S 3F M@P$S28[F#(_CE!SGQ-+U@B&Q-$D. C.!F20'28[#E!P4Y:@9#(FE27(0F G, M)#E(?K11T !->DW M1;BEWY7PMF:8I!LH>\/G^QDR&O?Y&%;_A'^0-%PZ3*60D^O^U%H3X-UM_;,- MN7N%$ZU\>^*5;X3//>"SX6SX[!A@U=H3KHK*4X&+H%: VOG('HVZQX"W!M(8 MF5DRLX1/PB?A\RAM,\E DH%[@EH?9.#YYJ#V@>"M@31&9I;,+.&3\$GX/$K; M3#*09.">H-;N=^QVMW,,@&L@CY&=)3M+^"1\$CZ/TCB3#B0=N"\=V.[;HS;I MP'KR&-G9W9Z*MPS:?E_A]2E 6Y/5VL>T]+24NJ\JZW::;?O'V9" 13182W>C M&IBTV8K@3? F>)/3M)W3U&O9Y\,^R03BT:/B40(F ;.6P"0#3_ F>!.\2;]N MA=A3$@C$H$?%H 1, F8M@4FFG>!-\"9XDW+="K&=0=L># UM08(F M0;.FT"0[3P*4!.BA ),$Z(&?EDQ&GHP\09.@>3#0)#-/^I/TYZ$ D_3G)JSV MVEU[V*8 :.TXD*P\"5""YG%"D^P\"5 2H(<"3!*@AWX^-%EYLO+%AC/1,9BLJB$S<,Z7S7?T71^4SJSX1:BJN2:B44,E7>VONE& M$]PX\-S*>W[GDK/(F:FCNM_S:^X%X9S[L?4ND/'F,[L;CA :[C370L: /P%5A_I8P<2:<*A&R(0+SU97)%[,_%@?NA\DL10NQZK@ M2?QP9W -?T?FUWC&(XO?AMR7\)"(>X F?XH/@E\LYOR5""D08#:41D+CVZ52 MX3-B+M4]4!*\YUTP#YF_T*@:=MKG%S++!C ) E>_6+V)NU@<-W%B>6:MK;DJ MG2OB),(N@6$(UPC?\1*L51PXWZ'.O9Y:ZB^?-;IV^?G+2AFI*HBQ:TUA[Z?20M* %?_G/CA-C+D3BR@T(NS0QA%1(E$B76AQ+TIH"LDD].W#/GB78%22/O00&]$ M9S9\H'_-U8,5PML#)1I XP@I$RBM,O:G8S4^2R8?U$HPF8"ZB:#H>,.\@#Q?PEF#J0Z5=N%&-_(GP M8> +<'6 %6*NRZ:+&J@K1&1-&/SGFGE :< WA:>:MZ9EP3=,N<\CQ8'8W(J. MN L7",^SQAS\*B:3*"<>]0#%.H6W:.J; 0RX\A #X%8U("26B4%)(Z:FEK") ML; "?KCFV@6Z-LZ=YN,S"SFZ\&AHH%*[ /6![X;$",]RK206GOBWHDNX[ZT' MF#B] $8N\96@'=& F/+T$2Z MH](G1T)^/YU$T$O"AY6.R&1=EE/'*$1/<9G6AS7;'JZ&&B46*1;N4X;2@8?]]YG+<7_@ 7@E^9 MWN\O]YUR4/&MT/9SY29?!^B8>UBJRD>DW84M7U4+,D)DA.K5F0TW0D6MBJ(P MR31EB1-@(,/P4R/;F!2E974,*N568 LHW&EFC-"8:*&I1.2-B&I1 I_' M;WP.\ENR:%%Z%K049Y%?I#?A@_U*M*$5FH*A._F9]5NA2=>[#MHNRH*A1;/+ MYD$4*[N^QA!:B<0_&/8J!@;37Y7U/+,^P8-Y%#/H2$=$3C('-:#\"=4_^#Q\ M"?SS VN28&2S5,T(ZQ:EZF&A&Z10'3L%$SY"S#&Z"@T(9=?Z(+,?*LAY5]UU MKR#:$*_11CE:KFCQ3/K\P>V=DD";]%IE;S4"6_H""0 M4P[5A5,S5=D4"UZAW8J*%LA$=-G;J"(SM)+ 7B*61=<+[BBX.\J2.AZ34H"K MJ.]SN9I=PODKS7T^4WR"OPT^#13#H@LQ"%E?J$.M[FI Z-'%EZ#P;PI+SU$ MJG4JH#J4)7:3*(OL92LKC%,"C06*P\3^$M^H& SY@;B(M2K( F.V)286"T-@ M (P;GND1JV1!X0YMHU55=/@W\X-T,ZR4W$_F8V@%>,KZ.DR@J[43AH%;^*"] MLS/K2Q"#-,$0+4P4- M[!FN8K5FP8UIP:S^#O.2LBJ!\PXT9C!4@HU!%YPHXA.#7[)=4#7Q%YSRC>L44%T91.:4E5YO-IF0(-/JXR- M8HV;(/%Z%9<;]@WEH&G&87V,9=7BM[MAZ\^TO, M0?6L?@U7>RR4\$OZ*>UZ: I04-F_L_.^\"\L4\[S_O.+B_45K$I[L,?=;#7; M,NF@;(EH;UM-=K ?7S:8FH+Q8"S# V)06P)X+9BA2E!$_\W)X&0)V)2/JV[# MH^'*^B'P3C?9/ S\_V,!"+?#('_,LL&[T^@C8-7NX'HHLCO(>2:('P2/@\ GZT] M 92.Y=^$N8X]Z _LWO_?WK?VMHTD[7Y?8/\#8>S@)(#LD)2H2S()X-QFO6+P9-MJR>4*2&%]N:7W^JNDF)%$F)NH:4"IB+)?%27?UTU5/5U=UZ M^Q0@1R:13"+AD_!)^"1\$CZ/#Y]$*>M!*0?]=JO;[9X"Y,@D'KU)7#.0VG!#^%4NG=_>#!*BR/;5C@X2* F4!,I:@9+BDA6I;MUHJ:I*,"/; M1[:/0$F@)% 2* F4)P9*8HG+<'9.\"*;UU2;=S1%W(U#:L.MWJ?9^5OQIH]5 M-]=UO5 ?R%#P1* N5I@I)BF#W',*<-+[)Y9/,(E 1* M B6!DD#9.% 2.UR&L[;6THT=%$&<-L;(\#4GS?T#)V1JLEL/F;\9VF[62W O MG&'6Z-G!(P0CF!.\ M"=[$7"LAMM-JJ_U6M^'+(XDHG+PE;5 1O$2K?F$07D\7KP1-@N:Q0#/I$H$; MQ?8BG$(C7DH()X2?,L(I\EH&6J.E][7&[\%.A(',*4&3H'DTT"1/3P@GA!/" MBJZVW6X;6[,W?B3"0.4W/([P*Q?8F>6U9#C/]U] 7H[DRRQY] )PL M!T7:N\IG=^Y'I3Q5=U;H@RH@I MGR]OWHL56\Q.#]&;T'1MT[<#Y?>);89,^>)=B+O.55UY<7GS>_+A94OYE9D! MM/;%K3?AEM+OZ"\OE-05BL_^BC@N##-!["!@# 2%+P%?-GPE0Q5O>!X%3#'A MYU"!5\,/\#O<-/%3EL)Z72FRAA^BG 9F1F*)L$("M#B M/)I.Q'#1&7XI[Y^84V%S6HKGBJ_O3<<$0Z0$(P8O'GJ^ H^4%P?*$P]' Y_ M'"B.YSXP'VXQ7473E3%TVPB>8L)%#&Z _^/30.V6XZ$P^-KO; I2#I$BXCA2 MS'LO"L6SL4'B/.\':0)+](4Z>L!FPLU( M]RQQJ?APK$M M((EOBJY#A($> U[6#,N!;N5#(/IAO H0=6R9P6C6'T+5T,2X1:@>*^2/T'1< M3UC0=''WT/&>X*4?9UJ'-H#JXQ?;"+.)[SURFXD'F&-$MQB!X@V ,G1"?FAR M-YQFGPH/XJ*;AC" 8SQ \Z#C;6@)/-MGH>\%$X9BPN.A+P/94>8$WFE:(]3H M3!($EL1^(/ZVS EZ62'#O,TQ[-@S#Z0.0%BX&)K,\"$@I:>80_@@A^X] P/E MXH5Q3P)A=D!A(73O>&+B0T$T>#KW[&10B,>(BX?3#")HK%@ M(!_K!.[! M7@ (@4@39G/14^:CR1WD[-G>AM:RX3!6!S9Q"+T"=TY!J" EJI!?^0B<8'P/ M?VA8RJ9J?1S/EA.)HY,$J.D6QA8C?IQT M;7U=Z[T)BG29*#S&O)^R#<'%,7A#HC9$;6I$;?X3.8+6]#:B-;US36NA-4$; M%2C78)G$8O:$U.A=E.RCM,L1#T;XL%]C,H(^2KB)3V#MP9'$]W3ZXAY0QJ.P MQ(&P]O]F]@/>G+ ES7CY6GEQ;?JA MDZM\0Z4"NS-#-"]ODN?! [\Q4)8U%8BW!?/G43W8("53R"YT 8V-/FYY+%PEP4 \3W'P=9> M"1\7)*TRE1L+_*+RZ=EBTAB_2 RNKKZ)K3)VVNQ;[(/@LV 'Q>NT$6A MP'FR9_0Q8.(5&]4FL*@,I=J4IQ%S%9LAV>'"5<$7H"]@A"G[SF]OL69(2X:M15UDO@B*)G1"@(4B601^1 Q2@ MZ.W!JM<'+Z4F\PT-8/Q/80 FG/8^RYC@HRE1&/,6<)OV#,0S!LXE'[)BY_K$ M@=+%?/5O2;=F]+M0VYX+>! JYR%J*@1K]" 4A>"1?,_GWY'-<^#GZ+SO&5QM MVFC&X#)\YA,,Y0OE,VI"#+WSA&JBZ#Z0+1SN8C 5J1#HNQOW@Y0_]%G,CS.A M@^0UR:=46TSL);"8T,.N'4#'GD.J%8P M7%1D) 8^4FD+N9RT1D--/BB,5B&!_P.!R2^(M4&09#Q0E '2\;O MLMXLTL$]A ; [U&_J3R#WWQ)E2?.R8W9K$HE]L#Y]3 A?GCN" MK;=%? @/6! T;A123VA2)&,Z91B!YD#PDC@A"0[DTPN89O)T)*I6! &P&X*$ M2+^M4&IN9.)S8,@EK)5H*='24Z.EZ1=NRA==%AN-=?@BWG&N LG$\<;<0(ZC MV:C3WL MX,&S/\=M=C='DRG@;QS,0(3:>.-Z4,T&R"_S$T%@E"!I9D)@V^743>3'N;\7KPY3LK(I(9IR023 M8 (6T@24Y,%#RXK6%F#P" XZ9L#NO#%!5A33"3S,!/EH%@.9B9I+8GM,VCRT MIU,4K$"@ *QL[#T2)P'7)AF>%]K+Q."!@#'+$CWJHYU[H;]4S"?1E0_0KC@1 M M[JS\B5_EIXT(!)/BH;"/?-VH>N&Y *_AQ"QZ(ISO(F&/3P MZF_LD;G@.85Z/L17QN[ZP^QY,4*Z:G>A!W]H6J7<+WY(TSYQ79QY3%<2K=5DNYC\)Y@C,Q&L")(QCB/@]E M_)8P6K ,PQ3#%",.'_+D18X=CRH%SZWQ1=1TT,$E2D+B8J*W9^K9C+6) B5- M57\"]>(UYZ!6+PI?#SE$UF_.% NL=]P+XC[\'-<>X>>BM:M5JU-^?A4%YP^F M.7E] ] 4LQEN./?-UYX#\0\+;@&][QU@ ._^^8^?DSL^\L!\>/#9@]#$UV'L M$V[QV;,;%&Z_/?N,[M:^T]J==K_3/Q.N!2[XQH9OSZY5[0[^05MXZZG=N[8J M_CY[1\/VH,-VZ&%F29 ,,][&,I!DKF1H^+*[ \1_@@-P7O>"NV"V0 FG$_;Z MF-T-15_%G9E2*];ZSK4EH974;RZMS\Q56VY M=<\6@$F;4>V=T"P9 VNM(TD+L6VK#EOXNZJ&]W;D,Z;\)JK>E$^NS>Q%.-_[ MKS9]>$*6U>Y*WKOJ42*KVU9;E6N*R2.01ZBG1R P$AAK T:B)T1/:DQ/;O@S MD1/R!^0/:K$+*&7V")U$G0F,1SB_LS&!6 G@U=1;)^I=]^'1\-GM3>"-)0A$ M:.L%0[+2![?2!&8"\]& F2A'L&0K#11#@(S@9DH!U&.XZ0< ME.6H&0S)2A/E(# 3F(ER$.4X3LI!68Z:P9"L]&&M=$/.&TZA)ODF#;?DNPS> M2H9)LH"RT__I,$-&XGX^AL6_W#U*,_QK-&8/YOG_DQO71).)4V$'^KH?J++< M^\\6Y!X43E3YUHA#J@B?ITQ*_W4*L%(/A"LZNFSIT66#UF#0[#-XC]>,D9LE M-TOX)'P2/D_2-Q,-)!IX(*@90 -[RY/:1X*W!IHQ>"@>J!FM@48\L)YV MC/SL;G?%6P2M80B\_@C0UJ1:^Y1*3_]@5NCY?XC#\90QLU'GBLWDT8*SWR":0';TI.PH 9. 64M@ MDH,G>!.\"=[$7RLA]IP( EG0D[*@!$P"9BV!2:Z=X$WP)G@3A M$VI/%[6U!RA!DZ!9$9I)ETC#9GO1O<.(E=+BTA^^N)2 2>'2KM/]NMKJ]9:? M^D9>GKS\\7EY@B9!LZ;0)#]/!)0(Z+$ DPCHD>^63$Z>G#Q!DZ!Y-- D-T_\ MD_CGL0"3^.7GR\NG"Y5>A"8:QZ'KQ0PRIMV?JV4R- J::JOX$F \//GL0ROLZ_,8>F1NQ M6[SR%C3[WO&L[^_^^8^?DQMNK!&S(X?AI9;WX$*'V5^[ N&(!_!:-F9U]M,+MMV>?32OD]IW6[K3[1@=:"E" "[ZQ MX=NS:U6[@W]T5>O?>FKWKJV*O\_>W8X88,9QO"=0B-2@ B\ H(-(@1+"SR;\ M:HF&*=X0H>KP,7=-?ZH,3>XKCZ83P97P$UX\B7QK9 8,WQYPZ"QY8^C)1XF& MB1V=G7F3\&MLT^NZ=O3"T$WY)?3(\^$=JR^VLTOM:,XJ;FQ?^=A\8/FOX6K' MG 3P2_)7:DMQ[L[_O>@9N*MX+&?8VX"V%,#0)!#1?7NFGRV ^:A6MAYT2*0# M1@O(%/,I8MP2YI^1XOTA*-YF."=#38:ZN8:Z08MJJYVUU3_4X6YD=V<(_."- MQQ #!R%&ZIFXN-').SK(QPB?9P_K,LM4)5CTZ1+4&4--;>K_7,E3U%"#7 M0$M&GO9HCU$-921^85!44DO3^&M^ FY[(]D0O)&I/'Y3N<6.DL]QWOW>@3MK ME7!/,!+.OTF#*_D.Q7E-I(%& HV$ZB.!(K8ZT!)-[;=Z^@[*&HF*D &NB0&F M6:0ZH+8!&#W\E&C%OVZ]T'1*BCNWJPMH'/9/R&!3V<#F]5V$;\(WX;N.^*8X MKZF\16^U!]V6OB(Z/$+(DDDFDWQD,X/'&6-29N08CELDJTSX)'P2/@F?%(@1 M9@FS9%-/"9\T6U<'U#8\O?7!#$:4F:HELL@>TNHNPB?ALQ;X/)(8J.'>^D6G MU1\8IX"W!MK#AF/K)4W@$-@.!;9+RX+'AH'B,XOQ1[&!(65EZ@@T8GF4-21\ M$CYK@4^*0NK@O%\8:DM3=Q"&U!]P#32(#0?7OL*0VH>\%(8<'FQ7[B-S0\^? M4DJEEO BR$AV0&_5^$ M\2TP3O%94W&OM8QNNV7HRX,Z8C+U,<[$9 [+9%*1YJM0;,V5E\)RF.G#^\/1 M7,BR1XMGQ$!^>Z:>S7I,0%)3(0)4Q#7GT PO"E\/^3.SWYPI%G.<6%/B/OP< MXQX_%X7#59OS\ZLH.'\PS7.AJ^\IF;LB'G-F78B[J MTOHKXCY\[@'UW5^K>>VKUKJ^+OLW<'&LW+AV[:5?T9!:"_:9$=:+C+N1TQ>)WC>$]P MAQ*Y9F2#W;'!XGB*Z%)ER%W3M,X';SPQ MW:D*!KY(U7JBOA.ON6?,!9$L)[+A0NZ6BH"GYF*BW<1V!2'\#RM# Q0' M2T9%>P+%CGS4 #XD'/F,B?<$_/E\#)TQ4N!"[MG08A??]I_(94I;E1*]7F8L MF@+C4W=*E1Q,2A,IM2*=GVM+>H>$5BVE33D2M#&=XF/S@>6_AJL=#*F#$S/Z],+@[3V$:/[UY4]Z^HF1M;8JLWD@93H84TKPK@8\BDJ9%) !> M:!*(Z+X]T\\6@)S*XU3)"6U33[ TGU28I:KG6$AS' NX'?,/E%9*"[%MJ^J5 M5KI%#CP'^6](@H/U04^]WJA>_X3137DO;V8D^[K:W?I12<2U79:3J )1A<91 M!0(O@;>QX"6>2XRGSHSGAC\3RSVQ/B>62T2!B$*=B,*J8G!"-,TOG,+\@BQ] MTI84/IT: ,FD[B/VF@=381Q,-;B(]31"L&:4$VT"2#SP0%!K=[NM'IT07U,[1GYV/3_;M"-6*"-=0Y.8S4@[7A H M9ACZ_#Z2NZ^$'KQJ//9<)1B9/AMY#O3U$9S 0A:4+"CADVSE@2.5^L.*(I4Z M0.V%UE+[_=9 '9P"YLB4U?5H$8(5,3AB<(3/(S%[Q."(P1V.P?5UH]7M',$1 M<63*ZH>O(SPNB&WN1.%_)'=,"ORQ:FNGY[E"9F? 0-X.F84BF=]'7XR?1<: M$5PS_P93HB7GMG;:_PT^$O4H]JRCW,)Q;%]^RF \&L]0T'T' MVV>T>]3[C![%\&@XL]X$WHT[MX(1C)=.ZY*H(VZ"-X M$[P)WA1Z#5\>243A MY"UI@XK@)5KU"X/P>KIX)6@2-(\%FDF7"-PHMA?A%!KQ4D(X(?R4$4Z1US+0 M&BV]KS5^#W8B#&1."9H$S:.!)GEZ0C@AG!!.7'8-T/9:;;W=,K1F;_Y.A(', M:7H>X54HMC?):\MRF.F_AKX8S959]FCQC!A];\_4V4G8$M&:JOX$3-;W=__\Q\_)TW_Q//N).\ZE:U^YH>D^8&W]91"P,%C\?.TYW)HJ MW'Y[]MFT0)0[K=UI]]N#,ZS+1SQ\8\.W9]>J=@?_Z*K6O_74[EU;%7^?O3O0 MD%P^_M).XL\H"/EP6C28&V[LBR27)I6'T'BK\DVK3C:>8T21(%DZA$O^;@HH M3OWDZTIVNBF=V? 1?B661KG,PDY5GG@X4L(14_Z +SS_#RX63(6^Z0:FN*(E M?D7W8+IHPAFXDB%GMF*Z\*\#7D'L,<9FNXT-3>XKCZ8307-A]DG[1@Q_QY^#F=4 &JJPYPE8*;@" M[,K(?&1@2FPVQ"B0*2^"R!K!Q3.C\E+Q? B:QAQOB (VC!SX^(A:1Q&&'K[ M"V(=)!?&5Z0E ],&W)H'(V'T%'/L0?#XM]3,!/K/D[9P#$+#G]XP<\6%1#"#0EEFJ)Y+1CT8!#@HI@^X37P6B!0*19UH:!X:0L6&Z^9S#,[VWL3%+S# MBZTI-&!FB)X8VM,9:;LW _@OR/^;Z9H/#(U-YJ' & -HB$0]*N/1!.L4@20F MTD;HM#FK@[=&8WE.&KXT1+A\9Z&"JN(6!X%!IC%B!QNEF/=>%"J!B0Y#&GC) M_M"6/S&TF8$R\4)4HNDH;#B$*T1_>/>!!S=9#!Q9"R0<3UC(8\K*K)$+V'C M)!^8#>_!9X%4-JK-9P\1<$S/!^/N/G+?<['!%\I[9IDH$EXSC,((5#0Q$4S8 M\^"6N"6Y,HQ_UQN#:;YG+O@?*8[T5GGMC\TIH#6$:Y'9X3+HE&9F-TD M"A;9WP*;'@2>Q<5X+0ZO3>NO"/X2SX:1;D[ 0CT+2PRC_5]&!T^T0OZG_!6! MS83_"R^11,[)8V,#(0-Q&ZP)1\. *=Y$8+RCU$\ U0^%H1?6Z^LD-N[+34F] M$]YKIZ33^>QYMESDO-^C1T2]@2*%8FYPKYCX_,]+"]3,P^DMRC#+CF<3W/V! MVNM3@KMV QMBK#&T:AK[[,*Q(?8%4CS1V8H9=[88JLB]',=["EX?@Y$FC[N> MQTVI%4LDYMJ2=C&9]EXZK9V;I-YXNAL\Q@/+?PU7.^8D@%^2OY*N!U6 0YC] M>V%P=W;L>=_XZ:@_05/[D5EL?,]\I:T!F%2MMYW5;1Q.M0;"E(SSP0DSX9OP3?BN([[5 M P&.X8F7Y5'ZSLSJ-0Q79OV/8:Y) 2: D4%(XS M'!->&V[[/CTSW^+!,:>0Z$?CT&]I>\C,B%_2U9MRXC@I,[, MW?04@/29 E>SH[N^^A^A8[S =+X.?_7VF=&;#QWOZ@#B?/7+V%"@.#D9' M#$9Y\$_Z$+2)[TT8'@V'I_.POR(^P3'<6G%TD#R:Y2G^?B*-8+GRN-_+.Y;T1AG]RWQA8V'>LHC MSBS3]\6Q=.*11>!R>&OD^RI$YF^X;8!THG7G/'3PC!<_) MD[>''AYY-F*./!XSP@/F.#R5F4'DXY%SH!MQ:IOI\T >*I<1RASCH:3QP7OB MF?A(8] /_H,XS.OEP[DOZ)SYK-G$284H-GP?@4_8_/RF1QA>ISNP]GQ1N9ME"Y MS=@XUG%>$G/>./',I[B?S"?LV!@8[!EZ#0]EE"-HFA@=SQ>290V:.+77!E4W M^=RQ36A^YN@Q]H W?Q/##223EZZ,"S2*"^K&$PX6%\20 1,WQ(0"6C"*!2@6 M:$1G-GR,IXF*)X[-9/)HX;$X.UF2Q/LH@!L"X3+A[3&5$G0)&;L\;1,^!7(< MMV*?SB6[F]T-_M(&SN)XD^168,QCG)$%-?\MOA-',3-)O2'JL",\'EFPDR": MX$O%$_'$84L>CLSQW!SD0>)P0Y3;FS%Q^ !_V13P2"!L2>G4!<= MEFB-.!OB/+$5B<-'O>&06\S')GE)@^0U\V;#J)!'H8[-[WAI$E,-N0L<% ]Z MYG/#)DX]AG\>'GSV@,&+./)8\.A)Y"._E>=S.^ FY>.!VGJ1;\7]PN+CN>&' M^?-!%/$"X"D-9AZ5F$.::GQ#!ARQ;S(<0>TNI1G]?H<.,:V?"3H8S8CAHJ3P M0C2#:$8C.K/A8[S,W?KQD.2!R)[Y/$[O0,PI_2"$[Y@Q 5D]6SI &_@!GGB, MA,")S_P./;3J001D ETT-.%A!+[?AMC>"N7#7ED0Y_,0,Q4V4@OPIS*I@EY, M:R+@,-S-(-FX0RQ0F$M".-T^<9X;^TQ$0! M1@$WN-81C%J@O/?0MO$@B'!*M>B*WR>8G52^>!?BJ>?J0'EQ>?-[^HN7"L8E MOBTC#VF=_3EADI$3:BN(GXK&])';&)Y$X0@BK] 4D=-#Q&V1@K<,TG VMMLPN-,>PC! M9C"4LPJ@E;'P9@\SSP4X0C>RX".XC ?EO(-XK\^&#I.!+Q-^#;0KQS?>.<^7 MQ\+)B:%DDD1\Z)TM/EKY>G=EP2_]Q/A<'?"J:3SS-LE\!A+/)'&_,3J4W,&UO(C-* M\HZ,4<9)1SD+IOP5F6@3I%66(QN34&(R<>90X,90DND+Y=_>$Y@WOY6UBCZR M7Q_-?$R8D1?SP'(\G (7YF?$G E<9]I,SHX5/1Y,#"H)9[OA*A0WU?A6; =% MAX *90E!!*_W0Q-(I\@+SFPOVLK,;#19)[).]>K,AENG].S !-/:7A3$Q0MQ M_4\X,HV?6#!X+N./(D>-D_%@ M20(P,_?(Z@)19Y/,+,SIGBP4D*]/F4VT"\&(3R98C'&9_A9G^.-?E"<.A"@2 M1$^DQ)4AJ%ZRKEA2*:C,'$AF*6RAR!_8PNS%J??%H@_,WS\E#!=,FQN(MP$I M:ZN*;4Z%?9Q$/I"S ,V>@Y(\C,0-<&]<'Q',"UM:L^>,3+#C]PP:S($:0C\, MN046GHP?&;]Z=6;#C=_OR%!FS"KA0:UTSC)E"(4%PJDEWW,*XK]4M"7BRZQQ M#,MF(Q.#V5HS3$Q9HI+P$$VRNT9TN%@PBO9<9FE%6TQ+UIWA8V55Z%1J WZ( M@ *6$ S4C.5BG&ZQ3!6JX+SQM*CT&?(:69,G2P'+G\^' MBHDI6@O="U9ZSE,-LK)OEG7&ZJ]4QWJQP9=L''^T&=:1I;HNZ:9LW\58P#>4 M2"6K&.'O8,B)O9(!KUMG-MR 7R*/6A)&R\',H?DN!M=J.^"#7K?*8N,W" M<3 L0YSFR43SWCV:JB#-TT6.BMF,HP3,?[Q.5H$Q M,1+Q =+R.=V/6?,B-;Q0KLWIS/S.RAM^C<;LP3S_?Q@3S),:8]-F8DG1!.?6 MV"P#@;4+P>Q),KNP4*(PI[#YQUDC9GUOI1_6$LNMN#^?NKI0_IU>II)=5"&S M)^@C?(YK(N3*BE0.0IG$C02*C#D.@949D,B0DR&O5V,RNO\=/592*2US!?/5=_.FH\7_ Q[F M^7_( NXD3QRG6K,E85AU[H]!^;;T2F)5H##_6!.?J08#Q5CQ*O>D??.!(_)& M^'Q,ZF:Q<(![!-H_KU(Z,=%_-"9\WPXQ&>(+0D4,^-(,$+P MP9FE)_QX>@7DA9*:.LTDPE/+35.=GKP5G-B36, I\V9RPM3!'LS.OQ:REG1< MB*L(@R#9S*"4T!2DM43M?KQNMN@UTHO )D)!\LFU\P=,W_NO-GUX0I;5[DK>6W4/_HIT<@,!(8:P-&HB=$3VI,3V[X,Y$3\@?D#VIQ;#9E]@B=1)T)C$M=]>#1\=GL3>.-.*T1HZP5#LM('M]($9@+ST8"9*$=SAL=I M4HX>6>EZP9"L-%$. C.!F2@'48[CI!R4Y:@9#,E*$^4@,!.8B7(0Y3A.RD%9 MCIK!D*ST8:WTJDJCE *PS;K::2EZNP__,8RYG=[["$BA)ODF#;?DNPS>2H9) MLH"RT__I,$-&XGX^AL6_W#U*,YS93"5U)M?ZIK4FP%OM_6<+<@\*)ZI\^\&5 M;X3/ ^"SX=;P7Z< *_5 N$HS3P$N@EH*:KU!:S!HGP+>&FC&R,V2FR5\$CX) MGR?IFXD&$@T\$-0,H(&]Y4GM(\%; \T8N5ERLX1/PB?A\R1],]% HH$'@IIF MZ"VMK9\"X!IHQ\C/DI\E?!(^"9\GZ9R)!Q(//!0/U(S60",>6$\[1GYVM[OB M+8+6, 1>?P1H:U*M?4JEIYFC^XI.W4Y.V][>&A*PR S6,MPH!B8MMB)X$[P) MWA0T50N:.FJKUS>()I =/2D[2L D8-82F.3@"=X$;X(W\==*B#TG@D 6]*0L M* &3@%E+8))K)W@3O G>Q%PK(5;O:JUNOTLT@>SH2=E1 B8!LY; ) =/\"9X M$[R)OU+FE2SH\5O0ANP&/$>K?F& 6>Q=Z(3:TT5M[0%*T"1H5H1FTB72L-E> M=.\P8J6TN/2'+RXE8%*XM.MTOZZV>KWEI[Z1ERGJ!)T*PI-,G/$P$E M GHLP"0">N2[)9.3)R=/T"1H'@TTR2S )/ZY#*L=K=WJ:Y0 K9T- M)"]/!)2@>9K0)#]/!)0(Z+$ DPCHL>\/35Z>O'RZ_!!#ZNV9 M>C93HX"IIJH_@5QXS3G(XT7AZR%_9O:;,\5BCA.++^[#SS$"\7-1R715&7]^ M%07G#Z8Y>?V-/3(W8M] ?P\(?\^]]AQN36]!J^\=S_K^[I__^#FY^,J%BT// MGWXSGWXS0;TP6H(O+/PZ_,:@%Q^AH[G]]NRS:87NW M%58K$%;3[]H:"MM;*JS6;K>-SJ;"QMV0$\G0C061U,Z=*L3IWWH5]:CK:J_7 MS_5Y10&Z90+T4@(LUXTQ&/1Z&[[?R"E 6UL!':W=US95@)%3@+:V L#C@<-; M+L#-R/39>S-@]@=O/&%N(,S9I>^;[@,; Y;>3^>77)M3_.KRR?3MKQ.\,/@: MA4%HNF@>OD3C>^;GX-WM5X5W@"\*%F&DZ8:JJO-6[%SBM#K>1P$8YB"XM/Z* M>" L4W#M>Y_14\7J6VQ@=]#9'JN:KG7U5%=5D&-KL7O;(ZS=[?8&[8W%_M4+ M@@\@ G0%_SJ^-/@% M_\OLO(2EIJ9,IX62@D:7OKX\9S<"#*,4E.ZAE7J]E3#2(WSTM=O*N0. M1HZAM_7N'F74[W>7F7,Z7']P:L/N@-]71EGW/XS=WDP8G9RPW\] M_SO V/?@IE6QAKY%8*1UC'Y!J%%=G)VW9I$-K!$YZ5H[#9,M6X/?F;XU@AL^ M L]QO E:FT_/:):8C&US7*:3XXW%5N/=@9(YRS,WZ>3BGU$0\N&T* W4\"1A MD>0R&<=#:+Q5^:8GF>.ZAS%<>$\"&'%:4PHR"MJ"Y<8] J!XC/'Q*@3'P2_*.:Q)\)6?(4M2YVK_)_A2^8B%SGJ49_7ZG3S2C M=G;G8#3C!D?LN8B E32 B& 0P6A$9S9\H-_.7;0R$7DF],Q )'@0X+2/\*CG M]V)\9OPJ4 )O. 0*X8/<-O?%@:_P)UIRWQ0?A$=,$Q!TI#'Q0'(!/A3\[X5R M$Z$+A_>9+OX D:MD$N"MX;G .@!T=D)#F#\&]QN@NQ)AL&*&PCDG]RLV.)ZE M3KO#^(=#?&#FK\UD06?,,#P;!BQE$_MSPB <(JY-ZBS1] M(X !$V&8![95#(@ 93)!4M\4)7RH8A26PP^/3,89CW$$)>WQA8(V.O5H4%!& M+V#Z($!"PPC/LI4HY [_6YA+N.^] Y@XO[%&G@.@DG><0[B(/0_!C,V<63> MO1X.H0_A&?=3P-@C:@'>Z7,,#4!%LJ.2)_L\^'X^]*&7.'!W'XTV-!$"+?P1 M RWQ)( [A)>@C"EGCKWPH\.'+(D3&826X50QQK6 M M0+CSF3-"9R*)IB"13SPS.8H#Q&7O\?#_?/ES7LPGV#][J=S MJ @;GC8]!6DIGKBH:!+;HMBOB!R7M$@9LP[>AG&1GC-?BNOE-6'BN-!;#'$F M'<5#0\5#\2B.3-NT1NC"0%7W+Q._E;T?OW$93B&9_C3S+- 4,WTW;=ZX"_XK MDHZ62Q,,WZ6B21IAYW-3-*W93 1[1DLM)GLR<4&*("L$=J7!'>%(+:P(YA(KR/IN)*1R<))*VSS6%/4Y: MD$\1I645@9A0GH"4+,5"-:)4P7":I0-)%!$T>"*FXLQ*8?7*%XB#[MKWACSW?D//%?RM7\:E MM=NJFJJ12KVOJACMQ54@&U1JM56];VPEA;%V]6-!L5*GV^NVMQ*CFU/&^N5_ MW;;1[ZZ4XMIG0X93OR(1=&WZ7_T;-%^V**:^9KZHRLR7=J\S:N[ MZ)YZ1% M;)^]4R]459N+6$V674B_6$2];,CM3_H/9H#SR?B_3T"XP<>@S[@,/T#$-@6C M65A5W^D7K4"J"DVUVVUWTX6K5438@<>! 1B^#@(7YXN9\G?GZO,'(KIA8 M*<16$O>[I;U2G6)L*NVVINT33H;+F*K,(/=W9)"UOJ9WVKNSR@6BK[!=GT2> M\2J>5PJN1*3\U-L2,BL1 &I*FW[QJ1J;:'23;J,)UJ^,8L![T0X M@PZQ2+I+&I17&N)"IX@)BJC ^P@IC MS#^*1<[@*A0!%ZHMIBFV1G3FXD159A$-SL1$H210WE#,@EMRL0QW(IQE<@'X M3@+\I'1)Y@:#5!5;,+]0%FO9R?2W'%EX#9:"/;#,0P*QE"C95,(6Q$+6A&3-GGH@PL75;54OA0,2<3L #H4R_DB!632JD[Y R/ M:(HL'IS-HDLUY"1WY=8O\)3R-@RAJ^44/I;]P1]R;O]"N?9"<.I88)B].<"Z M9="?N#%RV8S3Q>4GT/!YZ2)T3#!K2J:0C,=A@BP% 3\%,@=QK\I/(8:4X#[O MPZ2D>O;E)'&:R:Q7JD'AR R5$:@ [H)_0GXNH($]PT2E7[PF*M;@K/V6Z5B1 M,T-6(9Y$6S+S/C6#"1XP*#Y,,K8HM*::HW(M1R;:VDN>Q0ET9[C>$_" MT(G!+U)^8$?BRKVYR8^M1H&AR[K0Q%1EQVLK'M#P=TW2BQGS_CIS9OR!J9J6ZJU<[=[SM9L8V,+:8M/.]#6 M9)_Y@V]^K/WHK8]K"L:C\0P;Y* J K@4S- D$-%]>]8]6P!VTGV .B7P'&[3 M)O0_>'@TG%EO N]D'Y3-P$V6FBSU<5CJ5!DWD>*ZHIM(,9G:VH"13.T.2+%. MI+CNP^,$23%6E! AKA<,R4H?W$H3F G,1P-FHAS-&1ZG23EZ9*7K!4.RTO7* MP=7HL-3E1G@V^=[YZ3 C@8SO#(')HL_U#6CCX*4U$%V4^=TX\TOX)'P2/G>) M3_5 $T358%2\MCIT*?5-;JMCMX^!E#* M0;_=ZG:[IP Y,HE';Q+7S8P;AL!K_4#;.*0VW!#&VT-M;P8)463[:D<'"90$ M2@)EK4!)<-/'JIOKNEX(5T_,J3A]\7@G_!H'2#*=QU_X0* D M4)XF*"F&V7,,<]KP(IM'-H] 2: D4!(H"92- R6QPV4X:VLMW=A!$<1I8XP, M7W/2W#]P0J8FN_60^9NA[6:]!/?"&6:-GAT\0C"2Z=QS501MT$?P)G@3O"FX M.H'R(2((9$$)F 3,HP FN7:"-\&;X$W,M1)B.ZVVVF]U&[X\DHC"R5O2!A7! M2[3J%P;A]73Q2M D:!X+-),N$;A1;"_"*33BI81P0O@I(YPBKV6@-5IZ7VO\ M'NQ$&,B<$C0)FD<#3?+TA'!"."&&%PS7U3(7WL. MMZ:WH/[WCF=]?_?/?_R<7/J%/5U:%G1="#=<^YX+?UILS-PPD']=6Q=]G[PXTO):/ MI;3!_S,*0CZ<%@W,AAON(LFE>>0A--ZJ?-.J4XJ_,3PN6IDC2,E":.GH+/F[ M*1@Y]4.M*YG@IG1FPP?\E:M\9O=^9/I3!:QM%T09,>7SYDA>A.: MKFWZ=J#\/K'-D"E?O MQU[FJ*R\N;WY//KQL*;\R,X#6OKCU)MQ2^AW]Y862 MND+QV5\1QR58)H@=!(R!H/ EX,N&KV10X W/HX I)OP<*O!J^ %^AYLFGHM^ M#^Z$EP#-,>^YP\-I*Z%WSE09PT\1+M@R0]$D&$$!6IQ'TXD8+N_"+^7]$W,J M;$Y+\5SQ];WIF&"(E&#$X,5#SU?@D?+B0'GBX0C X8\#Q?'@Y,7S\8&B9.S'Z0) M+-$7ZN@!FPDWHVAK\ANJH*4\,!=>APK'MH DOBFZ#A$&>@QX63,L M![J5#X%2A_%Z.]2Q90:C67\(54,3XQ:A>H ]/$+3<>5>0=/%W4/'>X*7?IQI M'=H JH]?;"/,)K[WR&TF'F".$=UB!(HW ,K0"?FAR=UPFGTJ/(B+;AK" ([Q M ,V#CK>A)?!LGX6^%TP8B@F/A[X,9$>9$WBG:8U0HS-)$%@2^X'XVS(GZ&6% M#/,VQ[!CSSR0.@!AX6)H,L.'@)2>8@[A@QRZ]PP,%'*XI">!FCJ@L!"Z=SPQ M\:$@&CR=>W8R*,1CQ,5#[@+R803-%0N %I"/=0+W8"\ A$"D";.YZ"GST>0. MTLEL;T-KV7 8JP.;.(1>@3NG(%20$E7(KWP$3C"^AS\T+!H#ZH?CV7(B,=0Y MMI>/8\EGV A'7L RC[U0@,0"'D'E3H(ND /N&W,PC_:%<@L-_8#*<*?*" :I MZX5P:Z@PM T"ZJ@*#A=8L_%@VMXD 6JZA;'%B!\G75M?UWIO@B)=)@J/,>^G M;$-P<0S>D*@-49L:49O_1(Z@-;V-:$WO7--:2A(2*Q 3*R(H3DB-WD7)/DJ[ M'/%@A _[-28CZ*.$F_@$UAX<27Q/IR_N 64\"DL<"&O_;V8_X,T)6]*,EZ^5 M%]>F'RI7+].BH@W]$!OBSS/[H&L&)V;;@+'4?@+Q\UZB*X*O Z ? MTGO;[%F2$N&K45=9+X(BB3T'H"%(ED$?D0,4H.CMP:K7!R^E)O,-#6#\3V$ M)ISV/LN8X*,I41CS%G";]@S$,P;.)1^R8N?ZQ('2Q7SU;TFW9O2[4-N>"W@0 M*N1@#,ELE-M$ 09+P1UL&3\+NO-(AW<0V@ _![UFWHS,A[$ M48*JL0=R_RU1EC0O.V:W)I'8!^O3QX3PY;DCV'I;Q(?P@ 5!XT8A]80F13*F M4X81: X$+XD3DN! /KV :29/1Z)J11 NR%(B/3;"J7F1B8^!X90XFHTZ[0W<@C,@F9]CKM?3^L#U MKL9H,9B! ;3QQORICDG.?OS0"DN):ID;0T!1P(A2GD0/@#V@V07^:F M D&HP-+,A,&WRZB;20]S?B_>'"=E9%+#M&2"23 !"VD"2O+@H65%:PLP> 0' M'3-@=]Z8("N*Z00>9H)\-(N!S$3-);$])FT>VM,I"E8@4 !6-O8>B9. :Y,, MSPOM96+P0,"898D>]='.O=!?*N:3Z,H':%><" %O]6?D2G\M/&C )!^5#83[ M9NU#UPU(!7\.KLC$(Q#\4+(;P6/1%&=Y$PQZ>/4W]LA<\)Q"/1_B*V-W_6'V MO!@A7;6[T(,_-*U2[A<_I&F?N"[.O"9D(N729#NDE_HK JT)SID(_A_3%1EI M30@\*'6,B380).0.MW:'I6ZB*0UK>,;BM@2C()\I)P7F-O&> <7$)#/:3(2Z M)\)27\RKPCB5;JNEW$?A/,&9& W@Q!$,<9^',GY+&"U8AF&*88H1AP]Y\B+' MCD>5@B?$^")J.NC@JG?AQ+K5$.E*BF^@$-.W1I>N_1&ZU/$F>-^G9^0*;+%L MPNAJU<7O-Q_/(%JW^!C\+3;YG3;H]-3^7/JE$FPAJEXF:B\E:F^I MJ+K1ZZE[E[2=4VIG;:7"<_0#2)K3:6=MG6J&T=Y$T@\B2R&X[+7I?_5O<%#; M?V 2("D8RE7YJ/T%>2^#KVZ91N^ 4=R)YZ0E;I^]4R]459M+7$&0;>76%O6, MY(YI8K H7-?(E4X5PO7NUVC,'LR_H6-O(N#0TA[])MA@X(=@ MIC M!6)(.GOYS(.EN.D-!H-V&C=2O&HB+^*@&+>[%MD8#'J]344>5-/R'^!4 M/5]RW-^8C7.C,(XP/DA: <'-YDW0.FJO;VS8AJY:3>U[;H.ZJ?CM2LYNUZC1 M#%UKZYO*W*GD]78NLV8,M(UE-JKI><\PT;M:M]_=M W=:GK_L5 71EXD<]+9 MH,MYW<_[Z?R2.-USB2F*KR+X#;Y&83*!\2428?V"'GJ](L]5Z''E*8^Y/M - M54VU8N<2;TQ^>GHIHN]_WT M$BO,/N T4073T.YU]\WR>GJIW9\-[72-34CB>YSU8/ "S O*\B_=?3)UA92!. MRL5YOG9+-=068#DYSE1LZBXGVI""X9J2S._( T<,(ET,\97[:3JNA;\AYG\8 M*5\P3XOC3N_+[!3F_0(&43-.&6(V3AJ8/X2!^3^!F.,=NZE2MWN'/\05>K&D MR3N264Z?C>-).;W55S,R/C&?)3EIN#O]KJ34$(6[@_ MOT;,:L)%Z2=\K3 .3WG[W$U.=<3$_/,<*T M_8$_NM+^H%2. TV)3"<9HID1*2HM?N6/S(9+P8[BS*T8F\'[Z6_FGYY?-$8+ MS37:ZHRU7JN%J!N+?X29_*H$1*'@ M8%^$X"M>CQ+:C+_^Z%EB4ELVYQ-8(9QYR]>UGIY*C*UHP5:-+:7^S7).]?KO=7E?(A!T# MA.^Y*T*+#W&-J?APBQ& /+\JRYIC0@B/3WASGD,LMJHX LMD5J[(8&1N(TL)RV%IWZ8;2EJ?V>KF^DK()6;<%JC(J) MQ.5]WX/8H*\>@H49%9.&R[6/LQMJ[R#RMG/Z7=^G:&J[,] ZAY$WI]_UW4NO MV^T/-A,WY]2E,<@SGL5IDO781$=MZX-.SUC")N2+-Y)M<6YZ/3;6 ?G;Z\HF MX-^)1FJN_^>7BWUL,]XKJ.U M]\C">GII>N-@$6ME)IS/K;*^:NEB*[DXEIEDN0Z$FLT)I^8P_"DKKA%W-B7R/1M3/+^ MFYE..%)N+,Y<"POJ@%]<2/45O3&MN8]LXD.SY$03F/E4,W)JRYGN3>JA.GVC MF]+;DO=O+&9IV59U1]C6VFUM;2FSJ0&X\"M6"DH(X(*[,@-;Y':JZE/K&5I9 MZ<>I1( M^379_B#6?\Y:&NUJ)5 KAGT'B$"*6>9>NZ9,U6JS^]G4Y6%] ,^FVCES;$R\3? MIJ%%$P)SXW9$#5U>@GLG/-MOIC4">/G3,L*^;6NU[L!(&Y']-;NE=MMZ42)F M<\':U59OK1"LK74&_:+4Q^:"=:HMR5HN6-]H]]J]RG*5CNXOK""+6L3-*J\L MUCIZ%6\"+]Y5=%,0A ZV$"^I)HDSBY]9/IWN2JGFLSH?&&YGXN"&@L__%S<[SDXD==2*\S7OYE7AZ4FCA<^3ZH5.:^8JS Z_?2:T.)W M;R)=M:KDY7Y4-09:?QWA%FHZWJ/G%\VRQHTS."A3%'E7G2;MM0%8& MU2L%V%[@(EI;T6QU=;77T387>*=L1@X&>24>Y "D!NXLX&^%B<>]\3=#A7&Q M)P)7TN1]J1B76+B@FVE>IX6U-WO3Z:"MI\/LO;0Q4U]6.GBV*-_78+@;Z=BH M:(24OWF;,OTJ;[X$K=G',[,^^-Y;9L+B,8_&,GDNQ@WT. M*+UJCNXN7G&5!LI-LEF/K*3%MWLN1BU5%J3I7:.;L:T[:=X!]%5MLYK=ZVO0 MQ[7KS=-7Q:T9/L5;_XE)?[DD/*T[^,0*J[@_QIX4UM9THX%*JU8_$RLM M$(^^]IDLPQ#C]>1@5JVZ9V\:Z[35?K>)SF#M#&_Q?@!Z7VLB_>JOG4[8LXU(1@FFW+DYIWSFU&N M#^/.H-,>I#);2R780M0=I,+5#:2,-Q*+3P%:G O*K1?-E\$DW;9)P%F4F]7Z M*>>0D6X-L9=G,N\N;5NDETSGVN3VE?M!GFRWFR:TV]U!5^T,MF_%B@+0;PR/ M1F%VXA-V(_ZYWNUWC8'1W5[^+1)3W7Y/U7M59"A>K=3)K0=:IRZFW^UDG?1L M/=+RMQJYR:,UFMQK0Y,SS"CWUKVEC)>M)LDYTL*EC7M,FZ>7ZOP0#53>6<;H M[&!+C7.MKZEJV@J6[BRS0I@=;)UQWC>,;GH3G@UEJ9B-6RY+1X/@23.:MX],_O_*C8\T254\ MY+,^:^\&6D0\]$%ZU\4J@FPO^$XV*=0VEWJWM11).5!!.+%\%]!=LZ9N#VO\ M]E4R,FMF/GV9G40 W?M,YG0_XN;&]L?D2-8<==[!EE6Y7&Q%87;8BAUL9 6Q M"*X$^<$MZ>Q@BZL?WQ^='6Q\9> L]Q8MF1CXFQTK?NBXOSPBK5_F2SVINTH*_GK%J^ MV-_VC96J!&,R<6U.A;=T;1S[468'QY+-THQP+U6WTTX77J^4=&%V MM_C$ C&[MO(T B.W%NA0"1X-5\5LT9*=*Z)B/=Q^4R]MW%>T3EJIN"OCWO(A M==+%#M@#GMJQ=:,20_$Q8K>>W"+ #_ T1'A.?&!,B2OHM2MOU%JX*UVGEZ(- MJU^_K;"5=VXM5+367EO82ATC"T JX*5::FD/P84\=J M4[,5#R!;GC0:J*K17N8NJXBVC\;MH$3F7-=[_:6IO'4;EUSX#:#S ?[/PU*: MN,VZ9:V;7K)8^M(-)=MBP;*FJYWVFI)EYFTO'TWN(->]]5(C-;8=[\V 6_D8 M;1>[#2R?35XMU2X;M'YU:5&RMSO0VJ4GTARV09V=[&ZPM!#BL TR=K$KPL#H M=#KZ3MJS6 @L+L###[&6N,!9&IN<(%Y\;K0.+5$OU-1V&"N$V4KN3QO)_2MFJ;X.5_BM+9;8I]19]*[U9=EB]7P; M")=179XJ;:=-NF_C#^,8%A03,J5F/N::%+ M]7+RI>MAK MV\N_Q5ZR';W7&_1[%63(V](D3[?4J.]@%?!Y1U\Z]5H@QPX$W\%2W_,>NNPM M1*]2.+#%(C6CWS725F!Y?4 %80HWZJ\8P'8& ^"5585!@\AE5 0^_ .\$T8F M;?S:]4HZEKTV6_TC9AWSK]LB 5]: M,"5>M98D(CVYDY3**DG,:1(4RWK:ZHNLQA#6;]OOI[P%6 M^19C=H [/7WQ0I8DM_(C<3=;,JUZ[V:R[61K MI0564$' ;VP2=*KTXJPF!\+ MVQ"GQ1U35KU].TFWB)9RNZRL(VE:WYE)VEQGYP_1V.!ZN")T@O\!3N0L);#<7H^[.%%:7:A_MVL5Q&,OLZ/:M MBR>KDQK6/&',;SJS:1%WE==O+N8.>.V6,J9'3'JOP$+GD5^NN4$TH2-%+!9Z MF3"[:< .*$*OUV_WMI._)/CXS%T8%\M#H?PBS0VZP.CUVIV5L5"!.+MJQ"Y( MB Z\*MT1F[4B/G0,_Y$Q6S"\FVW/MR)=C;C(>NMT^#(E4HF4-D7;7E!TX M8AW74';WU9!+Z%[?GT)/%J:ZNKGJE P?ZZXX.":SLK22 #N0>&EJ8(6N!SVC MO5+7RT2>YYK 1N%:&317XK*D,#*W5"<'$J%B $I;"'QW[<.+0W;MF!9;/,GT M)KH/N,U-?WH#LGT=2I>?F^(L+N)L@Y^[@.BV,!M9)GZZM4O7Q,CO/WM^O/]+ M_@377/VOEAH=.U1 R5[=G5X_O#BKOG^Q_&O@;:0,E;S$9A G9%0BZ+# M=6*6@T?^!:$?H2HV[L*-&K%C+4#7=U<4-.U<"^I%>@E97;10N)17BX=WU94; MX#RU?3=MR?Z;O6[EV;-JIV6M$B"?ET_:LU"(^XV-38X3$[_R8=[Z="ON%K & M%-]=]W_3](^+^?HJXI4WZLH-P0$&W"KDF;WN#L)V;: :G?P^2\42Y&R] %5> MKG5.JUO'3(O7510BMT0J\9_S$UB"R D7NO>6A^A2K@!M$&U&IH.=>_?%<_\' M_N9#'OO9>(/!])U8"?'%'"^>TK*\A?HV+2P^FN^'^=!U1,^=1U #DV>)BVV+&B2T[L4K/' MZE5KR0[:7E[;T85H;,>#I'C_":VG[J?MPHTL:7JI8]Y#TPOW2*G4[FPKMF_V M\NT2=V]6-H1Z>;.+]Z#[AMX'V"?( YPGW^K2O17WT.I)5$2>5VYIF&W"UDTN M+[/8 [Z+F]S?=9-GZZT_,LN!_^56W_7*"SCV,ZJ7A$O=TBKBTN;L0@/+M^ \ M(&]0+]+K,S?00/%I9)<8+3P(P=Y/YY?$M;>73Z9OQY3Y#Q9 &)19)YFWA[EM M @ D\WSDP3E\R5K0!5>Q!\4<7/'Y,WD'A3C=M3*[QZC,W E5F? <_NC*+$/Q M1O;B=7BRGS5B7UV6UNP?<2GKJ:(T=^K+QHJ]??(V5*RV<.CV42AV^7DQ:REV MY+--,7M\JAUHG?7K.TK&*58I[C;3US)X@Y<)OUD0 RSI-W$NK M1F?=%I98F!RNWR_B>GXT*1Z:$9\#PX/OG\$>78$:X#TA1CAYV[?VKG^+\55' MQ%=Z=S$GML]F[$UGN#.EA947G@./<7@X+=):O^)>$4NTIHD\^)Y45MR*<@,G M_PJQOBR9W4G/#Q=8NU+49$/;"N-JD^()-)3IP;5>:TH25_E6EM>;[[J5!669 M_4X_O:=J6M!,1\ZBUXP0A;70O?(:[ST8_J)3@KJ=5.IIF>B;-G'0K>C;DH80=UZ^%6J%$?&C MQKJI7W]JDD-#T MU8)\U0':\>-U!YZFL&YF;D!7DL%3UEV_\G+\0MUU3D)WEP\//GL DK:BL"QW MG.)"B>9.O;/6T]L9@O^CU%#/OB@^P+3B*5K]7GLGZ8@ZJ?:7N#!1NK]?_(*] M'WOYHP(/,X^E%I.-QU;"&O MD4K(_3Y)T5E;.SRKKE<^:5/6M#V?5;=MR/K%$_MOK9[97W[ W>[]]8[+(TK:^2-4 MF3L:=,VE.4>JF8&JY_QLZ>+/8F-8%"KN5S.?QA/'FS(6+WHM]LBSYXB'![>> MW'AP]OL'+PB_>.'_,FB;Y3VX_._L&,JGT=K_7.[G^*-S?N>H.?$:_G=XG]> JVS:(287E"\L/,VM"\YZC,/M3,I.P MSN*V_;=E)^[DT_.$^^)B28_R"EIZE/!<4>^NC?_=@9]8E.< C<2ADYOS+TRA M'*R1NP'/\F1;7]TBV:853:+M0^I\)=CO(-629=I==?F"W/WLZY$[#:I0UJHU M*/U=[,Q>O,2IUS.[;97(D15ZXC_07ELN&]'=Q>D9*'0NO6TN2 M76S/FADY2X7!$W1NS6?Q?J.M<[>DJD>Z26IGSO, M9+*_(C3.CP5)SM1/M]-)M5S(8ER[\3Y,V91@O >^O.\;"^ &<>?G*(Q\EJ1/ M.OA1,*GYQ H M5$%:?%!X%,8:&N[I_4Y_E=#%LNRF#= !N81O#/;J)V^J_=P>+M7;P$70^EH> MDH"$;S$97+R+1.ZH#YR)&,R]A[KF;A(X6JN)LD+H))3X6%"R/M!R?*5X9+Z# M_P[.5>.\K2T5*_VRTJU\LI=]9('E>@H38TV!UX0CIC#3=SCS%6^HO#!?*K^94Z6MM11\ MG.+YRHO[ETK G\.I8IO30!EZCN,]83B!]]JH2GC.TXA;(_&-)>B\$HCJ8W@D M?H7V J1M(^<5SO230D[%W64?G'?;ZRCSO#( [IV// MLM=O*./2#8:J!LB9<;IK"9?FU*MK<9#>/'O7,I;:EW6TF!W3E43<-I4<JE>\:M1 MN.=[(->O\5%"$'S4_.NQ=/?O>.!U=*WW&G[]^57V)[CVU?P9!4^,%9]_J/PD M?U[[J8+%E#T3?US[B=D8;WZ!F-Q>4!7T+6+?\[=05<$S\.N/S/7&W"U^>'65 M+3SFU6);%G3A>Q=>'P#??GC$,TFUFQV?^QN_"_[[[_U!+ P04 " = MB0I-@RZ;&CH* "%90 &@ &-I:S P,#$V-#(S-S4M,C Q.# V,S N>'-D M[5QM;]LX$OY^P/T'GK]<#SC%5MRD3=!TD29I$2!MB%ERDZ3QB><$%C=M+S]P8] M1%@0AY1-3GJ)''NO>S^]_?.?WOS%\SX01CB6)$2C!W2.);[C./@J*?))!'2VQ_XK]$_!Z^/#_SCE_Z_T']./_X77=S>(0]]__Y]+P034IO8 M"^*9YZEN1# E,XPDYA,B/^$9$7,5,KY<;^OU"8)YB'T-R4XDE.EVE<= M#0Z'RO>(S B3[V,^.R=CG$3RI/WVOF\EXBRKR7IQ8A'N?RPKYI'6)!ZO5P4G$N%-,)XOQ<=8 MC+1HUJ"!\P:^-_27N,<)D_RA[(@@P=XDON]GC4KM544MX1R>29M>UFI0# DU MZT"#P3VR"*9F>=5B4*#LG@AI5DG;E-*PK,0P#8191S<9XA T,"M @Q+WR^) M@'R8$V&D1K<88A%RSBV=0(M!(21S3@*5#JQ/S%$?\X#'$0$/ NF1Q3S"#,N8 M/[R'WTM 8L:2F=E(*'E?>=P'(0^D"*?!4F^]4EE!<%F'!&X6@U,Y"#,60V:" M-*!_S>>4C6-UJ<;@L8KG#JPC=?'SY\MU^4/'?QX'BZ MDQZB &&CQ++SD(PIH]HU'Y(.)-)16$T'":_967P.I M FQH#37<,ZU,Q*2Q,N@F'^ H2")[!_T2S-OA?A:SD# P#1>8;S&:8/T!RHA,&97V 8=$V1@OT M1U7H4_TO6A\5#'01Z$MV#\'$?/F8%V^8 ?4'54 +.EW$\(;'D$7E@RJWX6&: MJUGN$Y$IGK9&"[9^%=M<7Z?MI86_(T9D%[$N#-?K\263)(I@-";RI;.PVLI40M@MPL8@&\32W;:0+JR_A2QK>U6F"OE;"F MI7ZG\5Z[L7Y.)*:1N",+5><[[L97E"SLU"I=E[UY]"(SCC+KG:3-;>F3(=5F MM92K6"BKU\XMEDN9[1UAZ]#W-V#,MU%6J\ WH SY.]+6$5#*D!MI6@@TE/CM M">QRLK04(J7LN$;&0DVMVK=7*UU.?LW@^BX,6--;K8!?2T%'DUDSOJ7LY29J M(:1%!;]+3J52OI20#/?-@ ^;B_DNYQU+J5[">8V,!?-V]?R. QN^I;3C)FIA MI%;JNS#2Z5G>@;$V6PBHE^[&[H+-YI#[-U_>FG(Q/>J4#";S\Q('?(+:]Q2S*9547 M#5_G:PJK<&0>Y":R[[&;CQD (WH="^.BGT?10_W'C PX:!M9F;8_:%P1'K6- M"U1(] <."1[_MB%51LPC!]8O?)'?+W^K#U'%7")F/#?$=D9&>N3(51QH,PTJ MZI>7ZWGJEN?O>T-_;R'"S+<6#JRB:N= KM?2 ?.A'XY=YPJJSP.7WAH/ [%T MJCLT*O9))$5^QUN9RDA[/TP' MIS@Y4E1<_MK&E=KY*B8WA%5+7VWS7-0/7G'!8:657FZ#0/4D%Y?^#%"?VEEKYJB7[]I!@]<3 R4?LV;GDIXKRDI9+3D4J(_N%6+CBFQ4+W MJ6%L2_N?DCH*Z%QD3=_<#C9)X[1\$M8YP?R6Q$N-KE*&X>$;UUI&J>@,KG M"+>56X\5=;[WILV7HYW%D&I*F? M!;D>7T ', 5EG_L]I'_5!NJ["*C*\4E/6#R6^?T?AM 6GK9_5JY@.I[@WU7& M3N;SM$FD:;P2>!C/,&4_:J9L]*-]6,5WVCY"E@AP=$[N:4!$W@,ESQ%F*[_: MAWT6L^P<8?W\%.:A9XAUO3/;\7K)@F=FL.!!^U#R5/]!_7WB.:C6]^;NGZG$ M&T7/%$"A]\U#>)YUP*-,];F1TP453UG8E/NU^!W*XY""LWJHK(O@7(_:)QW* MU:[;P_\I9O_(ST77F>UZKI50ZWWAP7"SF-.WX M')9.YT0$G,Y3/]P&S&,.]P9G-A_]OQ ZF4(>/X7Y%D_(9Z*8@6"NZ)B4@\P] M_N%9K=FES4.]9(HF00-=0CYQ[6)SXM'*UD^)>M:OQZNY 9Z6)YZ7K#YLD!XK MIFZ3T;]A^707WQ$^NUC(=&K8.KH6&U2N'FV3+9]Z+J[VO,ULO++U#/-QO7,7 M&OKI[OG;_P%02P,$% @ '8D*30I-6S?7Z.P,0?&,247S7DT"J$(F*$Y]&GJ<>$V+R/$(<&M(LPB^:4R%FYZV6 M:OXZ8N$)99/6:;M]UEHW;"Y;GK]RG&K]?RX6,[AH/GMH3WX=WIV0_OD\YN?SAK M*S7?7U$2 .$0R"^AK_3]M?Y2N A$0P?OC_DRYH;1R'R"R%!\,S17BT]N0ONP;S(;>?6'Y M%7Q!V1RKT=[U_XCE%]5;UR 0#@O:GZ=K7S;WR%SV!V48>"D[=?+[LFW J/0X ML>B2X$;VP$PQ]P"BE)UYNA*;?13Z<9BX^)VT,&4[O J0+A6LK5=:]Q4;DLA. M_=3S0A5+*4MWUNIQ2< <(SY*HF;,O0E"LY;JNQ:$@J]_27K3:W=6P?/[U<]? MNIPG$6FI.40C")/G?=ENT*K$L*N8,EG MU:+%XRA*M'E8QHRU_)C12-]7JP=2HZ4QEX^F,Z46AW[ 8(9PB S6K&57AMI,XDY39;)<"<#7X\(1"98SHXKGP)Q\^J' ML=K%^DQI\(+#T#@5V8@[3)D= "?#HP4]M: @KYO?:[JYM;4>_QLMT>\P&N$0 M"PQ-*_=J6BFV/UP%Q>NDX M0 NU@)(@Y2\LAJ 0;X6TN$*HY>K2"I.3W%[#&*1]P5":>"4_L<6>@$&F)KP9 M$#B90LN9#-21A"5!^N8UX49OO)-I\W4,3[0_'F-?!OL^VPS]%J/(0K@FE-E MV7/R;#@52OWIRSU$(VF'=F:680#[6$=2"1VN<&65@Y3 YV1@'+!5)$\,SSN( MT+:NA+?2/JK9&=J%Y&2F<46CB!(KGG:;UIND73Q.#J9N$."E10.$@QZY0C,L M4+AAO2F]MQ"N-XLV")U,4X:JAH% <(,8P63"Y1HECA0%$&3/@$6$Z\VK#4+[ M[.5@>U(Y!4 ']K'+F*N\G0R"]4WU16P7[Z8/\IU2:E99QBNW1N=?><#(Q*H!P(\WO M+4_]@OTXDE;QW\EWM!U@GZ55>Q*148-[8#]^ "&[CD9P1SGOSN4LI ;=$]U( MD%;3\B7BV#78ZEJ8E.FY\_'561 M0-PBS))#U6[PGY@+-8'VQ[\AQA QOL*:(U(X#(+K544D][L2[XCML)2&[F=>GS5];RY?]\[9?W8MFR,]Y=ZN MFCJS7PYQ?@[C'?R(0G/C0VW>H*W"R"%ZN9>T,HQ"]>)1?ZR6A6QNW)JP$:YT M-.@HR'PCV #"R37PF^&W:ETQA6"] _8;9<\],F#4!UZVX M1)0)_&?R>R9&4S'IWAY1.Y?8'_0""P-WRE>^WKKFQ"5' YF4T$ FWPP0AVM8 M?II.\PJIJ:!N15DFG48M*X++Q2^2BAYYVU/M^D(N.%01E+FHQ5I)I<.O#*6: M64%1=35E\]M V]^Q<]!@FL[)>F3W]D9C=+41KRG=Q4#JZ?U0\9G0KNT; M1P6%B$W)'1VC*71Z*G]PCLK5%87KFU6T5Q46XMA.X=&1;P=;[Q4?G?,*FPN2 M2H5TL\*C\PH[V'JO^.3:K+[V[;(^H)4_.LJU*+,V,JJE^"AKL+Z9TE)%69WJ MMPMUL%5*PK]UAUBKY%AWB+5@G=S#DG-*KJH><0FQ%UT\Z[S7MI+?-/_T/4$L#!!0 ( !V)"DT!L6QAD#4 (*( M P > 8VEK,# P,38T,C,W-2TR,#$X,#8S,%]D968N>&UL[7UM<]NXD^?[ MJ[KOD,N^SL1ZL&-/[>R6$]M3KDULK^.9N:VK*Q5-P3+_(Y$>DG+BN;KOO@U2 MLBD)C0<*4#?]SYL9QR; _O4/; "-[L:__OOWV?3-H\B+)$M_>=O[:>_M&Y'& MV3A))[^\G9=W[P[?_ON__<__\:__Z]V[7T4J\J@4XS>W3V].HC*ZR:/XSV+9 M^LW@I[TW\+_>WKOC^61>E._Z>[W#-_]G[_#G_=[/P][_??/_CK_\_S>G7V_> MO'OS[=NWG\;015EU\5.]_?V!N^7#[ZMG_SY>Y&L//UML'RV]_Y_?_G\-;X7L^A=DA9EE,8O MK60WJG:]HZ.C]]5?X=$B^;FHVG_.XJBL%&64ZPWZA/S7N^5C[^2OWO7Z[P:] MG[X7XV>YX)EQ^?R:9@?[[^L_OI7JRK.IN!9W;RI)?RZ?'L0O;XMD]C"5"*O? MW>?B[I>W-D[&.S)-_[+21;/9R(MC]/Q:5HFY=-Y>I?E MLPKGVS?R!;]=GZ\ GLRC? Q_O1?1M+R7W+V7C[W7]_3>D[R?LG0LTD*,X8HN#^; M9M]\$]7HUQ>6RWP2INWY)SY[Y0 M?9W/9E'^!,,@F:3)'7RH8$_C.)N#04TG5Z#;.!'+M[MA$:96 M [#=&WSA^UW$998_)G)9=QR#$2H2.>I;#3M37[N1V7%@&3O;C=2MAHYEE[X0 MG*>/8..SO*U94K7W)=M5GH'%+I_DBA04\2!GHPM1MI+3U-=N9&XU(BR[](6@ M,>@N[\[34DRG,"3A%4LYML'BW+DO5-=B*E_.W&YC-DK):H8-E@*6[7%J(=-NEBT.W M_M9CMX7X:PZO/)63R98K+WU?E.9]-)V^ M->)$'$=+OX_T&.U7J*O>MA$'?H9=&^C@W5C<1?-IZ5$X1=^>1,UF49*&D731 M]5:"5GV\FXG9K3R_%>^>H7L45-G[-N*F67GL];M9=E@) M!:,S2:OEQ&?H:N4E\,6+="S&R]=(:;9WA%9>[BQ>>=-4^I6S?!-/L51,(>*? M)MGC^[%(WDO3)W^H;."[O=["=_PO\*O1\M6--P(N<5Z*6;'L?AK=BFGUTI&I MR:AW^&%_?W^AJYV*?1/=OC!L%KEZO!;W<(/:XWQ5_3[-"C']Y6^9S4->\ "C9@^Q- M3E99#LN(7][V7 E<*N(N*FXK;JA)%-.R6/YFG]7A@B5 M1KS/7"@*UQL.O'(Y!DK&4YFP:31"5KSQ32]SOF,[5$-1* M/]C9,+\2>9+!&G=\ E^R8;RO/%LAZ'=UX*NAJ,GXL#,RSI(BCJ;_):+\#'YC M6NVO/5VCZ-I780*CIN1PQY34P\6>E,;S-9)!IVE1P5$31#/,;JD>K>0?!%KA!J-#BP39,.[MB(I/ ">/IN?I6'S_#_&DY6+MV1I" MF$UA:#(P* @;SOMW9S8^S?-\Q9#J)W7L\0K(?M?LE1$-0HOS%KWE1W*63$7^ M"02:9+G^$UEYLA8_C#B!H+PX+P3;VNLLMDL2ZM]Y]?[*!?%Y;R4\<0R M6%ION30-*U4,.VK&;' AI"TWX^]7/?"A?/(68;Y4'E*=@QY_>-1WWN=YE!GS MSJL?'/6'N_/)&U1F\-*^R/O#__[BD.OOT_G>=10Y>MPEC%?C;1\$VJU[\+3W M-^8, XY7XV$?]/E[UQW9\>Y5WYZEXZ* "?OX5NYGXU+#T.J#HS[),JO5A*20 MW).+W9?Z%[LF:Q;6GA_U278F&OWJB% )[\G[[L%H1<6]#+6#_\F(P<=H6@7? ME9^B/'^"I?COT72N6ZQ9M1\-2+;U9AH04V:-R9/?WL-G5>=W%-^YV6![7)@1./!;VVA-F3W MY;+W_5W Y'=9WHN\EO@B2V/'#P7K8#3HQL+- 8TO_[X/#NLLIJMI5,?H]GLZEW_O7+!M_2UX!<2DP&I($'K5T!532 M(CHFV/Q_3J+;9 HZ$S+=;C-[T,(_8]O%J$\ZDSCYSYPP(6P2^ :8MO[U_!& MHP'I+.)$@I%'%3:$.0*/P-)W<14]2<<%X(7?Y',QWD1@XC#(J2J!%T).#K+B ME"5'JL='0U)/72MZ4!P(,P3^B9.YN,DN[^Z2&": R[PY'5A\2\;&HR&I1Z_= M1V6'"N&0P#_A-)FIC#JIMZ_EEZ5$@7!"$;. %]S0'?KAK49#4@^?AU6C"1Q" MGI,S0E./9.5/HR\5WG4LHL(B%1PGND5^Z[Y& U+?A=5N;3MP"(L$CHZK?+$Z MJ@0WG;)[485U$R/D\_10])&4T;4NNVT<;&HWT2ZQB"2$NP"+4$KI)K65(K%>/3 M*$]A7BZ.XW@^FU>E\$YJU!IJS8U'^R3NY!#46H)%J'5RDVRYG%F6JL/H<^YC M1)-&YI/%=IB16&@25XI^(;[%D<)HG]0#YO4HH<*"L+:<9-AD.:W> ="QE*M>4)ZDR];!6R-OQE*?[+"]O1#X[$;=5<1I3NI/J^=%1F 7^ M-JE.AZB? X? )LUI0T1C6@W28G04:$%@G_"$:MN2G080-AE//OEAD_ODC2B& MR4]^,SN/PFR# YD[+0PV^5';)A$>!5H;>\CL/,+=26HB\6]!FQ()FXRJAJNXQ2=GT7ITQ"WS&B?.%@Z? MQ*N-,CQ6GYJFU>B(- "@+5U*&'SRLS8D/2^*N1M%=8O1$;L*"_O9$)K==HN\LV@:PD>80NI%B@,'&AWTM M"@&*D.7'3L2CF&95%8N%T-K(1DV[4;]'NITT*%_-F 4B-B[KKV(*?4Y U"]1 M_J=H0-4MK]%&@(XT_:(57R8X;!S6OXH4X$UE_O!X!LJ5T,KD49@9,[0$G*2U M*%K19H6)C[MZ Z/+U 5@2*>L5@0A*/BXII\%/$_C;"8^P^K'AI27IP$0NX!> MBY7$.@ ^'NF++,U6I5P6,C.O]XQM03<=8LL2#JOR8"(7A<62;^W)4;__X;!' M>L9MJ6PU4Q@:&9;J[2MJMQDOJ'MB+0#AR?6F47HK1:8*P\!S,SMZ@?W62U*3J?ZF*K M,4DGR6,R%FGE:JQKHSZ/(ANODGMGH#=N87<:)MOB\U&2S#H92JV@L54_,*!)I[NVG*PRO 5T/@7)$%74QN=YI)_/'EI]Q-3 M,&V9];\,.ZV$E+[T9#HOM8&#AI:P-.06FZ9AT0H,GQ)I?XAD<@]R'3_"LGXB M+N92%Y=WE>B-L#I[,MMU"&IA5_\)YW@;C'PJL5V+1Y'.M0[MY2.@#&XA\1IZ M5J4V5$]C$0NZ"'59K5?1L9#0(86CI6U(Z#!0G(UK2&BE-.1X4R'Q*PD)K0LK1: %N&A:K:@6+"K/&V"0VMR=+3BH-A$QZZ)J(Q$E'Y/(SQ0,LW]R!1 M7.?(8@X'Q"96U!M)[")&O;'%,G#T>5/W967QHT_5:0U'$1MZ+:KBME=17C[=Y%%:1'&E8[W!T[0"H&$">@-9 M/B,4/D&CB*C&KTS;;C0,=31A;0V-%#@QUX3%)[PT&'=! NM#>?UP$'S"3?T5UQR&.LW;LOIII7!+AII0^$26>N6(B_GS29;1Y!$X M*_S6PA@&2EX)?>"A!L(GWG3;H@O#?IBUNX]B&)6J$=\L@H3/9;4>B&%CZ?PQ M9#1T!%Z,Q:TAQ@LW5IX#,-SR^C7'\@K1^41:UN20AG-N45O@)9;!I1B"&P-T$<&FT75" V7[+(( MS8:-UZ>HN#^;9M\Z5Z5W>$"P!VP=DGT09N7H'))]8+[1IR%QQT.R_1S&'(19 M\6WED3S (^MQ$&Q"KSWZ^3\$6A9L>Q9S@-YAJH7")O#:*T5L')0>N6(8=GWZ M798N@>WZ?9UV)84VF#RL"2@ES+8HD-73XV 3BJT2T^KCTC>$\4@=MZ@GP)ZT M=5!L8K(#4L?%/(;AD.'5=H%R]0["K$5"+13-8-C$>'M* SNDCF>TT#GRF>& MV$1Y>R.)BSWTSQ;'..\+44H?T%6>R;([XX]/O\%>_CQ]+LQZ')?)(ZC?JKZ] M>V TG@&UEQ.,MSUC1.IF)% MY)O,WP<;XG6@^U)415\ N'7*D/+#9N&8\73 (@TI&W7W*(JX!0XKXKCT3IK50T %FEP MW*Z9U6G!1X"]?0B,%.1V71 D TJU:MNF.\!+&M:V*]:WUQ&?<'Y032XB:8SJ M_S>4L0A*L%C[V7<"ZB2=SOVNZ%QQ\TD6T$A^7!3"JEBX=1\ GG2>=Z7)F6P5 M7#[I!IN"'\=Q-@585/F\_01)L L M3[0E2[7M "1I*&L@-C<0\LE\V!3V*AG7HY. ?XK.E]QQ6W(J]@A[<$NPAOND\[F?OFU0XNP2N!:0]#+ M;4CA*QY"TQFHDEV2L7,\A!$?0C>!2PW6$LOLKOBO>9(+P (#O7RZFL( A26& M#.9Y6*2[8#3;=P(VC*,GU4B8FGY7W CM%'>VK4M^GI91.DGDLM*T2S>V!;"D MGM/ )*OA(JDK?"+:%/"]6&Z SW&Z;LFV*VZ$=IK(-I7D9TD:I;&GB5O3&2B5 M76D(YXG;B ^AF\#5!J+'0HR+,]#$15:*I5= 9[B1)C"22==<;#":LHGC8NL&I"+<6++V$H; $=Z M2A6..@5,A$,"%U73*,A"%0!67-ZM7;BD:08020\APM&L1HJ02>"]:LK:-$[-P#;#9&O; MQ6A_C_30(1S)9M0(X03^*WLM>-GM 'R.9P\M27?%C=!.X+^28L/4(O\G?6R/ MT50.U[H0W/H9FL5VMTUWH%AVI?/P#6][A$A]#XH*N X8/)$-XY[47]V>MNV' M08T=H9_ P:66_1A,6)X_@;6J3MF<>5]K#Z!)?=>[(5P)&F&:HD#6_.&A+K86 M39<%^L[3NRR?U1EF9H-NV0, []!IHQ,HA$V2R+ Z@4P6C805AS;89^7)^G2< MU/XZJ5S-&@8*(8@F1BN;B9OHN_25)KJ"IVM/UEAH"_S[($@-"B&(P'NU!':1 MI3'\^'(8E8X5:_63I) 5*>>Y[+N+(L+4[D_<_3 MX@;>, ?N68T'B7J!5OFM!XIYN)&]*W/&"Q%ZO2NOM\;LJK29) M3Z<:")OBQ-M>R-7;"^05\W!36J5I9&6 (&%3D=@#+^P*RVU/$,,RQ%_GMX7X M:R[KYLG,39O"Z^H6@"^,N:,88WA7>>$]?9((R[YQN,_+ "YNE MLS^"POL.BKQLD 3_6B<(?B4C+\?SN+S,%U<,(T8->Q20,/02;-HRO?RAW ,N M#!3'Z7@A6(%^)=KG 4N@PU"C =.K%Z4"PQ#*![![/J@-EU=BO&[TK#5M 1#)GMUB^*_2XHC(PV[=FIK?10R-'Q,Y!K^( M,>P*IR>B@K.4#S:%EE0Y]#7J]4FV]%M2YXR0S>5"U^)1I'.MLVSY"$A.&MWA MME-=E=IP+1!'5TNO<[X6BFSUUKZ6?IB-NK.O98"6;51)_,/7TMB7]1GN3_KH M7M$ Y/7X6@:!XG9]^%KZZ#D8AN3U^%H& ^HM2P"".,9I!+D%M=UP M,&PB-_Q2V!E!;VPQC-98E'5 '07*Y\"NDQ9^ MTWP.:D84TK.)K+BL9#B'_>IW,;[)J@R&O*@A6H00VC0'U?"[H5LS-]EC8N.F M,8EL-(=V'0#J0)Y3ZTG,GIQVY#:!\KDL>H?\T\79P E?(Z>QAFCV) MNG)5#<4X2:)M8,HAS39W^>:0-8T>&I]KI.N15V;N33T!( $]^L:/=U(2Y,&W [O2"YED@.WO7Z MFI9G^Z8. !/QY8EM"&N#D<\EQL=IF8R3Z;Q,'L7+&#O]'D_G8S&6A1BE;V-> M5DJXO#N-\C1))[(65'5Y\_%,'DAKOE$O_8/22"O6NIW%>H1LN/688RA"5PM' MT%1.:1F0, RSSG0.2!A:%XZ0$O\(2&@<7CZ7M&.TMQNBJQ$#D-<3D#!D??P516.&/([B]N>((8!"6=2J>(S+%W&ZU=,?7SZ$OTCRRLH!KOGT OH M(4P,4"!+Z R-3>B"1O(7N2^BF?D P;$GT -U2ITS:\[DX\#9A$60#@ NYIMN M)# ,N=ARJ_KQ2=V!878(^%;0,\.D:GPV":X*-K$E:D&MK(VI*2"ECD0(SJ/+ M\%G7#)O(E,!C@,L4PW@P& ^ MH]GLG7/?%&]H*OUW ZZE&.\'^;@P?E([\ ZQUA* M_.-(K^'^WV>8V;!O+L^G!O)ZCO0.&.<8[Z,AZQB2UW.D=]"%'&-7@GX1B M5T-QZ?<0JE69RO,T;E&0\KD5H"!-HK7\9%8YLL;%)_-YB?-3-KM-TLJ#^BF# MT3M>W%9YDT=I4>?8U!G$RWN.B_KVS>-T+'\PN.(\O@44R.TF6HU'SSMP/KG7 M#M ^)]%M,JT.R^%#F,M?^1DLBHY!3:0I;L'&!XJ5S^&A QK=/<8NW8 *V"6N M>:%[@8S/2:-"]FL19Y,T^1NV!("&ECL;>,CK M1[T/[&Y-V]'PTVK$1]X]OT$H\]]3D/-I1Z/N^7V@5'81.+L99FLJX%,7(-BW M=)6+AR@9+P*6X/G+\E[DQH @$GF %'9Q1@3FSZPB0YV"CH[;JSQ[$'GY=#65 M!0_JMN2EDOA'6&PCA.X#PV"P#VA8GP'(ZPF+/:0.%3!H M6DT/AN3UA,4>LCG_]T@0P[!8Q1DZ['2SLRR?18L+ =T".=9; VYVW@-\&K,& MQ";X52?QA2C/4UC!B<]9X1C[INX#L+/;O*M?P*-"*S\>FZM IE>T(7>IU<5-UU._ ILJ5H&YLJMIFGQPR M=!OA%DX+@_.6R6?JPA%5$2$K%NR)4\#BO$7R2R$70QF*2Z\Y>S3))T>DK@C+ M+V:5(FM5))O,SXTW8*&V)WZ;S$JC$CYW,Y:"_Y%E/?9^.5"J$;LT,_/G[PVX(0UQ1X[N M96SWR]U87?-J]_L=NA2KWP^S#G+U:E=*L_)J5Q+_\&J_>,#Z?7ZUGOOXA<<& M(*_&J]WO\[T4J]*TM=.T0O)JO-J AHNSQB-!#+W:SUE:U]&W+P T3Z)I<2'* MRSM9C3E_U,;EFQL#:FY9XII)S!8/&Z?WL\"RP%=Q+\8RR+R 1>,?6?[GN8R; MB&'QZ4RG?6^@#VY)W#;\N@)DXR)_1@!"VC )CXWZ VZ)SC84/4O.(K)GF9S5 MS,L"";NZ^1D0I-VVWOP,PAP).&]^!N88D(;$/S8_C872@-_-935)KIN? 9XK MU\%%=JBKYWUL?@;HWA1#\GHV/P,V5TIZ)(CAY@=-N?[X= /O-M@[B]: FZ'; M![=\UI#8[(!0B:6\QH_/HC7@#70.96TEK5EQ)'4=))M=SDY(Y6)B=\,NPW+> MEW=W22R>Y47CAK3/ S92!X3UQZ5F3X.)3;10?:.GR.V90EJ,^D-23\267&E1 ML8G8J0H8?8GB>]BXYBO^"O,'9F@*2$EKF6W[K5G!XQ-N\UE$A;C/IN/SV4.> M/58KN,)(HJ85 "3-VMV2/R,R/E$U9_,&F[Z?7XWG=4DN1Z] M[:.[["X>O>U3WS%IT+3]R%BJB O?OX4A8>GN=YDDYD!:;BMS2[ ME=%R$O9Y^C O95WB-$ZF]8ZA"=)\5VN@5X)FJ>N7&%@W#)4@^F!SXO?*1AJ7 M.83=D&-X#(ENAXT.6T-+P$OJ[@EK.AQ]"TV5L#G9;/JUUMQ9&MHUK0 ?.T<0 MOGCW<\U$WB/KSC!^@4@B%Y/=[Q M@RYDY;L2Q-$[+I4J/L-2L7%56[V-__CT)?I'EEOYR^U[ 3TP3-'#+:$S-#X^ M=5SR%[DOHIDYS\&Q)]!#('>4O0?:7Q-(-I[DJ^BI"D>_R1;U@M>1ZXX13&T!*SM'"K[GM(3# MQK=9?E7D3\FL;9\CEM'H_X'=F59=(X$=VP& M=_2./&;7H@IAOHK =%35-J-8OJ"@=90A4MFXS4Q-1_U#@BW_U_A>C.=3(2LG MJ17^\6GE+R9?6YO^8-P1U(JQ(P3YKMK#[+8?#X%KV-%J6H%2..Q@M^ 3.?8S M(&;C]$,D->YBM.W@VPF4^6:]:34RX$1<$Q8;OV PZKAL-T-QR-!U6%^ ^K*Z MDV\R&U9-*U 0AQHVO@VK$3$;CR$BJ?'KU+8#C-1E;8P,.!'7A,7&UQ>,.BZ& M-12'#+UT-TDIS<]Y.DX>DS'L&0TF5?D\8 MSM$EK3#58V;CH-F3\(RGO*Y02 M\'WR<).=IF52/AF_3L>>0 _4=18U_%@2:@.1C4N/E&HNIGD7G)O,-$7LZ?.L M4E^H(ZLV9:ET2-M&":G: 5@.=[;ZMML6F/F$IZ[):/QVE<_#KHUZW6NA=#5; M&D!\2NAX8XF+'?5/E]%J4I2(N,_R\D;DLQ-Q6UH4OU4^#^ X5!OP;B5QK'S* MVFP(:?SRD!8 C#SZ$E>X)4--*(9J-EWEB(U]]$B6T3(2^'"DE.=I4>9S.0D8 MS.+FPP"+0VT"WS81 XKP1N"O6970*J .:P+0J'?PF+YMV%D'@G!$DH#KE2,N M)M$?64:#2.!=.9F+FZPN7)T7EWD5&B3+LL*_/LWS7%]+T=QXU#\BK3*\33B' M+3KDT'['H5%-\>K-"M%]5HN\C#^B'/1=7N;7R>3>*H50WQ!T39%.*&/B/D:% M&,NM'YB,^D1$2CBI]I$?GUX>601+'G\#ABZK\5"5+D?Z,9ARV_0AE=L<1E.'VR"IY3J,474X8U GP3W2[?GV(3$8V0<122E MWPS7(P;!&T;"],YI-2@VT5-;9U4>D?M;])K6?H4;2-A$0GG@ANDUJC*2 FS87R/,EM(/,0Z10G?^[M[?4.AOW!A_V* MHKV#P5Y%T,J?1@M1BE_E?X5J4:I]'@0FS6)RI\("CH?H)&?]?XK26&;%V3/P MW&(TV"--.O+%P1H@#S%&SBR.<[ 79ENRS8ZS4JSSCK-"TNU<++\[SL%>F ;7SO.FC#''6<% MBHV+8-N=S6"/^CC+H&GK#4V%Y-5X @ -_QVG,T$,DZ2V]1(W]F$7J:SAW<:ZH>!OHD_.V-^#@0I7!)KE-6]^E^N/S^2CN]FC?&6B#]&;B+89& M2ZQLTN*V/S"O<,FM5?"ET,:[1OW^T5ZHV#SN5@77!F]/'%')I6#^N*&3R\;5 MT?P2D'(".[(34<1Y4C%KZW=&.Y!Q+1_ZI%?4V*C6PA-MALC&U_9R*<_X'_.B ME-_T,WZKN^]4[6J8I#?/N#/IAHR-[VTIV7$ZKC V-Z6+*Y8DA.HF)0V?+MW4 M2B"]JZ8]O:V .Y!X 5<'WX6:8]8DWKDAEF( M>COXZ*&.6R,L-BXVE:1&5SO>J 88R)UJ?1IB5+\]:VNPV'BOPO#&Y;0D%($, MRR"MRWR5)['X/9-50J:)1=URJ_85_ &I*]KBX[(C50^0C1]H7>SKI/CS+!>R M>K?(15%>P\[*F5R\DUH!I/Y@;PQ;H&13&LESK$>/036S=DL> R@^]8RV#BKH M,0[VZ)E"KC:0\*E'Y($8+NL7CPP9,Y8I4JI$GHCB^ JZ%'DNQI7(QLE,TPKV MS!S.JS8^#L34F8 P*D-4B?JQ%5/*5@ P4 'Q<$QI@ 2K-U3D98,E^-WCDO$#%I^,. DT&!.#>39D*#:#YHH$R!?@>ZQV'$ M4-4#-BG11N5-$(C2G?;;NU,ZM>'QJWVCT2'82_N_"6C0#^/UV,'BRP@+X8W/ M#4Y;7AHS&%)7F3%2X,1<$Q;"W:NYJPE 4IO+T"0:#2A%QLW\MA!_S67I]T?X MCT5X$-("-!/&";F+T-HP84$L),<2'2 MBWC24W)YYW+%J[DQP*7V]!FH0/BS1(8025&G)3R1G"QI($9-1G5 $*!PE2>/ ML#2^FD9QM3XVGGBK&\"<05H9PO:34M.GPX1011&A$.1ZN4&@[*U=!M+AP!#V M"'PK?FXG&X1*QO)TAURE=#5;&D (2P1>%&\LL9G.O--EG,4(_"4@YBQ+[4*V M-IX=#?9)X_TU'X::&@0!0@>!2\0QB$X==+9/&J+O3 H. N&%P/VAG&8-JP>T M#2BCLUF'!E (8P0^#Z6@MB'?JE8P) /%#UNO( S*=V"L"0G)[:5+F_#+&9?U M1 CRC&4:"3P>OXNB3-*)P3@VG@+\G0L\1F$@/!#X)Q:B&3^?E>=&@U 9G-9& M;D.E6LTWQ49T3^!P:*U[+L:J+0E&@\2G<*RLRB5]7?&]N$S-:;(.O8!E)LU? M47P:B!O(%1-"*I^RK0W1;[YE'DA][@440'J]GD=2US AI/(IE]H4'5[GXUMM M] -*(*VGYI/8=50(M10Y),EC,A;IV.1R7WD.M-&Y,&L-$(0-BJ21I7#F/(35 M)P$(]298H5@# TW1$0XHDD*VX8#+.G$;,HRWVA%X()9BGHAX"M9V;)QJU W M^I)6=E0.?3TQ*@ (+P1.A7J6,P=SKCP'L#L;PJD @K!!49O!5 6YP,H@O\!* MQU?3*+7*A0OQ.AC@U.?!"HJ=%GX>\"-#BB)$XW4,*2[S,OG8,D[N!(Z@LR2% M;5(23:V3V9$6H-#.AL!J(2%<$?AWJBBT.Y'+&L1?1?Z8Q+!'OKQ32%_(,5BH M_V2T SY? RJD#JK5DJL>#_XU@ PB G]21P<1ETF$P6@R3B,$KJR%P35N#5>> M@SF1],H3_Y^Y>@ H0"/,420Q+4/ZOL8BC?(DLXW_;3X/Z+L?][L)"&&)(EMI M(=MO:?$@XN0N$6/S>AYK T.0NE*X1ND(2WHP2'UPBBPEWTQQF?G\4F::Q X( M'&K+'9O! C8? _R=K1R\B0.A@B*1R-9IL;[+'E G/&]J5:_]IN"(_@E<3UOH MGXN]:D^$T38Y^6FL2Q%=9.E_SJ-I92B;-RZBBVJ7YJ/! 6E:@FJXK_+AC@9A MA\(SDY0R8_ \'E=#;F4P,(88G"];$NY!])>7\MII5[M[A/ M'FZRT[24%SP:O1MN/8T&0^H(4@U!EHS:0$2X)G!(D'+-90KG&R=+)IV$] M67X">>"M.I^3O@%,(:0I8:V^+]V,J0:(D$*1?/229W@5Y9=YM9\<5S=F7HF\ M.D_3?(46K0$PA\L,VEQ/: L.N3V+PLVANR^\_OU9EM=>5:'W)[IT!&H@C3AN MSW$;G C=%"5;&F)6%X%9?+)H&P#7L=N:+2$A?!'X3Y00%Q>MBTKRE[N)%W\M M>CKSVZ8_4$I'[W+> BXR!KC<^=NXM=B5[D93@-K1:YSMD"$DAO'[+ ?2'T+* M(L;'CR*/)N):2%6 2)^3.Y69=>\$L)&>M[JSUA8CPI^39\B9O_.TA'F]2.)J MX6;-V&HSD)^T])4OCE2H$%:HDJHJ.VY:OU0/C08?2)VG6RY8&A@0"B@*W>K6 MPQ?B6_6GUAN'YPX -NDV/]"&80T?0BM).(E2ZLH*;,'J:GL W=&=O@,\A%," MS\UJ,:)EW3(%=D$SANUS,5R,[M, M>W+F=*,' -Y1=XT30(19*C_-K29U89&Y<+N>N; X7I6)UV)\,9=JO;RKYQK3 M$LGSZT"E7?8.!=$&,L ('$ORQK)/60H[+WD$=9DGDP1$DK\]GF7SM-0YD8QM M 6Q'W0J6T! >*9Q#+T<.S\;-^+GCC0!>QUP+MI@0ROC4[-DP+QM9:6=1DEY4+ /ET UE(N6$R&/N2[0=D=\WOL6#7(..139J@=X-/O M#R*6AYV9//F>)N73+D>B^NVCP6&7W3V[4 XR&@E<>:LS;_T3"/V2H-,\L[-? MG9@Z C5TU*_4!B="-ZW;4$=F\S& T'UOT0(%0@1EN:35G7+U']U7IFD&$#OJ M!#*C0HBC2"7SLDL]3VO/Y?/$H?T: [T25-M1]U)8C:@'VQ%%F%C;!37$Q@U6R,#2"7 M"77/"N,OG^_;P.%=M3_&TP9R.CB6(T, M@W@C\AEHM?HYQ'AJ]@]*^V=S(V["1\8,@.$T2FZG8FW#VW =_?:P]"XU$TZ5ITK.O8%" M.NI]:PT68=_)XVH=TJJ-/5N&>"[CX55&?9ON &_'_'7;HT78=7*P;LMNM:;U M1JZZ-T#;,1??UF 1:BEB,[=T.EU(D[33^"#DC:#8?U*_GU8AR$@C\#&?SAZF MV9,0BW1&]=KV&4L%L+C)RFC:_/NGK"@OLO*_1'DMXFR2)G^OE@+1C+N=O!^4 MWE&'WP[5HQZ3O;T.^J(;#J&U#*25S," +A-+"4#S_Z2N/"<%84.S2V&[I]\? MDKQZN%Z(A)B+U]\!VNNRE\Z?"K !U$'7;^/#V=E1!?I.T&Y'@TD#JP0;<%Y^BAP26!_5B]%H4L*ZHREFM\$KON1OW^A_U^1V>ZK0!C MXR!07<+%5N-E?PO&T,(Q@+2K473L W=#AO$3)O]\79JO\]M_B+B\R>3)P.GW MCM P]EJ'KGIA;[F:/%''NENVK$%VS)*Z8L,( MI,IMKU=JLIRM#!=)"^T*6=D H!WUAAVCS1(2QM9RPGC_ A=>]^>J N1O5C0@ MI#$>ORPU5G3P[=NWGR9S6#M#RWL13_V^)2E\C9A MD<:)*$Y$&273X@;ZGH.(5+=M/"M;.WS6'QX-*=;ZSW)498!M!*[K!0_WPAS2 M1M,I/K0QI6'#>5-B^=YQ^7,,HP8&R>FT^OLO;PLQ600K+/X^S6 3]\O;,I>[ M9&3@$Y*U^,:K#];V3I?U-J"0,$>Q3B6IE23IZ50#49-$5YZOSCHU%2#>?!C0 M!#K_2E=3S(Q5]XS M:%JLJ9X'13"X?5=#$7)<@D)ALU3;D-'B'FUE"QC;U'=3:?1M25 3"IM5FU>* MV*S?/'+%< &W;BHL[)ZZ!:@DS&(MK.73@=$OU6A),G]:6!O %NBLUM[^Z;1N M3503#G*]RBN@BHT=],R9R1;2+^.-EV@KGP<[3WHJ:_A0K)AJ(D$*9NR>G3K) MSCP_K3P'H!G<"^LZ*RD@(#'E#"/<"BRVZ@55.K:^US3$ZT;#?>IK !4,8ZO) M4/BQ(\(?0ZJE2KG,U.1CRS2U]PB\.WYNAAT&NM8ZZ&RB@8+P0^#>H;LG=+@? M*(5YRSMAAYM7,V\%$>&:P$]$RC47*[T+THV&.$R@\LL-J(B1U3T.*F!P^[:M MC34C030?)@3Y10#TT]$W@%$3*.??: W-JK13?1,(HOPPQ1J\*)_://EGP6B$ MG#T]Q7H,\%@D]>P#/ZQ/.O"KT6F&*7S]$1@J@2I2&"T/JKM-%6]*C.C7V3.S"_U2&Y&C.:.($@$ M69,6'Y^:?VFW459T DKK8-2]*SXDSIO8\>&T_WH>M8&*76R[849U;V:P"0UA MBMCAT9(I+B8S)&4F&SK8WM]1Y&6#-OC7.F7PJ]&UC+Q!S.+*WP%BAZ+M%:(C M>M[>%6&O9S2^=^T)&"!4"4,*Q2&:;8J*Z'9[?T(8W5(;F#9*-AH,HBR19)Q$ M^=/72$:*6.TQL3:@AS"[F.#I/!HX"%<4_H 7\:3SXO+.Q:-M;@Q#-% 2@E.. MCX8*A#]+9 B1%#DCX8FDMH\[8-1H3JFJC&'7A]2_/\OR1>EVO1_/I:.JX%J/ MM"I9JZH [4 B=&O*E+V7KY>%H?_MOP%02P,$% @ '8D*31P5.*"Z/P M[94# !X !C:6LP,# Q-C0R,SS]AS.4&1E(-G:9$KT?:>=9QP@$!U$V,TT ;0E.B- M_>];%P -H.YH=&6U'V9,D96%S,HOLVY9F7__MT_K##WALDJ+_!^?G;T\_0SA M/"Z2-%_]X[-MO3SYZV?_]L__^E_^_M].3K[#.2ZC&B?HX1E=1G5T7T;QKU5+ MC5Z_/$7D/V>G)^?;U;:J3[X\/?LK^OGTK]_^^>S;K\[^$_W?\^__'[KZ<(]. MT,>/'U\FI(N:=?$R+M8G)_0S69K_^A!5&!&V\NH?GSW6]>;;5Z]H\T\/9?:R M*%>OOCP]??VJ;?@9;_GMIRH=M/[XNFU[]NI_?W_S(7[$Z^@DS:LZRN,=%>U& M1G?VS3??O&)_)4VK]-N*T=\4<52S@3+RA90MZ+].VF8G]%O#Y[^:E* M/J-C4!89?H^7B'W^V_IY@__Q696N-QEEF_WNL<1+.0]96;ZB]*]RO**JHOU_ M0_L_^YKV_Z?FUS?1 \X^0[3E#^^OE>)\,^BK(7KEB<<[7*9%GC>^.SMNX$O>(IXUKCW).;FN14^?! M'(QB1G^^(=\?<(8_U3A/<-+R1BDUGI-US#PNZ[*(!YUEU/46Y5#../WUE#CX MK[_Z\O5?_LRFF].O7Y\RD09_^N6RB+=KG-?G.7$)=5H_7^?+HEPS9W[^4-%9 MJ&Z[9L*P#_XRI9/=@ SX+W%5;,L8.PT&'^(A6]'#)+;(?$>ZH),ZSD]^^/#9 M/ULR1.@0)T0]2O1S2_N??^>,='*=ET/51&7<,DE^- C6M'@5%V0:WM0G QF7 M9;&>/O(-3\7T09I1=TGS0?:%L'1H8UE4N(I(QR2KC"\K#6(?=@,=VL)-F-M MBXD6$LNH>F!,;ZN3511M."YP5E?M;\8 :7[]"UG:U)BR%\C!?6!!5+Q!H10R3-0(!B/>PM6JS'W!]D^AQ<%NLH%1QJ M3U!98X\@D?)J0@=O"(H/]1B/@:$>8)\3"UEMXFL"4)G;,)/ 33!]ONTF&4J! M&$E(,XTP_H;91AC\@X/EGO1K =OXAD,#5]*Y=._0RNZ/W8RQ?8'[F"*/"=? M2NC7WF;12J')41M/JAQS-M9E]W=$&T I4SI^?6U*!^_@=MF=S%V2!8;!0$=M M/5OJF%.ER?*&9 >6T'-Q<.N5CK#,C*7#>W O$VK.,K^ T?E6_(;TP0NM/8, M I%;)0QX4T3;(M88&@B*D99!03',GL# @6@/AT%[$$ ,.39!HG$0 8%",N)J M6$B&^V# X,=8[_$JI4=7>?TN6JMF"7E33W!0\#E&0G,JMVN':$,H#.@&MZ]^ MW<@>6/,7!'5EE%WG"?[T/_&S5O5"6Z^Z%SE5*+]IB%A+1)K"JE\QPJ+^%<-[ M, !<;,MR,!7I%XGJYIY@H.%7./'A30=+!.CEHFFX^X PC?6!G<+;-,/E!?G> MJBCU+F'4TJM#&'.I< >L&6K;P?H"Z<"*GD ZJH>>"(KUNLC9,>.'QXAH['9; MT^@=&IJDGQ6TA'ZG"+T,JOF"4?'#X07BA*A'"3Q]6.A%,I=8* 7@$NIV^3;- MHSQ.R2*WJ%)#/( ;.<35E%Z>,=XZ,GH7T1&BEA(X!F"*LI2W6!:: H"?ZGI< MU1 "4JHK\1UX ._!]2.J1 /TW;=P>Z+3O7!UXE?_-YH;JQX&;F"OJ5;BN+&:<<4./0!!X%&X[6 /-9+$WBT^X?"BZ4,A].86$IUSA8VC* MM>T;ELV>SQJ=0GOO(!4YEB-@@=K]>"B@-7/> MYPG]S]5OV_0IR@@[U7E]$97E,]F"_!AE6]U"S)+>9Z"1I40"C@@!(OLNQ'[H MD2Y05*.6&C%R*)O81[;9>=X(+S)FY_M-E-%7250!#WB5YCG5 -F2\4\?2*+= MVYA#RH,)TI22> UP<_$ 0LR;B_E[G*?CN-@21M[C&!.FR)[F':X;7ZN;KK5D M/F=M/?_"Y-TT1[OV"T0HNND<; Z?*$?9M0>=SRU0)$SK%A#R9P?7^1/Y;E$^ M$R8TN!\V\XCS$7]C/'1_9FB& K$EDRD6%I][9A!]VI,,C6/[D4'1 MG[W,!3M/5J0BN,Q"IIVJ&D(/C.X\HUY0]#]G18=8R!K MH0%T8F%[4@%W0F$^F8#QL28FV4MO%(=Y%&%U! 'M;,DNXK9^Q"5GZAT1T]'[ MJCL <\<:F0S^F1U$,%K4XG]''H;/=A#N$F_HU6) SMN$-KTW-T'-IPT5&US6 MSW=DO-DC:;()W]"[&_V"7T_FU5ZT_(M6PILO$"-@5M*1'&:3D.!EFK-K\>^V M:=+DR)E9'"8'WLF1'T .JVEN=G4L$)L980W?;"*BN9OMP^NRDUK*)M5_2[5/[YNTN@AS(F7 MF'PZ>4^^?D'^FUJ$"&EH/)J8CG/Q\)VW1;0QXJW!C<=%@-;XVRM@9BI)*Y5, M"I]&8@31V"2,"/*Y LMQ=;NTQ;Z\N==5EY1?<;V58QI;&0C6';F.63O8Q94: M%N*R2HT)CYY\B^^+V^4RC<:; MZ:6LM+7?T%0)MY(XU.9@I*\X[__]]"6!$MTX MH"=*\S=T=KH@Z*+_0Q5/'Q5MZ\>B3'\7A?,5D&/5X)9@D+,@XRNZB-+G.+Z)-2G:'/<9T-X$6Q#XO &UD M$4[Y.R)$J5":HX9N,CPD]_Q&Z8%2E+R1^(YR(_%QYS]BH48 MD0992OP.*[-7/V*$>6[ECX]I_(C(XI\L\NLR?=C6+"RI+E@CLK,@[5ZB>_)S MM*8A/1TYP4*Q3N.FG\\K*0HUG2+,'H<0ANI!Y])N.)=I18>->,:N,[(QX5(^ MIANR=*PQT7M-UY#5]J%*DS0JGX4N\J+6L?4B)R O\II (J-[G[;7!5JG.=E( MD:[:7WU!!X;TN),$KS=%V?LH'7K2H"K6N$[7I$5,!*!WFKA<1SD;!=;PY91Z MM(>/=;>[%U20!A3;KK\S[,6T'VJQY'IY:"L%=R?92)90Y@-7F+G&L ,D+'XL MROJ>&.\E?F!%_TR%>N7M?:8M5G L7"C0=B?$KZT1;;E@91=#J-.K&W$AA;%N MN %18BS2JZ2 1(JR7*\"*P%4[36,O!$OT^KWSGVE=!>5-%2([A+9L>0=+EF- M".M;)G4'8!=/&IF,=U&$ED>VL0,!1DXKR/%*(.%D,"HR\.LEY M=XM@#4*1$ Q\$AF,H&O*S)P'>$^H4HD>8"I]@-P>3G!Q5M0P=XP.SFUX[1BL M9W-0E>92+1R?)I1;LG)H6BH8J%FX,FFYK##\F(4:-' *RH-Q9GC @ N$6@I( M^'1,2GCO,Q&KJV;1[K$*H?3A,@ MA((#1M",(6Y$C,^PS H3<6EUJ$O\A+."Y<]M^-* WD#G-1A3+X$8A\G;-T'Q M'45K"W"1EWO(D>PH8",O+= D!EU:0,GC;3!F@42$F^^C\E?<,U/=A;"&R.>= ML(YWX5J8-V;XZ9KO*L^ +L+=!(FR)I)FW38&O=0V DBXUS:BQ^,J'.=D8IG9CH"R&S#1@I?:[6C5((*V1.P?/8#6@",8G]1(H&-*!; #N "=L" M.W0!;A5LM "" ^0GH#=EVVT"XWQH"Q -N MU3!N#J=?T(8'>U3EAF4MY_37S>, WK[(PT"RB XEED5H^$/SNR(OAGRT5:#, M)S@6M!Z1;B/)&#U]F@[Z#=D7 1SN3)&)UU5KO?JWD,9@#:ZQ:5@CRVN9(O8: MQKR@%UKZ+3XTXE)2C8<_'P(^MW'@%,LY]7LY*M6^I#B03/4!N/,I;CP,]^WJ MMN<#]#><\QRO:&C?OFMG+^T?]V^CM&2QE^?)O[85RUMW MN_PI*LLHUU91,M!YQ+])@C%Z:/LFE'9'0>_46QHHQSY)$);7AW+_L6F(3HA- MU 1,9$%/?T\,).7+>Y30][WS[TEHYC4OLJ%UD:3+-&;20!J\E=&,C=[*8CQ. M>+BVVH>/VOF[;G0^>K9]QYYL@V[&;83(R)_ -DH3^?,ZO\J@ M*LRI,IQ"/8JZ3)_2!.[G@(X M4YA%[+Y(;09[XJD^X)*^SC]OHQ/I/][0/,B$MYI5@-T,LUB"'D],![O^"9H+ MTF=-B#1D@U:6P72-<;N\Q'B-DY8OBZNNR R684$456_W19$@I7Q\NBY)5 M41OI&"BMCL+IC1X&7*\WDU8)BF[@UPUV9A*T):"H MS/T5I1O>)]T7O$5>3/NA-5*6QQO*<>X+:-5M) M:;&O;KNA;K7_B*^K(\7Z"F"'/5E@NL<5TK[%339M^K2OZ2.8?; ]@+4[97OT M^C/4-AMJFPZ L4&C==-L6VM?4QLI/1JB68HQ#KM$O5V*A\:P>.@XIP.."G27 MJK.N#9&J;U'H?_SIKU^>G?T-/70R)KP72".S!-_8J"R1Y\^(?L+IZI%\^9PH M-EKA=UN:.?1VR9CKO5*VMZVI'7HTNXD1@IE MG?,/0-0,0-]PJT'QAR"M>#_TCXU[/^C[?%SUA/.M-C)XU\3KDZF.+_%5$?\3 MW"LH$VNP[YN&"A6?,@VUZ?'54KN;(V8@)%ZUN.*PI/?YELE2(K'46GL806<' M2=VU0-)4.&E,>#'DHBX %')&R YF4^3LML"0=U=/!X$ZA03"'H%#:M$C: MPJ3EZCC5Y>)"/_-FH)!0#J\FZ=9P;,'+LAEA8:"#+\:FA,NH#MO)K@Y;$."Q M4HAEV3(H4(V+01G1I"( K$RFQ(]8C4P%&W\[/TO6)573@L"\'B^F4F-0**>I M]*]SLF%@D0&&=;JLL4=T2WD5;G%)([1K%Y<:P0!.K5_SB5,&G3V.3 G5L7%*4^CYV^R%/:Y?D^$)[[\=O(L>* M(SC:4)L%WZ>9V?(NF!MZD;;A 3.^)'HB/R?1,&[$3W-L-RSSTGE8AK=(:-RG![YC"W^.X6.6I M[/7 X.S/$P=>CV=]C:KN@5I=H-&Y+]J=^S8%/$X>* >HS\*BN55HN%B@CH\V M\3[BG* >*S#OTN'&>?C"_0E7=?NT#Q4;\&Q@9BGC> >(]-,YAT23I:'M! M73>^;PSFE9B2LD4',?LVJI(-0AM(V6:[P$TG((Y@!DS+WR'" =KM->*^:F[" M+E+VV(GJNG[$.W^?XX^-UE,._81#GS;BBUT452A"1,YM5@_RN[2P<'^]N*\+ MXZ'/L_DP97>A.#&UO"Y>K D8/Q(W9B^SNQ^#WF;- 7(GI^8#X;-X-7NM[QY" M@+@P?WO69C",!3PG]!78/G(LZ1X[PJ8K14700SNX.86>)[E::%LV*:BG;+ZD MB 9Y?7 158]OL^*C35XE/1G,6P,9_]HG!I0 ,8KP'A8HE:%Y3Z#4A,?@[T\T M$^V @1 800,9['"T0)0HB/@!.ZW8H$I4B==<)=0OWI4%S:&2O'G^@:R6K_.N M\L%Y7*=/9&*V*A@YI3._&4O<995E&6 S8]L->GA&+VA/9('Z!=K5Z=CU%D!* MP5E$E\D&G*9D(G8EF4HF A=H+TGO%O(XS? @Q\I],9\M'^9S4#O2^<;+L&GM M/H3$[$8TI]'1>0Z882R[8DAC52[?9[9 M0GU&Y6^(LE-VMD%KX*V+LDY_EQXR#L+)-51>8_-UW(OA^;O6"[*>W60\3R0K MS=@C7:!W1;XIBV0;\W^"9F*:+B,OT-AK#_L"P0@T\1&"$65@Y8WHQD%C(-+6 M<&6.&FY-I8X6;),72,$C!<\T7^R633_#XD!=0 M6:0^:@RED?J0\7C@*@VVT1VU*@A\'K*J>!:.5Q5Q;# A:?9LT\NWANU8P[;7 MLV M3H138"U(Y@UIH)]Z&']*\6Y$=O"[7W?^0QI@ .S8_3"OAJ^?\0H6JU*EMZ;+H&;M/$Y&7JR M(UL@S**V9!AH"\WQFKG1 !'/J.Y]%RBH@6PO6>K[RR8%?F]#V5S:6APON73B M==GJ()NXFFUJ KQHR;^@:\'=P4Z7R 3\5&R;\(0(<',%6%:UY3)TNC MAS2#/XQQ!ZJX)'9%:1!F>,YTL9\5COL(PP@%R9QMD/<0M@D:I7S1$G^Q*T1" MI#P)U-KD>'0P-CD8(6WM/([IG%Z]QS%.G^@NW\G,9.2@%B:5Q]*X6EJT(X8J ME#)1L$Z"4BD!K"FIX6:V(C76( WH.G\BR_&"%J!SLIP!':C)#"6PM)4>T>S' M^ON:BDF@[J]AV88$26:CD, (TAKN2KR)TN2R*6O4',%VU0G9].=D)G8=@MJ/ MIQ"[O9 M;8/WVXI).PIC/R:7T7E3UNLF[)V9J[Q)7]Y0MV<:H#KLT30H#6&C=L?O8NDU M/K_ [?$[:>NF[S"(S9Q!9M?M7=,=#U=I;L%[/0*'J&$QQY@M6GWD](85GT<#SU4AN<.3G#K MHR=4U5Q/L+2=P5NC7E9'J^PZ"^LAQ2RBRV0+T#(ML&MIH1; ]6>I9$'<9BN( M?]NF)2;<$@]2/]\1)=5DG4QS,6UH$XV%NG3BT3*=9!O#LB5F:3LX.6KI%XCU ML&"+N:X3X./8_:0E3#W2]7>Q1)N&CDF'6R)(DW0'Z=@4W1$*:(+7>4UTD])] MJNF6Q((6TN DDMC8V8ZLN>D(QJ9L!.J9$GU0D64XKK=1UME54):DPIK1@%1 M"W&1./92#K9X:2=7T%L\#3ZG+R"#L;ZW:1[E\4Q;/&UG M\-:HE]71*KO.CF*+YR:Z3+8 +=,"NY86:@%T4>E"SUBQ5)VL? KY- O2!3OKC M2;VEW$/!7 H>'=ZER(%9L;2ITF^7=V5SL&I_G"?\%)G]DO[%(@["''>OG9,MYJDB MP3.F3(6GSMALL!GB ?8L!]>!'EC/R'7D^+MDBL+*X>_E)I1O%!L_'L UNA)/4>F W34&!'*?SH6HYS#& $2RFXWFXQ5@(JRM@+4=;XLRC5/ZVQ1S,NV!Y\I M9ZVE$G)/]BAW);Y0CSB .6\F\9*TBK.BVI;\FH$*NZ3"IKNN0*=$1VP*66W= M@.D_53FMY$>2$XU+KN9T_($8;^N/6]:]AP'*31IGZQN"UMF[,+&Z09'&JZZZSJ !=E&&Z*/*J MR-*D+=%T1S3=9OF_7396%V5=%6B;]Q4S]>_13.8:$:'@9Z_?!1KTW,9#=7U3 M@'>]HUWW@=0.GQ4T8WN8%3%'8DB[Z>L>?ZK?9/J8POD_=2SF)1^G@UA:?T5) M/X;8UX[7[#00F]4"-?CR6-Z7)UTC2\0[PGQL6:170^2SU*Z.=T5Z/;H?:%L' M,D>852"48#6.O\>U?+K*TV4:TQ0- ELV/MJV Y_K?UN9A)W!CA!) 1>(?W13 MFK .=]*8/RB^V5;T341U4:P?B+MEQ:HLO)F>S"/L#/R/P=8V1_WV@?@T&U6, M866C!U PN:T];3N !9C=.E$&M1#7?6Y*LP!@$&NTMFC$L]/QN);*ZW60CGM5 MN8]GNX-JOU*H;'1A 29 IZ1,SF;A MFBQH_;Z",4HB>?[2SS(X3#(8B+^RUI#D/8B=>@) FYLO<^LF! S:^3H]' /T M?U/T:0W3(/SC=T61?$RSC# V3L/GM(QS[,BRS!9447MO4SS=!G\VS(0.@[C$XG@S2PKB'X''$2EBDR$$=H MIQ1IV)I1(]#02PXG37T]/3\^^_NK+UW_Y M,X/&Z=>O3QDP!G_ZY4U4I17+;]K%0!/?]T.%;Y=759VN(YIMGD8,/O/_U\%G MMIX]@&R^41!"L&A?Z'8YC,DGW2'2'_U]UR,/-WU&/S?_!4;LS,!H<1TB*I(B MWJ[;[WM%1V_Q5"QIU?@V]'C#,4 ?KS\P!/$DRSL$T878EB>+Q>U77_9Q$L25 MZ?C??$2F79NJ^@KCZE0IJ=OUZ4+VJ[ OA.E)?41MR6Q MV4U11=GM\J;(5S?I$T[ZS%E=N$[JSN<-[#1YA2O9KAM$'%G;$:M%0;HZ87T% MCO)]-"_+W^.X6.4I7?/80]""UNO]KED2\5:7T: >4:C@LU:4>)%K MJ26?H*LP$9\FJ+PDW&4%"TR\^K3!>86-BU8+OSC('?!H)-0<3I5OV(! MCFG*]8=DLM^/5JN2ELADB66:Q>\]+=QK U]+>H^8M95(UFYV=& M&PHVG30V!J23NCR>[<2/.-EF^'9Y3DPE2;-MG3[A#SC>EBS+),]9C1-:4HHN M/[9M'J3QS&!U$'2 C_D\-3K$6 E'3,U'J!GT/X-VWT'MAWC-MMZG*)&X)@G, MC X'.>$@ZV!X@S#0YECD=YQ<)V0>2Y=I>T)\'O^V34ORKSRY2:.'-&/2D;]M MUSBQGE!F_Q*(:4_ MC1!CLN*'DV7QEA;+Z-7,<,DG9-T30&(A>RF5&89Z72SHY@.Q7H:%8H*RA(D: M5B4?V59Y_L(PBG*7U0UMWB>(VW27 M7.='E>_P%JCMDL8 \4X#P_;>:%#[W(E0 +$$NO5]$U7TEFEW\<0$N-WP! "\ M&LGSA(7#],YA;&/Z6 A&0KLZ>:!]H7YG"VXRJ.EOT1;[>0[7./8$B,9*]D0' MV/N9>_*]\T^IKHR]D@+N[4R/:]/+&43;HI]IZY#>S8S'W?!J9CSHH'BY+-91 M*CPST,O:TL!BIN/<$C6\?6BX&8Z_!7*&@S\9.U59]W!#_C7&#/D572PGV[B^ M+3_@\BF-5;,1(E113N/*^8QAV-L-7\'18YV-,=K8>E0>BPXR+;^UWF"/^'DOF 5 M1-M3-(N-MQVYS\* =O((Q?X8&6KH4%WP$K;EYU5SS+H(99/NHC"A))^#ML*! MH'$O;]M!0#!4+MRM@1C OM]-<:Y@G.E$P/WAQ7J3%<\8]TY&C?.AAL;G8PL- MY\(SBZ;MX( \B%G3./["@PK3X/LM(U2Q=&86LL>>200*OLD)!O%$H\Y]Z MB&4U@>3C"P6(BZC&JZ)LBN(:O8H-,1A@%+*H 01[_.2N$#V<=-KP^7R5,%76 M-'?+)7ZH=V'81FP9*;T^5S5)(3Y3[2@0)>E'\H*$3:66)U7F#KP?3UG()$=4U3SXZ(B:Y5$XYU"VZI(?/MGJRF.- M]?U>D9ROZ7M$C9^;J7^?E=MG&A&AR/L\+Y\6B'\!M"K\G* 1"LC/B1A_AO0V MS=,:LQQ7XX1N;YZ_C_Y5E!=95%6&/8E3+QZ-PDVZ,?0Y=9,*32QA]?",6!>( M]1' 'F>"+L99W8'#0!_WJ\:QR#*-GN_:!=_4>4#3S L<&0M!6:#5WF$G![4$[ M.RA O0AG*K!5CAU"9W3V5A&"[\E@ZV)#>W_W% '8YTC(*$C_!ASU*8Q8/YY/ M&"X/VE,>80DM?&I0>0C5Z! X2E,RP8Z+UC1_[N_-U#1>&.JWDH=H*DH# MQ)05L:@G%["!+(1' ZM*85\[+3@A880F-)[/*1M&1!K#RM%60#,:EV#A8Y?IW'$V+$>U2@ MT>!][K5QWZ1A0-=J6@68 [F%T??OBLB>_2'-V81Z4>15FN"29\6AU;OY11^/ MK2.3+298J"L6<4MOT>@9>P&XV^8V)3R'?[E(6-E^?SYU\PP4O2"R9B$4IO3DWY^6-U;>KQ].7@FGS ;4A;CXD_A)^S'^"FMDZ%RJ[9 M'\;Y&/%_O>T?JZOHCYLFW=9_\(W@RW?@I!3U6AR68 MUR$]E&!;Q^F2!H[VKL2;*$V:ZJZD_6W]B$MCE X0/T?JTEQ&'&@YUW#5EC5F MA(PQ1>32,7K&?=30CD\$'L<%Z@J\+0!M_,!QNE]E!0A/[E;S_2-UK[H1]>1. M1\5+%L/J)7\$Y^DRR&U;-@I8-0K'ZC2-!GQ()VFTWN-TBKO 8E^KSL$7C]3Q M#4?-DZM3O'7]0ZP0]0/:"^?_8RT#)=9WV'VT8'J@$>%56Z.PJ4OM%A,N4L-& MA4ND<:U3V5!"ARZY"4799R4F48YK5/)V09BH!=0LHMM5. O#=-[A^CJ/BS6^ M*2K'USBJ/@(QH[%DKL9$Z!'O +V@77P1HEF9A!P:5T8:H:BNR_1A6[/50UV@ MN DS MG?0!6&.>-B9V)CYZP=,^X"G*[OW. O$/L(*M[!.!&<<>D+$PF3WP$I AC=F^ MQ%5WR3Z+$#F??3Q^X@83QIE%=DKW2[?XPJ73]K#?1MBSTGTC;(HXZL6 MB)"ACF[!3@'(.J.EA=I=3)**BK)N&T/7!+##EZPF@!VX *R%WJA4CSCYKB@2 M6ESNIZ+\]9IN:6(R*SF;CTMO$/;D)*W&P-I^$.N(W5?1KE":HZ8SP>H6B#V6 M S>^O8:@DWM%J8,P1W< *^W3';W^#%9Y]_[&I@*?%;5'@[231A7:T02Z#.-< M@JF]YZ"I,1(=U!0 \BA+QD165M0A(&\@S23D!9#1RD%7UM@3%>6QZN-RF<:X M8\58L$C1WF=-1P7'0@E'UFX'HB J$FF'6RC-J!MKG]6M:!IJ7-J#1$GAM9J5 MBFM)3B36,C"H&(9=+%JE'7./'H6&;\KB M";,"C48ST5)YM! ]]T*&J;8UZCZL=YM#A3CL61 '&_7VXS&_%_B38GCE(69DY\SS-([YTD_ M&_V4=W3S?<)G&8+YQD62RJ3M&O7[IO?]3>\,\_W^38_=%N@-7J4Y#<-";R+2 M()XQD-SM:<@!1^Z&1E%$O>%+>A]@ Q+U>@:M^S"S60D5(F:V*8^+HB@M?XRR M+:V415^M6-7=5-/X7!)I.!=LG#8(IV*F:E#J3Q.,VX8?3G,93,/]DD(M,X_;EJP M!W 9<&C(**WE0'@)8+]AW+8:*4/8<2@WL-HM1Q#[6$O-6&\WH':T-+PSRW!< M;Z.L9^2=\M=XV[Q'@24S"H0 T5,X^\/0!]HC0P>''RYI;[U M#I=ID?0CYM\6Y0?B9]-8&[OEVI%'H#G+. 8?ZZ -*>==(-['HGEUL6C_NBQ* MU/8$BATC=9I2/:(W?L3)-L,THHKMWNXB8DLLHWH4L]>.;YX'?S%4'IK8 MGT\L3Y18@'33#P\MY-M_1H#Z?2W0P_/HSS^S'D$][EY:%R"^C\I]3O3TJ>Z' MFO!!UQLW]$NIL6ZDELKK5*_C7ISKV4OSKCEJVP>P][?0@SC=&Y4 CB/C)MY M!X\EY79:@Z8 -M=6^K!$%-0V]SZMJ?^\SI/T*4W(HM;@E13M/6)(Q;$0&4+; M\2K(;O FS3'U\3AZCR;F=0C&"WDD*)/MA- M/U,RQ.A 06BKG#'J;#7C,>"8GDS?+G^*2L).?5N^3U>/M6F#JB/R&7:LXUV( M/&8W&602;9K31_F,((2]I%D+0@BR407 &+)Q5"9":"SIG)0&3X$X*3NU6 $+ MT$&UR8=P0J/N,7&9;-M*N5MA_IILU^0N>J:_.O\8E:!^H_QW4^Q ]L^NW:SZ&V-<6J/G> O6^ MR!X?A[,XX!GP=EM7 M=40V&/G*=0XGIV=??_7EZ[_\F=GYZ=>O3YF5#_[T M2_.UZCOZ_]+4@H;V'NS9Q/$8'VT+U#3Q_6S.E5\=GA4B^,"S%5!:$/M#25+$ M6SIM1K)"$AZO4#]BQ!W=R[Z" M#F*@%]2M99F#B?8HP(RTS[723+M&OA?*[CSK3/5M42XQ>Y8%LMJUA(W>8 ^# MF6DFJ].#B]'&;3\09GOU"9=Q6CF8;8\"S&S[7"O-MFL4AMGJ>-:9K5(,.*,5 M0*,WVL,@9IK1ZK3@8K2X[6<&HPWCZ*ZWDN<#<<"#.\FWCNC83C92ASRTZWVO MS?T-N@#@0]PK]N<0#@<.YD7F/HE4NI#C\;ALS]>=HYKR$1SD M:T?D=>6C=4B_R[^XNR=I$B?,[HIJLO0SYCCR,WR QSD>K&IN'Z0QJ>/Q0KUC M 0]7MM*O'9$7DH_6(;U0[XN'N++UZ8/L!@_XG,J#72T3V>AO"Y4R7K8N [^'7@7,56C ?SRJB87U7@>N@85_" MMXYH!2$;*0^NH5\Y#BI/JX^A^_=MCM'KTP6B0%^TY[24Y)@7$TKSFC_ 2V%; M_EQ1D_R%'0,&K[%^YZN*6)M0RE 81K[,=Q, P^+&N.[,AT1 M,'*4K\54V G@M9A9!S;X@7H#-N;EKDQC_&-!'ZEEJ46*'4MZ0%RI)#)"C.;. MI"4G=K1!I.%QTI@)>EIUP:'P?5K]^K;$N"WJ^3ZJL3,4=9T XE$KFP4H*3VB M'>QJP-(N@L2F68\F@)J5Z'&[2':PN#J_(UWBLL0)V\4:8:FE\KF%TW(O;,98 M:W2.NO:()X<* 686BA"V"&8M^ ;2FTE 4E!Y!Y**>P60W@0,)*TBY$#2:N$@ M,8N*S:"N,5BDHF(#V 4IPFWYS&.KC^ISW>8YJUFY>],W!U.UV4S;@'LUF MC/4*A]J7?=@^5&F21N7SAXAF$6%NQG @I*'Q.3UH.!H :LW\#"+'"DKQM6-E@H: M0Y^2[1J1?X.#R% M=/81=CQ\KND"D3Z"6-U.T*5E:)A.D2%A]?YC,0-6>[T$A=6^=%.Q2OHX$JP* MNG3'JJ#(H+!*/C>'9QWT$Q9>!Q).1BSMY5@P*^IT FI%A?K#[25-OH[SQ%0K M=M3.(^[&'(YQU?T]@/6^=#3'B) .)8#&C:M^H26$UI4K_Y[> UC[*T95J7NH M]7_+P"6.,^*8$N.$I"( P(+ LPH2J&T9Q#2B'W(50N3C[0\H?(8R/[,8M?,( MBS&'0OUD^O=0'E%(AU,H/R\;2_ U[.Z=4*5Z*+1C/$]H35QZ*6N^5#_(Y^!7 MQ/N.E_#R];?V8>RR21J-9EKBL"'1Y4=TT7]TN)?Q5 M%."5_$_F"FJS?L9G>;5YQ\<&S6'L,@X!#*$NVP%0X3/C2%,,\T.,\ZA,"U-0 MJ+R]U[PAT@BYDN-"/LLT0X__H/>;7!<;I,<6)>H:IIO);Z M5G.N LD"]5H'X;J,XR\6Y#8,OL>(O6;Y:/ EPV8^(_2&_ F1>>1?B/X] -"]Q%9?I1E:'0/7P3M,!U/M% MG4R*%XV]%3Q\;'6E??7H1U&3:EFX*.S^$:-DUX*&4N.=[A*JNUW9 M"Z "%MW#XCQAX=#]%._C7!B:I9I;-QX7_%X-*T,("5(@EX%3 ME#E>)$[1I.<;M(JG]62Y@^YPR7YGN@:3T_B^RU)P+HWDJA!OW*:!(NUYZDGP MFRG=^$NOEW2##_QVI\W^RGCK_E@U?ZW.-+B:V!_T>Q\+B1T*X+:]-2#=M:FZ M1J )Q?=2NM4#(EN-'R1=QT^8?@0GYT^XC%;X/:8[>^*I;]*ES"5.Z00LM8=! M-N54W=*AAA!UE(B2!K-&ME*>/CN(-\U-J_OFJ,'W>$-X8W>!72VXCZTRHT:9 M9:?,C/1R^%J-UWE=IGF5QC]&V=;>IL9D8%8D\*^TFZXE8DW#L1.Y"O26<<#Q MGV8+1CW(T)]V*GFB5)!%#MGT9EIE-XU\+ZM;WJ3K:+XR 5\T#\9/NDH>#%X@ M)43>X8_L3_H;?KL.0BD5TI=)0 P[L.>4B)-V= K93CI#:GZAB" MSL#!R'SF'E@0<6B!NOW16?MRQ1F!DA[ M02B3RAJ'U>Y4=-&]20H/BTK-V<%1J3;/6X '\N,WMDB\S M3)N)V3_G>ULR_W@=LF05_V1;K8HELF2?!=\Y'0AVTCW8@3#G\?DI?J@OBOP) MEQ5AZK9,5VD>9?2WY^MBF]>Z"PT+6I^/4BTD$=ZGDK^B'1%!=T.&Z%\6B%." MOE6UU8_P;-56.1XOU(KUNLB'4Y71M>N(?%Z-Z7@7 [5HXR::KVN^",!!FE4@ MW&$9QS^@]["JIX=OH[1D>\1SLD%<<_\KJ]1B6F(<]MLAO92=820/L/B@7^>G M&:CW?66-(?"EB ^LSE9S_=$#5DD%D_I+SKTP#MAB74%OP_X20 M^DFG"V6*,(TBCNUD]3KG%V>=R]>YS,-]\NA.6*7C=OA35I3FW67N;A4$OKXY M( P/<]JJQN 1;&8&DISG2;LTNR_HKWK/+OB9\B%V-,XL',.VQGUH3S;3F-R7=TNV<^'<"S#_H_!28Q&Y &S[Y HS'8 MOX_29&6PFY&<;?9/U=&6]-4[BH>-^9BL:3$89+*:C^>$]!WEW6OX MJ?*+1W0^JAZU0^YJNJ_^L>)0#1"<^W#4@#]_IGNUWF3%,\8\S3&6+_(Z;ID( MU7U11UG_[Q=%5;\KZO_ ]7L<%ZL\_7V8>$YCR)Z^[]&L?8VH4".A^2YJ/HQ4 M5M^S86[=U6+H%[3BV&>1$A#]PK8L=E[1>L1'#.4$8))0:I M5PYXTFG-P3$<63B/ZB'G^\%!I9"X99A<"'P!X _#9QSK!>;P8' M<^H?Z,K/B,0#SIK05W;#T[F+:).293_?U;_'%=DOX.1M4;[=UML2MZ?2VEN' M*=V!Y0JPEM>8.*#IJ3W<;?M"RZ)$O+?NWB*<- )NZM;G%'#3];RU(9K#J#8C M&IL;I5DL+.G\5X-02B"4@>"'E[>]=*A-8_BT>@8]**H^>%""6V(]>V70/.PU M/2=!>7>FW*78PYP,)3S%4DW:;MA2[7"I)<>%6C MV;I -=4L;CO;*\MEA>.7J^+I5D"ZW7S,[7(U[VE%?_M+]?L/W1 =HY$ M?ZIH2^C![JQE&&MG1]&9VCB7-X2!N>FD-2DWA8 @JE\TQ U20TI83(VDL #5 MN%A-8*"2J<4"53*=>,Z1R;>HM*(;C3?-*^UQC(+ =Q9,&<_RM)=D-_9#GM;- MF09BQ?8:&O!4E\J1E^:V5 Z[S_>J59P5M'#+/9ECWY O_7K^4-5E%.L"$[54 M7E^KZK@7'ZNVK1%MCEA[]'-+ 5JDT4(/XE-5HQ+\X>BFJ*J+(J_)-@GG\?-E MM(Y6N/I0;%>/M>E$V(+6(Z9L)!DCB]*@'M$"-62(TRW@#UBM%32&F;5V/$YR MVX<*_[8ET^[5$_F_^^@ATTYQTN8^)S@YO\+TUC5#K!WZF;6$+1RM&6IA3M., M,Q@XE$5!#>WAX*$L"2KB [ PJ-5P&Q#BI2JLHFRXOCE@15A%&?%^/5BP.N(V M8VRJ!>M:5WR"RI7%PTT$@&I7%A/O*QZPFKC=6)N4[UY=G/)=C8];$ISR"8'\ M,)X'R*]^N<&K*+LB:Y;Z66'^TE8>U"_G3EA/TA:(-P$T=\U0MHK6C./!M,L_ MI31RL8DGO8[X$J*D&W4"&K%J]/K:E V=O]7;>YQ%-0VX*.OG^S+**[*;I>$6 M;Y[[?U$8]91./*[SG&03*X"Q)HBU ?0)TQ4U7@RZ:PD&ADI'HVL,!"NE\QG! M!] 'F8=8!Q0HOS3:N=RD.;ZN\5K[4%!) K>W[/-MWE[2UH@U#VF+*8R]89N).0 \>,# !X M !C:6LP,# Q-C0R,SO-1?)TM;9MN-/[M/[[/HS?/+,W")/[M[>"7@[=O6!PDTS">_?9V MD3^\.W[['__^7__+O_VW=^\^L9BE?LZF;^Y?WIS[N7^7^L%?V:KVF]$O!V_@ M?X.#=Z>+V2++WPT/!L=O_O?!\:^'@U_'@__SYO^>?OE_;RYN[]Z\>_/MV[=? MIM!$7C3Q2Y#,W[WCGXG"^*][/V-OH%MQ]MO;QSQ_^O7]>U[\^WT:_9*DL_?# M@X/1^U7!MV7)7[]GX5;I;Z-5V<'[__7E\VWPR.;^NS#.#X;O1X)?OV?0MET&: M1.R&/;PI/O]K_O+$?GN;A?.GB'>[^-UCRAY^>QN$?QT O*/QU[LO;RE]QWU]RR)IRS.V!1^R)(HG'(U^^A'G*O;1\;RS*S7.NWMK^_7 M?@H2?&1Y&/A1UT!JC?>*ZA8&+./:D$T>)D]\,H N=T$-UO!^T$P>;O,D^.LQ MB:8PE5W\O0 U[Q*4N/V],77F9X^74?*M:Z(J[7:%99+._#C\IZ ?9IR/BRR, M698UU36-YKKJ^>UB/O?3%Z ZG,7A PQ&F#.#(%G I!G/KD%^0<@,NZ_;9E<8 M_F!!GJ3/(5_-3P-0TRPT7S#01KKJY57\#/J7I,;BW*K856^NTP2T*7_AZR. M?>)CXRO+S7J&-M)5+RM$3!ZNXIQ%$="T\*/5E\WZJ]%<5SV_81&?=V"5RU]@ MOQEG?M!@(L!;Z6S\MUQ!^ETAYO,P+V9MT#"8SOGT ;M\XQ$D;:B[F?0^8W\O MX",7?+P:SYGUVON=X?N^??1_T@6K7<\PK6!("BJ1Y6LR:]%%3O M>65KTDM%4_W-P8TT%VUE;[O<]\4>UXSUMO?+]SR?+K?4PFZZ9) M$ UZA#0@PM1( 9M]H><5H)':J=K:3Y\-%4O9V'YZW4AU-)OL8>UMI!^B^CVO MOHWZJ6IK/WUNI!&:3>[MG-P&BW'C?9^AVX#1;;._O5VSG03>3.\]-=TA2-KI MO:_-5GYE:WNP:+0!8-!L7]:.=CLO>5M%GY]2EL$?B[/ 9^CB5N>A)(NG;+KJ M/F^VO9NP<.PFP=:7(NY*35)M.6W]R9-][O0^XU[E?-5TY-^SJ/B@9]Z(-SC^ M<'AXLI2=%@@NK0S$57A],Q;\,DN>WT]9^)[CX3\4P-X=#)8^W_\.OUKWI=*% MXM0I "$K7G;W6$#U:;K==3\-5FW#CSL\;[NLER7>/Q6^QG?!8QBM5>0A3>:M MI;OL66* <)%!CY,G_@>NVTD*L\YO;V%N!-0/+$W9]',I,Q15 :D0K"F]*W8? M_.R^:&^1O9OY_E-),8OR;/6;.M?+7WMK/]I9Y,/AO'00GGX/,P'ARCJE3#[0 ML*Y%UC:_^H#$) \=(;D*ZSR9^V$L87>W<"F%(QI:]3D2I=]"N@D1>A(,<#P96D;;+ $[<%@8Q M48=V$G4*W9]R")>1/T.8VBI3PAPZ1Y48A)BK(SNY6B&_9FF8P)YO>@XKAV)T M;94M8 _='69B,&(./]C-X668!7[TG\Q/+^$WJH6N5KJ$[MX85,$1,WGL I.E M:NIS62E?PA\YSJ8(D)C/$SOY+,_0-VP6\J-SG'_UY]CD*BI:@!X1G25:L"C% M@I@ #FQF\ QDD/K153QEW_\'>Y%26"M;XK;KF*_/(08&(7$_AAQC$L\6:;JU M1,CW.5CQ OVA>Y.J$@_"YGXL-@V'Y&48L?0,4,R25#X@MTJ6F(ELK:V'HQ@* M0I^EMIGEQ)+,YTE<&)IN'T%HV621\UM>_ J;?'J55"SD-W9VKM5!AG#=RF3S MONY=ZL_CI''%B\JF/WFX#&/H1PC[SJ1T^$N<4B;5O?5&G (7YI$2%_2&8TM, MURJ!*KP3&S0_?4X;\_^0R(@MH-&V[,T0JTS^]FY M=#@V95JN^-R(RW:A)1-9,;50=N:N(AW1YW22[80$# ML+ B?67Y4EJRD2VIYHV(3S.FE"O!=.3.HF5Z=07CI;@NCS);+>:-B$\NIDSN M=+XCQQ4M<]_+#Z<7W)V[%40].87F/RJ75E$L<15?.+(LV4[J;*(_*J=5X M;MWI?5=>K#S)_\FC^, 1YK71=.4RHQWE&OQN4!.%8QIS MN-5CA*?]!#EWM8E2[IZ\,;'UWM#F5/07H<;8RD2Y4?H<^O=A!#,XX]=$=V^] M:A@1=9OPAL3+IY&)V @5H@F.F9HJD/5-R'@E;T2\:!I1J-0"$3J$=\<,3ROS MVK7_PFUK("OX3;J ON^@U[ X:K3BC8EMS@I:Y59(78"([;A M_Z&&\1FMXXV)+<^-B)?#0:(N'#-V\261YT'69%A4W!L3&Z,;D8LB07@U-H,1 M#]\%NTLF#P]A ,O>)*TN@AKC6%G9&Q,;K9L-:#UH@..A7A=K_I:@%:% E*>V,B,TP[]E"W MEA ?PK5K 6";NR_*6*]:4>^0R/C2!\M"< C%CMG<3J?3L(1P[8?3J_C,?PIA M;U%!+#.Y*"M[AT3S>A]JH D740S'C'(W/.%AS*87?AK#7B8[#8+%?%$D*CTO M)291#'5E[Y#(X=*'8FC"111C;P:YEIO 51I2C'SC-CRJ6]M=ZD SU,@-&V.C MGH[9W8E]T#YUL7$&72W$Y)-QC7DEK>"7$<2%.2A4!($^KVP.Y5 MEBW,F"UK>">V6*$:L5H!09I=MP=&Y;D]=:IY@P-;C%&-R-V!TD?*76K[_%I$ M<##X,3X"3DZ$_R0>H!(I:AE=Q]*!H8C4U_' MV3H/[#+O%029VO<*$&[;X=L:^(8'MAPBQ>QHF_@*(*_$_M[0QC<\L,O(IS,F M:[UWV]I^PYY9O)!> 5@5 ;CVG>8+"L2$;??[5>3I/$NR?/+ \SP4$2LL?0X# MEMTFD?R AU4"R=AW=)15)-F\ 1Y ACR#[#FL*U%2I,5: M I8NGI)ZWG! ?,Q44(1M/,3BT$V$4_.,9V'*UN1"^"HRL[NA5;L=*$^ADVFSJ$;DJ#*&P)(3/;?M4A=)6LDY+- MKTF<;.-;I:)5;["5=4&J3C&M">AUI.B\BG,&I&CLL6LEO>'PP_& V$:L2968 M9PQ05SD]:8F]],.T"*HYG?YKD>7E19,__92_;2R;JJ7U2AD16[-:D:X'KZO< MH;0J@ JJR6Q>RH;8--V*>C6TUHE"3TK:8S;CL05WE"LZR[5V9EOE8$-CB]-/ M;Z7>[7Q7.3^)GT>H1,2>A\_AE,6%,;Y\%F ]<^G8/\T; XG;%RTNT8*F"*DS M@&HG'-@&R-.:,M[IR<,Y RE-5X@%2M"H'1A(Q--\4T:W]:,%^-990[<7 KOF MD5K0T]7\J=$,(FP&Q$>\.^Q&=YIC;YV8U K5V5I93Y_],.*!&W=))4ATF<3A MHY^%@>X&0]T2"-$I-VLC>%VE+J741-VX_:% M34LT0 M.5ZE-:0^4?[)P]@B83J$;_HQ]7?!T/I.' G8E6EQ?%9HU""*U)<94 M2T/:H.PQ-:HUH??+>,WM]$ATV7$:/;.B5=\;KV/['(C.'UL3MJ:6*>)4%P!Z M);'ZI1!@E_&4Q,5F5C->7U0/!&/+GJM"E()2'(C;1"EP<2ULB 8LNLA!>M%;)L+@"B()X$V5,K0S(JPC]Y^G9KF+8/2Z*.Y_RC=-N89"$ M+:=/Y6X)Z[W;:7.V47WUY^H<@U@5$ ?QUA>C2(?0.@ZW\^3X^2D:J$X78Z' 2>!70('X'AFG.X2^H[)S?8X29JL5I'TD0Z'PI382=J/L371_/HF M1#&(KN+Y'M6A@EW%:'KHPY[<%"MZ*=692R""[X6]A M96'.EIE2K@M<-RQ(9G'1HM0ML)<> '&VK -:VK=7L71V8X _B]9?$'B!K,RW M>KY(8326<(J[3*O[2Q??61J$F3#DJD5K("?[KH4(U*T\^7PFS7O?!+.)]IYHW/AH36DM- M ]V/;#D=HZ)4V$PK.!R/;^_&;WQDRWFU0HR1W_@(/8TZXU[LSFW\@7IGB7-D MZ#;^@&XS77$O7GSGZ5,68?98SE<I/677#40MQ^5[>@*V;$M1TB<)V0,XWC< M#GQO'0YR9(N51W^0UGKO=HC[5Y;S ]YUFO!$,M./+[]G;'H5KW/+G@9Y^!SF MH=;+!N:-P?)ERYBNT8H::1LA?!5Y\1N:X8^)8VR;?B/KPAQDM2" M\4P<:]P?Y6(54PJCJSL%5B45YV=HB88(2H,PB -@]ZT9J!"ZNHY _,B/,%I/ M:@P650"1$(?1[ELO9'+HZG)#WY&+',)]'0)R!U*TTVW3'$B*V+FW+XUI+Z6? M#Q](7P88'Q+//=UN=_7P=G6/H]D[YJ2;*PJ(L!=7;VP35-.@R!9 MP"P*JST+GQ7!2#K587TFCF@Q9%97/3"HK6]B6)%%?1?O5?P,PD[24/K^H;0> M"(@X;*(G7=C!^#I>8=@%>IVR)S^U(; M??"OXVD&B1@_A_Y]&.GZ!,P: E*(CS^];U%0U*_C9@B^^E[[+WSIY1;I($@7 M@&8CB48[%UF#,!:)HQ":J(#IAD8M@=?Q),2N!%83<5,=$M3WQB?$<0M]J@P* MN,>W'ZR,>>DDU@5$]ZJ\TJ;($:4Q-N*2/DG5[&AKI@B1Y3&.%;7PNW*91C[<=#1=D72&-!ARW77-ML5)4+D MXJ1C@;\ .V!LFEV"%+\F.5M9"F0+#E(%1A#Q/K4IE<@Z(\6)T&\<1$L9B7## MGI9K:7FS4$)ZO2@(@7B4=TNV&!]"LKZEU8H]1!4;GQ)Y=@_H>:C+]U8=$ RQ MOZ\_X@5 $0W0-XM:H0'5J8PG"0-!L*FFA],PJJ0;B(7;(]*X0&Q Z8_%5'C1M3%,3NIO@0[.9V"Z.STPS14&5/DB-(81\%2 M&C8X8%A.^?^X%?C9C_@P*1/GUOV8&J:-)LT!);8D"=(R;C3'B"B,8\&P)O@[ M4A48;\0>F>:DMU>B$CVB/$Z94<6H3V':3=,7F&&+RRK&.E.K#^(B]LWL1UF$ ML)$\9<865/JG._:E*\2^&2I=01TS8V-S*W4^Y=O%TU-4K-]^M$JN>A4_).F\ M)%,CT:U>"R VIZ)&C& AVN!1V2^F$\$\+$G&.P M$'K=BT5-YNS._\X]1Z'L&8M:R5(.U$^N=4&O&!9"KV.FSY50OB9Q #]N0@KB MJ> 4?AYF091DBU3W9-JF:2#%*1=\-W@1M7+,C%IY&&@@VP54BI4#B]B\U0V' MR-Y !!:ANPLSZ![?89BD,S]>YEP"47U<9-P'F2WCJ7D"DCWK7[5#F[5C2ZD>;9R,TYK9.V@=E.=G_T&S5]8W&WX&R?(SD_M6N/^4=#H@])AWR M+IXD^A%9#^]7['%VN5W,YW[Z,GFX#6=Q^! &/(:ZO!+&GYP#$07,2#2B5V\:#2Q^;V MD*JF)=F[T:;\](O1@5U2RSNDL#SM=$=GZ,BJ>>0)?Z02Q@Q0Q&/,%*;;8ZZRP9L\ M_1]2I+IMS"*0/+U:Y!&*YA1.]Y@0.(M0[JEM[8I:WL# M8H^:.0>H6TT+J]M#$)^: PZ555O0/!L+=8IL_%FT(HW( Y4T*)! M/-1,8;H]Y H_S&,233?IVNF0VS+3;\ ;D M#R(J"9 X_[0ANCW ^,/S89F(?6%')EHD25-"L;UP:'CC,!3M-XH^^EF8%3?)-QH= M3W_/V.3A(LO#N9\O1?A2_E%XR_(0@[/0Y"GWYE7>^(^F7-)M3KP1+3;GQ/@8SVC($H M^<7-N=9DIGL##1; M\(Z( XX:*8$).+$B&"=D(5*$"S^-03;\\G?QMJN^ BAJ>D?$]IQ&Q.N $A-N MG%"%B/"O[%M%,FD2PX]!>7G"=.]GVI1W1.R[:J02C5"*=<0X;XK5MK\[GD37 M>? ^B!8Q=GDJ0[T86JTMO]15*ZY#>^<<\ MZK>H&RE73W+HP6)(?^^)9G;OX_;3!X+@NXVF+6T(_[#IU13(@]5T94QCX2Q[U&U5**E5#NSLQN+W"K 19&=.P>[WDB5\J^5], MKN)IMN11OQO24(6:P'1[ZJ_!X*+19NY9]^QLD7)-;3"+RYOP M/I _/X/80VJM65_DV"GA,?*[1D[IXE&G" M5L2=6SYWD4W2FW#VJ!GHV;1-[Y@\WZF2(-4JUP2R MVZ>-"G9N(/GH9]QEMO&B%1*9/)5[\3)]W$N#W5'3QKUC\D2*[96J#7:W#RK* M['KG+/?#J!A1"\#G4D*YO>7:&ZS?,]CK,KGLQYWB-^3L(!% "!#'HWVW+RS=P?=4XU-< X1!ODO7'ITR"&Z'[@J@*8%003DIQ[C);36>[?#;)'7_9;GEG:/ M(PH: 9$1NP@#KAMS&E]<[W$"]K72SD MTO[@>C#D@"0#=U,3@<49M0>2C-H"%#_/_95#V<"R<_^@R;E_\//<3Y^I2LJ. M_KD?ST=%=.[/TKS"(_RKSB'\BGN#IXL@GZ2W+'T. ^R@CQ4%V):=\'?'H;SO M5AWM32CCZ9>6:#)TY$G+@P"(3GYR2E#Z, A4YW?M#"^?%W,V\__AW5\_M)=] M8?-[E@I(TZX+Z(E._@N;PH8_.F>%#%:@8*.GR;!! M6]Y@2'30:\FX,4:W3_&M;7(#6]PA^MO;6N_=O@"[O%$FHVU5!/25^ X=1H&8 ML.U^_PAW4)=VEX'SAI?AR"'#R]#>G"Z%(/4,+T/TB/Z#&EZ&EAWXAGA0G!S$ M#VYX&5$_.2YG1]_P,D)-H\X$7*Q$4<9\\L#-)"XBQ#1'J:@>B-$ROZ[&2,6! M6&6G,6:XADLY8(7E01"VG IPGL0$2_"X'7RQC-9'3_K"^-)'R("13T MW^V@BS(8_@I.'=_9]"XIWIM?WQ521[SI5 =YVN+<4,[ ^GC<-LRH<"IG9KT& M0%3$,3;ZA#93B"I.MTT]%_.G*'EAK')'1CF=HW5@:B0^'YD0ARS6=TK/>(.>/ 20;/0!JS)%W>P5$.7'5ED!&Q M.1?C38=E'!'"NBM6K+,$<*8Y3\9_SN[S33HN)>6*FB ="UZ[UF$0,8GHP$/( M[]_8I>U0+6%DQ5VYZU6?BA5(TXNJ:@ $07QZ;L9S$Y0(W<[9PYIZ3T?$^3D: M6+YJO4<8=,7>U3)SXNF<>VYD3K(NV@=)VW(^K[$OUI4.02/JU#ZN_-_?QY8O_KR0M<"O&K$$K(#1;7/_*46P,RVTW ML03N!NQ7?ZYV4QBV!,(CW@H;,VVL,#ANMUW0+8\%'U_$#2@FG!Z_"J18=KD/ MGZ!Z%X/;7G8Q.JT93%45Q$/L8NV=>Q.5JPO&*C>]UKVV&YBM9?^JV&[NUB7QL67"HQDF^UGO' MW=C2)T0E9$KK@6I;>!=IC,:%:H!QW&]].N?O0O^SW /4SR2R_8^T(LC&%E.< M%M$Z:/IP4M,_D464]*>/-[(&AT<.N2 .B6V<:E'J.2$.<8>^(W-@QTZ(0UN\ MMA6"C)T0AZC=Z8=Q0AS98H86LZ/OA#AR_@8:@1/BT)8DE,I1; SKIQ.BH3'^ MB-CN:\QT1TZ((]30ZXH30O LHF*R0&J ,"P+L,*'/551PTR%&UK@6(+7D'6$'*-J/:R*RRV._?1'QD MBX5)_YQ5Z[W;-GZ! 8&_,11.E^]9W:5^G)4PRNM]L-E@0%6>%9?^^ O6_ >% MV:3#KX#0;?$JU!1!/J5W!KTKE\0S2^^3C'VV7N\J+Z3#W,D?ZYUVHVJ"AD'$ MMD0M=JU=*-JNG!_.*-2@&_49@/ALL1)VK2Q+;%UY2_(D]R-[%..&!M<&JVO))Z4ZAJS&4";O@:%+=^V+TM"*PP$5KQ1O2>U13[O#3[88H#9O_)* M9=+Z3N:K4V%^HSF&?K[L26?7WP-"+(QSV8^2UH30^BKGJ]/*K5%\G;(G/YPN M0XJ@_"1_9*DR^H:D/T"H+287VJE7+21$Z_7-ZZ].ZZ_3Y(FE^M5@@%T6)];\&KT^*-OW1?LW/EBT"*+1>/"'85-3$@ MNJGO_;!"-S\ER?1;&$4295H5 =BV7"O18G^[WPA=KCSD( ^>W?O+#;U$SW[X M0.@$-(V>_4!L/E6+4N$*K.#X&3U;"6W\8(MILD*0@DHQB!\\>O;8%@.(F!TQ MI1@0MZ-G6T=:'-MB<=4?D[7>NQWR*@@CRN#H=IFDSFY'KMT[_/8ZGN?Q]KW/H]_ MWOOYXDM6V$Q._HGUQ-T ^S*R;7#:UO'EMF5\-$I MA?#J#K)=7MLZ(;932)G3)UN BNKV)FJ2KRT-?%UQY87/!3\G+OYI-U T^ **VT-!P@J:! MZQ*UVQ<[E9*H"^*<94$:%G#;J)6D61"KA;$3+91)B=7MJZ4EV"\L?TRFFV>I M)M]BEF:/X=,U2P/.X4QF=]%N P1FX;507#D,@3F>A]+!6\8G%MX#5<\UG4'O M(R/F'LWFJ_L+FQ>:]FTC7]^@. ^S($JR10%$+<-Y&VM,<.A M+5M?_3%9Z[W;%O'U6G/C?_L" -/0C[*O+)\\\-SCZ;/TGHFZ,HC(%J]DC38Q MR;J(7D5,7,M,,4 MXJN(^EJC!X Z>@#%O.'(EM!=,X+7?>_(UKZ316:/!\K5)I M'- :M4%(Q$8(;28-%:&.T>T<^I.'AS!@:W!HB)>T/ B"^,BIS9:8; DJMP.[ MRL=@6:I/,%+#&XZ)#YTM*9;BSHBJ(ASBRK^W( MU@+846P6K2GI,_,S]IA$TZOY4YH\%_N=3*D!DEH@&^);$RW)5V)S.Z#J$;3;%JM8C2_#HU4%31_O\NZ1Z=,@6,P7$4]"=\Z@QT'HE]>TGR)6 MTM*=;W*\C13P*4NY5E%4#\=@21=)N4EEC:9U* MW7JW(U'ZAYZ]C^-CA[R/8UL-8=ORU/,^CO$W-!Q9ASOV/A[:$GA1(VK)?%K.C[WT\1+?*KG@?+_TP_<./%NSC2Y$Q6NO-;ZP.",2N MB\B2$:H X;9_<0UN^0(U\_F%B^F$YPI?I&D8SWABKNSW.+GG(7U<5E?QTR+G MJ<3C((S*/7U5,NJ'OWOZ)-!!; 55:(I"O7H1A]M.3W23I+2>*FJ"<(C/TOW2 M;GCTJ@K%;3]J:]OKH2WY-_5WCK7>N^TCK9J*:A8B"9.26B 4"^TCAZA)70G% M[?P4_&H B(\_ WG.GEF4%!/0\C$G"B 86UPF6AQK@'';X_F)Q2SU(ZZ_ MTSF_+I+SZ^S/3,VSHB8(QY: 5"VFM>"X[N]D$;0Y XQ?_/0OEL//:I[Q2B 3 M"^]%X12KD#B>D:&2!6?RP+-/1!$+N/5ZM9NDM6FO'CKBB3#6KU25>VJC! Y& M[7C#HX%#MNXCXG-Q ]GJV;V/\,<>79D[N[5['UEV>L$?*%. ^,'MWD>V;&?% M[.C;O8^<3_+ ;SOG[#/LV78FKX\O7_Q_):F6)5R_%1":+5X/Y2@VAN6XM1R' MNP'[U9^K;^88M@3"H[97FC)MK# X;K>-V*(]L])^C5<"D1"?@!MQ*%8'%:!4M4% 5EHYSA"H_8U ;EM MGBXVKV5JS?,%]\)=LS1,IM4LT9=)>LO2YS"0)@0R:\@;?K E8DE+%YJ@Z\&B MO4:1B\5%6!-(IL,L$CFRXBQG-(B?OW M\67K+RI36)/V #JQ'46/'&1L-H?LMBT-@:LXF4MJ@5"H3^+-N<0\CPJT;AO> M$'C*X[BTGC>D?I15R9H1V554;MOFRO=E-UL7_B7UB)?4 FE2W['J>L0KT;IM MDD/@*4>\M!X(AOCDK63-B.PJ*K>-:7=ASL?&53P-G\,I[+@58UU8'@1![5_I M>I1+<+IM0]L!]F>8/Q:BX5)Z#)_NDHLX#_,7Y8@W; F$1VQGE7"JJ00Z"-VV MT*VGNO)U%)X\*(FYE4K7ARZJ!X*AMLQU/3]HX'7;<%?#I9P-A.5A3VR+Q1WG M24RP!(_;H:2WCTF:W[%T?L[N+HI[[O)AO%L89$!]9[3K,8R!=#RISC8LK7@8 MK K(@W@7CG&DPV@=1^LD-E9:5W6B&U1503[$05[(9JJ"_875)F MY4VS25KXA7DB1_C7V2+EF5E;TC]8+D>B\ADH(D/T8%6-KD]NL:KN,IC M"-'K*KL=^9KD.I<_Y!6!)(('/)?1U'_Z*6A=/DEOPMFC\N8'7@E 4/LR-80L M'D6PV;G50N>U@%B*<+/(L]^-I&,],*:]4!?$0'VYUZ#,@?@=;1\[F MIS*Z-(=-N''BUB#\Z^#@8' T'HX^'!8D'QR-#@J*M_[D+:%DG_A_-]O@"J_2 M\@"8V&ED3J8&(.+'.XW9._/C@%\IT>=O7<,;'1 [";IBL :IK8O7BM3)16SY M1S]C4^[D8G 0+\D!P#-6/A>U*;*\JW#Z#4ZLDP)X=O']*4Q+3_A57(:K2ST* MG7^-OWA^."0^A#6?\/N42%O7Z(#8PMWC9J_ UI7;N=SM7<1;2F"#/7/P6@R:HX.Q)6.KA4%S M=$ =JJTA9&.#9H'JIT%S8V$:'=AK&"G(,C5H%H!^;(/FZ,"6)'YB=K0-F@60 MGP9-T79B=$!LM&XV;G50N6W0;'N0J^S[OBX4:4PZ_Q808+>5K5"0?D[0B# L ML+':H9B%W7)M7% ]U=?#U[S1P&X#8H_*B8JC(P-R#IMLJ@=[V\KF,DD?6/'@ MZ3Y,CX*O 1-V&YUZ5$Q4'!U=?")53%D:EN*/:^,K;K!LWAC(T6Z3EDRM&J+M MZ):4R],9\09P0)R,P:H-X #-X6!\OTMH=G5(+9<#E1_P>E?+G6]YP^') ?55 M!3K-Q.71E5- $$!@@TN *.]7;XZ!P:$E%J@VCH$!^25>M9#-'0,#_&ED5RQ/ MW3H&!A8;& >2U(E20#^X8V!@KV-@@*Z>&!"W'0.WL!]DV>GUJJ\%/&7B:DDM M;S2VX[BX0Q0R4E50'/<#%/ ^-N)76 N$8L?1S(A?"12K4F5E:5[A%OY5YQ5^ MY=WP_3JRHF[]'>1BHQ\%73T%G;"ZC+_Q&A,'&6&4:1#:!T'528HXP!K9 #BA4$F-GJX MT &H0D*6PLF8*G1HR8J#.A+9:%2"UZ&IBL'QG$S=9U >#>TXY!FNA$I(CN=D MZB=/\FA,;(-3TF;$=A65X[F:;A?W&?M[ > NGN$_.HD3Q35 C': N8XZ3[DF7V*V9:@0AETQ0?63EWXTM/@NG(;+&P>%T.U* MDO)NLL^/AK;D^<*)$C,LP8,$-+B2C!PPS9-8SS>Z4]8;'1*[!23$(+$,8@P( MBZZ8N0R=W&*7\"&QA=F82QP&0JY9#<*N>-1L0;HAT:I&Q5>XWPY8S!27S%@U_BX(?VX)%-8CPXJ4$K,#T1 M.PX$)"('5%-4B"ZX8G]2X[W[EG2@"^M60&K$-N@.=:&&"M$%9RQ5:KSPN2YF MADH[(#EB\W27^E#'A6B$*\:L<_YZ*(NG*EOE5CD0H5,!6!(0R+4-5RQ6:T3J MH,?MDH">^(0D($/!6K7G"&^NV*A6F,Y9$(&TILH95UP!IB!B)X&0'#F/(@@( MG:[8J,H50AUVLU4.9.5DL(T !$*?*_8GY8WX#+L2OY%%/+V._%@K_KR/S\$P M(O8G"=3":)/5 7Q$#5TQCUV&,>PQ0S_2OIR"U #I.QD%)(6#D.N*":T(EH!N M9J"[MRQ]#@,XD4P>!) SKN&9^$_*N:7+SX#86^5@/B7VDW7/HUA?!+ 1PITQ^*T".VX#%OMIF.B&(57+@\C<#C_:!8/0 MZHSM;@GH]SA[8D'X$+*I>J>)U0%%IXXFQ(E"F)5C0=AUQ0ZWVLXJQFJU& C+ MR:0XNQB0W!JN&.&T#W[U,\N(>(W=94+.6+7?"&?]&^"T+ZU^3>+_N?"C8J:H M)OE$=T(FU;W1$;%S6T3*-GWF>!!273'#W84Y#U&_BJ?;:<_E9]#Y193+SK'R"C"_$;LL&S$CF]#%$!$N73&3?6%^MDB+@\%5 M_+30N$O3GYP,]Q7"0EAV16;E B?%,-+O640 X1T0=7#%EUL#=A]M=ERMA5 MG#/@+;_QKEC">GNC;NQDS)H.*B1WJ2OVL\HU MQ&L_G:2%:7CZAQ\MV#5+BU &>WJVK SMO$Z4(U%A']=>(@2N!(1)WVCI_S] M99*6GD F=V>9- 2RLS%40DLUFB!%M,05"U\56[%)TI@@T#H@$>+XAA;1CH\.UN4+L8$.X[]]X:)R)]D_& ;#IZ3-+_1F[8?PL!3@^AP^BM<"\ M$1"(C:9#*=E-42*T]V]--*8=CKVPT]#CRE7TK_M3XY+9N &1EHR&G M_8FMAA#1!E?,> C48J)JH0S;]4%2SAIV# BK]^X8M_;3DVUN@;(+=< .>"D MS623O4YUD).-=^FT%$$?'Z('KICXQ$"SE>5B=2_46!5V6@!I.6O4,X*(*(13 MUKQ[]4O$]\A+Q#RO YN6CQ!/'LI55+5K[/ASP(/;-L1>Y('HI2OF1_ZPTED2 MPWDY P23-)R%@(/_]G2>+.)<9FI4U@4).6M%T@2'T.^,"7'CU3@<5?]T;';EOW]B$>1(E=,?AN[RG*GP#I MYA)WU=6MO_-2-02R<]:,V 0IHB4.&I=E.E M!KA?@W%PB0/ASQ5S\,:0L67? M*/XC&].2:B 79VU^:ES($]NNV'R[L2U<1__0U6::2%3@/>Z,19^ZP)0D0;7/$3+"V$X7W$:O:&BIWP]Z>5 M*9$;%:6>3N/60(K.&EL;PT64IG^[O'94O30<=15COKHU)%IYVC0'0G+./-L> M+Z(4_9OAVRI%<3;H3"?$K8&(G+/HMH:+:(0KAOVV%L:O?-;<:Q@?\D5@XX+5V:/0"V?EC# MK9&($(5VREO19-VZ^/X4ID7AZ$@*C=C^(=J S1O3G! MT&\"(\Z&E_+?)&RE053^_*< M7G,\J>#AT-FUN!5D1'LL2H:R.JUM+ LP66L899!Z)7+G)A,S; BK%N4ZJ2.X M7=S_BP7Y7<*]5!??,U9N[7]-_+4H-WRQKDKV]M%XI'&VN\)S&TS(;9^5H6\\! M+]$#DV9*T3FW\+>"BFB),_;2C4>#/__&0WOC3&IU$E8 <9P,QLXM_IJ@$(Y; M&2??5X4$G?RK+CC^NRW),7[LF&X.XSNRFRW\= HU'YD?Y8^_!,F\_"Q/N1 6 MLQQ7[;,DSD&A61R$+#MGN1]&V1VTO0!H>[_"EP51PL<5[\!'^-)?I_=9GOJ! M;$:2U/+&!P<48VCY\&SQ]()T[%0+0F>)0]B4DL1&RRX,\1!Q9:U<(UI.(<5\ MH/O(=;T."(0X#$U$D()*,0@QJZZL;55,RK? =@N#"(C#=Q3LB"G%@"#/63O" MY5H4Z_5<9VAN%O_Q 7$<8(,Q6>L]\@J3(P1^3K)LL_5X.??G_HQEM\D"]F@J M3Z>R+@B(V!R!D2:F6!,0DK#7D6WG[>(^8W\OH.&+9[[WI-UKUGNCL='$JGCC MT9!@!MSNC7*O*2@.':>>!:4B1>9#%(GCF\['),VY/XDGW]%XE598'@1!O4E! MZ<$B-% 8;F\W=X I]YQ(#6],;4F1<*1):A6)XSO/FGYK#%1Q#9 ?]2;%=*C* M@+B]'15 4P]7K X(A-@7(F5*F]PJFA[VGG3T*A__%9:'V8LXC$7!D1:Q52Q( MRC='2"TOUJOGWZUR("EBAY3IK"OH/G*CSQ'>E#&Y&1:4NQ%%/.6.F:_^7&=7 MU?WGO/$A<5H"@59@6[&^X".A+XYHX5V81VSR:;$A1\I9A%A>1 \]=;< M<#:1P$#8/]ZPJ" D>PR?[I*+. _S%^6$8=@2# 9BOYV$4TTET$&( M6%?Z#WS2CG0[@\XOHMR'^4L\EF7%05Z6[>ZPH:Q&@5#5OR6L 57H<)17 )TD M\JJJQ:]'5Q4'0MA^3%U9/7IXRL)RWH4?ZM,M_,K[S&9^5$X0R$ 3E((3!_&6 M27=\H9U'6-J/Y2(=R.F.U(E&(1B5VQ/"#[E-E1:#Y2?V,^CI,V([2HJA&]7 MS%+'1%3/5-BPM4Q-6!?2:V-6#<:3#:!T' MPJLKAI^.@SO'=H50J)UX!Y2>^[D](@YQ8 @ 12NW%5#]@K9 MQY?J7YKME06-@(0=BYTQQ8;H@RL14E501MOG]9@@=OV9\J5FO8H,89L?3( I- @4AUQ5K4043/W=- M'DQ,1NK*, L\'))Z$,XUP2&D.^*Z:@V%#[KW&U"JH T'8MSDB-!F'7%F"3- MY%_^_C))EPF*Y98(DX:*-#4#NT)4:L1B5HI&,!$M:66:$EZ1>L][S7.9_OO_ M!U!+ 0(4 Q0 ( !V)"DWRH]V='LL /'>#@ : " 0 M !C:6LP,# Q-C0R,S M " &UL4$L! A0#% @ '8D*31P5 M.*"Z/P [94# !X ( !\A0! &-I:S P,#$V-#(S-S4M,C Q M.# V,S!?;&%B+GAM;%!+ 0(4 Q0 ( !V)"DU\UNGKB3D /'C P > M " >A4 0!C:6LP,# Q-C0R,S